
<html lang="en"     class="pb-page"  data-request-id="97718872-1b15-4b39-aa61-d238b45b016b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm500415t;issue:issue:10.1021/jmcmar.2014.57.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Synthetic Lethality Anticancer Therapeutics" /></meta><meta name="dc.Creator" content="Bingliang  Fang" /></meta><meta name="dc.Description" content="The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new gen..." /></meta><meta name="Description" content="The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new gen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 13, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500415t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500415t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500415t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500415t" /></link>
        
    
    

<title>Development of Synthetic Lethality Anticancer Therapeutics | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500415t" /></meta><meta property="og:title" content="Development of Synthetic Lethality Anticancer Therapeutics" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0010.jpeg" /></meta><meta property="og:description" content="The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new genotype-selective anticancer therapeutics. These efforts include screening for novel anticancer agents, identifying novel therapeutic targets, characterizing mechanisms of resistance to targeted therapy, and improving efficacies through the rational design of combination therapy. This review discusses recent developments in synthetic lethality anticancer therapeutics, including poly ADP-ribose polymerase inhibitors for BRCA1- and BRCA2-mutant cancers, checkpoint inhibitors for p53 mutant cancers, and small molecule agents targeting RAS gene mutant cancers. Because cancers are caused by mutations in multiple genes and abnormalities in multiple signaling pathways, synthetic lethality for a specific tumor suppressor gene or oncogene is likely cell context-dependent. Delineation of the mechanisms underlying synthetic lethality and identification of treatment response biomarkers will be critical for the success of synthetic lethality anticancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500415t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500415t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500415t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500415t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500415t&amp;href=/doi/10.1021/jm500415t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7859-7873</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500364u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm5006463" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Synthetic Lethality Anticancer Therapeutics</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bingliang++Fang">Bingliang Fang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Thoracic and Cardiovascular Surgery, Unit 1489, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 713-563-9147. Fax: 713-794-4901. E-mail: <a href="/cdn-cgi/l/email-protection#660400070801260b02070802031415090848091401"><span class="__cf_email__" data-cfemail="e68480878881a68b828788828394958988c8899481">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500415t&amp;href=/doi/10.1021%2Fjm500415t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7859–7873</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 3, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 March 2014</li><li><span class="item_label"><b>Published</b> online</span>13 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 October 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500415t" title="DOI URL">https://doi.org/10.1021/jm500415t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500415t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5064</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500415t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Synthetic Lethality Anticancer Therapeutics&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bingliang&quot;,&quot;last_name&quot;:&quot;Fang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;7859-7873&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500415t&quot;},&quot;abstract&quot;:&quot;The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new genotype-selective anticancer therapeutics. These efforts include screening for novel anticancer agents, identifying novel therapeutic targets, characterizing mechanisms of resistance to targeted therapy, and improving efficacies through the rational design of combination therapy. This review discusses recent developments in synthetic lethality anticancer therapeutics, including poly ADP-ribose polymerase inhibitors for BRCA1- and BRCA2-mutant cancers, checkpoint inhibitors for p53 mutant cancers, and small molecule agents targeting RAS gene mutant cancers. Because cancers are caused by mutations in multiple genes and abnormalities in multiple signaling pathways, synthetic lethality for a specific tumor suppressor gene or oncogene is likely cell context-dependent. Delineation of the mechanisms underlying synthetic leth&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500415t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500415t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500415t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500415t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500415t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500415t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500415t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500415t&amp;href=/doi/10.1021/jm500415t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500415t" /></input><a href="/doi/pdf/10.1021/jm500415t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500415t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500415t%26sid%3Dliteratum%253Aachs%26pmid%3D24893124%26genre%3Darticle%26aulast%3DFang%26date%3D2014%26atitle%3DDevelopment%2Bof%2BSynthetic%2BLethality%2BAnticancer%2BTherapeutics%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D19%26spage%3D7859%26epage%3D7873%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jmcmar.2014.57.issue-19/20141009/jmcmar.2014.57.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0010.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new genotype-selective anticancer therapeutics. These efforts include screening for novel anticancer agents, identifying novel therapeutic targets, characterizing mechanisms of resistance to targeted therapy, and improving efficacies through the rational design of combination therapy. This review discusses recent developments in synthetic lethality anticancer therapeutics, including poly ADP-ribose polymerase inhibitors for <i>BRCA1</i>- and <i>BRCA2-</i>mutant cancers, checkpoint inhibitors for p53 mutant cancers, and small molecule agents targeting <i>RAS</i> gene mutant cancers. Because cancers are caused by mutations in multiple genes and abnormalities in multiple signaling pathways, synthetic lethality for a specific tumor suppressor gene or oncogene is likely cell context-dependent. Delineation of the mechanisms underlying synthetic lethality and identification of treatment response biomarkers will be critical for the success of synthetic lethality anticancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Genetic and epigenetic alterations that lead to the functional deregulations of several signaling and metabolic pathways are known to be the major driving forces behind carcinogenesis and cancer progression.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Those functional deregulations in cancer cells have been exploited for pathway-targeted anticancer therapy. Small molecules and antibodies that directly inhibit critical nodes in oncogenic signaling networks, most notably kinases or enzymes, have been used to treat various cancers in humans,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> resulting in substantial improvement in clinical symptoms and outcomes in a subset of cancer patients. However, many critical nodes in oncogenic signaling networks may not be targeted directly by small molecules or antibodies. For example, functional losses in tumor suppressor genes caused by gene mutations or deletions may not be restored through small molecules. Moreover, the functions of some intracellular oncogene products, such as RAS and c-MYC, have been found to be difficult to modulate directly through small molecules.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Nevertheless, functional alterations in nondruggable targets may lead to changes in signal transduction and metabolism that render the mutant cells more susceptible to functional changes in other genes or to pharmaceutical interventions aimed at other targets, providing an opportunity to selectively eliminate those mutant cells through synthetic lethality. Synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>) offers the potential to eliminate malignant cells by indirectly targeting cancer-driving molecules that are difficult to target directly with small molecules or antibodies.</div><div class="NLM_p">The concept of synthetic lethality is illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A. The two genes <i>A</i> and <i>B</i> are synthetic lethal if the mutations in any one of them will not change the viability of a cell or an organism, but simultaneous mutations in both <i>A</i> and <i>B</i> genes will result in a lethal phenotype. This concept has has been used in genetic studies to determine functional interactions and compensation among genes for decades<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and has recently been exploited for the development of new genotype-selective anticancer agents,<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> identification of novel therapeutic targets for cancer treatment,<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> and characterization of genes associated with treatment response.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> For example, if gene <i>A</i> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B is mutated, small interfering RNA (siRNA) or small molecules targeting the genes <i>X</i>, <i>Y</i>, or <i>Z</i> would likely induce synthetic lethality in cells with an abberant <i>A</i> but not in the cells with a wild-type <i>A</i>. Therefore, using paired isogenic cell lines with and without abberant <i>A</i>, one can screen for siRNA or compounds that specifically kill the cells with an abberant <i>A</i>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concept and models of synthetic lethal interactions. (A) Synthetic lethality between genes <i>A</i> and <i>B</i>. <i>A</i><sup><i>+</i></sup> and <i>B</i><sup><i>+</i></sup> represent wild types, while <i>A</i><sup><i>–</i></sup> and <i>B</i><sup><i>–</i></sup> represent mutants. Synthetic lethality refers to a lethal phenotype observed only in the combination group of <i>A</i><sup><i>–</i></sup> and <i>B</i><sup><i>–</i></sup>. (B) An essential survival function is regulated by two pathways conducted by A, B, C and X, Y, X, respectively. A functional change in either of these pathways is insufficient to induce viability changes. However, the simultaneous presence of mutations or dysfunctions in both pathways, such as a mutation in A and any mutation in X, Y, or Z, induces lethal phenotype. Thus, A is synthetic lethal with X, Y, and Z, and vice versa. (C) An essential survival function is regulated by pathway A alone, in which A2 is a multiprotein complex composed of X, Y, and Z; and A3 has homologues of α, β and γ. Synthetic lethality may exist among X, Y, and Z and among A3α, β, and γ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several models of interactions among genes and/or proteins have been proposed to account for synthetic lethality,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> including the components of parallel pathways that together regulate an essential biological function, the presence of homologous genes or protein isomers derived from the same ancestral gene (paralogs), subunits of an essential multiprotein complex, and components of a single linear essential pathway (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B,C). Studies in yeast revealed that synthetic lethal interactions occurred significantly more frequently among genes with the same mutant phenotype, among genes encoding proteins with the same subcellular localization, and among genes involved in similar biological processes, such as those in parallel or compensating pathways or bridging bioprocesses.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For a particular tumor suppressor gene or oncogene, synthetic lethality can be identified by using isogenic cell lines to screen an siRNA library for synthetic lethal genes or a chemical library for synthetic lethal compounds. This review discusses recent advances in the development of synthetic lethality based anticancer therapeutics. In particular, it emphasizes the development of anticancer agents that target DNA damage response and oncogene Ras pathways through a synthetic lethality approach.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">DNA Damage Response Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The <i>TP53</i> gene, which encodes tumor suppressor protein p53, a master transcriptional regulator of cellular response to DNA damage, is commonly inactivated in about 50% of human cancers by either gene mutations or degradation through HDM2.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Moreover, pathways involved in DNA damage response are often constitutively activated in a majority of tumors, even in early stages of tumor development and in tumor specimens from untreated patients, presumably because of oncogene-mediated deregulation of DNA replication.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Different mechanisms are used in cells in response to different types of DNA damage. Single-strand breaks (SSBs) activate poly ADP-ribose polymerase (PARP) and are repaired mainly by PARP-mediated base-excision repair, while double-strand breaks (DSBs) are repaired by the mechanisms of homologous recombination (HR) and nonhomologous end joining (NHEJ).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> PARP can be activated by binding to SSBs,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> leading to SSB repair through base excision mechanisms (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). However, if SSBs are not repaired, they will cause a blockage or collapse of DNA replication forks during DNA synthesis and the formation of DSBs. DSBs can also be incurred by endogenous and exogenous DNA-damaging agents such as ionizing radiation.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. DNA damage repair pathways. Single-strand break (SSB), double-strand break (DSB), and single strand DNA derived from DNA damage or stalled replication fork are recognized by various sensor molecules (marked yellow), leading to activation of signal transducers (marked green), which in turn activate different DNA repair pathways and checkpoint pathways, thereby preventing transmission of the genetic lesion to the daughter cells. Those parallel pathways provide opportunities of eliminating some cancer cells with mutations in those pathways through synthetic lethality.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">DSBs are detected by the MRE11/RAD50/NBS1 complex or by Ku70/Ku80 heterodimers. The single-strand DNA present at stalled replication forks or generated by processing of DSBs is recognized by replication protein A (RPA).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The assembly of those sensor molecules in the damaged DNA sites leads to the recruitment and activation of signal transducers, including three phosphatidylinositol 3-kinase related kinases (PIKKs) (ataxia telangiectasia mutated (ATM), ATM- and Rad3-related (ATR), and DNA-dependent protein kinase (DNA-PK)) that in turn activate downstream effectors, resulting in the activation of checkpoint and DNA repair pathways.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> The phosphorylation of H2AX by ATM, ATR, or DNA-PK at S139 (known as γH2AX) triggers the recruitment of DNA repair proteins and leads to the assembly of DNA repair complexes at the damaged DNA sites.<a onclick="showRef(event, 'ref25 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref27">(25, 27)</a> Consequently, the cell cycle progression is arrested to permit the repair of the damaged DNA, thereby preventing transmission of the genetic lesion to the daughter cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_p last">Both BRCA1 and BRCA2 are required for the assembly of protein complexes for HR, including recruitment of recombinase RAD51 to the DNA DSBs.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> DSB repair through HR is mostly error free and can occur only in the late S and G2 phases of the cell cycle because it requires an intact sister chromatid as a template for repair. In contrast, NHEJ involves Ku70/80, DNA-PK, XRCC4, and DNA ligase IV, often results in gene deletion or translocation, and can occur in all phases of the cell cycle.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Most NHEJ occurs independent of the MRE11/RAD50/NBS1 complex and ATM activation because the Ku70/Ku80 heterodimer can directly bind to the ends of double-strand DNA, recruit DNA-PK to the site, and initiate an NHEJ process.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In the absence of Ku proteins, an alternative NHEJ initiates with the involvement of PARP1, XRCC1, and ligase I/III<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">PARP and PARP Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PARP is a group of ADP-ribose transferase enzymes that catalyze polyADP-ribosylation of proteins by transferring ADP-ribose groups from the donor substrate nicotinamide adenine dinucleotide (NAD<sup>+</sup>) to glutamic acid, aspartic acid, and lysine residues in the acceptor proteins, thereby regulating the functions of those proteins. Seventeen PARP family members have been identified in humans.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> DNA-dependent PARP subfamily members PARPs 1–3 have been reported to regulate various DNA damage response processes. The recognition and binding to damaged DNA structures by PARP1 and PARP2, either through their own DNA binding domain or through interaction with damaged DNA-binding protein 2,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> lead to the activation of their enzymatic activity and the polymerization of ADP-ribose units of a number of proteins, including PARP1/2, histones, topoisomerase, and DNA-PK.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> The polyADP-ribose on those proteins provides a docking site for recruiting cell cycle checkpoint proteins and DNA repair proteins (e.g., p53, XRCC1, DNA-PK, Ku70, and ATM) to the sites of DNA lesions,<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35-38)</a> thereby regulating various processes of DNA repair, including base-excision repair, HR, and NHEJ. PARP1 regulates base-excision repair by interaction with XRCC1,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> DNA polymerase β,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and the base-excision repair enzymes apurinic/apyrimidinic endonuclease 1 <a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and ALC1.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> PARP1 also interacts with DNA-PK and Ku and is required for an alternative and PARP-dependent NHEJ pathway.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Moreover, PARP1 participates in HR by interacting with MRE11 and ATM.<a onclick="showRef(event, 'ref36 ref45'); return false;" href="javascript:void(0);" class="ref ref36 ref45">(36, 45)</a> Although <i>PARP1</i><sup><i>–/–</i></sup> embryonic stem cells and embryonic fibroblasts exhibit normal repair of DNA DSBs and RAD51 foci formation,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><i>PARP1</i><sup><i>–/–</i></sup> mice have increased deletion mutations and insertions and/or rearrangements in vivo after treatment with the alkylating agent <i>N</i>-nitrosobis(2-hydroxypropyl)amine.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Interestingly, <i>PARP1</i><sup><i>–/–</i></sup> mice are viable and fertile and do not develop spontaneous tumors, possibly because of functional compensation from PARP2, as PARP1 and PARP2 double knockout is embryonically lethal.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Nevertheless, <i>PARP1</i><sup><i>–/–</i></sup> mice or cells exhibit defective DNA SSB repair and increased HR, sister chromatid exchange, and chromosome instability.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> PARP1, but not PARP2, is required for the survival of cells with defects in the HR pathway because knockdown of both <i>PARP1</i> and <i>BRCA2</i> significantly reduces the survival of human cells, whereas knockdown of both <i>PARP2</i> and <i>BRCA2</i> has no effect on cell survival.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The mechanisms underlying the synthetic lethality of <i>PARP1</i> and <i>BRCA</i> genes are still not clear, although evidence suggests that it might be caused by the deregulation of NHEJ,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> increased spontaneous DNA breaks that need to be repaired by HR,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> or the suppression of BRCA and RAD51 expression by E2F4/p130-mediated transcriptional repression<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> caused by PARP1 inhibition.</div><div class="NLM_p">The synthetic lethality of <i>PARP1</i> and <i>BRCR1/2</i> genes reported in 2005 by Farmer et al.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and Bryant et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> sparked much interest in the concept of using PARP inhibitors to selectively eliminate <i>BRCA1</i> or <i>BRCA2</i> mutant tumor cells. Germ line mutations in <i>BRCA</i> genes predispose carriers to breast, ovarian, and other cancers in an autosomal dominant manner,<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> with 50–80% penetrance for breast cancer and 30–50% for ovarian cancer.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Early studies revealed that PARP1 activation facilitates DNA repair and maintenance of genomic integrity and is required for recovery from DNA damage in mice and in cells.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, excessive PARP1 activation leads to cell death because of overconsumption and depletion of NAD<sup>+</sup> and ATP in the cells, whereas genetic disruption or pharmaceutical inhibition of PARP protects animals from ischemia-induced brain and heart damage.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> In addition, PARP1 was found to regulate the transcriptional activity of NFκB and other inflammation-related transcription factors, promoting the expression of inflammation mediators.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Thus, PARP inhibitors have been investigated for the therapeutic benefits of protecting tissue from ischemia-induced injury, suppressing inflammation, and sensitizing cancer cells to DNA damage-based anticancer therapy.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> Several excellent review articles have discussed the development of PARP inhibitors.<a onclick="showRef(event, 'ref32 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref32 ref61 ref62 ref63">(32, 61-63)</a> Briefly, PARP inhibitors used in clinical investigation mostly compete with the ADP-ribose donor substrate NAD<sup>+</sup> and inhibit both PARP1 and PARP2. A binding assay with catalytic domains from 13 of the 17 human PARP family members revealed that many of the best known PARP inhibitors, including those used in clinical studies such as olaparib (<b>1</b>), veliparib (<b>2</b>), and rucaparib (<b>3</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), bind to several PARP family members, suggesting nonspecific activity of those inhibitors.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of PARP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PARP inhibitors are currently under intensive investigations as therapeutic agents for the treatment of cancers with deficiencies in BRCA or other DNA repair proteins. An initial preclinical study by Farmer et al. revealed that the <i>BRCA1/2</i>-defective cells were 57- to 133-fold more sensitive to PARP inhibitors KU0058684 (<b>4</b>) and KU0058948 (<b>5</b>) than wild-type cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> At the same time, Bryant et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> showed that HR-defective cells with a deficiency in XRCC2, XRCC3, or BRCA2 (XRCC11) were killed by PARP inhibitors such as NU1025 (<b>6</b>) and AG14361 (<b>7</b>) at concentrations that were nontoxic to normal cells.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Recent studies revealed that defects in other DNA repair proteins, such as ATM,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> MRE11,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> ERCC1,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and p53<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> or PTEN,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> also induce synthetic lethality with the PARP inhibitors. A high-throughput RNA interference screen for 230 known and putative DNA repair proteins revealed additional genes that have synthetic lethality with compound <b>5</b>, including ATR, PCNA, RAD51, and XRCC1.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> A similar study with a novel potent PARP1/2 inhibitor (BMN 673) (<b>8</b>) and an siRNA library targeting 960 genes, including kinases and kinase-related genes, tumor suppressors, and DNA repair proteins, showed synthetic lethality of <b>8</b> with HR and DSB repair genes.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Moreover, PARP1 inhibitors induced synthetic lethality in cancer cells with positive E26 transformation-specific gene fusions<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and with EGFR inhibitors.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Because of the critical roles of PARP1 in the DNA repair process, PARP inhibitors have also been intensively tested for sensitizing radiotherapy and chemotherapy that induces DNA damage.</div><div class="NLM_p">Compounds <b>1</b> and <b>2</b> are the most extensively investigated inhibitors in clinical trials for the treatment of BRCA1/2-mutated cancers. Other PARP inhibitors under clinical trials are niraparib (MK-4827) (<b>9</b>), <b>3</b>, and <b>8</b>. A phase I study of the combination therapy of rucaparib with temzolomide in patients with advanced solid tumors showed that <b>3</b> at a dose of 12 mg/m<sup>2</sup> inhibited 74–97% of PARP activity in peripheral blood mononuclear cells. A dose of 12 mg/m<sup>2</sup><b>3</b> in combination with 200 mg/m<sup>2</sup> temozolomide was tolerated, with a dose-limiting toxicity of myelosuppression.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> A phase II study of intravenous administration of 12 mg/m<sup>2</sup><b>3</b> with temozolomide in patients with metastatic melanoma showed that 150–200 mg m<sup>–2</sup> day<sup>–1</sup> temozolomide can be safely given in the combination therapy, with a response rate of about 17% and an increase in progression-free survival over historical controls in metastatic melanoma patients.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Phase I clinical trials with compound <b>1</b> in recurrent/advanced cancer patients with or without <i>BRCA1/2</i> mutations<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> revealed that the maximum tolerated dose for <b>1</b> was 400 mg twice daily, with dose-limiting toxicities of mood alteration, fatigue, and thrombocytopenia. Clinical benefit was observed in 30–60% of <i>BRCA1/2</i> mutant breast or ovarian cancer patients.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> The pharmacokinetics study revealed a maximum concentration of 2.6–4.8 μg/mL at doses of 400 mg twice daily. The mean maximal PARP inhibitions in peripheral blood mononuclear cells and tumor tissues were 50% and 70%, respectively.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Mean terminal half-life was about 7–11 h.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Subsequently, <b>1</b> has been evaluated in combination therapy with various conventional anticancer agents, including cisplatin and gemcitabine, topotecan, bevacizumab, dacarbazine, and the VEGFR inhibitor cediranib.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81, 82)</a> The overall response rates were variable, from 0% to 44%.</div><div class="NLM_p last">A phase II comparison study of <b>1</b> versus liposomal doxorubicin treatment for <i>BRCA1/2</i> mutant ovarian cancer patients who had recurrent tumors after platinum therapy revealed overall response rates of 25–31%, not significantly different from that of doxorubicin alone (18%).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Phase I trials of a combination of <b>2</b> (half-life of about 5 h) with cyclophosphamide or topotecan<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> in refractory solid tumors and lymphomas showed promising activity in a subset of patients with <i>BRCA</i> mutations. The maximum tolerated dose was defined as 60 mg of <b>2</b> with 50 mg of cyclophosphamide once daily or 0.6 mg m<sup>–2</sup> day<sup>–1</sup> topotecan administered intravenously on days 1–5 and 10 mg of <b>2</b> twice daily on days 1–5 in 21-day cycles. PARP activity was significantly inhibited in peripheral blood mononuclear cells (by 50%) and in tumor biopsies (by 80%). A phase II trial of the combination compared with single-agent cyclophosphamide is ongoing for cases of <i>BRCA</i> mutant ovarian cancer, triple-negative breast cancer, and low-grade lymphoma. The dose-limiting toxicity was myelosuppression. A phase 1 dose-escalation trial of <b>9</b> in <i>BRCA</i> mutation carriers and patients with sporadic cancer revealed a maximum tolerated dose of 300 mg/day. Dose-limiting toxicities were fatigue, pneumonitis, and thrombocytopenia. The maximum concentration at 300 mg/day was about 2000–4000 nM. The mean terminal elimination half-life was 36.4 h. Pharmacodynamic analyses confirmed that PARP inhibition exceeded 50% at doses greater than 80 mg/day, and antitumor activity was documented at doses beyond 60 mg/day. Clinical benefit was observed in 40–50% of <i>BRCA1/2</i> mutation carriers with ovarian or breast cancer. Antitumor activity was also reported in sporadic high-grade serous ovarian cancer, non-small-cell lung cancer, and prostate cancer.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> A phase I study of <b>8</b> in solid tumors showed that RECIST and/or CA-125 response occurred at doses of >100 μg/day in 11/17 <i>BRCA</i> carrier ovarian/peritoneal cancer patients.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> In summary, the results from these clinical studies revealed that myelosuppression is the major dose-limiting toxicity of various PARP inhibitors and that clinical benefit is variable in the single-agent and combination therapies, with significant benefit observed in <i>BRCA</i> mutant cancers, consistent with the findings in the preclinical studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Checkpoint Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ATM/checkpoint kinase 2 (CHK2) and ATR/CHK1 signaling pathways regulate many common downstream proteins, including p53, CDC25 phosphatases, and Wee1 kinase, thereby regulating G1, S, and G2/M checkpoints (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Because activation of oncogenes can cause replication stress and DNA damage, inhibiting checkpoint pathways may trigger synthetic lethality in cancer cells by enhancing the DNA damage-induced apoptosis or senescence, which may be modulated by p53 status. Phosphorylation of p53 on S15 by ATM/ATR and/or on S20 by CHK1/CHK2 stabilizes p53 protein<a onclick="showRef(event, 'ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89">(87-89)</a> and up-regulates the expression of p21 (also known as CIP1/WAF1), an inhibitor of cyclin E/cyclin-dependent kinase 2 (CDK2) that controls G1/S progression. In contrast, phosphorylation of CDC25 phosphatases by CHK1/CHK2 promotes degradation of CDC25, which is required for dephosphorylation and activation of cyclin B/CDK1 kinases that control the transition of G2/M phases<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Evidence has shown that ATR/CHK1 is critical in regulating the activity of CDC25 and S/G2 checkpoints.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91, 92)</a> Although p53 also regulates the G2 checkpoint,<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> G2 arrest is normally induced in p53-deficient cancers, suggesting that some p53-independent mechanisms are sufficient for G2 checkpoint functioning. Recent studies showed that p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38 mitogen-activated protein (MAP) kinase/MAP kinase-activated protein kinase 2 (MK2) pathway for survival after DNA damage.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Evidence has shown that p53-mediated apoptosis or cell cycle arrest is modulated by ATM and CHK2 activities.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In cells and tumors that lacked a functional p53 pathway, inactivation of ATM or its downstream molecule CHK2 was sufficient to globally sensitize the cells to genotoxic chemotherapy with cisplatin or doxorubicin.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In contrast, in p53 wild-type cells, the inhibition of ATM or CHK2 resulted in a substantial survival benefit, suggesting that a combination of cisplatin and doxorubicin with inhibitors of ATM and CHK2 could benefit patients with p53 mutant tumors. Genome-wide small hairpin RNA screening also revealed that inhibiting ATM or MET induced synthetic lethality with a p53 stabilizing/activating compound nutlin-3 (<b>10</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) and converted the cellular response from cell cycle arrest to apoptosis in various cancer cell types without affecting the expression of key p53 target genes.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Although ATM inhibitors such as CP466722 (<b>11</b>) and KU59403 (<b>12</b>) do not have single-agent activity in cancer cell lines, they could sensitize cancer cells to ionizing radiation and/or genotoxic chemotherapeutics.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Checkpoint pathways and cell cycle regulations. DNA damage caused by physical, chemical, and biological factors, such as oncogene activation, activates phosphatidylinositol 3-kinase related kinases ATM and ATR, leading to the activation of CHK2, CHK1, and p38/MK2, which further regulate activity and stability of cell cycle regulators, including p53 and CDC25. p53/p21 is the major regulator of G1/S checkpoint. The loss of p53 function in cancer cells makes the cells addicting to the S and/or G2/M checkpoints for DNA repaire and survival. Inhibiting S and/or G2/M checkpoint regulators may induce synthetic lethality in p53 mutant cells when DNA is damaged. Arrow indicates activation, and the line terminating with a black circle indicates suppression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of nutlin-3 and inhibitors of ATM/ATR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar results have shown that inhibiting ATR and CHK1 exacerbates levels of oncogene-induced replicative stress, promoting the cell killing of oncogene-overexpressing cells and sensitizing tumor cells to DNA-damaging therapy. Inhibiting ATR by a dominant negative construct selectively sensitizes G1 checkpoint-deficient cells to DNA damage-induced lethal premature chromatin condensation.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Knockdown of ATR expression selectively enhanced cisplatin sensitivity in human colorectal cancer cells with inactivated p53, whereas the restoration of p53 in ATR-deficient cells increased cell survival after cisplatin treatment.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Reduced ATR expression prevented the development of Myc-induced lymphomas or pancreatic tumors in mice by enhancing Myc-induced replicative stress and apoptosis, which is more pronounced in p53-deficient cells.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Transgenic mice with diminished ATR function in the skin have increased apoptosis after ultraviolet exposure and reduced ultraviolet-induced skin carcinogenesis, suggesting that the inhibition of the replication checkpoint function may have therapeutic and/or preventive benefits.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Inhibiting ATR also induced synthetic lethality in XRCC1-deficient cancer cells<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> and sensitized cancer cells to DNA-damaging chemotherapeutic agents.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Synthetic lethality in XRCC1-deficient cancer cells is also elicited by the ATM inhibitor KU55933 (<b>13</b>) and the DNA-PK inhibitor NU7441 (<b>14</b>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_p">A cell-based screening of 623 PI3K inhibitors led researchers to identify an mTOR- and ATR-selective inhibitor, ETP-46464 (<b>15</b>), that induces replicative stress and synthetic lethality in p53-deficient or cyclin E-overexpressing cells.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The IC<sub>50</sub> values of <b>15</b> for mTOR and ATR are 0.6 and 14 nM, respectively, but >36 nM for DNAPK, PI3K, and ATM. AZ20 (<b>16</b>), an ATR inhibitor derived from the mTOR inhibitor sulfonylmorpholinopyrimidine, was reported to have single-agent activity when administered orally in mice bearing the xenograft established from colon cancer cell line LoVo.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Through high-throughput screening and compound optimization, Charrier et al. developed an ATR-selective inhibitor, VE-821 (<b>17</b>), with IC<sub>50</sub> values for ATR, ATM, and DNAPK of 12 nM, >8 μM, and >8 μM, respectively.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> In vitro study revealed that treatment with <b>17</b> alone induced selective killing of ATM- or p53-deficient cancer cells but only reversibly limited cell cycle progression in normal cells. <b>17</b> also increased cisplatin potency 10-fold in HCT116 cells, suggesting that inhibiting ATR could potentiate the efficacies of radiotherapy and genotoxic drugs.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> VE-822 (<b>18</b>), an analogue of <b>17</b>, was found to have in vivo activity in blocking ATR and sensitizing pancreatic cancer cells to gemcitabine-based chemoradiation therapy.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Nevertheless, no clinical studies with ATM or ATR inhibitors have yet been reported.</div><div class="NLM_p">In comparison to the development of ATM/ATR inhibitors, the development of CHK inhibitors, specifically CHK1 inhibitors, is more advanced possibly because it is easier to perform enzymatic analysis on CHK1/CHK2. CHK1 and CHK2 have a highly conserved kinase domain but have distinct overall protein structures.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> However, several small molecular inhibitors inhibit both CHK1 and CHK2 with a similar potency. In an Eμ-Myc-driving lymphoma model, inhibiting CHK1, CHK2, or both with small molecule inhibitors induced cell death, although the Eμ-Myc p53 null lymphoma cells were more sensitive to a dual CHK1/CHK2 inhibitor than to a CHK1-specific inhibitor.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> AZD7762 (<b>19</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), a dual CHK1/2 inhibitor, also enhances radiosensitivity- and chemotherapy-induced apoptosis in p53 mutant and/or p21-deficient tumor cells to a greater extent than in p53 wild-type tumor cells.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112, 113)</a> The potentiation of DNA damaging agent-induced apoptosis by CHK inhibitors is possibly caused by abrogation of the G2 checkpoint and/or inhibition of HR DNA repair.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of CHK1/2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Gene knockout studies revealed that knockout of CHK1 or CHK2 caused defects in the induction and/or maintenance of irradiation-induced G2 arrest.<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a> Intriguingly, knockout of ATM or CHK2 is viable for cells and animals, although phenotypes of ataxia telangiectasia, chromosomal abnormality, and the development of thymic lymphomas are observed in ATM knockout,<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> whereas resistance to ionizing radiation-induced apoptosis is observed in CHK2 knockout.<a onclick="showRef(event, 'ref115 ref118'); return false;" href="javascript:void(0);" class="ref ref115 ref118">(115, 118)</a> In contrast, knockout of ATR or CHK1 is lethal for cells and embryos with defects in the G2/M DNA damage checkpoint,<a onclick="showRef(event, 'ref116 ref119'); return false;" href="javascript:void(0);" class="ref ref116 ref119">(116, 119)</a> indicating that the ATR/CHK1 pathway is essential for cell survival. Therefore, inhibitors of ATR and/or CHK1 could be more potent and toxic than those of ATM and/or CHK2. A synthetic lethality siRNA screening of 572 kinases for improving gemcitabine or cisplatin response in pancreatic or ovarian cancer cells revealed the greatest potentiation by siRNA targeting of ATR and/or CHK1.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Similar results were obtained by inhibiting CHK1 with small molecule inhibitors such as PD407824 (a dual inhibitor of CHK1 and Wee1) (<b>20</b>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p last">A phase I study on <b>19</b> single-agent therapy and combination therapy with gemcitabine in patients with advanced solid tumors showed that the dose-limiting toxicities are cardiac and liver function abnormalities and myelosuppression. No objective responses were observed, although disease stabilization was observed in some patients.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> UCN-01 (7-hydroxystaurosporin) (<b>21</b>), a protein kinase C inhibitor that also inhibits many other kinases, including CHK1, and abrogates the G2 checkpoint has been reported to enhance the effectiveness of genotoxic agents in p53-deficient cells.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> A phase I study of <b>21</b> in combination with perifosine or irinotecan showed some partial response in p53-defective triple-negative breast cancer,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> whereas a phase II trial in metastatic melanoma showed that <b>21</b> as a single agent is not active in refractory melanoma.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Both <b>19</b> and <b>21</b> have been found to be not favorable for further development because of pharmacokinetic and toxicity issues. MK-8776 (SCH900776) (<b>22</b>) and LY2603618 (<b>23</b>) are CHK1 selective inhibitors (50- to 500-fold more active than on CHK2)<a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125, 126)</a> that are being used in clinical trials for the treatment of leukemias and solid tumors. Cardiac toxicity and myelosuppression were observed in phase I trials of both <b>22</b> and <b>23</b> in combination therapy with cytarabine and pemetrexed, respectively.<a onclick="showRef(event, 'ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref127 ref128">(127, 128)</a><b>22</b> was used in combination with cytarabine to treat refractory acute leukemias. Complete remissions occurred in 8 (33%) of 24 patients, mostly at a dose of 40 mg/m<sup>2</sup> or higher of <b>22</b>. The maximum tolerated dose for <b>22</b> was approximately 56 mg/m<sup>2</sup>.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a><b>23</b> in combination with pemetrexed (500 mg/m<sup>2</sup>) for the treatment of solid tumors revealed a maximum tolerated dose for <b>23</b> of 150 mg/m<sup>2</sup>; some partial response or disease stabilization was observed. <b>23</b> is currently in phase II trials in combination with cisplatin and pemetrexed.<a onclick="showRef(event, 'ref126 ref129'); return false;" href="javascript:void(0);" class="ref ref126 ref129">(126, 129)</a> Some CHK2-selective inhibitors have been identified, including PV1019 (<b>24</b>)<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> and CCT241533 (<b>25</b>).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Both agents were reported to be highly selective against CHK1 and have radioprotective effects in mouse thymocytes.<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130, 131)</a> As single agents, both <b>24</b> and <b>25</b> had mild antitumor activity but were found to potentiate the cytotoxicity of genotoxic agents and PARP inhibitors, respectively.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> However, clinical evaluation is not available for these agents.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Oncogenic RAS and Anti-RAS Therapeutics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Activating mutations in three oncogenic <i>RAS</i> genes (<i>H-</i>, <i>N-</i>, and <i>K</i>-<i>RAS</i>) is among the first and the most common genetic alterations identified in human cancers, occurring in approximately 30% of human tumors.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The <i>KRAS</i> gene encodes two splicing isoforms, a major KRAS 4B and a minor KRAS 4A. Therefore, mammals have four small (21 kDa) oncogenic Ras proteins of about 190 amino acids in size, with the first 165 aa conserved in the N-terminal for all the RAS proteins. The KRAS 4B, HRAS, and NRAS isoforms are ubiquitously expressed, whereas KRAS 4A is expressed mainly in kidney, liver, and gastrointestinal tissues.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> As a subfamily of small guanine nucleotide-binding proteins, RAS proteins cycle between an active guanosine triphosphate (GTP) bound form and an inactive guanosine diphosphate (GDP) bound form.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Binding of RAS with GTP is facilitated by guanine nucleotide exchange factors through catalyzing the release of GDP and is required for the interaction of RAS with target proteins. The intrinsic GTPase activity that is enhanced by GTPase-activating proteins converts GTP to GDP, leading to a GDP-bound, inactive RAS. <i>RAS</i> mutations that diminish the GTPase activity or decrease the GDP binding capacity render RAS in a constitutively active, GTP-bound status. In the absence of a <i>RAS</i> mutation, increased Ras activity is frequently detected in human cancer because of gene amplification,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> overexpression,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> an increase in upstream signals from tyrosine-kinase growth-factor receptors such as HER2 and EGFR,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and altered expression of micro-RNA such as let-7.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Increased RAS activity is associated with resistance to chemotherapy and radiotherapy, leading to a poor prognosis.<a onclick="showRef(event, 'ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref139 ref140">(139, 140)</a></div><div class="NLM_p">As a key mediator in the signaling transduction for a variety of growth factors, cytokines, and hormones, RAS proteins are transferred to the inner leaflet of the plasma membrane, where they interact with a diversity of membrane receptors and execute signal transduction in a variety of signaling pathways that govern cell growth, proliferation, differentiation, and death. Several steps of posttranslational modifications are critical for trafficking RAS proteins to the plasma membrane, including farnesylation at the cysteine residue of the carboxy-terminal CAAX motif and methylation of farnesyl cysteine at the C-terminal.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The enzymes involved in these processes, such as farnesyltransferase,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> geranylgeranyltransferase,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and isoprenylcysteine carboxyl methyltransferase,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> have been intensively investigated in preclinical and clinical trials for anti-RAS therapy. Small molecules binding irreversibly to the KRAS (G12C) mutant protein<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> or interfering with Ras–effector protein interaction<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> have recently been reported. Targeting the Ras downstream pathways, particularly the RAF/MEK/ERK and PI3K/AKT/mTOR pathways,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> has also been investigated for inhibiting <i>Ras</i> mutant cancer cells. A clinical trial with biomarker-integrated targeted therapy for lung cancer has revealed that sorafenib (<b>26</b>), a pan-RAF and VEGFR inhibitor, has impressive benefits for <i>KRAS</i> mutant patients.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> However, selective inhibition of BRAF with a dominant negative construct<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> in mice or with BRAF-selective inhibitors such as vemurafenib (<b>27</b>) in patients<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> promoted the development and/or progression of <i>RAS</i> mutant cancers possibly because of the activation of other RAF isoforms, such as RAF-1. Thus far, effective anti-RAS therapeutics is not clinically available.</div><div class="NLM_p">Indirect anti-Ras therapy with the synthetic lethality-based approach has recently been investigated by several groups. It is noteworthy that expression of oncogenic <i>RAS</i> in primary normal human or rodent cells often results in apoptosis or senescence, whereas expression of oncogenic <i>RAS</i> in immortal cells or cells with inactivation of p53, p16, or the transcriptional activator interferon regulatory factor 1 leads to transformation and tumorigenesis,<a onclick="showRef(event, 'ref151 ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref151 ref152 ref153">(151-153)</a> suggesting that <i>RAS</i> transformed cells have additional signaling context for survival, which provides opportunity of synthetic lethality based anti-RAS therapy. In fact, RAS pathways interact with many other cancer related pathways. Several studies on siRNA library screens with isogenic cell lines harboring mutant and wild-type <i>RAS</i> genes have revealed synthetic lethal interactions of oncogenic <i>RAS</i> with some key nodes in cancer signaling network, including Polo-like kinase 1 (PLK1), a serine/threonine protein kinase that regulates cell mitosis;<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the transcription factor Wilms tumor 1 (WT1);<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> TANK-binding kinase 1 (TBK1), a noncanonical IκB kinase that regulates the stability of IκB;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> spleen tyrosine kinase (SYK);<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and CDK4<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Some small-molecule inhibitors of PLK1, CDK4, and SYK are already being used in clinical trials for anticancer therapy.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156, 157)</a> The synthetic lethality interactions of those targets with oncogenic <i>RAS</i> suggest that <i>RAS</i> gene mutation might be used as a marker to identify responders.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Ras signaling pathways and synthetic lethal interactions. Receptor tyrosine kinases (RTK) activate RAS and PI3K/AKT/mTOR pathways. RAS in turn activates RAF/MEK/ERK, PI3K/AKT/mTOR, and RalGEF/Ral pathways and crosstalks with RTK, WNT, c-Jun N-terminal kinases (JNK), reactive oxidative species (ROS), STAT3, and tumor necrosis factor α (TNFα)/NFκB pathways. Several key nodes in those signaling networks, such as TBK1, PLK1, CDK4, SYK, and WT1 (colored tan), have been reported to have synthetic lethal interactions with oncogenic RAS. In contrast, activation of p53 and JNK may lead to apoptosis. Arrow indicates activation, and the line terminating with a black circle indicates suppression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several innovative anticancer agents that selectively induce cytotoxic effects in cancer cells with <i>RAS</i> mutations have been identified by screening chemical libraries, including triphenyltetrazolium (<b>28</b>) and a sulfinyl cytidine derivative (<b>29</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) that demonstrated approximately 6-fold selectivity for cell lines containing mutant <i>KRAS</i>;<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> erastin (<b>30</b>), which exhibited lethal selectivity in human tumor cells harboring mutations in the <i>HRAS</i>, <i>KRAS</i>, or <i>BRAF</i> oncogenes by acting on mitochondrial voltage-dependent anion channels and inducing oxidative cell death;<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> lanperisone (<b>31</b>);<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> and oncrasin-1 (<b>32</b>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Interestingly, <b>30</b>,<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a><b>31</b>,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> and analogues of <b>32</b><a onclick="showRef(event, 'ref161 ref162'); return false;" href="javascript:void(0);" class="ref ref161 ref162">(161, 162)</a> all induced cell-killing effects in <i>RAS</i> mutant tumor cells by triggering oxidative stress, although through different underlying mechanisms. While <b>30</b> may act on mitochondrial voltage-dependent anion channels and induce oxidative cell death,<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a><b>32</b> and its analogues act on RNA polymerase II, protein kinase Cι (PKCι), and STAT3.<a onclick="showRef(event, 'ref8 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref8 ref163 ref164">(8, 163, 164)</a> Most of the molecules involved in oncrasin-induced antitumor activity are directly involved either in signal transductions in RAS, MYC, and STAT3 pathways or in causing synthetic lethality in cells with elevated activity of <i>RAS</i> or <i>MYC</i> oncogenes.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of oncogenic Ras synthetic lethal agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Similar to the agents identified through other approaches, substantial efforts will be required for optimization of compounds identified through synthetic lethality screening. Effort has been made in the Developmental Therapeutics Program at the National Cancer Institute and in our own laboratory for compound optimization of oncrasin 1. One of the most active analogue compounds, NSC-743380 (<b>33</b>), was tested in vitro with the NCI-60 cell panel and 50 non-small-cell lung carcinoma cell lines and was highly active (IC<sub>50</sub> between 10 nM and 1 μM) in 30 of 102 cancer cell lines tested.<a onclick="showRef(event, 'ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref164 ref165">(164, 165)</a> In 50 non-small-cell lung cancer cell lines tested, 16 (32%) were highly responsive to this compound (IC<sub>50</sub> < 0.33 μM), including many <i>KRAS</i> mutant cancer cell lines,<a onclick="showRef(event, 'ref8 ref165'); return false;" href="javascript:void(0);" class="ref ref8 ref165">(8, 165)</a> suggesting that a large subset of cancer patients may potentially benefit from treatment with this agent. In vivo studies performed in our laboratory and by the National Cancer Institute’s Developmental Therapeutics Program have shown that intraperitoneal administration of <b>33</b> at doses of 67–150 mg/kg caused complete tumor regression or significant growth suppression in some xenograft tumor models,<a onclick="showRef(event, 'ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref164 ref165">(164, 165)</a> suggesting that this compound has the potential to move to further development. Nevertheless, most compounds developed by synthetic lethality screening for oncogenic <i>RAS</i> are still at the preclinical evaluation stage.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Future Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The enthusiasm for developing synthetic lethality based anticancer therapeutics has been increasing recently, with increasing numbers of publications on this topic. Most potential therapeutic targets or therapeutic agents developed through the concept of synthetic lethality are identified by cell-based screening with pairs of isogenic cell lines. Although this approach may facilitate development of genotype-specific anticancer therapeutics, several studies have demonstrated that synthetic lethality is likely cell context dependent. For example, <i>KRAS</i> mutant cancer cell lines have been characterized as either <i>KRAS</i>-dependent or <i>KRAS</i>-independent, on the basis of cell-killing effects induced by knockdown of the <i>KRAS</i> gene itself.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> When 45 genes that have synthetic lethality with EGFR inhibitors in the cervical adenocarcinoma cell line A431 were tested for sensitization to erlotinib or cetuximab in seven other cell lines, none of the genes sensitized all tested cell lines, although several of the genes sensitized three to five of the cell lines.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Similarly, resistance to the synthetic lethality of PARP inhibitors in <i>BRCA1</i> and <i>BRCA2</i> mutant cancers has been observed both in experimental tumor models and in clinical trials.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The differences in genetic and/or epigenetic backgrounds in individual cells may explain the cell-context-dependent synthetic lethality observed in various studies. Because a tumor may harbor an average of 30–70 mutated genes,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> an individual primary tumor or established cancer cell line may carry multiple concomitantly activated oncogenes or inactivated tumor suppressor genes. The activation in other signaling pathways may provide redundant input that drives and maintains downstream survival signaling, resulting in resistance to therapeutic agents that target a particular genetic lesion either directly or indirectly through synthetic lethality. Moreover, even though some passenger mutations in tumor cells may not contribute to tumorigenesis, these mutations may affect drug response because of altered drug metabolism or drug efflux. As a result, querying for the synthetic lethality partners of an oncogenic <i>KRAS</i> gene can identify different candidate genes or lead compounds in different cell lines.<a onclick="showRef(event, 'ref9 ref10 ref154'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref154">(9, 10, 154)</a> Similarly, a synthetic lethality gene–agent combination identified in one cell line may not necessarily be applicable to another cell line.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Mechanistic delineation of molecules or pathways that mediate responses to synthetic lethality anticancer therapeutics and the identification of predictive biomarkers for treatment responses will be critical for the successful development of synthetic lethality anticancer therapeutics. On the other hand, the concept of synthetic lethality has also been explored for characterizing mechanisms of resistance and for combination therapy or multimodality therapy to enhance the efficacy of anticancer drugs.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Simultaneous targeting the redundant survival pathways is expected to overcome resistance and/or enhance efficacy in anticancer therapy. However, toxicity may increase as well.</div><div class="NLM_p last">Our own experience in developing synthetic-lethality-based anticancer therapeutics suggests that mechanistic characterization<a onclick="showRef(event, 'ref163 ref167'); return false;" href="javascript:void(0);" class="ref ref163 ref167">(163, 167)</a> and compound optimization<a onclick="showRef(event, 'ref164 ref168'); return false;" href="javascript:void(0);" class="ref ref164 ref168">(164, 168)</a> could be challenging and time-consuming. The biological functions of compounds identified through cell-based synthetic lethality screening are largely unknown. Technological developments in chemical biology, such as conjugating compounds to biotin or resin beads and performing affinity-based target precipitation and subsequent protein identification by mass spectrometry analysis, may facilitate target and mechanistic characterization. However, conjugating and immobilizing a small compound may change its biological function and protein-binding specificity. Alternatively, target proteins may be enriched by protecting the targets from protease-mediated degradation through the binding of unmodified compounds to their targets. The results may depend on the efficiency and specificity of the protection. Robust efforts on in vivo optimization of the lead compound are also essential in drug development, as compounds with similar chemical structures and in vitro activity may have dramatically different in vivo toxicity and efficacy profiles.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm500415t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingliang Fang</span> - <span class="hlFld-Affiliation affiliation">Department
of Thoracic and
Cardiovascular Surgery, Unit 1489, The University
of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82e0e4e3ece5c2efe6e3ece6e7f0f1edecacedf0e5"><span class="__cf_email__" data-cfemail="7c1e1a1d121b3c11181d1218190e0f131252130e1b">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Bingliang Fang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=BIO-d1710e1347-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bingliang Fang</b> received his M.D. degree in human genetics at Hamburg University (Germany) in 1989. He has been a faculty member in the University of Texas MD Anderson Cancer since 1995 and is currently a Professor in the Department of Thoracic and Cardiovascular Surgery at MD Anderson Cancer Center, TX. His primary research interest is innovative anticancer therapy, the mechanisms of action of and/or resistance to anticancer agents, and molecular signatures or biomarkers for predicting treatment response or early diagnosis of cancers. One of his current research projects is to develop synthetic lethality anticancer therapeutics.</p></figure></div><div class="ack" id="ACK-d1710e1352-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">I thank Shuhong Wu for assistance in preparation of the manuscript and Luanne Jorewicz in the Department of Scientific Publications of The University of Texas MD Anderson Cancer Center, TX, for editorial review of the manuscript. The research was supported by National Institutes of Health/National Cancer Institute Grant R01 CA 124951.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i10" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i10"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i11" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i11"> Abbreviations Used</h2><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ALC1</td><td class="NLM_def"><p class="first last">amplified in liver cancer protein 1</p></td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">ataxia telangiectasia-mutated</p></td></tr><tr><td class="NLM_term">ATR</td><td class="NLM_def"><p class="first last">ataxia telangiectasia-mutated and Rad3 related</p></td></tr><tr><td class="NLM_term">BRCA</td><td class="NLM_def"><p class="first last">breast cancer</p></td></tr><tr><td class="NLM_term">CA-125</td><td class="NLM_def"><p class="first last">cancer antigen 125</p></td></tr><tr><td class="NLM_term">CDC</td><td class="NLM_def"><p class="first last">cell division cycle</p></td></tr><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CHK</td><td class="NLM_def"><p class="first last">checkpoint kinase</p></td></tr><tr><td class="NLM_term">DNA-PK</td><td class="NLM_def"><p class="first last">DNA-dependent protein kinase</p></td></tr><tr><td class="NLM_term">DSB</td><td class="NLM_def"><p class="first last">DNA double-strand break</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ERCC</td><td class="NLM_def"><p class="first last">excision repair cross-complementing rodent repair deficiency</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">H2AX</td><td class="NLM_def"><p class="first last">histone H2AX</p></td></tr><tr><td class="NLM_term">HDM2</td><td class="NLM_def"><p class="first last">human homologue of double minute 2</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HR</td><td class="NLM_def"><p class="first last">homologous recombination</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mitogen activated protein</p></td></tr><tr><td class="NLM_term">MEK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase</p></td></tr><tr><td class="NLM_term">MET</td><td class="NLM_def"><p class="first last">mesenchymal epithelial transition factor</p></td></tr><tr><td class="NLM_term">MK2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase-activated protein kinase 2</p></td></tr><tr><td class="NLM_term">MRE11</td><td class="NLM_def"><p class="first last">meiotic recombination 11 homologue</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">MYC</td><td class="NLM_def"><p class="first last">v-myc avian myelocytomatosis viral oncogene homologue</p></td></tr><tr><td class="NLM_term">NBS1</td><td class="NLM_def"><p class="first last">Nijmegen breakage syndrome 1</p></td></tr><tr><td class="NLM_term">NFκB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">NHEJ</td><td class="NLM_def"><p class="first last">nonhomologous end joining</p></td></tr><tr><td class="NLM_term">NOX1</td><td class="NLM_def"><p class="first last">NADPH oxidase 1</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP-ribose polymerase</p></td></tr><tr><td class="NLM_term">PCNA</td><td class="NLM_def"><p class="first last">proliferating cell nuclear protein</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PIKK</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase related kinase</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">PLK1</td><td class="NLM_def"><p class="first last">Polo-like kinase 1</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">RAC1</td><td class="NLM_def"><p class="first last">ras-related C3 botulinum toxin substrate 1</p></td></tr><tr><td class="NLM_term">RAF</td><td class="NLM_def"><p class="first last">rapidly accelerated fibrosarcoma</p></td></tr><tr><td class="NLM_term">RalGEF</td><td class="NLM_def"><p class="first last">Ral guanine nucleotide exchange factor</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma</p></td></tr><tr><td class="NLM_term">RECIST</td><td class="NLM_def"><p class="first last">response evaluation criteria in solid tumors</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxidative species</p></td></tr><tr><td class="NLM_term">RPA</td><td class="NLM_def"><p class="first last">replication protein A</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SSB</td><td class="NLM_def"><p class="first last">DNA single-strand break</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">SYK</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">TBK1</td><td class="NLM_def"><p class="first last">TANK-binding kinase 1</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">TP53</td><td class="NLM_def"><p class="first last">tumor protein p53</p></td></tr><tr><td class="NLM_term">VEGFR</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor</p></td></tr><tr><td class="NLM_term">WNT</td><td class="NLM_def"><p class="first last">wingless-type MMTV integration site family</p></td></tr><tr><td class="NLM_term">WT1</td><td class="NLM_def"><p class="first last">Wilms tumor 1</p></td></tr><tr><td class="NLM_term">XRCC</td><td class="NLM_def"><p class="first last">X-ray repair complementing defective repair in Chinese hamster cells</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 168 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">Cancer genome landscapes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1235122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23539594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=1546-1558&author=B.+Vogelsteinauthor=N.+Papadopoulosauthor=V.+E.+Velculescuauthor=S.+Zhouauthor=L.+A.+Diazauthor=K.+W.+Kinzler&title=Cancer+genome+landscapes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer genome landscapes</span></div><div class="casAuthors">Vogelstein, Bert; Papadopoulos, Nickolas; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6127</span>),
    <span class="NLM_cas:pages">1546-1558</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer.  For most cancer types, this landscape consists of a small no. of "mountains" (genes altered in a high percentage of tumors) and a much larger no. of "hills" (genes altered infrequently).  To date, these studies have revealed ~140 genes that, when altered by intragenic mutations, can promote or "drive" tumorigenesis.  A typical tumor contains two to eight of these "driver gene" mutations; the remaining mutations are passengers that confer no selective growth advantage.  Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance.  A better understanding of these pathways is one of the most pressing needs in basic cancer research.  Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXBcf6dWj0bVg90H21EOLACvtfcHk0lhEsKV2CvtEEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOhsb0%253D&md5=da190782f210873557cbf15441540ee7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1235122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1235122%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DCancer%2520genome%2520landscapes%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D1546%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Patel, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halling-Brown, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tym, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span> </span><span class="NLM_article-title">Objective assessment of cancer genes for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=35-50&author=M.+N.+Patelauthor=M.+D.+Halling-Brownauthor=J.+E.+Tymauthor=P.+Workmanauthor=B.+Al-Lazikani&title=Objective+assessment+of+cancer+genes+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BN.%26aulast%3DHalling-Brown%26aufirst%3DM.%2BD.%26aulast%3DTym%26aufirst%3DJ.%2BE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26atitle%3DObjective%2520assessment%2520of%2520cancer%2520genes%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D35%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hartwell, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szankasi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Integrating genetic approaches into the discovery of anticancer drugs</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.278.5340.1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9353181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Wju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1064-1068&author=L.+H.+Hartwellauthor=P.+Szankasiauthor=C.+J.+Robertsauthor=A.+W.+Murrayauthor=S.+H.+Friend&title=Integrating+genetic+approaches+into+the+discovery+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating genetic approaches into the discovery of anticancer drugs</span></div><div class="casAuthors">Hartwell, Leland H.; Szankasi, Philippe; Roberts, Christopher J.; Murray, Andrew W.; Friend, Stephen H.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5340</span>),
    <span class="NLM_cas:pages">1064-1068</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 48 refs. The discovery of anticancer drugs is now driven by the numerous mol. alterations identified in tumor cells over the past decade.  To exploit these alterations, it is necessary to understand how they define a mol. context that allows increased sensitivity to particular compds.  Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies by which drugs can be profiled for their ability to selectively kill cells in a mol. context that matches those found in tumors.  Similarly, it may be possible to identify and validate new targets for drugs that would selectively kill tumor cells with a particular mol. context.  This article outlines some of the ways that yeast genetics can be used to streamline anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbQLv4QwxtZrVg90H21EOLACvtfcHk0lhEsKV2CvtEEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Wju7k%253D&md5=6bd5b219e8b5f5dd28b400003a9e4edb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5340.1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5340.1064%26sid%3Dliteratum%253Aachs%26aulast%3DHartwell%26aufirst%3DL.%2BH.%26aulast%3DSzankasi%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DMurray%26aufirst%3DA.%2BW.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DIntegrating%2520genetic%2520approaches%2520into%2520the%2520discovery%2520of%2520anticancer%2520drugs%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1064%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dobzhansky, T. H.</span><span> </span><span class="NLM_article-title">Genetics of natural populations. XIII. Recombination and variability and populations of drosophila pseudoobscura</span> <span class="citation_source-journal">Genetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1946&pages=269-290&author=T.+H.+Dobzhansky&title=Genetics+of+natural+populations.+XIII.+Recombination+and+variability+and+populations+of+drosophila+pseudoobscura"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobzhansky%26aufirst%3DT.%2BH.%26atitle%3DGenetics%2520of%2520natural%2520populations.%2520XIII.%2520Recombination%2520and%2520variability%2520and%2520populations%2520of%2520drosophila%2520pseudoobscura%26jtitle%3DGenetics%26date%3D1946%26volume%3D31%26spage%3D269%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lucchesi, J. C.</span><span> </span><span class="NLM_article-title">Synthetic lethality and semi-lethality among functionally related mutants of <i>Drosophila melanfgaster</i></span> <span class="citation_source-journal">Genetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fgenetics%2F59.1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=5683639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADyaF1M%252FhtFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1968&pages=37-44&author=J.+C.+Lucchesi&title=Synthetic+lethality+and+semi-lethality+among+functionally+related+mutants+of+Drosophila+melanfgaster"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality and semi-lethality among functionally related mutants of Drosophila melanfgaster</span></div><div class="casAuthors">Lucchesi J C</div><div class="citationInfo"><span class="NLM_cas:title">Genetics</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>
        ISSN:<span class="NLM_cas:issn">0016-6731</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXM96_03HVQCO2kE7krGOBfW6udTcc2eZDZ65t_Rsjcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1M%252FhtFyrtg%253D%253D&md5=0a74c995f844634c47a35e6a5b39b90a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fgenetics%2F59.1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgenetics%252F59.1.37%26sid%3Dliteratum%253Aachs%26aulast%3DLucchesi%26aufirst%3DJ.%2BC.%26atitle%3DSynthetic%2520lethality%2520and%2520semi-lethality%2520among%2520functionally%2520related%2520mutants%2520of%2520Drosophila%2520melanfgaster%26jtitle%3DGenetics%26date%3D1968%26volume%3D59%26spage%3D37%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Farmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarosa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature03445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15829967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=917-921&author=H.+Farmerauthor=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+Tuttauthor=D.+A.+Johnsonauthor=T.+B.+Richardsonauthor=M.+Santarosaauthor=K.+J.+Dillonauthor=I.+Hicksonauthor=C.+Knightsauthor=N.+M.+Martinauthor=S.+P.+Jacksonauthor=G.+C.+Smithauthor=A.+Ashworth&title=Targeting+the+DNA+repair+defect+in+BRCA+mutant+cells+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span></div><div class="casAuthors">Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian; Knights, Charlotte; Martin, Niall M. B.; Jackson, Stephen P.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">917-921</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers.  Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks.  The authors show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis.  This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination.  These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVTKE4mFwfrVg90H21EOLACvtfcHk0lglcoLyyr-O5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D&md5=03b5ba0adc21a5627fe17ae535f45078</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03445%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DH.%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BB.%26aulast%3DSantarosa%26aufirst%3DM.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520DNA%2520repair%2520defect%2520in%2520BRCA%2520mutant%2520cells%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dolma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessnick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=285-296&author=S.+Dolmaauthor=S.+L.+Lessnickauthor=W.+C.+Hahnauthor=B.+R.+Stockwell&title=Identification+of+genotype-selective+antitumor+agents+using+synthetic+lethal+chemical+screening+in+engineered+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolma%26aufirst%3DS.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DIdentification%2520of%2520genotype-selective%2520antitumor%2520agents%2520using%2520synthetic%2520lethal%2520chemical%2520screening%2520in%2520engineered%2520human%2520tumor%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D285%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7403</span><span class="NLM_x">–</span> <span class="NLM_lpage">7408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7403-7408&author=W.+Guoauthor=S.+Wuauthor=J.+Liuauthor=B.+Fang&title=Identification+of+a+small+molecule+with+synthetic+lethality+for+K-ras+and+protein+kinase+C+iota"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520with%2520synthetic%2520lethality%2520for%2520K-ras%2520and%2520protein%2520kinase%2520C%2520iota%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7403%26epage%3D7408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Barbie, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meylan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiling, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadlow, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoersch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittner, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span> </span><span class="NLM_article-title">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature08460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19847166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=108-112&author=D.+A.+Barbieauthor=P.+Tamayoauthor=J.+S.+Boehmauthor=S.+Y.+Kimauthor=S.+E.+Moodyauthor=I.+F.+Dunnauthor=A.+C.+Schinzelauthor=P.+Sandyauthor=E.+Meylanauthor=C.+Schollauthor=S.+Frohlingauthor=E.+M.+Chanauthor=M.+L.+Sosauthor=K.+Michelauthor=C.+Mermelauthor=S.+J.+Silverauthor=B.+A.+Weirauthor=J.+H.+Reilingauthor=Q.+Shengauthor=P.+B.+Guptaauthor=R.+C.+Wadlowauthor=H.+Leauthor=S.+Hoerschauthor=B.+S.+Wittnerauthor=S.+Ramaswamyauthor=D.+M.+Livingstonauthor=D.+M.+Sabatiniauthor=M.+Meyersonauthor=R.+K.+Thomasauthor=E.+S.+Landerauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=D.+G.+Gillilandauthor=T.+Jacksauthor=W.+C.+Hahn&title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span></div><div class="casAuthors">Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7269</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to std. therapies.  Although the identification of specific oncogenes has led to the development of clin. effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach.  A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele.  Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IκB kinase TBK1 was selectively essential in cells that contain mutant KRAS.  Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression.  In these cells, TBK1 activated NF-κB anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction.  These observations indicate that TBK1 and NF-κB signaling are essential in KRAS mutant tumors, and establish a general approach for the rational identification of co-dependent pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlw2rhGywK0bVg90H21EOLACvtfcHk0li14AyGReJgmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL&md5=aab467de18805a08c3b1484f432ea64a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature08460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08460%26sid%3Dliteratum%253Aachs%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DDunn%26aufirst%3DI.%2BF.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMeylan%26aufirst%3DE.%26aulast%3DScholl%26aufirst%3DC.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DMichel%26aufirst%3DK.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DReiling%26aufirst%3DJ.%2BH.%26aulast%3DSheng%26aufirst%3DQ.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DWadlow%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DHoersch%26aufirst%3DS.%26aulast%3DWittner%26aufirst%3DB.%2BS.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DSystematic%2520RNA%2520interference%2520reveals%2520that%2520oncogenic%2520KRAS-driven%2520cancers%2520require%2520TBK1%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D108%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuele, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlabach, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2009.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19490893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=835-848&author=J.+Luoauthor=M.+J.+Emanueleauthor=D.+Liauthor=C.+J.+Creightonauthor=M.+R.+Schlabachauthor=T.+F.+Westbrookauthor=K.+K.+Wongauthor=S.+J.+Elledge&title=A+genome-wide+RNAi+screen+identifies+multiple+synthetic+lethal+interactions+with+the+Ras+oncogene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene</span></div><div class="casAuthors">Luo, Ji; Emanuele, Michael J.; Li, Danan; Creighton, Chad J.; Schlabach, Michael R.; Westbrook, Thomas F.; Wong, Kwok-Kin; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">835-848</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Oncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understanding of the vulnerabilities of these cancers is lacking.  We undertook a genome-wide RNAi screen to identify synthetic lethal interactions with the KRAS oncogene.  We discovered a diverse set of proteins whose depletion selectively impaired the viability of Ras mutant cells.  Among these we obsd. a strong enrichment for genes with mitotic functions.  We describe a pathway involving the mitotic kinase PLK1, the anaphase-promoting complex/cyclosome, and the proteasome that, when inhibited, results in prometaphase accumulation and the subsequent death of Ras mutant cells.  Gene expression anal. indicates that reduced expression of genes in this pathway correlates with increased survival of patients bearing tumors with a Ras transcriptional signature.  Our results suggest a previously underappreciated role for Ras in mitotic progression and demonstrate a pharmacol. tractable pathway for the potential treatment of cancers harboring Ras mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmWFKW3XYaabVg90H21EOLACvtfcHk0lirbHSlSfD4IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCltb4%253D&md5=f06fd1f1c469495489ad2ac7f0cab090</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DEmanuele%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DWestbrook%26aufirst%3DT.%2BF.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520genome-wide%2520RNAi%2520screen%2520identifies%2520multiple%2520synthetic%2520lethal%2520interactions%2520with%2520the%2520Ras%2520oncogene%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D835%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Puyol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizcueta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=63-73&author=M.+Puyolauthor=A.+Martinauthor=P.+Dubusauthor=F.+Muleroauthor=P.+Pizcuetaauthor=G.+Khanauthor=C.+Guerraauthor=D.+Santamariaauthor=M.+Barbacid&title=A+synthetic+lethal+interaction+between+K-Ras+oncogenes+and+Cdk4+unveils+a+therapeutic+strategy+for+non-small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuyol%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMulero%26aufirst%3DF.%26aulast%3DPizcueta%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DA%2520synthetic%2520lethal%2520interaction%2520between%2520K-Ras%2520oncogenes%2520and%2520Cdk4%2520unveils%2520a%2520therapeutic%2520strategy%2520for%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D63%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Astsaturov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratushny, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnyukova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhmyanova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skobeleva, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecherskaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasto, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebriiskii, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golemis, E. A.</span><span> </span><span class="NLM_article-title">Synthetic lethal screen of an EGFR-centered network to improve targeted therapies</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscisignal.2001083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20858866" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=ra67&author=I.+Astsaturovauthor=V.+Ratushnyauthor=A.+Sukhanovaauthor=M.+B.+Einarsonauthor=T.+Bagnyukovaauthor=Y.+Zhouauthor=K.+Devarajanauthor=J.+S.+Silvermanauthor=N.+Tikhmyanovaauthor=N.+Skobelevaauthor=A.+Pecherskayaauthor=R.+E.+Nastoauthor=C.+Sharmaauthor=S.+A.+Jablonskiauthor=I.+G.+Serebriiskiiauthor=L.+M.+Weinerauthor=E.+A.+Golemis&title=Synthetic+lethal+screen+of+an+EGFR-centered+network+to+improve+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2001083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2001083%26sid%3Dliteratum%253Aachs%26aulast%3DAstsaturov%26aufirst%3DI.%26aulast%3DRatushny%26aufirst%3DV.%26aulast%3DSukhanova%26aufirst%3DA.%26aulast%3DEinarson%26aufirst%3DM.%2BB.%26aulast%3DBagnyukova%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DSilverman%26aufirst%3DJ.%2BS.%26aulast%3DTikhmyanova%26aufirst%3DN.%26aulast%3DSkobeleva%26aufirst%3DN.%26aulast%3DPecherskaya%26aufirst%3DA.%26aulast%3DNasto%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DC.%26aulast%3DJablonski%26aufirst%3DS.%2BA.%26aulast%3DSerebriiskii%26aufirst%3DI.%2BG.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DGolemis%26aufirst%3DE.%2BA.%26atitle%3DSynthetic%2520lethal%2520screen%2520of%2520an%2520EGFR-centered%2520network%2520to%2520improve%2520targeted%2520therapies%26jtitle%3DSci.%2520Signaling%26date%3D2010%26volume%3D3%26spage%3Dra67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Whitehurst, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodemann, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardenas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michnoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. A.</span><span> </span><span class="NLM_article-title">Synthetic lethal screen identification of chemosensitizer loci in cancer cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=815-819&author=A.+W.+Whitehurstauthor=B.+O.+Bodemannauthor=J.+Cardenasauthor=D.+Fergusonauthor=L.+Girardauthor=M.+Peytonauthor=J.+D.+Minnaauthor=C.+Michnoffauthor=W.+Haoauthor=M.+G.+Rothauthor=X.+J.+Xieauthor=M.+A.+White&title=Synthetic+lethal+screen+identification+of+chemosensitizer+loci+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitehurst%26aufirst%3DA.%2BW.%26aulast%3DBodemann%26aufirst%3DB.%2BO.%26aulast%3DCardenas%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMichnoff%26aufirst%3DC.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DSynthetic%2520lethal%2520screen%2520identification%2520of%2520chemosensitizer%2520loci%2520in%2520cancer%2520cells%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D815%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomeusz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span> </span><span class="NLM_article-title">KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5532</span><span class="NLM_x">–</span> <span class="NLM_lpage">5543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5532-5543&author=B.+Daiauthor=S.+Y.+Yooauthor=G.+Bartholomeuszauthor=R.+A.+Grahamauthor=M.+Majidiauthor=S.+Yanauthor=J.+Mengauthor=L.+Jiauthor=K.+Coombesauthor=J.+D.+Minnaauthor=B.+Fangauthor=J.+A.+Roth&title=KEAP1-dependent+synthetic+lethality+induced+by+AKT+and+TXNRD1+inhibitors+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DS.%2BY.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DGraham%26aufirst%3DR.%2BA.%26aulast%3DMajidi%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DCoombes%26aufirst%3DK.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DKEAP1-dependent%2520synthetic%2520lethality%2520induced%2520by%2520AKT%2520and%2520TXNRD1%2520inhibitors%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5532%26epage%3D5543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">The concept of synthetic lethality in the context of anticancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=16110319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=689-698&author=W.+G.+Kaelin&title=The+concept+of+synthetic+lethality+in+the+context+of+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Concept of Synthetic Lethality in the Context of Anticancer Therapy</span></div><div class="casAuthors">Kaelin, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">689-698</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Two genes are synthetic lethal if mutation of either alone is compatible with viability but mutation of both leads to death.  So, targeting a gene that is synthetic lethal to a cancer-relevant mutation should kill only cancer cells and spare normal cells.  Synthetic lethality therefore provides a conceptual framework for the development of cancer-specific cytotoxic agents.  This paradigm has not been exploited in the past because there were no robust methods for systematically identifying synthetic lethal genes.  This is changing as a result of the increased availability of chem. and genetic tools for perturbing gene function in somatic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf4V-KQ6I5ILVg90H21EOLACvtfcHk0ljNCRHOfwy5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleks7c%253D&md5=4d5e38282cd8a3d2c3451d56ca88ac8b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1691%26sid%3Dliteratum%253Aachs%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DThe%2520concept%2520of%2520synthetic%2520lethality%2520in%2520the%2520context%2520of%2520anticancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D689%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Le Meur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentleman, R.</span><span> </span><span class="NLM_article-title">Modeling synthetic lethality</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=R135&author=N.+Le+Meurauthor=R.+Gentleman&title=Modeling+synthetic+lethality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BMeur%26aufirst%3DN.%26aulast%3DGentleman%26aufirst%3DR.%26atitle%3DModeling%2520synthetic%2520lethality%26jtitle%3DGenome%2520Biol.%26date%3D2008%26volume%3D9%26spage%3DR135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berriz, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brost, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levinson, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munyana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonikian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sdicu, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burd, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretscher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, C.</span><span> </span><span class="NLM_article-title">Global mapping of the yeast genetic interaction network</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1091317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14764870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=808-813&author=A.+H.+Tongauthor=G.+Lesageauthor=G.+D.+Baderauthor=H.+Dingauthor=H.+Xuauthor=X.+Xinauthor=J.+Youngauthor=G.+F.+Berrizauthor=R.+L.+Brostauthor=M.+Changauthor=Y.+Chenauthor=X.+Chengauthor=G.+Chuaauthor=H.+Friesenauthor=D.+S.+Goldbergauthor=J.+Haynesauthor=C.+Humphriesauthor=G.+Heauthor=S.+Husseinauthor=L.+Keauthor=N.+Kroganauthor=Z.+Liauthor=J.+N.+Levinsonauthor=H.+Luauthor=P.+Menardauthor=C.+Munyanaauthor=A.+B.+Parsonsauthor=O.+Ryanauthor=R.+Tonikianauthor=T.+Robertsauthor=A.+M.+Sdicuauthor=J.+Shapiroauthor=B.+Sheikhauthor=B.+Suterauthor=S.+L.+Wongauthor=L.+V.+Zhangauthor=H.+Zhuauthor=C.+G.+Burdauthor=S.+Munroauthor=C.+Sanderauthor=J.+Rineauthor=J.+Greenblattauthor=M.+Peterauthor=A.+Bretscherauthor=G.+Bellauthor=F.+P.+Rothauthor=G.+W.+Brownauthor=B.+Andrewsauthor=H.+Busseyauthor=C.+Boone&title=Global+mapping+of+the+yeast+genetic+interaction+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of the yeast genetic interaction network</span></div><div class="casAuthors">Tong, Amy Hin Yan; Lesage, Guillaume; Bader, Gary D.; Ding, Huiming; Xu, Hong; Xin, Xiaofeng; Young, James; Berriz, Gabriel F.; Brost, Renee L.; Chang, Michael; Chen, YiQun; Cheng, Xin; Chua, Gordon; Friesen, Helena; Goldberg, Debra S.; Haynes, Jennifer; Humphries, Christine; He, Grace; Hussein, Shamiza; Ke, Lizhu; Krogan, Nevan; Li, Zhijian; Levinson, Joshua N.; Lu, Hong; Menard, Patrice; Munyana, Christella; Parsons, Ainslie B.; Ryan, Owen; Tonikian, Raffi; Roberts, Tania; Sdicu, Anne-Marie; Shapiro, Jesse; Sheikh, Bilal; Suter, Bernhard; Wong, Sharyl L.; Zhang, Lan V.; Zhu, Hongwei; Burd, Christopher G.; Munro, Sean; Sander, Chris; Rine, Jasper; Greenblatt, Jack; Peter, Matthias; Bretscher, Anthony; Bell, Graham; Roth, Frederick P.; Brown, Grant W.; Andrews, Brenda; Bussey, Howard; Boone, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A genetic interaction network contg. ∼1000 genes and ∼4000 interactions was mapped by crossing mutations in 132 different query genes into a set of ∼4700 viable gene yeast deletion mutants and scoring the double mutant progeny for fitness defects.  Network connectivity was predictive of function because interactions often occurred among functionally related genes, and similar patterns of interactions tended to identify components of the same pathway.  The genetic network exhibited dense local neighborhoods; therefore, the position of a gene on a partially mapped network is predictive of other genetic interactions.  Because digenic interactions are common in yeast, similar networks may underlie the complex genetics assocd. with inherited phenotypes in other organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbAm9UJCYBrLVg90H21EOLACvtfcHk0ljNCRHOfwy5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKntg%253D%253D&md5=2bff102d32c6a0218ac6f110b6a4486d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1091317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1091317%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DA.%2BH.%26aulast%3DLesage%26aufirst%3DG.%26aulast%3DBader%26aufirst%3DG.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXin%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DBerriz%26aufirst%3DG.%2BF.%26aulast%3DBrost%26aufirst%3DR.%2BL.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DChua%26aufirst%3DG.%26aulast%3DFriesen%26aufirst%3DH.%26aulast%3DGoldberg%26aufirst%3DD.%2BS.%26aulast%3DHaynes%26aufirst%3DJ.%26aulast%3DHumphries%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHussein%26aufirst%3DS.%26aulast%3DKe%26aufirst%3DL.%26aulast%3DKrogan%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLevinson%26aufirst%3DJ.%2BN.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMenard%26aufirst%3DP.%26aulast%3DMunyana%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DA.%2BB.%26aulast%3DRyan%26aufirst%3DO.%26aulast%3DTonikian%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DSdicu%26aufirst%3DA.%2BM.%26aulast%3DShapiro%26aufirst%3DJ.%26aulast%3DSheikh%26aufirst%3DB.%26aulast%3DSuter%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DL.%2BV.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurd%26aufirst%3DC.%2BG.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DRine%26aufirst%3DJ.%26aulast%3DGreenblatt%26aufirst%3DJ.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DBretscher%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DF.%2BP.%26aulast%3DBrown%26aufirst%3DG.%2BW.%26aulast%3DAndrews%26aufirst%3DB.%26aulast%3DBussey%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DC.%26atitle%3DGlobal%2520mapping%2520of%2520the%2520yeast%2520genetic%2520interaction%2520network%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D808%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidransky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">p53 mutations in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=49-53&author=M.+Hollsteinauthor=D.+Sidranskyauthor=B.+Vogelsteinauthor=C.+C.+Harris&title=p53+mutations+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3Dp53%2520mutations%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Olivier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainaut, P.</span><span> </span><span class="NLM_article-title">TP53 mutations in human cancers: origins, consequences, and clinical use</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a001008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=a001008&author=M.+Olivierauthor=M.+Hollsteinauthor=P.+Hainaut&title=TP53+mutations+in+human+cancers%3A+origins%2C+consequences%2C+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlivier%26aufirst%3DM.%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DHainaut%26aufirst%3DP.%26atitle%3DTP53%2520mutations%2520in%2520human%2520cancers%253A%2520origins%252C%2520consequences%252C%2520and%2520clinical%2520use%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26spage%3Da001008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horejsi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koed, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tort, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guldberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orntoft, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=864-870&author=J.+Bartkovaauthor=Z.+Horejsiauthor=K.+Koedauthor=A.+Kraemerauthor=F.+Tortauthor=K.+Ziegerauthor=P.+Guldbergauthor=M.+Sehestedauthor=J.+M.+Neslandauthor=C.+Lukasauthor=T.+Orntoftauthor=J.+Lukasauthor=J.+Bartek&title=DNA+damage+response+as+a+candidate+anti-cancer+barrier+in+early+human+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DHorejsi%26aufirst%3DZ.%26aulast%3DKoed%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DTort%26aufirst%3DF.%26aulast%3DZieger%26aufirst%3DK.%26aulast%3DGuldberg%26aufirst%3DP.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNesland%26aufirst%3DJ.%2BM.%26aulast%3DLukas%26aufirst%3DC.%26aulast%3DOrntoft%26aufirst%3DT.%26aulast%3DLukas%26aufirst%3DJ.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DDNA%2520damage%2520response%2520as%2520a%2520candidate%2520anti-cancer%2520barrier%2520in%2520early%2520human%2520tumorigenesis%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D864%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span> </span><span class="NLM_article-title">Genome maintenance mechanisms for preventing cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2F35077232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=11357144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=366-374&author=J.+H.+Hoeijmakers&title=Genome+maintenance+mechanisms+for+preventing+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Genome maintenance mechanisms for preventing cancer</span></div><div class="casAuthors">Hoeijmakers, Jan H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">366-374</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 67 refs.  The early notion that cancer is caused by mutations in genes crit. for the control of cell growth implied that genome stability is important for preventing oncogenesis.  During the past decade, knowledge about the mechanisms by which genes erode and the mol. machinery designed to counteract this time-dependent genetic degeneration has increased markedly.  At the same time, it has become apparent that inherited or acquired deficiencies in genome maintenance systems contribute significantly to the onset of cancer.  This review summarizes the main DNA caretaking systems and their impact on genome stability and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLg3z9y6ZD7Vg90H21EOLACvtfcHk0lgw-7hV1XkZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D&md5=7ef77f478c786849b0ec44a9d3c5bd28</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2F35077232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077232%26sid%3Dliteratum%253Aachs%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26atitle%3DGenome%2520maintenance%2520mechanisms%2520for%2520preventing%2520cancer%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D366%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Langelier, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, J. M.</span><span> </span><span class="NLM_article-title">Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1216338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22582261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=728-732&author=M.+F.+Langelierauthor=J.+L.+Planckauthor=S.+Royauthor=J.+M.+Pascal&title=Structural+basis+for+DNA+damage-dependent+poly%28ADP-ribosyl%29ation+by+human+PARP-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1</span></div><div class="casAuthors">Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6082</span>),
    <span class="NLM_cas:pages">728-732</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase-1 (PARP-1) (ADP) has a modular domain architecture that couples DNA damage detection to poly(ADP-ribosyl)ation activity through a poorly understood mechanism.  Here, the authors report the crystal structure of a DNA double-strand break in complex with human PARP-1 domains essential for activation (Zn1, Zn3, WGR-CAT).  PARP-1 engages DNA as a monomer, and the interaction with DNA damage organizes PARP-1 domains into a collapsed conformation that can explain the strong preference for automodification.  The Zn1, Zn3, and WGR domains collectively bind to DNA, forming a network of interdomain contacts that links the DNA damage interface to the catalytic domain (CAT).  The DNA damage-induced conformation of PARP-1 results in structural distortions that destabilize the CAT.  The results suggest that an increase in CAT protein dynamics underlies the DNA-dependent activation mechanism of PARP-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdGq__cCoyMLVg90H21EOLACvtfcHk0li5pOUdnORubA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFymurk%253D&md5=27070d2b1f5801ed1ce258a4ff545d5e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1216338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1216338%26sid%3Dliteratum%253Aachs%26aulast%3DLangelier%26aufirst%3DM.%2BF.%26aulast%3DPlanck%26aufirst%3DJ.%2BL.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPascal%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520basis%2520for%2520DNA%2520damage-dependent%2520poly%2528ADP-ribosyl%2529ation%2520by%2520human%2520PARP-1%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D728%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ali, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timinszky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas-Bosacoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladurner, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. W.</span><span> </span><span class="NLM_article-title">The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22683995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlCrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=685-692&author=A.+A.+Aliauthor=G.+Timinszkyauthor=R.+Arribas-Bosacomaauthor=M.+Kozlowskiauthor=P.+O.+Hassaauthor=M.+Hasslerauthor=A.+G.+Ladurnerauthor=L.+H.+Pearlauthor=A.+W.+Oliver&title=The+zinc-finger+domains+of+PARP1+cooperate+to+recognize+DNA+strand+breaks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks</span></div><div class="casAuthors">Ali, Ammar A. E.; Timinszky, Gyula; Arribas-Bosacoma, Raquel; Kozlowski, Marek; Hassa, Paul O.; Hassler, Markus; Ladurner, Andreas G.; Pearl, Laurence H.; Oliver, Antony W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase 1 (PARP1) is a primary DNA damage sensor whose (ADP-ribose) polymerase activity is acutely regulated by interaction with DNA breaks.  Upon activation at sites of DNA damage, PARP1 modifies itself and other proteins by covalent addn. of long, branched polymers of ADP-ribose, which in turn recruit downstream DNA repair and chromatin remodeling factors.  PARP1 recognizes DNA damage through its N-terminal DNA-binding domain (DBD), which consists of a tandem repeat of an unusual zinc-finger (ZnF) domain.  We have detd. the crystal structure of the human PARP1-DBD bound to a DNA break.  Along with functional anal. of PARP1 recruitment to sites of DNA damage in vivo, the structure reveals a dimeric assembly whereby ZnF1 and ZnF2 domains from sep. PARP1 mols. form a strand-break recognition module that helps activate PARP1 by facilitating its dimerization and consequent trans-automodification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuObmZ8n9SLVg90H21EOLACvtfcHk0li5pOUdnORubA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlCrurs%253D&md5=38dfc87a8543158bbf4ddfaf8241f691</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2335%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DA.%2BA.%26aulast%3DTiminszky%26aufirst%3DG.%26aulast%3DArribas-Bosacoma%26aufirst%3DR.%26aulast%3DKozlowski%26aufirst%3DM.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHassler%26aufirst%3DM.%26aulast%3DLadurner%26aufirst%3DA.%2BG.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DOliver%26aufirst%3DA.%2BW.%26atitle%3DThe%2520zinc-finger%2520domains%2520of%2520PARP1%2520cooperate%2520to%2520recognize%2520DNA%2520strand%2520breaks%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Luijsterburg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrouwe, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullenders, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantuma, N. P.</span><span> </span><span class="NLM_article-title">DDB2 promotes chromatin decondensation at UV-induced DNA damage</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2012&pages=267-281&author=M.+S.+Luijsterburgauthor=M.+Lindhauthor=K.+Acsauthor=M.+G.+Vrouweauthor=A.+Pinesauthor=A.+H.+vanauthor=L.+H.+Mullendersauthor=N.+P.+Dantuma&title=DDB2+promotes+chromatin+decondensation+at+UV-induced+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuijsterburg%26aufirst%3DM.%2BS.%26aulast%3DLindh%26aufirst%3DM.%26aulast%3DAcs%26aufirst%3DK.%26aulast%3DVrouwe%26aufirst%3DM.%2BG.%26aulast%3DPines%26aufirst%3DA.%26aulast%3Dvan%26aufirst%3DA.%2BH.%26aulast%3DMullenders%26aufirst%3DL.%2BH.%26aulast%3DDantuma%26aufirst%3DN.%2BP.%26atitle%3DDDB2%2520promotes%2520chromatin%2520decondensation%2520at%2520UV-induced%2520DNA%2520damage%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2012%26volume%3D197%26spage%3D267%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Goodarzi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, P. A.</span><span> </span><span class="NLM_article-title">The repair and signaling responses to DNA double-strand breaks</span> <span class="citation_source-journal">Adv. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=1-45&author=A.+A.+Goodarziauthor=P.+A.+Jeggo&title=The+repair+and+signaling+responses+to+DNA+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodarzi%26aufirst%3DA.%2BA.%26aulast%3DJeggo%26aufirst%3DP.%2BA.%26atitle%3DThe%2520repair%2520and%2520signaling%2520responses%2520to%2520DNA%2520double-strand%2520breaks%26jtitle%3DAdv.%2520Genet.%26date%3D2013%26volume%3D82%26spage%3D1%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sperka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, K. L.</span><span> </span><span class="NLM_article-title">DNA damage checkpoints in stem cells, ageing and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm3420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22914294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=579-590&author=T.+Sperkaauthor=J.+Wangauthor=K.+L.+Rudolph&title=DNA+damage+checkpoints+in+stem+cells%2C+ageing+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage checkpoints in stem cells, ageing and cancer</span></div><div class="casAuthors">Sperka, Tobias; Wang, Jianwei; Rudolph, K. Lenhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA damage induces cell-intrinsic checkpoints, including p53 and retinoblastoma (RB), as well as upstream regulators (exonuclease 1 (EXO1), ataxia telangiectasia mutated (ATM), ATR, p16INK4a and p19ARF) and downstream targets (p21, PUMA (p53 upregulated modulator of apoptosis) and sestrins).  Clearance of damaged cells by cell-intrinsic checkpoints suppresses carcinogenesis but as a downside may impair stem cell and tissue maintenance during ageing.  Modulating the activity of DNA damage checkpoints can either accelerate or decelerate tissue ageing and age-related carcinogenesis.  The outcome depends on cell-intrinsic and cell-extrinsic mechanisms that regulate the clearance of damaged cells and on the mol. context in ageing tissues, including the level of DNA damage accumulation itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHH5hhJRv5LVg90H21EOLACvtfcHk0lhkJhkuIAR7tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbjN&md5=10ecb3400938bda8c5954ff075743cdd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm3420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3420%26sid%3Dliteratum%253Aachs%26aulast%3DSperka%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DK.%2BL.%26atitle%3DDNA%2520damage%2520checkpoints%2520in%2520stem%2520cells%252C%2520ageing%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D579%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballif, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smogorzewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E. R.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalarski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerenthal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1140321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17525332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Kit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1160-1166&author=S.+Matsuokaauthor=B.+A.+Ballifauthor=A.+Smogorzewskaauthor=E.+R.+McDonaldauthor=K.+E.+Hurovauthor=J.+Luoauthor=C.+E.+Bakalarskiauthor=Z.+Zhaoauthor=N.+Soliminiauthor=Y.+Lerenthalauthor=Y.+Shilohauthor=S.+P.+Gygiauthor=S.+J.+Elledge&title=ATM+and+ATR+substrate+analysis+reveals+extensive+protein+networks+responsive+to+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage</span></div><div class="casAuthors">Matsuoka, Shuhei; Ballif, Bryan A.; Smogorzewska, Agata; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Bakalarski, Corey E.; Zhao, Zhenming; Solimini, Nicole; Lerenthal, Yaniv; Shiloh, Yosef; Gygi, Steven P.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5828</span>),
    <span class="NLM_cas:pages">1160-1166</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular responses to DNA damage are mediated by a no. of protein kinases, including ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related).  The outlines of the signal transduction portion of this pathway are known, but little is known about the physiol. scope of the DNA damage response (DDR).  We performed a large-scale proteomic anal. of proteins phosphorylated in response to DNA damage on consensus sites recognized by ATM and ATR and identified more than 900 regulated phosphorylation sites encompassing over 700 proteins.  Functional anal. of a subset of this data set indicated that this list is highly enriched for proteins involved in the DDR.  This set of proteins is highly interconnected, and we identified a large no. of protein modules and networks not previously linked to the DDR.  This database paints a much broader landscape for the DDR than was previously appreciated and opens new avenues of investigation into the responses to DNA damage in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZIQna2pqRWrVg90H21EOLACvtfcHk0lhkJhkuIAR7tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Kit7o%253D&md5=ee6ee3a4a06556f457c8efabc2fe62be</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1140321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1140321%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DBallif%26aufirst%3DB.%2BA.%26aulast%3DSmogorzewska%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%2BR.%26aulast%3DHurov%26aufirst%3DK.%2BE.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DBakalarski%26aufirst%3DC.%2BE.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DSolimini%26aufirst%3DN.%26aulast%3DLerenthal%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DATM%2520and%2520ATR%2520substrate%2520analysis%2520reveals%2520extensive%2520protein%2520networks%2520responsive%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1160%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantor, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, R.</span><span> </span><span class="NLM_article-title">Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=317-328&author=J.+Chenauthor=D.+P.+Silverauthor=D.+Walpitaauthor=S.+B.+Cantorauthor=A.+F.+Gazdarauthor=G.+Tomlinsonauthor=F.+J.+Couchauthor=B.+L.+Weberauthor=T.+Ashleyauthor=D.+M.+Livingstonauthor=R.+Scully&title=Stable+interaction+between+the+products+of+the+BRCA1+and+BRCA2+tumor+suppressor+genes+in+mitotic+and+meiotic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSilver%26aufirst%3DD.%2BP.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DCantor%26aufirst%3DS.%2BB.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DTomlinson%26aufirst%3DG.%26aulast%3DCouch%26aufirst%3DF.%2BJ.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26aulast%3DAshley%26aufirst%3DT.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DScully%26aufirst%3DR.%26atitle%3DStable%2520interaction%2520between%2520the%2520products%2520of%2520the%2520BRCA1%2520and%2520BRCA2%2520tumor%2520suppressor%2520genes%2520in%2520mitotic%2520and%2520meiotic%2520cells%26jtitle%3DMol.%2520Cell%26date%3D1998%26volume%3D2%26spage%3D317%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pellegrini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkitaraman, A. R.</span><span> </span><span class="NLM_article-title">Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature01230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12442171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2002&pages=287-293&author=L.+Pellegriniauthor=D.+S.+Yuauthor=T.+Loauthor=S.+Anandauthor=M.+Leeauthor=T.+L.+Blundellauthor=A.+R.+Venkitaraman&title=Insights+into+DNA+recombination+from+the+structure+of+a+RAD51-BRCA2+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</span></div><div class="casAuthors">Pellegrini, Luca; Yu, David S.; Lo, Thomas; Anand, Shubha; Lee, MiYoung; Blundell, Tom L.; Venkitaraman, Ashok R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">6913</span>),
    <span class="NLM_cas:pages">287-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The breast cancer susceptibility protein BRCA2 controls the function of RAD51, a recombinase enzyme, in pathways for DNA repair by homologous recombination.  We report here the structure of a complex between an evolutionarily conserved sequence in BRCA2 (the BRC repeat) and the RecA-homol. domain of RAD51.  The BRC repeat mimics a motif in RAD51 that serves as an interface for oligomerization between individual RAD51 monomers, thus enabling BRCA2 to control the assembly of the RAD51 nucleoprotein filament, which is essential for strand-pairing reactions during DNA recombination.  The RAD51 oligomerization motif is highly conserved among RecA-like recombinases, highlighting a common evolutionary origin for the mechanism of nucleoprotein filament formation, mirrored in the BRC repeat.  Cancer-assocd. mutations that affect the BRC repeat disrupt its predicted interaction with RAD51, yielding structural insight into mechanisms for cancer susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo44KTdJmBb5rVg90H21EOLACvtfcHk0lhKQkjeYRC91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVektLY%253D&md5=5dc084f8efb75cf95bc31d4f5b1797e3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature01230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01230%26sid%3Dliteratum%253Aachs%26aulast%3DPellegrini%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%2BS.%26aulast%3DLo%26aufirst%3DT.%26aulast%3DAnand%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26atitle%3DInsights%2520into%2520DNA%2520recombination%2520from%2520the%2520structure%2520of%2520a%2520RAD51-BRCA2%2520complex%26jtitle%3DNature%26date%3D2002%26volume%3D420%26spage%3D287%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ramsden, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellert, M.</span><span> </span><span class="NLM_article-title">Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=609-614&author=D.+A.+Ramsdenauthor=M.+Gellert&title=Ku+protein+stimulates+DNA+end+joining+by+mammalian+DNA+ligases%3A+a+direct+role+for+Ku+in+repair+of+DNA+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DD.%2BA.%26aulast%3DGellert%26aufirst%3DM.%26atitle%3DKu%2520protein%2520stimulates%2520DNA%2520end%2520joining%2520by%2520mammalian%2520DNA%2520ligases%253A%2520a%2520direct%2520role%2520for%2520Ku%2520in%2520repair%2520of%2520DNA%2520double-strand%2520breaks%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D609%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Simsek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasin, M.</span><span> </span><span class="NLM_article-title">Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.1773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20208544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=410-416&author=D.+Simsekauthor=M.+Jasin&title=Alternative+end-joining+is+suppressed+by+the+canonical+NHEJ+component+Xrcc4-ligase+IV+during+chromosomal+translocation+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation</span></div><div class="casAuthors">Simsek, Deniz; Jasin, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-416</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chromosomal translocations in hematol. and mesenchymal tumors form overwhelmingly by nonhomologous end-joining (NHEJ).  Canonical NHEJ, essential for the repair of radiation-induced and some programmed double-strand breaks (DSBs), requires the Xrcc4-ligase IV complex.  For other DSBs, the requirement for Xrcc4-ligase IV is less stringent, suggesting the existence of alternative end-joining (alt-NHEJ) pathways.  To understand the contributions of the canonical NHEJ and alt-NHEJ pathways, translocation formation was examd. in cells deficient in Xrcc4-ligase IV.  Xrcc4-ligase IV was not required for but rather suppressed translocations.  Translocation breakpoint junctions had similar characteristics in wild-type cells and cells deficient in Xrcc4-ligase IV, including an unchanged bias toward microhomol., unlike what was obsd. for intrachromosomal DSB repair.  Complex insertions in some junctions showed that joining can be iterative, encompassing successive processing steps before joining.  The results imply that alt-NHEJ is the primary mediator of translocation formation in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNk90asZ_3LVg90H21EOLACvtfcHk0lhKQkjeYRC91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVCitLs%253D&md5=790ec53459d49d015b8bea66a8636192</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1773%26sid%3Dliteratum%253Aachs%26aulast%3DSimsek%26aufirst%3DD.%26aulast%3DJasin%26aufirst%3DM.%26atitle%3DAlternative%2520end-joining%2520is%2520suppressed%2520by%2520the%2520canonical%2520NHEJ%2520component%2520Xrcc4-ligase%2520IV%2520during%2520chromosomal%2520translocation%2520formation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D410%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gibson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, W. L.</span><span> </span><span class="NLM_article-title">New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm3376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22713970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=411-424&author=B.+A.+Gibsonauthor=W.+L.+Kraus&title=New+insights+into+the+molecular+and+cellular+functions+of+poly%28ADP-ribose%29+and+PARPs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs</span></div><div class="casAuthors">Gibson, Bryan A.; Kraus, W. Lee</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes.  The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signaling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signaling responses.  PARPs act in a complex response network that is driven by the cellular, mol. and chem. biol. of poly(ADP-ribose) (PAR).  This PAR-dependent response network is crucial for a broad array of physiol. and pathol. responses and thus is a good target for chem. therapeutics for several diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIm3s5z-XFELVg90H21EOLACvtfcHk0lh6CvO6wvxv_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVaht70%253D&md5=b72f18e950b804fed13258a3930fe004</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrm3376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3376%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DB.%2BA.%26aulast%3DKraus%26aufirst%3DW.%2BL.%26atitle%3DNew%2520insights%2520into%2520the%2520molecular%2520and%2520cellular%2520functions%2520of%2520poly%2528ADP-ribose%2529%2520and%2520PARPs%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, W. L.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribosyl)ation by PARP-1: “PAR-laying” NAD+ into a nuclear signal</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1951</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1951-1967&author=M.+Y.+Kimauthor=T.+Zhangauthor=W.+L.+Kraus&title=Poly%28ADP-ribosyl%29ation+by+PARP-1%3A+%E2%80%9CPAR-laying%E2%80%9D+NAD%2B+into+a+nuclear+signal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DKraus%26aufirst%3DW.%2BL.%26atitle%3DPoly%2528ADP-ribosyl%2529ation%2520by%2520PARP-1%253A%2520%25E2%2580%259CPAR-laying%25E2%2580%259D%2520NAD%252B%2520into%2520a%2520nuclear%2520signal%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1951%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ruscetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehnert, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trong, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. R.</span><span> </span><span class="NLM_article-title">Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">14461</span><span class="NLM_x">–</span> <span class="NLM_lpage">14467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=14461-14467&author=T.+Ruscettiauthor=B.+E.+Lehnertauthor=J.+Halbrookauthor=H.+L.+Trongauthor=M.+F.+Hoekstraauthor=D.+J.+Chenauthor=S.+R.+Peterson&title=Stimulation+of+the+DNA-dependent+protein+kinase+by+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuscetti%26aufirst%3DT.%26aulast%3DLehnert%26aufirst%3DB.%2BE.%26aulast%3DHalbrook%26aufirst%3DJ.%26aulast%3DTrong%26aufirst%3DH.%2BL.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DD.%2BJ.%26aulast%3DPeterson%26aufirst%3DS.%2BR.%26atitle%3DStimulation%2520of%2520the%2520DNA-dependent%2520protein%2520kinase%2520by%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D14461%26epage%3D14467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ahel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=81-85&author=I.+Ahelauthor=D.+Ahelauthor=T.+Matsusakaauthor=A.+J.+Clarkauthor=J.+Pinesauthor=S.+J.+Boultonauthor=S.+C.+West&title=Poly%28ADP-ribose%29-binding+zinc+finger+motifs+in+DNA+repair%2Fcheckpoint+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhel%26aufirst%3DI.%26aulast%3DAhel%26aufirst%3DD.%26aulast%3DMatsusaka%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DPines%26aufirst%3DJ.%26aulast%3DBoulton%26aufirst%3DS.%2BJ.%26aulast%3DWest%26aufirst%3DS.%2BC.%26atitle%3DPoly%2528ADP-ribose%2529-binding%2520zinc%2520finger%2520motifs%2520in%2520DNA%2520repair%252Fcheckpoint%2520proteins%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Haince, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, G. G.</span><span> </span><span class="NLM_article-title">Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">16441</span><span class="NLM_x">–</span> <span class="NLM_lpage">16453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1074%2Fjbc.M608406200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17428792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVajtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16441-16453&author=J.+F.+Hainceauthor=S.+Kozlovauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=M.+J.+Hendzelauthor=M.+F.+Lavinauthor=G.+G.+Poirier&title=Ataxia+telangiectasia+mutated+%28ATM%29+signaling+network+is+modulated+by+a+novel+poly%28ADP-ribose%29-dependent+pathway+in+the+early+response+to+DNA-damaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ataxia Telangiectasia Mutated (ATM) Signaling Network Is Modulated by a Novel Poly(ADP-ribose)-dependent Pathway in the Early Response to DNA-damaging Agents</span></div><div class="casAuthors">Haince, Jean-Francois; Kozlov, Sergei; Dawson, Valina L.; Dawson, Ted M.; Hendzel, Michael J.; Lavin, Martin F.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">16441-16453</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Poly(ADP-ribosyl)ation is a post-translational modification that is instantly stimulated by DNA strand breaks creating a unique signal for the modulation of protein functions in DNA repair and cell cycle checkpoint pathways.  Here we report that lack of poly(ADP-ribose) synthesis leads to a compromised response to DNA damage.  Deficiency in poly(ADP-ribosyl)ation metab. induces profound cellular sensitivity to DNA-damaging agents, particularly in cells deficient for the protein kinase ataxia telangiectasia mutated (ATM).  At the biochem. level, we examd. the significance of poly(ADP-ribose) synthesis on the regulation of early DNA damage-induced signaling cascade initiated by ATM.  Using potent PARP inhibitors and PARP-1 knock-out cells, we demonstrate a functional interplay between ATM and poly(ADP-ribose) that is important for the phosphorylation of p53, SMC1, and H2AX.  For the first time, we demonstrate a functional and phys. interaction between the major DSB signaling kinase, ATM and poly(ADP-ribosyl)ation by PARP-1, a key enzyme of chromatin remodeling.  This study suggests that poly(ADP-ribose) might serve as a DNA damage sensory mol. that is crit. for early DNA damage signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_7jlZ-ppnPbVg90H21EOLACvtfcHk0lh6CvO6wvxv_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVajtLg%253D&md5=9401678e8556575105acec9f3a84d108</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608406200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608406200%26sid%3Dliteratum%253Aachs%26aulast%3DHaince%26aufirst%3DJ.%2BF.%26aulast%3DKozlov%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DAtaxia%2520telangiectasia%2520mutated%2520%2528ATM%2529%2520signaling%2520network%2520is%2520modulated%2520by%2520a%2520novel%2520poly%2528ADP-ribose%2529-dependent%2520pathway%2520in%2520the%2520early%2520response%2520to%2520DNA-damaging%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D16441%26epage%3D16453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chou, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dephoure, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nottke, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colaiacovo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">18475</span><span class="NLM_x">–</span> <span class="NLM_lpage">18480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18475-18480&author=D.+M.+Chouauthor=B.+Adamsonauthor=N.+E.+Dephoureauthor=X.+Tanauthor=A.+C.+Nottkeauthor=K.+E.+Hurovauthor=S.+P.+Gygiauthor=M.+P.+Colaiacovoauthor=S.+J.+Elledge&title=A+chromatin+localization+screen+reveals+poly+%28ADP+ribose%29-regulated+recruitment+of+the+repressive+polycomb+and+NuRD+complexes+to+sites+of+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DD.%2BM.%26aulast%3DAdamson%26aufirst%3DB.%26aulast%3DDephoure%26aufirst%3DN.%2BE.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DNottke%26aufirst%3DA.%2BC.%26aulast%3DHurov%26aufirst%3DK.%2BE.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DColaiacovo%26aufirst%3DM.%2BP.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520chromatin%2520localization%2520screen%2520reveals%2520poly%2520%2528ADP%2520ribose%2529-regulated%2520recruitment%2520of%2520the%2520repressive%2520polycomb%2520and%2520NuRD%2520complexes%2520to%2520sites%2520of%2520DNA%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D18475%26epage%3D18480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pleschke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleczkowska, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althaus, F. R.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">40974</span><span class="NLM_x">–</span> <span class="NLM_lpage">40980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40974-40980&author=J.+M.+Pleschkeauthor=H.+E.+Kleczkowskaauthor=M.+Strohmauthor=F.+R.+Althaus&title=Poly%28ADP-ribose%29+binds+to+specific+domains+in+DNA+damage+checkpoint+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPleschke%26aufirst%3DJ.%2BM.%26aulast%3DKleczkowska%26aufirst%3DH.%2BE.%26aulast%3DStrohm%26aufirst%3DM.%26aulast%3DAlthaus%26aufirst%3DF.%2BR.%26atitle%3DPoly%2528ADP-ribose%2529%2520binds%2520to%2520specific%2520domains%2520in%2520DNA%2520damage%2520checkpoint%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40974%26epage%3D40980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masutani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span> </span><span class="NLM_article-title">Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1242%2Fjcs.128272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23868975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=4414-4423&author=L.+Weiauthor=S.+Nakajimaauthor=C.+L.+Hsiehauthor=S.+Kannoauthor=M.+Masutaniauthor=A.+S.+Levineauthor=A.+Yasuiauthor=L.+Lan&title=Damage+response+of+XRCC1+at+sites+of+DNA+single+strand+breaks+is+regulated+by+phosphorylation+and+ubiquitylation+after+degradation+of+poly%28ADP-ribose%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)</span></div><div class="casAuthors">Wei, Leizhen; Nakajima, Satoshi; Hsieh, Ching-Lung; Kanno, Shinichiro; Masutani, Mitsuko; Levine, Arthur S.; Yasui, Akira; Lan, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4414-4423</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Single-strand breaks (SSBs) are the most common type of oxidative DNA damage and they are related to aging and many genetic diseases.  The scaffold protein for repair of SSBs, XRCC1, accumulates at sites of poly(ADP-ribose) (pAR) synthesized by PARP, but it is retained at sites of SSBs after pAR degrdn.  How XRCC1 responds to SSBs after pAR degrdn. and how this affects repair progression are not well understood.  We found that XRCC1 dissocs. from pAR and is translocated to sites of SSBs dependent on its BRCTII domain and the function of PARG.  In addn., phosphorylation of XRCC1 is also required for the proper dissocn. kinetics of XRCC1 because (1) phosphorylation sites mutated in XRCC1 (X1 pm) cause retention of XRCC1 at sites of SSB for a longer time compared to wild type XRCC1; and (2) phosphorylation of XRCC1 is required for efficient polyubiquitylation of XRCC1.  Interestingly, a mutant of XRCC1, LL360/361DD, which abolishes pAR binding, shows significant upregulation of ubiquitylation, indicating that pARylation of XRCC1 prevents the poly-ubiquitylation.  We also found that the dynamics of the repair proteins DNA polymerase beta, PNK, APTX, PCNA and ligase I are regulated by domains of XRCC1.  In summary, the dynamic damage response of XRCC1 is regulated in a manner that depends on modifications of polyADP-ribosylation, phosphorylation and ubiquitylation in live cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPj3VHY4k58bVg90H21EOLACvtfcHk0lgyNd7eqZEekg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSmsL3L&md5=e27808fb25d37ea2c308c9f2ac24333a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1242%2Fjcs.128272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.128272%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DC.%2BL.%26aulast%3DKanno%26aufirst%3DS.%26aulast%3DMasutani%26aufirst%3DM.%26aulast%3DLevine%26aufirst%3DA.%2BS.%26aulast%3DYasui%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DDamage%2520response%2520of%2520XRCC1%2520at%2520sites%2520of%2520DNA%2520single%2520strand%2520breaks%2520is%2520regulated%2520by%2520phosphorylation%2520and%2520ubiquitylation%2520after%2520degradation%2520of%2520poly%2528ADP-ribose%2529%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26spage%3D4414%26epage%3D4423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Prasad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrik, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Berg, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span> </span><span class="NLM_article-title">DNA polymerase beta-mediated long patch base excision repair. Poly(ADP-ribose)polymerase-1 stimulates strand displacement DNA synthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">32411</span><span class="NLM_x">–</span> <span class="NLM_lpage">32414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=32411-32414&author=R.+Prasadauthor=O.+I.+Lavrikauthor=S.+J.+Kimauthor=P.+Kedarauthor=X.+P.+Yangauthor=B.+J.+Vande+Bergauthor=S.+H.+Wilson&title=DNA+polymerase+beta-mediated+long+patch+base+excision+repair.+Poly%28ADP-ribose%29polymerase-1+stimulates+strand+displacement+DNA+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DR.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DKedar%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%2BP.%26aulast%3DVande%2BBerg%26aufirst%3DB.%2BJ.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26atitle%3DDNA%2520polymerase%2520beta-mediated%2520long%2520patch%2520base%2520excision%2520repair.%2520Poly%2528ADP-ribose%2529polymerase-1%2520stimulates%2520strand%2520displacement%2520DNA%2520synthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D32411%26epage%3D32414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Sukhanova, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodyreva, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedeva, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrik, O. I.</span><span> </span><span class="NLM_article-title">Human base excision repair enzymes apurinic/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1222-1229&author=M.+V.+Sukhanovaauthor=S.+N.+Khodyrevaauthor=N.+A.+Lebedevaauthor=R.+Prasadauthor=S.+H.+Wilsonauthor=O.+I.+Lavrik&title=Human+base+excision+repair+enzymes+apurinic%2Fapyrimidinic+endonuclease1+%28APE1%29%2C+DNA+polymerase+beta+and+poly%28ADP-ribose%29+polymerase+1%3A+interplay+between+strand-displacement+DNA+synthesis+and+proofreading+exonuclease+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukhanova%26aufirst%3DM.%2BV.%26aulast%3DKhodyreva%26aufirst%3DS.%2BN.%26aulast%3DLebedeva%26aufirst%3DN.%2BA.%26aulast%3DPrasad%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DHuman%2520base%2520excision%2520repair%2520enzymes%2520apurinic%252Fapyrimidinic%2520endonuclease1%2520%2528APE1%2529%252C%2520DNA%2520polymerase%2520beta%2520and%2520poly%2528ADP-ribose%2529%2520polymerase%25201%253A%2520interplay%2520between%2520strand-displacement%2520DNA%2520synthesis%2520and%2520proofreading%2520exonuclease%2520activity%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D1222%26epage%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ahel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horejsi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiechens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Wilson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen-Hughes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, S. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1240-1243&author=D.+Ahelauthor=Z.+Horejsiauthor=N.+Wiechensauthor=S.+E.+Poloauthor=E.+Garcia-Wilsonauthor=I.+Ahelauthor=H.+Flynnauthor=M.+Skehelauthor=S.+C.+Westauthor=S.+P.+Jacksonauthor=T.+Owen-Hughesauthor=S.+J.+Boulton&title=Poly%28ADP-ribose%29-dependent+regulation+of+DNA+repair+by+the+chromatin+remodeling+enzyme+ALC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhel%26aufirst%3DD.%26aulast%3DHorejsi%26aufirst%3DZ.%26aulast%3DWiechens%26aufirst%3DN.%26aulast%3DPolo%26aufirst%3DS.%2BE.%26aulast%3DGarcia-Wilson%26aufirst%3DE.%26aulast%3DAhel%26aufirst%3DI.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%2BC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DOwen-Hughes%26aufirst%3DT.%26aulast%3DBoulton%26aufirst%3DS.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529-dependent%2520regulation%2520of%2520DNA%2520repair%2520by%2520the%2520chromatin%2520remodeling%2520enzyme%2520ALC1%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1240%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Couto, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiely, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddaway, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pears, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakin, N. D.</span><span> </span><span class="NLM_article-title">PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2011&pages=367-375&author=C.+A.+Coutoauthor=H.+Y.+Wangauthor=J.+C.+Greenauthor=R.+Kielyauthor=R.+Siddawayauthor=C.+Borerauthor=C.+J.+Pearsauthor=N.+D.+Lakin&title=PARP+regulates+nonhomologous+end+joining+through+retention+of+Ku+at+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCouto%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DGreen%26aufirst%3DJ.%2BC.%26aulast%3DKiely%26aufirst%3DR.%26aulast%3DSiddaway%26aufirst%3DR.%26aulast%3DBorer%26aufirst%3DC.%26aulast%3DPears%26aufirst%3DC.%2BJ.%26aulast%3DLakin%26aufirst%3DN.%2BD.%26atitle%3DPARP%2520regulates%2520nonhomologous%2520end%2520joining%2520through%2520retention%2520of%2520Ku%2520at%2520double-strand%2520breaks%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D194%26spage%3D367%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mansour, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikomey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahm-Daphi, J.</span><span> </span><span class="NLM_article-title">The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1134-1142&author=W.+Y.+Mansourauthor=K.+Borgmannauthor=C.+Petersenauthor=E.+Dikomeyauthor=J.+Dahm-Daphi&title=The+absence+of+Ku+but+not+defects+in+classical+non-homologous+end-joining+is+required+to+trigger+PARP1-dependent+end-joining"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DW.%2BY.%26aulast%3DBorgmann%26aufirst%3DK.%26aulast%3DPetersen%26aufirst%3DC.%26aulast%3DDikomey%26aufirst%3DE.%26aulast%3DDahm-Daphi%26aufirst%3DJ.%26atitle%3DThe%2520absence%2520of%2520Ku%2520but%2520not%2520defects%2520in%2520classical%2520non-homologous%2520end-joining%2520is%2520required%2520to%2520trigger%2520PARP1-dependent%2520end-joining%26jtitle%3DDNA%2520Repair%26date%3D2013%26volume%3D12%26spage%3D1134%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Aguilar-Quesada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Gamez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Oliva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peralta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matinez-Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiles-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menissier-de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz de Almodovar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span> </span><span class="NLM_article-title">Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition</span> <span class="citation_source-journal">BMC Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1471-2199-8-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17459151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BD2s3nt1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=29&author=R.+Aguilar-Quesadaauthor=J.+A.+Munoz-Gamezauthor=D.+Martin-Olivaauthor=A.+Peraltaauthor=M.+T.+Valenzuelaauthor=R.+Matinez-Romeroauthor=R.+Quiles-Perezauthor=J.+Menissier-de+Murciaauthor=G.+de+Murciaauthor=M.+Ruiz+de+Almodovarauthor=F.+J.+Oliver&title=Interaction+between+ATM+and+PARP-1+in+response+to+DNA+damage+and+sensitization+of+ATM+deficient+cells+through+PARP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition</span></div><div class="casAuthors">Aguilar-Quesada Rocio; Munoz-Gamez Jose Antonio; Martin-Oliva David; Peralta Andreina; Valenzuela Maria Teresa; Matinez-Romero Ruben; Quiles-Perez Rosa; Menissier-de Murcia Josiane; de Murcia Gilbert; Ruiz de Almodovar Mariano; Oliver F Javier</div><div class="citationInfo"><span class="NLM_cas:title">BMC molecular biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">ATM and PARP-1 are two of the most important players in the cell's response to DNA damage.  PARP-1 and ATM recognize and bound to both single and double strand DNA breaks in response to different triggers.  Here we report that ATM and PARP-1 form a molecular complex in vivo in undamaged cells and this association increases after gamma-irradiation.  ATM is also modified by PARP-1 during DNA damage.  We have also evaluated the impact of PARP-1 absence or inhibition on ATM-kinase activity and have found that while PARP-1 deficient cells display a defective ATM-kinase activity and reduced gamma-H2AX foci formation in response to gamma-irradiation, PARP inhibition on itself is able to activate ATM-kinase.  PARP inhibition induced gamma H2AX foci accumulation, in an ATM-dependent manner.  Inhibition of PARP also induces DNA double strand breaks which were dependent on the presence of ATM.  As consequence ATM deficient cells display an increased sensitivity to PARP inhibition.  In summary our results show that while PARP-1 is needed in the response of ATM to gamma irradiation, the inhibition of PARP induces DNA double strand breaks (which are resolved in and ATM-dependent pathway) and activates ATM kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfw2r-L7o8tt0Q2ypr7jHkfW6udTcc2eYz3BNJ13CKb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3nt1ajsg%253D%253D&md5=d8c4d51698467602c0cc817ca4b77ad8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1471-2199-8-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2199-8-29%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar-Quesada%26aufirst%3DR.%26aulast%3DMunoz-Gamez%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Oliva%26aufirst%3DD.%26aulast%3DPeralta%26aufirst%3DA.%26aulast%3DValenzuela%26aufirst%3DM.%2BT.%26aulast%3DMatinez-Romero%26aufirst%3DR.%26aulast%3DQuiles-Perez%26aufirst%3DR.%26aulast%3DMenissier-de%2BMurcia%26aufirst%3DJ.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DRuiz%2Bde%2BAlmodovar%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26atitle%3DInteraction%2520between%2520ATM%2520and%2520PARP-1%2520in%2520response%2520to%2520DNA%2520damage%2520and%2520sensitization%2520of%2520ATM%2520deficient%2520cells%2520through%2520PARP%2520inhibition%26jtitle%3DBMC%2520Mol.%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Yang, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3872</span><span class="NLM_x">–</span> <span class="NLM_lpage">3882</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fsj.onc.1207491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15021907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3872-3882&author=Y.+G.+Yangauthor=U.+Cortesauthor=S.+Patnaikauthor=M.+Jasinauthor=Z.+Q.+Wang&title=Ablation+of+PARP-1+does+not+interfere+with+the+repair+of+DNA+double-strand+breaks%2C+but+compromises+the+reactivation+of+stalled+replication+forks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks</span></div><div class="casAuthors">Yang, Yun-Gui; Cortes, Ulrich; Patnaik, Srinivas; Jasin, Maria; Wang, Zhao-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3872-3882</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant DNA end-sensing and binding mol.  Inactivation of PARP-1 by chems. and genetic mutations slows cell proliferation, increases sister chromatid exchange (SCE), micronuclei formation and chromosome instability, and shortens telomeres.  Given its affinity to DNA breaks and temporal occupation on DNA strand break sites, PARP-1 is proposed to prevent inappropriate DNA recombination.  The authors investigated the potential role of PARP-1 in repair of DNA double-strand breaks (DSBs) and stalled replication forks.  PARP-1-/- embryonic stem cells and embryonic fibroblast cells exhibited normal repair of DNA DSBs by either homologous recombination (HR) or nonhomologous end-joining (NHEJ) pathways.  Inactivation of PARP-1 did not interfere with gene-targeting efficiency in ES cells.  However, PARP-1-/- cells were hypersensitive to the replication damage agent hydroxyurea (HU)-induced cell death and exhibited enhanced SCE formation.  Ablation of PARP-1 delayed reactivation of stalled replication forks imposed by HU and re-entry into the G2-M phase after HU release.  These data indicate that PARP-1 is dispensable in HR induced by DSBs, but is involved in the repair and reactivation of stalled replication forks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob45UCqZt86rVg90H21EOLACvtfcHk0ljmgge8SKtllg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ylt78%253D&md5=8336ccce02aae385138c7061c713b4b3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207491%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%2BG.%26aulast%3DCortes%26aufirst%3DU.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DJasin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DAblation%2520of%2520PARP-1%2520does%2520not%2520interfere%2520with%2520the%2520repair%2520of%2520DNA%2520double-strand%2520breaks%252C%2520but%2520compromises%2520the%2520reactivation%2520of%2520stalled%2520replication%2520forks%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D3872%26epage%3D3882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Shibata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohmi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teraoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masutani, M.</span><span> </span><span class="NLM_article-title">PARP-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1328</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1328-1337&author=A.+Shibataauthor=N.+Kamadaauthor=K.+Masumuraauthor=T.+Nohmiauthor=S.+Kobayashiauthor=H.+Teraokaauthor=H.+Nakagamaauthor=T.+Sugimuraauthor=H.+Suzukiauthor=M.+Masutani&title=PARP-1+deficiency+causes+an+increase+of+deletion+mutations+and+insertions%2Frearrangements+in+vivo+after+treatment+with+an+alkylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DMasumura%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTeraoka%26aufirst%3DH.%26aulast%3DNakagama%26aufirst%3DH.%26aulast%3DSugimura%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DMasutani%26aufirst%3DM.%26atitle%3DPARP-1%2520deficiency%2520causes%2520an%2520increase%2520of%2520deletion%2520mutations%2520and%2520insertions%252Frearrangements%2520in%2520vivo%2520after%2520treatment%2520with%2520an%2520alkylating%2520agent%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D1328%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Menissier de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ame, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Femboj%2Fcdg206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12727891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVKmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=2255-2263&author=J.+Menissier+de+Murciaauthor=M.+Ricoulauthor=L.+Tartierauthor=C.+Niedergangauthor=A.+Huberauthor=F.+Dantzerauthor=V.+Schreiberauthor=J.+C.+Ameauthor=A.+Dierichauthor=M.+LeMeurauthor=L.+Sabatierauthor=P.+Chambonauthor=G.+de+Murcia&title=Functional+interaction+between+PARP-1+and+PARP-2+in+chromosome+stability+and+embryonic+development+in+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Ricoul, Michelle; Tartier, Laurence; Niedergang, Claude; Huber, Aline; Dantzer, Francoise; Schreiber, Valerie; Ame, Jean-Christophe; Dierich, Andree; LeMeur, Marianne; Sabatier, Laure; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2255-2263</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The DNA damage-dependent poly(ADP-ribose) polymerases, PARP-1 and PARP-2, homo- and heterodimerize and are both involved in the base excision repair (BER) pathway.  Here, we report that mice carrying a targeted disruption of the PARP-2 gene are sensitive to ionizing radiation.  Following alkylating agent treatment, parp-2-/--derived mouse embryonic fibroblasts exhibit increased post-replicative genomic instability, G2/M accumulation and chromosome mis-segregation accompanying kinetochore defects.  Moreover, parp-1-/-parp-2-/- double mutant mice are not viable and die at the onset of gastrulation, demonstrating that the expression of both PARP-1 and PARP-2 and/or DNA-dependent poly(ADP-ribosyl) ation is essential during early embryogenesis.  Interestingly, specific female embryonic lethality is obsd. in parp-1+/-parp-2-/- mutants at E9.5.  Meta phase analyses of E8.5 embryonic fibroblasts highlight a specific instability of the X chromosome in those females, but not in males.  Together, these results support the notion that PARP-1 and PARP-2 possess both overlapping and non-redundant functions in the maintenance of genomic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFm6QExlZgjrVg90H21EOLACvtfcHk0ljmgge8SKtllg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVKmu7w%253D&md5=4f881464925f74a16724321bb9b1d107</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg206%26sid%3Dliteratum%253Aachs%26aulast%3DMenissier%2Bde%2BMurcia%26aufirst%3DJ.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DTartier%26aufirst%3DL.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DA.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DAme%26aufirst%3DJ.%2BC.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DSabatier%26aufirst%3DL.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DFunctional%2520interaction%2520between%2520PARP-1%2520and%2520PARP-2%2520in%2520chromosome%2520stability%2520and%2520embryonic%2520development%2520in%2520mouse%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D2255%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutrillaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walztinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">7303</span><span class="NLM_x">–</span> <span class="NLM_lpage">7307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.94.14.7303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9207086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=7303-7307&author=J.+M.+de+Murciaauthor=C.+Niedergangauthor=C.+Truccoauthor=M.+Ricoulauthor=B.+Dutrillauxauthor=M.+Markauthor=F.+J.+Oliverauthor=M.+Massonauthor=A.+Dierichauthor=M.+LeMeurauthor=C.+Walztingerauthor=P.+Chambonauthor=G.+de+Murcia&title=Requirement+of+poly%28ADP-ribose%29+polymerase+in+recovery+from+DNA+damage+in+mice+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Niedergang, Claude; Trucco, Carlotta; Ricoul, Michele; Dutrillaux, Bernard; Mark, Manuel; Oliver, F. Javier; Masson, Murielle; Dierich, Andree; LeMeur, Marianne; Walztinger, Caroline; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7303-7307</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase [PARP; NAD+ ADP-ribosyltransferase; NAD+:poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyltransferase, EC 2.4.2.30] is a zinc-finger DNA-binding protein that detects specifically DNA strand breaks generated by genotoxic agents.  To det. its biol. function, the authors have inactivated both alleles by gene targeting in mice.  Treatment of PARP-/- mice either by the alkylating agent N-methyl-N-nitrosourea (MNU) or by γ-irradn. revealed an extreme sensitivity and a high genomic instability to both agents.  Following whole body γ-irradn. (8 Gy) mutant mice died rapidly from acute radiation toxicity to the small intestine.  Mice-derived PARP-/- cells displayed a high sensitivity to MNU exposure: a G2/M arrest in mouse embryonic fibroblasts and a rapid apoptotic response and a p53 accumulation were obsd. in splenocytes.  Altogether these results demonstrate that PARP is a survival factor playing an essential and pos. role during DNA damage recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwmTBk-nHc7Vg90H21EOLACvtfcHk0lhkWSsCLzLBEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D&md5=a652d7d877fa0c29ff1aeb9769fbd86f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.14.7303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.14.7303%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DTrucco%26aufirst%3DC.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DDutrillaux%26aufirst%3DB.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DWalztinger%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DRequirement%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520recovery%2520from%2520DNA%2520damage%2520in%2520mice%2520and%2520in%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D7303%26epage%3D7307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><div class="note"><p class="first last">(Erratum appears in  <cite>Nature</cite> <span class="NLM_year">2007</span>, <em>447</em>, 346)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature03443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15829966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=913-917&author=H.+E.+Bryantauthor=N.+Schultzauthor=H.+D.+Thomasauthor=K.+M.+Parkerauthor=D.+Flowerauthor=E.+Lopezauthor=S.+Kyleauthor=M.+Meuthauthor=N.+J.+Curtinauthor=T.+Helleday&title=Specific+killing+of+BRCA2-deficient+tumours+with+inhibitors+of+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase</span></div><div class="casAuthors">Bryant, Helen E.; Schultz, Niklas; Thomas, Huw D.; Parker, Kayan M.; Flower, Dan; Lopez, Elena; Kyle, Suzanne; Meuth, Mark; Curtin, Nicola J.; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">913-917</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage.  Nevertheless, PARP1-/- mice are viable, fertile and do not develop early onset tumors.  Here, the authors show that PARP inhibitors trigger γ-H2AX and RAD51 foci formation.  The authors propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair.  Furthermore, the authors show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired.  Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells.  The authors exploit this requirement in order to kill BRCA2-deficient tumors by PARP inhibition alone.  Treatment with PARP inhibitors is likely to be highly tumor specific, because only the tumors (which are BRCA2-/-) in BRCA2+/- patients are defective in homologous recombination.  The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumor, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJ6B7d7dB77Vg90H21EOLACvtfcHk0lhkWSsCLzLBEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D&md5=44631eba667cf75ef99c31d011d6db44</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnature03443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03443%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BM.%26aulast%3DFlower%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMeuth%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DSpecific%2520killing%2520of%2520BRCA2-deficient%2520tumours%2520with%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D913%26epage%3D917%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Patel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span> </span><span class="NLM_article-title">Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">3406</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=3406-3411&author=A.+G.+Patelauthor=J.+N.+Sarkariaauthor=S.+H.+Kaufmann&title=Nonhomologous+end+joining+drives+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+lethality+in+homologous+recombination-deficient+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BG.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DNonhomologous%2520end%2520joining%2520drives%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%2520lethality%2520in%2520homologous%2520recombination-deficient%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D3406%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1685-1691&author=H.+E.+Bryantauthor=T.+Helleday&title=Inhibition+of+poly+%28ADP-ribose%29+polymerase+activates+ATM+which+is+required+for+subsequent+homologous+recombination+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520poly%2520%2528ADP-ribose%2529%2520polymerase%2520activates%2520ATM%2520which%2520is%2520required%2520for%2520subsequent%2520homologous%2520recombination%2520repair%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D1685%26epage%3D1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hegan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachelek, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindra, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, P. M.</span><span> </span><span class="NLM_article-title">Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2201</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2201-2206&author=D.+C.+Heganauthor=Y.+Luauthor=G.+C.+Stachelekauthor=M.+E.+Crosbyauthor=R.+S.+Bindraauthor=P.+M.+Glazer&title=Inhibition+of+poly%28ADP-ribose%29+polymerase+down-regulates+BRCA1+and+RAD51+in+a+pathway+mediated+by+E2F4+and+p130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegan%26aufirst%3DD.%2BC.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DStachelek%26aufirst%3DG.%2BC.%26aulast%3DCrosby%26aufirst%3DM.%2BE.%26aulast%3DBindra%26aufirst%3DR.%2BS.%26aulast%3DGlazer%26aufirst%3DP.%2BM.%26atitle%3DInhibition%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520down-regulates%2520BRCA1%2520and%2520RAD51%2520in%2520a%2520pathway%2520mediated%2520by%2520E2F4%2520and%2520p130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2201%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Antoniou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pharoah, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narod, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risch, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyfjord, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radice, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoukian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton-Culver, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronwald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinius, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorlacius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eerola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrjakoski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, D. F.</span><span> </span><span class="NLM_article-title">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span><div class="note"><p class="first last">(Erratum appears in  <cite>Am. J. Hum. Genet.</cite> <span class="NLM_year">2003</span>, <em>73</em>, 709)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1086%2F375033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12677558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=1117-1130&author=A.+Antoniouauthor=P.+D.+Pharoahauthor=S.+Narodauthor=H.+A.+Rischauthor=J.+E.+Eyfjordauthor=J.+L.+Hopperauthor=N.+Lomanauthor=H.+Olssonauthor=O.+Johannssonauthor=A.+Borgauthor=B.+Pasiniauthor=P.+Radiceauthor=S.+Manoukianauthor=D.+M.+Ecclesauthor=N.+Tangauthor=E.+Olahauthor=H.+Anton-Culverauthor=E.+Warnerauthor=J.+Lubinskiauthor=J.+Gronwaldauthor=B.+Gorskiauthor=H.+Tuliniusauthor=S.+Thorlaciusauthor=H.+Eerolaauthor=H.+Nevanlinnaauthor=K.+Syrjakoskiauthor=O.+P.+Kallioniemiauthor=D.+Thompsonauthor=C.+Evansauthor=J.+Petoauthor=F.+Lallooauthor=D.+G.+Evansauthor=D.+F.+Easton&title=Average+risks+of+breast+and+ovarian+cancer+associated+with+BRCA1+or+BRCA2+mutations+detected+in+case+Series+unselected+for+family+history%3A+a+combined+analysis+of+22+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies</span></div><div class="casAuthors">Antoniou, A.; Pharoah, P. D. P.; Narod, S.; Risch, H. A.; Eyfjord, J. E.; Hopper, J. L.; Loman, N.; Olsson, H.; Johannsson, O.; Borg, A.; Pasini, B.; Radice, P.; Manoukian, S.; Eccles, D. M.; Tang, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tulinius, H.; Thorlacius, S.; Eerola, H.; Nevanlinna, H.; Syrjakoski, K.; Kallioniemi, O.-P.; Thompson, D.; Evans, C.; Peto, J.; Lalloo, F.; Evans, D. G.; Easton, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1117-1130</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the av. magnitude of these risks is uncertain and may depend on the context.  Ests. based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk ests. from studies based on cases unselected for family history have been imprecise.  We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2.  Breast and ovarian cancer incidence rates for mutation carriers were estd. using a modified segregation anal., based on the occurrence of these cancers in the relatives of mutation-carrying index case patients.  The av. cumulative risks in BRCA1-mutation carriers by age 70 yr were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer.  The corresponding ests. for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%).  Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers (P trend.0012) but not for BRCA2-mutation carriers.  Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 yr of age.  We found some evidence for a redn. in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes.  The pattern of cancer risks was similar to those found in multiple-case families, but their abs. magnitudes were lower, particularly for BRCA2.  The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNfcConjQ5W7Vg90H21EOLACvtfcHk0livr2iwi6zZHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslagtbg%253D&md5=97dea4dccdd6e57c4dd1120640090c21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1086%2F375033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F375033%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniou%26aufirst%3DA.%26aulast%3DPharoah%26aufirst%3DP.%2BD.%26aulast%3DNarod%26aufirst%3DS.%26aulast%3DRisch%26aufirst%3DH.%2BA.%26aulast%3DEyfjord%26aufirst%3DJ.%2BE.%26aulast%3DHopper%26aufirst%3DJ.%2BL.%26aulast%3DLoman%26aufirst%3DN.%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DJohannsson%26aufirst%3DO.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DPasini%26aufirst%3DB.%26aulast%3DRadice%26aufirst%3DP.%26aulast%3DManoukian%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DD.%2BM.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DE.%26aulast%3DAnton-Culver%26aufirst%3DH.%26aulast%3DWarner%26aufirst%3DE.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DGronwald%26aufirst%3DJ.%26aulast%3DGorski%26aufirst%3DB.%26aulast%3DTulinius%26aufirst%3DH.%26aulast%3DThorlacius%26aufirst%3DS.%26aulast%3DEerola%26aufirst%3DH.%26aulast%3DNevanlinna%26aufirst%3DH.%26aulast%3DSyrjakoski%26aufirst%3DK.%26aulast%3DKallioniemi%26aufirst%3DO.%2BP.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DPeto%26aufirst%3DJ.%26aulast%3DLalloo%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DD.%2BG.%26aulast%3DEaston%26aufirst%3DD.%2BF.%26atitle%3DAverage%2520risks%2520of%2520breast%2520and%2520ovarian%2520cancer%2520associated%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520detected%2520in%2520case%2520Series%2520unselected%2520for%2520family%2520history%253A%2520a%2520combined%2520analysis%2520of%252022%2520studies%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D72%26spage%3D1117%26epage%3D1130%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D73%26spage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breast Cancer Linkage Consortium</span><span> </span><span class="NLM_article-title">Cancer incidence in BRCA1 mutation carriers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2F94.18.1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12237281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt1Gnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1358-1365&author=D.+Thompsonauthor=D.+F.+Eastonauthor=Breast+Cancer+Linkage+Consortium&title=Cancer+incidence+in+BRCA1+mutation+carriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Incidence in BRCA1 Mutation Carriers</span></div><div class="casAuthors">Thompson, Deborah; Easton, Douglas F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1358-1365</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Germline BRCA1 mutations confer a substantial lifetime risk of breast and ovarian cancer, but whether cancer at other sites is increased is less clear.  To evaluate the risks of other cancers in BRCA1 mutation carriers, we conducted a cohort study of 11 847 individuals from 699 families segregating a BRCA1 mutation that were ascertained in 30 centers across Europe and North America.  The obsd. cancer incidence was compared with the expected cancer incidence based on population cancer rates.  Relative risks (RRs) of each cancer type in BRCA1 carriers relative to risks for the general population were estd. by weighting individuals according to their estd. probability of being a mutation carrier.  All statistical tests were two-sided.  BRCA1 mutation carriers were at a statistically significantly increased risk for several cancers, including pancreatic cancer (RR = 2.26, 95% confidence interval [CI] = 1.26 to 4.06, P =.004) and cancer of the uterine body and cervix (uterine body RR = 2.65, 95% CI = 1.69 to 4.16, P<.001; cervix RR = 3.72, 95% CI = 2.26 to 6.10, P<.001).  There was some evidence of an elevated risk of prostate cancer in mutation carriers younger than 65 yr old (RR = 1.82, 95% CI = 1.01 to 3.29, P =.05) but not in those 65 yr old or older (RR = 0.84, 95% CI = 0.53 to 1.33, P =.45).  Overall, increases in the risk for cancer at sites other than the breast or ovary were small and evident in women (RR = 2.30, 95% CI = 1.93 to 2.75, P =.001) but not in men (RR = 0.95, 95% CI = 0.81 to 1.12, P =.58).  In carriers of BRCA1 mutations, the overall increased risk of cancer at sites other than breast and ovary is small and is obsd. in women but generally not in men.  BRCA1 mutations may confer increased risks of other abdominal cancers in women and increased risks of pancreatic cancer in men and women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKlOCJQe1CvbVg90H21EOLACvtfcHk0livr2iwi6zZHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt1Gnurs%253D&md5=04e4d8a355b2dace5d0ba41c18dd54d7</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F94.18.1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F94.18.1358%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DEaston%26aufirst%3DD.%2BF.%26aulast%3D%26atitle%3DCancer%2520incidence%2520in%2520BRCA1%2520mutation%2520carriers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1358%26epage%3D1365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Roy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. N.</span><span> </span><span class="NLM_article-title">BRCA1 and BRCA2: different roles in a common pathway of genome protection</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc3181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Gksb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=68-78&author=R.+Royauthor=J.+Chunauthor=S.+N.+Powell&title=BRCA1+and+BRCA2%3A+different+roles+in+a+common+pathway+of+genome+protection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA1 and BRCA2: different roles in a common pathway of genome protection</span></div><div class="casAuthors">Roy, Rohini; Chun, Jarin; Powell, Simon N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The proteins encoded by the two major breast cancer susceptibility genes, BRCA1 and BRCA2, work in a common pathway of genome protection.  However, the two proteins work at different stages in the DNA damage response (DDR) and in DNA repair.  BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination.  The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes.  As discussed here, the proteins work in concert to protect the genome from double-strand DNA damage during DNA replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-oyZ81uPqU7Vg90H21EOLACvtfcHk0lgobVZysknVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Gksb7M&md5=97d95a505fdbf7859e3a62e456021c72</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrc3181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3181%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DS.%2BN.%26atitle%3DBRCA1%2520and%2520BRCA2%253A%2520different%2520roles%2520in%2520a%2520common%2520pathway%2520of%2520genome%2520protection%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Thiemermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myint, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia–reperfusion injury in the heart and skeletal muscle</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=679-683&author=C.+Thiemermannauthor=J.+Bowesauthor=F.+P.+Myintauthor=J.+R.+Vane&title=Inhibition+of+the+activity+of+poly%28ADP+ribose%29+synthetase+reduces+ischemia%E2%80%93reperfusion+injury+in+the+heart+and+skeletal+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DMyint%26aufirst%3DF.%2BP.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520the%2520activity%2520of%2520poly%2528ADP%2520ribose%2529%2520synthetase%2520reduces%2520ischemia%25E2%2580%2593reperfusion%2520injury%2520in%2520the%2520heart%2520and%2520skeletal%2520muscle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D679%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Eliasson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandir, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurn, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traystman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnm1097-1089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9334719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1089-1095&author=M.+J.+Eliassonauthor=K.+Sampeiauthor=A.+S.+Mandirauthor=P.+D.+Hurnauthor=R.+J.+Traystmanauthor=J.+Baoauthor=A.+Pieperauthor=Z.+Q.+Wangauthor=T.+M.+Dawsonauthor=S.+H.+Snyderauthor=V.+L.+Dawson&title=Poly%28ADP-ribose%29+polymerase+gene+disruption+renders+mice+resistant+to+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia</span></div><div class="casAuthors">Eliasson, Mikael J. L.; Sampei, Kenji; Mandir, Allen S.; Hurn, Patricia D.; Traystman, Richard J.; Bao, Jun; Pieper, Andrew; Wang, Zhao-Qi; Dawson, Ted M.; Snyder, Solomon H.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1089-1095</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Nitric oxide (NO) and peroxynitrite, formed from NO and superoxide anion, have been implicated as mediators of neuronal damage following focal ischemia, but their mol. targets have not been defined.  One candidate pathway is DNA damage leading to activation of the nuclear enzyme, poly(ADP-ribose) polymerase (PARP), which catalyzes attachment of ADP ribose units from NAD to nuclear proteins following DNA damage.  Excessive activation of PARP can deplete NAD and ATP, which is consumed in regeneration of NAD, leading to cell death by energy depletion.  The authors show that genetic disruption of PARP provides profound protection against glutamate-NO-mediated ischemic insults in vitro and major decreases in infarct vol. after reversible middle cerebral artery occlusion.  These results provide compelling evidence for a primary involvement of PARP activation in neuronal damage following focal ischemia and suggest that therapies designed towards inhibiting PARP may provide benefit in the treatment of cerebrovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSq-7dMGKE7Vg90H21EOLACvtfcHk0lgobVZysknVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFyqtb8%253D&md5=d83a2bb75e066d20b415119fb4452e21</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnm1097-1089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1097-1089%26sid%3Dliteratum%253Aachs%26aulast%3DEliasson%26aufirst%3DM.%2BJ.%26aulast%3DSampei%26aufirst%3DK.%26aulast%3DMandir%26aufirst%3DA.%2BS.%26aulast%3DHurn%26aufirst%3DP.%2BD.%26aulast%3DTraystman%26aufirst%3DR.%2BJ.%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520gene%2520disruption%2520renders%2520mice%2520resistant%2520to%2520cerebral%2520ischemia%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1089%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ha, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hester, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3270</span><span class="NLM_x">–</span> <span class="NLM_lpage">3275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=3270-3275&author=H.+C.+Haauthor=L.+D.+Hesterauthor=S.+H.+Snyder&title=Poly%28ADP-ribose%29+polymerase-1+dependence+of+stress-induced+transcription+factors+and+associated+gene+expression+in+glia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DH.%2BC.%26aulast%3DHester%26aufirst%3DL.%2BD.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520dependence%2520of%2520stress-induced%2520transcription%2520factors%2520and%2520associated%2520gene%2520expression%2520in%2520glia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D3270%26epage%3D3275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Calabrese, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canan-Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkacz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalitzky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2Fdjh005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14709739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=56-67&author=C.+R.+Calabreseauthor=R.+Almassyauthor=S.+Bartonauthor=M.+A.+Bateyauthor=A.+H.+Calvertauthor=S.+Canan-Kochauthor=B.+W.+Durkaczauthor=Z.+Hostomskyauthor=R.+A.+Kumpfauthor=S.+Kyleauthor=J.+Liauthor=K.+Maegleyauthor=D.+R.+Newellauthor=E.+Notarianniauthor=I.+J.+Stratfordauthor=D.+Skalitzkyauthor=H.+D.+Thomasauthor=L.+Z.+Wangauthor=S.+E.+Webberauthor=K.+J.+Williamsauthor=N.+J.+Curtin&title=Anticancer+chemosensitization+and+radiosensitization+by+the+novel+poly%28ADP-ribose%29+polymerase-1+inhibitor+AG14361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361</span></div><div class="casAuthors">Calabrese, Christopher R.; Almassy, Robert; Barton, Stephanie; Batey, Michael A.; Calvert, A. Hilary; Canan-Koch, Stacie; Durkacz, Barbara W.; Hostomsky, Zdenek; Kumpf, Robert A.; Kyle, Suzanne; Li, Jianke; Maegley, Karen; Newell, David R.; Notarianni, Elena; Stratford, Ian J.; Skalitzky, Donald; Thomas, Huw D.; Wang, Lan-Zhen; Webber, Stephen E.; Williams, Kaye J.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) facilitates the repair of DNA strand breaks.  Inhibiting PARP-1 increases the cytotoxicity of DNA-damaging chemotherapy and radiation therapy in vitro.  Because classical PARP-1 inhibitors have limited clin. utility, we investigated whether AG14361, a novel potent PARP-1 inhibitor (inhibition const. <5 nM), enhances the effects of chemotherapy and radiation therapy in human cancer cell cultures and xenografts.  Methods: The effect of AG14361 on the antitumor activity of the DNA alkylating agent temozolomide, topoisomerase I poisons topotecan or irinotecan, or x-irradn. or γ-radiation was investigated in human cancer cell lines A549, LoVo, and SW620 by proliferation and survival assays and in xenografts in mice by tumor vol. detn.  The specificity of AG14361 for PARP-1 was investigated by microarray anal. and by antiproliferation and acute toxicity assays in PARP-1-/- and PARP-1+/+ cells and mice.  After i.p. administration, the concn. of AG14361 was detd. in mouse plasma and tissues, and its effect on PARP-1 activity was detd. in tumor homogenates.  All statistical tests were two-sided.  Results: AG14361 at 0.4 μM did not affect cancer cell gene expression or growth, but it did increase the antiproliferative activity of temozolomide (e.g., in LoVo cells by 5.5-fold, 95% confidence interval [CI] = 4.9-fold to 5.9-fold; P = .004) and topotecan (e.g., in LoVo cells by 1.6-fold, 95% CI = 1.3-fold to 1.9-fold; P = .002) and inhibited recovery from potentially lethal γ-radiation damage in LoVo cells by 73% (95% CI = 48% to 98%).  In vivo, nontoxic doses of AG14361 increased the delay of LoVo xenograft growth induced by irinotecan, x-irradn., or temozolomide by two- to threefold.  The combination of AG14361 and temozolomide caused complete regression of SW620 xenograft tumors.  AG14361 was retained in xenografts in which PARP-1 activity was inhibited by more than 75% for at least 4 h.  Conclusion: AG14361 is, to our knowledge, the first high-potency PARP-1 inhibitor with the specificity and in vivo activity to enhance chemotherapy and radiation therapy of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpwvo2sC6rVg90H21EOLACvtfcHk0lhgO6Hw8Br0Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislarsw%253D%253D&md5=1b14488c625431de24ba11fad79ad9e5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjh005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjh005%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DBarton%26aufirst%3DS.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCanan-Koch%26aufirst%3DS.%26aulast%3DDurkacz%26aufirst%3DB.%2BW.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNotarianni%26aufirst%3DE.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWilliams%26aufirst%3DK.%2BJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DAnticancer%2520chemosensitization%2520and%2520radiosensitization%2520by%2520the%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520inhibitor%2520AG14361%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrd1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15864271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&author=P.+Jagtapauthor=C.+Szabo&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span></div><div class="casAuthors">Jagtap, Prakash; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-440</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are involved in the regulation of many cellular functions.  Three consequences of the activation of PARP1, which is the main isoform of the PARP family, are particularly important for drug development: first, its role in DNA repair; second, its capacity to deplete cellular energetic pools, which culminates in cell dysfunction and necrosis; and third, its capacity to promote the transcription of pro-inflammatory genes.  Consequently, pharmacol. inhibitors of PARP have the potential to enhance the cytotoxicity of certain DNA-damaging anticancer drugs, reduce parenchymal cell necrosis (for example, in stroke or myocardial infarction) and downregulate multiple simultaneous pathways of inflammation and tissue injury (for example, in circulatory shock, colitis or diabetic complications).  The first ultrapotent novel PARP inhibitors have now entered human clin. trials.  This article presents an overview of the principal pathophysiol. pathways and mechanisms that are governed by PARP, followed by the main structures and therapeutic actions of various classes of novel PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDsrfd_xv8g7Vg90H21EOLACvtfcHk0lg15zqxdUGaAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D&md5=1dfd177b8064b017efb5dd7779655d55</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrd1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1718%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Rouleau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, G. G.</span><span> </span><span class="NLM_article-title">PARP inhibition: PARP1 and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc2812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20200537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=293-301&author=M.+Rouleauauthor=A.+Patelauthor=M.+J.+Hendzelauthor=S.+H.+Kaufmannauthor=G.+G.+Poirier&title=PARP+inhibition%3A+PARP1+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">PARP inhibition: PARP1 and beyond</span></div><div class="casAuthors">Rouleau, Michele; Patel, Anand; Hendzel, Michael J.; Kaufmann, Scott H.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-301</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent findings have thrust poly(ADP-ribose) polymerases (PARPs) into the limelight as potential chemotherapeutic targets.  To provide a framework for understanding these recent observations, the authors have reviewed what is known about the structures and functions of the family of PARP enzymes, and then outlined a series of questions that should be addressed to guide the rational development of PARP inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOiY_n1IClmbVg90H21EOLACvtfcHk0li6KHPvrJloWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D&md5=fa3e3964e84229317dadbd505f11ad86</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc2812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2812%26sid%3Dliteratum%253Aachs%26aulast%3DRouleau%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DPARP%2520inhibition%253A%2520PARP1%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Ferraris, D. V.</span><span> </span><span class="NLM_article-title">Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4561</span><span class="NLM_x">–</span> <span class="NLM_lpage">4584</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100012m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1WksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4561-4584&author=D.+V.+Ferraris&title=Evolution+of+poly%28ADP-ribose%29+polymerase-1+%28PARP-1%29+inhibitors.+From+concept+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic</span></div><div class="casAuthors">Ferraris, Dana V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4561-4584</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1) has been an actively pursued drug discovery target for almost 3 decades.  Often referred to as the "guardian angel of DNA", this abundant nuclear enzyme has been the focus of over 20 medicinal chem. programs in a wide range of therapeutic areas encompassing stroke, cardiac ischemia, cancer, inflammation, and diabetes.  Despite the great therapeutic potential for this target and the tremendous academic and industrial efforts dedicated to it, only recently have PARP-1 inhibitors made headway in clin. trials.  Recent results from several PARP-1 inhibitors in phase II clin. trials for cancer therapy have attracted the attention of national media.  Of the several potential therapeutic indications for PARP-1 inhibitors, the two major areas that hold the most promise are ischemia and cancer.  This review is structured to provide the readers with a brief summary of the rationale for PARP-1 as a therapeutic target, to explain the PARP-1 inhibitor pharmacophore, and to provide an update on the progress of the PARP-1 drug discovery programs.  This Perspective will offer a historical account of the crit. PARP-1 publications that instilled the interest of the biopharmaceutical industry in the late 1980s and early 1990s.  Furthermore, I will discuss why PARP- 1 received so much attention in the late 1990s and early 2000s followed by the slight decline in the medicinal chem. efforts today.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPhFTTs4raarVg90H21EOLACvtfcHk0li6KHPvrJloWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1WksLs%253D&md5=6c093238562c908d45dfcd2f3055457d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm100012m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100012m%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26atitle%3DEvolution%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520%2528PARP-1%2529%2520inhibitors.%2520From%2520concept%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4561%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Wahlberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frostell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, J.</span><span> </span><span class="NLM_article-title">Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=283-288&author=E.+Wahlbergauthor=T.+Karlbergauthor=E.+Kouznetsovaauthor=N.+Markovaauthor=A.+Macchiaruloauthor=A.+G.+Thorsellauthor=E.+Polauthor=A.+Frostellauthor=T.+Ekbladauthor=D.+Oncuauthor=B.+Kullauthor=G.+M.+Robertsonauthor=R.+Pellicciariauthor=H.+Schulerauthor=J.+Weigelt&title=Family-wide+chemical+profiling+and+structural+analysis+of+PARP+and+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlberg%26aufirst%3DE.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DKouznetsova%26aufirst%3DE.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DThorsell%26aufirst%3DA.%2BG.%26aulast%3DPol%26aufirst%3DE.%26aulast%3DFrostell%26aufirst%3DA.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DOncu%26aufirst%3DD.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DRobertson%26aufirst%3DG.%2BM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DWeigelt%26aufirst%3DJ.%26atitle%3DFamily-wide%2520chemical%2520profiling%2520and%2520structural%2520analysis%2520of%2520PARP%2520and%2520tankyrase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D283%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Skalitzky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marakovits, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0255769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=210-213&author=D.+J.+Skalitzkyauthor=J.+T.+Marakovitsauthor=K.+A.+Maegleyauthor=A.+Ekkerauthor=X.+H.+Yuauthor=Z.+Hostomskyauthor=S.+E.+Webberauthor=B.+W.+Eastmanauthor=R.+Almassyauthor=J.+Liauthor=N.+J.+Curtinauthor=D.+R.+Newellauthor=A.+H.+Calvertauthor=R.+J.+Griffinauthor=B.+T.+Golding&title=Tricyclic+benzimidazoles+as+potent+poly%28ADP-ribose%29+polymerase-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm0255769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255769%26sid%3Dliteratum%253Aachs%26aulast%3DSkalitzky%26aufirst%3DD.%2BJ.%26aulast%3DMarakovits%26aufirst%3DJ.%2BT.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DEkker%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DEastman%26aufirst%3DB.%2BW.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DTricyclic%2520benzimidazoles%2520as%2520potent%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D210%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Weston, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldreive, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skowronska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudzki, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankovic, T.</span><span> </span><span class="NLM_article-title">The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=4578-4587&author=V.+J.+Westonauthor=C.+E.+Oldreiveauthor=A.+Skowronskaauthor=D.+G.+Oscierauthor=G.+Prattauthor=M.+J.+Dyerauthor=G.+Smithauthor=J.+E.+Powellauthor=Z.+Rudzkiauthor=P.+Kearnsauthor=P.+A.+Mossauthor=A.+M.+Taylorauthor=T.+Stankovic&title=The+PARP+inhibitor+olaparib+induces+significant+killing+of+ATM-deficient+lymphoid+tumor+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeston%26aufirst%3DV.%2BJ.%26aulast%3DOldreive%26aufirst%3DC.%2BE.%26aulast%3DSkowronska%26aufirst%3DA.%26aulast%3DOscier%26aufirst%3DD.%2BG.%26aulast%3DPratt%26aufirst%3DG.%26aulast%3DDyer%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DJ.%2BE.%26aulast%3DRudzki%26aufirst%3DZ.%26aulast%3DKearns%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DP.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DStankovic%26aufirst%3DT.%26atitle%3DThe%2520PARP%2520inhibitor%2520olaparib%2520induces%2520significant%2520killing%2520of%2520ATM-deficient%2520lymphoid%2520tumor%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D4578%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Vilar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartnik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniesta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, S. B.</span><span> </span><span class="NLM_article-title">MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2632</span><span class="NLM_x">–</span> <span class="NLM_lpage">2642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2632-2642&author=E.+Vilarauthor=C.+M.+Bartnikauthor=S.+L.+Stenzelauthor=L.+Raskinauthor=J.+Ahnauthor=V.+Morenoauthor=B.+Mukherjeeauthor=M.+D.+Iniestaauthor=M.+A.+Morganauthor=G.+Rennertauthor=S.+B.+Gruber&title=MRE11+deficiency+increases+sensitivity+to+poly%28ADP-ribose%29+polymerase+inhibition+in+microsatellite+unstable+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilar%26aufirst%3DE.%26aulast%3DBartnik%26aufirst%3DC.%2BM.%26aulast%3DStenzel%26aufirst%3DS.%2BL.%26aulast%3DRaskin%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DIniesta%26aufirst%3DM.%2BD.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DRennert%26aufirst%3DG.%26aulast%3DGruber%26aufirst%3DS.%2BB.%26atitle%3DMRE11%2520deficiency%2520increases%2520sensitivity%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%2520in%2520microsatellite%2520unstable%2520colorectal%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2632%26epage%3D2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Postel-Vinay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friboulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontebasso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorvault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olaussen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5377</span><span class="NLM_x">–</span> <span class="NLM_lpage">5387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=5377-5387&author=S.+Postel-Vinayauthor=I.+Bajramiauthor=L.+Fribouletauthor=R.+Elliottauthor=Y.+Fontebassoauthor=N.+Dorvaultauthor=K.+A.+Olaussenauthor=F.+Andreauthor=J.+C.+Soriaauthor=C.+J.+Lordauthor=A.+Ashworth&title=A+high-throughput+screen+identifies+PARP1%2F2+inhibitors+as+a+potential+therapy+for+ERCC1-deficient+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostel-Vinay%26aufirst%3DS.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DFriboulet%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DFontebasso%26aufirst%3DY.%26aulast%3DDorvault%26aufirst%3DN.%26aulast%3DOlaussen%26aufirst%3DK.%2BA.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DA%2520high-throughput%2520screen%2520identifies%2520PARP1%252F2%2520inhibitors%2520as%2520a%2520potential%2520therapy%2520for%2520ERCC1-deficient%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D5377%26epage%3D5387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Williamson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliocco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebb, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees-Miller, S. P.</span><span> </span><span class="NLM_article-title">Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1002%2Femmm.201200229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22416035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=515-527&author=C.+T.+Williamsonauthor=E.+Kubotaauthor=J.+D.+Hamillauthor=A.+Klimowiczauthor=R.+Yeauthor=H.+Muzikauthor=M.+Deanauthor=L.+Tuauthor=D.+Gilleyauthor=A.+M.+Maglioccoauthor=B.+C.+McKayauthor=D.+G.+Bebbauthor=S.+P.+Lees-Miller&title=Enhanced+cytotoxicity+of+PARP+inhibition+in+mantle+cell+lymphoma+harbouring+mutations+in+both+ATM+and+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53</span></div><div class="casAuthors">Williamson, Chris T.; Kubota, Eiji; Hamill, Jeffrey D.; Klimowicz, Alexander; Ye, Ruiqiong; Muzik, Huong; Dean, Michelle; Tu, LiRen; Gilley, David; Magliocco, Anthony M.; McKay, Bruce C.; Bebb, D. Gwyn; Lees-Miller, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Poly-ADP ribose polymerase (PARP) inhibitors have shown promise in the treatment of human malignancies characterized by deficiencies in the DNA damage repair proteins BRCA1 and BRCA2 and preclin. studies have demonstrated the potential effectiveness of PARP inhibitors in targeting ataxia-telangiectasia mutated (ATM)-deficient tumors.  Here, we show that mantle cell lymphoma (MCL) cells deficient in both ATM and p53 are more sensitive to the PARP inhibitor olaparib than cells lacking ATM function alone.  In ATM-deficient MCL cells, olaparib induced DNA-PK-dependent phosphorylation and stabilization of p53 as well as expression of p53-responsive cell cycle checkpoint regulators, and inhibition of DNA-PK reduced the toxicity of olaparib in ATM-deficient MCL cells.  Thus, both DNA-PK and p53 regulate the response of ATM-deficient MCL cells to olaparib.  In addn., small mol. inhibition of both ATM and PARP was cytotoxic in normal human fibroblasts with disruption of p53, implying that the combination of ATM and PARP inhibitors may have utility in targeting p53-deficient malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc8TNr6X4i5rVg90H21EOLACvtfcHk0lgTjeEr7PMh0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOnu7Y%253D&md5=73d6fadf9301ba2e9f8a7ccf58665abc</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Femmm.201200229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201200229%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DC.%2BT.%26aulast%3DKubota%26aufirst%3DE.%26aulast%3DHamill%26aufirst%3DJ.%2BD.%26aulast%3DKlimowicz%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DMuzik%26aufirst%3DH.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DL.%26aulast%3DGilley%26aufirst%3DD.%26aulast%3DMagliocco%26aufirst%3DA.%2BM.%26aulast%3DMcKay%26aufirst%3DB.%2BC.%26aulast%3DBebb%26aufirst%3DD.%2BG.%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26atitle%3DEnhanced%2520cytotoxicity%2520of%2520PARP%2520inhibition%2520in%2520mantle%2520cell%2520lymphoma%2520harbouring%2520mutations%2520in%2520both%2520ATM%2520and%2520p53%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1002%2Femmm.200900041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20049735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=315-322&author=A.+M.+Mendes-Pereiraauthor=S.+A.+Martinauthor=R.+Broughauthor=A.+McCarthyauthor=J.+R.+Taylorauthor=J.+S.+Kimauthor=T.+Waldmanauthor=C.+J.+Lordauthor=A.+Ashworth&title=Synthetic+lethal+targeting+of+PTEN+mutant+cells+with+PARP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors</span></div><div class="casAuthors">Mendes-Pereira, Ana M.; Martin, Sarah A.; Brough, Rachel; McCarthy, Afshan; Taylor, Jessica R.; Kim, Jung-Sik; Waldman, Todd; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">315-322</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The tumor suppressor gene, phosphatase and tensin homolog (PTEN), is one of the most commonly mutated genes in human cancers.  Recent evidence suggests that PTEN is important for the maintenance of genome stability.  Here, we show that PTEN deficiency causes a homologous recombination (HR) defect in human tumor cells.  The HR deficiency caused by PTEN deficiency, sensitizes tumor cells to potent inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP), both in vitro and in vivo.  PARP inhibitors are now showing considerable promise in the clinic, specifically in patients with mutations in either of the breast cancer susceptibility genes BRCA1 or BRCA2.  The data we present here now suggests that the clin. assessment of PARP inhibitors should be extended beyond those with BRCA mutations to a larger group of patients with PTEN mutant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqq6kbXT_l7Vg90H21EOLACvtfcHk0lgTjeEr7PMh0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL%252FK&md5=c14c7e0d1ae6a753deabbfb125dcc5a2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Femmm.200900041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.200900041%26sid%3Dliteratum%253Aachs%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DS.%2BA.%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DSynthetic%2520lethal%2520targeting%2520of%2520PTEN%2520mutant%2520cells%2520with%2520PARP%2520inhibitors%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D315%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2010-2019&author=C.+J.+Lordauthor=S.+McDonaldauthor=S.+Swiftauthor=N.+C.+Turnerauthor=A.+Ashworth&title=A+high-throughput+RNA+interference+screen+for+DNA+repair+determinants+of+PARP+inhibitor+sensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DMcDonald%26aufirst%3DS.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DA%2520high-throughput%2520RNA%2520interference%2520screen%2520for%2520DNA%2520repair%2520determinants%2520of%2520PARP%2520inhibitor%2520sensitivity%26jtitle%3DDNA%2520Repair%26date%3D2008%26volume%3D7%26spage%3D2010%26epage%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Cardnell, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masrorpour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, L. A.</span><span> </span><span class="NLM_article-title">Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6322</span><span class="NLM_x">–</span> <span class="NLM_lpage">6328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-13-1975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=24077350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6322-6328&author=R.+J.+Cardnellauthor=Y.+Fengauthor=L.+Diaoauthor=Y.+H.+Fanauthor=F.+Masrorpourauthor=J.+Wangauthor=Y.+Shenauthor=G.+B.+Millsauthor=J.+D.+Minnaauthor=J.+V.+Heymachauthor=L.+A.+Byers&title=Proteomic+markers+of+DNA+repair+and+PI3K+pathway+activation+predict+response+to+the+PARP+inhibitor+BMN+673+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer</span></div><div class="casAuthors">Cardnell, Robert J.; Feng, Ying; Diao, Lixia; Fan, You-Hong; Masrorpour, Fatemah; Wang, Jing; Shen, Yuqiao; Mills, Gordon B.; Minna, John D.; Heymach, John V.; Byers, Lauren A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6322-6328</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Small cell lung carcinoma (SCLC) is an aggressive malignancy affecting nearly 30,000 people annually in the United States.  We have previously identified elevated PARP1 levels in SCLC and demonstrated in vitro sensitivity to the PARP inhibitors AZD 2281 and AG014699.  Here, we evaluate activity of a novel, potent PARP inhibitor, BMN 673, and identify markers of response as a basis for developing predictive markers for clin. application.  Exptl. Design: Inhibition of SCLC proliferation by BMN 673 was assayed in vitro and effects on tumor growth were measured in SCLC xenograft models.  Protein expression and pathway activation was assessed by reverse phase protein array and western blot anal.  PARP inhibition was confirmed using a PAR ELISA.  Results: We demonstrate striking, single agent activity of BMN 673 in SCLC cell lines and xenografts, with single agent BMN 673 exhibiting in vivo activity similar to cisplatin.  Sensitivity to BMN 673 was assocd. with elevated baseline expression levels of several DNA repair proteins, whereas greater drug resistance was obsd. in SCLC models with baseline activation of the PI3K/mTOR pathway.  Furthermore, we developed and confirmed these data with a novel "DNA repair score" consisting of a group of 17 DNA repair proteins.  Conclusions: Elevated expression of multiple DNA repair proteins, as well as a corresponding "DNA repair protein score," predict response to BMN 673 in in vitro SCLC models.  These observations complement recent work in which PI3K inhibition sensitizes breast cancer models to PARP inhibition, suggesting cooperation between DNA repair and PI3K pathways.  Clin Cancer Res; 19(22); 6322-8. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjX1GczmvrarVg90H21EOLACvtfcHk0lgYNY_B1BCe4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7bJ&md5=b801c3e12708b8fc5014bdc0bfbd20e8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1975%26sid%3Dliteratum%253Aachs%26aulast%3DCardnell%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DDiao%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DMasrorpour%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DByers%26aufirst%3DL.%2BA.%26atitle%3DProteomic%2520markers%2520of%2520DNA%2520repair%2520and%2520PI3K%2520pathway%2520activation%2520predict%2520response%2520to%2520the%2520PARP%2520inhibitor%2520BMN%2520673%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6322%26epage%3D6328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Brenner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ateeq, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanisamy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabolch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basrur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonigro, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenitoba-Johnson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navone, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=664-678&author=J.+C.+Brennerauthor=B.+Ateeqauthor=Y.+Liauthor=A.+K.+Yocumauthor=Q.+Caoauthor=I.+A.+Asanganiauthor=S.+Patelauthor=X.+Wangauthor=H.+Liangauthor=J.+Yuauthor=N.+Palanisamyauthor=J.+Siddiquiauthor=W.+Yanauthor=X.+Caoauthor=R.+Mehraauthor=A.+Sabolchauthor=V.+Basrurauthor=R.+J.+Lonigroauthor=J.+Yangauthor=S.+A.+Tomlinsauthor=C.+A.+Maherauthor=K.+S.+Elenitoba-Johnsonauthor=M.+Hussainauthor=N.+M.+Navoneauthor=K.+J.+Pientaauthor=S.+Varamballyauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Mechanistic+rationale+for+inhibition+of+poly%28ADP-ribose%29+polymerase+in+ETS+gene+fusion-positive+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DAteeq%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYocum%26aufirst%3DA.%2BK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DPalanisamy%26aufirst%3DN.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DSabolch%26aufirst%3DA.%26aulast%3DBasrur%26aufirst%3DV.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DMaher%26aufirst%3DC.%2BA.%26aulast%3DElenitoba-Johnson%26aufirst%3DK.%2BS.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DNavone%26aufirst%3DN.%2BM.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMechanistic%2520rationale%2520for%2520inhibition%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520ETS%2520gene%2520fusion-positive%2520prostate%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D664%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Nowsheen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e46614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46614&author=S.+Nowsheenauthor=T.+Cooperauthor=J.+A.+Stanleyauthor=E.+S.+Yang&title=Synthetic+lethal+interactions+between+EGFR+and+PARP+inhibition+in+human+triple+negative+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNowsheen%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DT.%26aulast%3DStanley%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DSynthetic%2520lethal%2520interactions%2520between%2520EGFR%2520and%2520PARP%2520inhibition%2520in%2520human%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De46614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinfeldt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, H.</span><span> </span><span class="NLM_article-title">Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7917</span><span class="NLM_x">–</span> <span class="NLM_lpage">7923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-08-1223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19047122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7917-7923&author=R.+Plummerauthor=C.+Jonesauthor=M.+Middletonauthor=R.+Wilsonauthor=J.+Evansauthor=A.+Olsenauthor=N.+Curtinauthor=A.+Boddyauthor=P.+McHughauthor=D.+Newellauthor=A.+Harrisauthor=P.+Johnsonauthor=H.+Steinfeldtauthor=R.+Dewjiauthor=D.+Wangauthor=L.+Robsonauthor=H.+Calvert&title=Phase+I+study+of+the+poly%28ADP-ribose%29+polymerase+inhibitor%2C+AG014699%2C+in+combination+with+temozolomide+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Plummer, Ruth; Jones, Christopher; Middleton, Mark; Wilson, Richard; Evans, Jeffrey; Olsen, Anna; Curtin, Nicola; Boddy, Alan; McHugh, Peter; Newell, David; Harris, Adrian; Johnson, Patrick; Steinfeldt, Heidi; Dewji, Raz; Wang, Diane; Robson, Lesley; Calvert, Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7917-7923</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: One mechanism of tumor resistance to cytotoxic therapy is repair of damaged DNA.  Poly(ADP-ribose) polymerase (PARP)-1 is a nuclear enzyme involved in base excision repair, one of the five major repair pathways.  PARP inhibitors are emerging as a new class of agents that can potentiate chemotherapy and radiotherapy.  The article reports safety, efficacy, pharmacokinetic, and pharmacodynamic results of the first-in-class trial of a PARP inhibitor, AG014699, combined with temozolomide in adults with advanced malignancy.  Exptl. Design: Initially, patients with solid tumors received escalating doses of AG014699 with 100 mg/m2/d temozolomide x 5 every 28 days to establish the PARP ID (PID).  Subsequently, AG014699 dose was fixed at PID and temozolomide escalated to max. tolerated dose or 200 mg/m2 in metastatic melanoma patients whose tumors were biopsied.  AG014699 and temozolomide pharmacokinetics, PARP activity, DNA strand single-strand breaks, response, and toxicity were evaluated.  RESULTS: Thirty-three patients were enrolled.  PARP inhibition was seen at all doses; PID was 12 mg/m2 based on 74% to 97% inhibition of peripheral blood lymphocyte PARP activity.  Recommended doses were 12 mg/m2 AG014699 and 200 mg/m2 temozolomide.  Mean tumor PARP inhibition at 5 h was 92% (range, 46-97%).  No toxicity attributable to AG014699 alone was obsd.  AG014699 showed linear pharmacokinetics with no interaction with temozolomide.  All patients treated at PID showed increases in DNA single-strand breaks and encouraging evidence of activity was seen.  CONCLUSIONS: The combination of AG014699 and temozolomide is well tolerated, pharmacodynamic assessments showing proof of principle of the mode of action of this new class of agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3DGcSbf45bVg90H21EOLACvtfcHk0lgYnMXAAKQ-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegt7%252FM&md5=76b77d0a31dcb652c31e049a7f6163c2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1223%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DMiddleton%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DA.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DBoddy%26aufirst%3DA.%26aulast%3DMcHugh%26aufirst%3DP.%26aulast%3DNewell%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DSteinfeldt%26aufirst%3DH.%26aulast%3DDewji%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRobson%26aufirst%3DL.%26aulast%3DCalvert%26aufirst%3DH.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%252C%2520AG014699%252C%2520in%2520combination%2520with%2520temozolomide%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7917%26epage%3D7923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steven, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbattista, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, H.</span><span> </span><span class="NLM_article-title">A phase II study of the potent PARP inhibitor, rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1007%2Fs00280-013-2113-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23423489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=1191-1199&author=R.+Plummerauthor=P.+Loriganauthor=N.+Stevenauthor=L.+Scottauthor=M.+R.+Middletonauthor=R.+H.+Wilsonauthor=E.+Mulliganauthor=N.+Curtinauthor=D.+Wangauthor=R.+Dewjiauthor=A.+Abbattistaauthor=J.+Galloauthor=H.+Calvert&title=A+phase+II+study+of+the+potent+PARP+inhibitor%2C+rucaparib+%28PF-01367338%2C+AG014699%29%2C+with+temozolomide+in+patients+with+metastatic+melanoma+demonstrating+evidence+of+chemopotentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation</span></div><div class="casAuthors">Plummer, Ruth; Lorigan, Paul; Steven, Neil; Scott, Lucy; Middleton, Mark R.; Wilson, Richard H.; Mulligan, Evan; Curtin, Nicola; Wang, Diane; Dewji, Raz; Abbattista, Antonello; Gallo, Jorge; Calvert, Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1191-1199</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose poly(ADP ribose) polymerase inhibition has been shown to potentiate the cytotoxicity of DNA damaging agents.  A phase I study of rucaparib and temozolomide showed that full-dose temozolomide could be given during PARP inhibition.  We report the results of a phase II study of i.v. rucaparib 12 mg/m2 and oral temozolomide 200 mg/m2 on days 1-5 every 28 days in patients with advanced metastatic melanoma.  Methods Patients with chemotherapy naive measurable metastatic melanoma, performance status ≤2 and good end-organ function were recruited.  Treatment was given until progression.  A two stage phase II design was used, with response rate the primary endpoint.  Population pharmacokinetics and pharmacodynamics were also explored.  Results Forty-six patients were recruited with 37 patients receiving at least 2 cycles and 17 patients at least 6 cycles.  Myelosuppression occurred with 25 patients (54 %) requiring a 25 % dose redn. in temozolomide.  The response rate was 17.4 %, median time to progression 3.5 mo, median overall survival 9.9 mo, and 36 % of patients were progression-free at 6 mo.  Conclusions This study showed that temozolomide (150-200 mg/m2/day) can safely be given with a PARP ID of rucaparib, increasing progression-free survival over historical controls in metastatic melanoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBJwDTgW-YGLVg90H21EOLACvtfcHk0lgYnMXAAKQ-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVemsLw%253D&md5=ae12a942aeec5c9443327f28472fa943</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00280-013-2113-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-013-2113-1%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DLorigan%26aufirst%3DP.%26aulast%3DSteven%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DE.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDewji%26aufirst%3DR.%26aulast%3DAbbattista%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%26aulast%3DCalvert%26aufirst%3DH.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520the%2520potent%2520PARP%2520inhibitor%252C%2520rucaparib%2520%2528PF-01367338%252C%2520AG014699%2529%252C%2520with%2520temozolomide%2520in%2520patients%2520with%2520metastatic%2520melanoma%2520demonstrating%2520evidence%2520of%2520chemopotentiation%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26spage%3D1191%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Fong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carden, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergui-Roelvink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messiou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">A’Hern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span> </span><span class="NLM_article-title">Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2512</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2009.26.9589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20406929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVyjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2512-2519&author=P.+C.+Fongauthor=T.+A.+Yapauthor=D.+S.+Bossauthor=C.+P.+Cardenauthor=M.+Mergui-Roelvinkauthor=C.+Gourleyauthor=J.+De+Greveauthor=J.+Lubinskiauthor=S.+Shanleyauthor=C.+Messiouauthor=R.+A%E2%80%99Hernauthor=A.+Tuttauthor=A.+Ashworthauthor=J.+Stoneauthor=J.+Carmichaelauthor=J.+H.+Schellensauthor=J.+S.+de+Bonoauthor=S.+B.+Kaye&title=Poly%28ADP%29-ribose+polymerase+inhibition%3A+frequent+durable+responses+in+BRCA+carrier+ovarian+cancer+correlating+with+platinum-free+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval</span></div><div class="casAuthors">Fong, Peter C.; Yap, Timothy A.; Boss, David S.; Carden, Craig P.; Mergui-Roelvink, Maria; Gourley, Charlie; De Greve, Jacques; Lubinski, Jan; Shanley, Susan; Messiou, Christina; A'Hern, Roger; Tutt, Andrew; Ashworth, Alan; Stone, John; Carmichael, James; Schellens, Jan H. M.; de Bono, Johann S.; Kaye, Stan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2512-2519</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Selective tumor cell cytotoxicity can be achieved through a synthetic lethal strategy using poly(ADP)-ribose polymerase (PARP) inhibitor therapy in BRCA1/2 mutation carriers in whom tumor cells have defective homologous recombination (HR) DNA repair.  Platinum-based chemotherapy responses correlate with HR DNA repair capacity.  Olaparib is a potent, oral PARP inhibitor that is well tolerated, with antitumor activity in BRCA1/2 mutation carriers.  Patients and Methods: Patients with BRCA1/2-mutated ovarian cancer were treated with olaparib within a dose-escalation and single-stage expansion of a phase I trial.  Antitumor activity was subsequently correlated with platinum sensitivity.  Results: Fifty patients were treated: 48 had germline BRCA1/2 mutations; one had a BRCA2 germline sequence change of unknown significance, and another had a strong family history of BRCA1/2-assocd. cancers who declined mutation testing.  Of the 50 patients, 13 had platinum-sensitive disease, 24 had platinum-resistant disease, and 13 had platinum-refractory disease (according to platinum-free interval).  Twenty (40%; 95% CI, 26% to 55%) achieved Response Evaluation Criteria in Solid Tumors (RECIST) complete or partial responses and/or tumor marker (CA125) responses, and three (6.0%) maintained RECIST disease stabilization for more than 4 mo, giving an overall clin. benefit rate of 46% (95% CI, 32% to 61 %).  Median response duration was 28 wk.  There was a significant assocn. between the clin. benefit rate and platinum-free interval across the platinum-sensitive, resistant, and refractory subgroups (69%, 45%, and 23%, resp.).  Post hoc analyses indicated assocns. between platinum sensitivity and extent of olaparib response (radiol. change, P = .001; CA125 change, P = .002).  Conclusion: Olaparib has antitumor activity in BRCA1/2 mutation ovarian cancer, which is assocd. with platinum sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyvj9Ym5yY27Vg90H21EOLACvtfcHk0liL2a_h0iQs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVyjtr4%253D&md5=4198806c2b9d41e7068d26049fd0cd3f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.26.9589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.26.9589%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DP.%2BC.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DBoss%26aufirst%3DD.%2BS.%26aulast%3DCarden%26aufirst%3DC.%2BP.%26aulast%3DMergui-Roelvink%26aufirst%3DM.%26aulast%3DGourley%26aufirst%3DC.%26aulast%3DDe%2BGreve%26aufirst%3DJ.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DShanley%26aufirst%3DS.%26aulast%3DMessiou%26aufirst%3DC.%26aulast%3DA%25E2%2580%2599Hern%26aufirst%3DR.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26atitle%3DPoly%2528ADP%2529-ribose%2520polymerase%2520inhibition%253A%2520frequent%2520durable%2520responses%2520in%2520BRCA%2520carrier%2520ovarian%2520cancer%2520correlating%2520with%2520platinum-free%2520interval%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D2512%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domchek, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audeh, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzel, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmutzler, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span> </span><span class="NLM_article-title">Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=235-244&author=A.+Tuttauthor=M.+Robsonauthor=J.+E.+Garberauthor=S.+M.+Domchekauthor=M.+W.+Audehauthor=J.+N.+Weitzelauthor=M.+Friedlanderauthor=B.+Arunauthor=N.+Lomanauthor=R.+K.+Schmutzlerauthor=A.+Wardleyauthor=G.+Mitchellauthor=H.+Earlauthor=M.+Wickensauthor=J.+Carmichael&title=Oral+poly%28ADP-ribose%29+polymerase+inhibitor+olaparib+in+patients+with+BRCA1+or+BRCA2+mutations+and+advanced+breast+cancer%3A+a+proof-of-concept+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DRobson%26aufirst%3DM.%26aulast%3DGarber%26aufirst%3DJ.%2BE.%26aulast%3DDomchek%26aufirst%3DS.%2BM.%26aulast%3DAudeh%26aufirst%3DM.%2BW.%26aulast%3DWeitzel%26aufirst%3DJ.%2BN.%26aulast%3DFriedlander%26aufirst%3DM.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DLoman%26aufirst%3DN.%26aulast%3DSchmutzler%26aufirst%3DR.%2BK.%26aulast%3DWardley%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DG.%26aulast%3DEarl%26aufirst%3DH.%26aulast%3DWickens%26aufirst%3DM.%26aulast%3DCarmichael%26aufirst%3DJ.%26atitle%3DOral%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520olaparib%2520in%2520patients%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520and%2520advanced%2520breast%2520cancer%253A%2520a%2520proof-of-concept%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D235%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Bundred, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardovskis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglitis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramonov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=949-958&author=N.+Bundredauthor=J.+Gardovskisauthor=J.+Jaskiewiczauthor=J.+Eglitisauthor=V.+Paramonovauthor=P.+McCormackauthor=H.+Swaislandauthor=M.+Cavallinauthor=T.+Parryauthor=J.+Carmichaelauthor=J.+M.+Dixon&title=Evaluation+of+the+pharmacodynamics+and+pharmacokinetics+of+the+PARP+inhibitor+olaparib%3A+a+phase+I+multicentre+trial+in+patients+scheduled+for+elective+breast+cancer+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBundred%26aufirst%3DN.%26aulast%3DGardovskis%26aufirst%3DJ.%26aulast%3DJaskiewicz%26aufirst%3DJ.%26aulast%3DEglitis%26aufirst%3DJ.%26aulast%3DParamonov%26aufirst%3DV.%26aulast%3DMcCormack%26aufirst%3DP.%26aulast%3DSwaisland%26aufirst%3DH.%26aulast%3DCavallin%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDixon%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamics%2520and%2520pharmacokinetics%2520of%2520the%2520PARP%2520inhibitor%2520olaparib%253A%2520a%2520phase%2520I%2520multicentre%2520trial%2520in%2520patients%2520scheduled%2520for%2520elective%2520breast%2520cancer%2520surgery%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nokihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahina, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span> </span><span class="NLM_article-title">A phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1111%2Fj.1349-7006.2011.02179.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22145984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2012&pages=504-509&author=N.+Yamamotoauthor=H.+Nokiharaauthor=Y.+Yamadaauthor=Y.+Gotoauthor=M.+Taniokaauthor=T.+Shibataauthor=K.+Yamadaauthor=H.+Asahinaauthor=T.+Kawataauthor=X.+Shiauthor=T.+Tamura&title=A+phase+I%2C+dose-finding+and+pharmacokinetic+study+of+olaparib+%28AZD2281%29+in+Japanese+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors</span></div><div class="casAuthors">Yamamoto, Noboru; Nokihara, Hiroshi; Yamada, Yasuhide; Goto, Yasushi; Tanioka, Maki; Shibata, Takashi; Yamada, Kazuhiko; Asahina, Hajime; Kawata, Toshio; Shi, Xiaojin; Tamura, Tomohide</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Olaparib (AZD2281) is an orally active Poly(ADP-ribose) polymerase (PARP) inhibitor with favorable antitumor activity in advanced ovarian and breast cancers with BRCA1/2 mutations in Western (USA and European) studies.  This Phase I dose-finding study evaluated the tolerability, pharmacokinetics, PARP inhibitory activity, and antitumor activity of olaparib in Japanese patients with solid tumors.  Olaparib was administered as a single-dose on day 1, followed by twice-daily dosing for 28 days from 48 h after a single dose.  Doses were escalated from 100 mg b.i.d. in successive cohorts, up to a max. of 400 mg b.i.d.  The present study enrolled 12 patients (n = 3, 3, and 6 in 100, 200 and 400-mg b.i.d. levels, resp.).  The most common adverse events were nausea, increased blood creatinine, decreased hematocrit, leukopenia and lymphopenia; dose-limiting toxicities were not obsd. up to and including the 400-mg b.i.d. dose level.  Following twice-daily dosing, olaparib showed no marked increase in exposure at steady state over that expected from the single-dose pharmacokinetics.  PARP-1 inhibition was obsd. from the 100-mg b.i.d. dose level in peripheral blood mononuclear cells from 6 h post-dose on day 1 during the multiple-dosing period.  A patient with metastatic breast cancer (100 mg b.i.d.) had a partial response for 13 mo and four patients (two each in the 200 and 400-mg b.i.d. levels) had stable disease >8 wk.  Olaparib was well tolerated up to the 400-mg b.i.d. dose in Japanese patients with solid tumors.  Preliminary evidence of antitumor activity was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnA3Dxz9hnbVg90H21EOLACvtfcHk0liL2a_h0iQs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1eru7k%253D&md5=56706a86e4388164e010ea363bd1524c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.02179.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.02179.x%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNokihara%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DTanioka%26aufirst%3DM.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DAsahina%26aufirst%3DH.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTamura%26aufirst%3DT.%26atitle%3DA%2520phase%2520I%252C%2520dose-finding%2520and%2520pharmacokinetic%2520study%2520of%2520olaparib%2520%2528AZD2281%2529%2520in%2520Japanese%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Sci.%26date%3D2012%26volume%3D103%26spage%3D504%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Rajan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kummar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannargudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span> </span><span class="NLM_article-title">A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-11-2425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22371451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2344-2351&author=A.+Rajanauthor=C.+A.+Carterauthor=R.+J.+Kellyauthor=M.+Gutierrezauthor=S.+Kummarauthor=E.+Szaboauthor=M.+A.+Yanceyauthor=J.+Jiauthor=B.+Mannargudiauthor=S.+Wooauthor=S.+Spencerauthor=W.+D.+Figgauthor=G.+Giaccone&title=A+phase+I+combination+study+of+olaparib+with+cisplatin+and+gemcitabine+in+adults+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors</span></div><div class="casAuthors">Rajan, Arun; Carter, Corey A.; Kelly, Ronan J.; Gutierrez, Martin; Kummar, Shivaani; Szabo, Eva; Yancey, Mary Ann; Ji, Jiuping; Mannargudi, Baskar; Woo, Sukyung; Spencer, Shawn; Figg, William Douglas; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2351</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the safety and tolerability of olaparib with cisplatin and gemcitabine, establish the max. tolerated dose (MTD), and evaluate the pharmacodynamic and pharmacokinetic profile of the combination.  Exptl. Design: We conducted a phase I study of olaparib with cisplatin and gemcitabine in patients with advanced solid tumors.  Treatment at dose level 1 (DL1) consisted of olaparib 100 mg orally every 12 h on days 1 to 4, gemcitabine 500 mg/m2 on days 3 and 10, and cisplatin 60 mg/m2 on day 3.  PAR levels were measured in peripheral blood mononuclear cells (PBMC).  RESULTS: Dose-limiting toxicities (DLT) in two of three patients at DL1 included thrombocytopenia and febrile neutropenia.  The protocol was amended to enroll patients treated with ≤2 prior severely myelosuppressive chemotherapy regimens and treated with olaparib 100 mg once daily on days 1 to 4 (DL-1).  No DLTs were seen in six patients at DL-1.  Because of persistent thrombocytopenia and neutropenia following a return to DL1, patients received 100 mg olaparib every 12 h on day 1 only.  No hematol. DLTs were obsd.; nonhematol. DLTs included gastrointestinal bleed, syncope, and hypoxia.  Of 21 patients evaluable for response, two had partial response.  Olaparib inhibited PARP in PBMCs and tumor tissue, although PAR levels were less effectively inhibited when olaparib was used for a short duration.  CONCLUSIONS: Olaparib in combination with cisplatin and gemcitabine is assocd. with myelosuppression even at relatively low doses.  Modified schedules of olaparib in chemotherapy naive patients will have to be explored with std. doses of chemotherapy.  Clin Cancer Res; 18(8); 2344-51.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI7TqGiAg307Vg90H21EOLACvtfcHk0lh_bS8ucVeQPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOnu7o%253D&md5=c1b311dfb8abb03ba06b7d5b5a9739b6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2425%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DA.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DKelly%26aufirst%3DR.%2BJ.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DYancey%26aufirst%3DM.%2BA.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DMannargudi%26aufirst%3DB.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DS.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DA%2520phase%2520I%2520combination%2520study%2520of%2520olaparib%2520with%2520cisplatin%2520and%2520gemcitabine%2520in%2520adults%2520with%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D2344%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buss, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyburski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulonis, U. A.</span><span> </span><span class="NLM_article-title">A phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2972</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2972-2978&author=J.+F.+Liuauthor=S.+M.+Tolaneyauthor=M.+Birrerauthor=G.+F.+Flemingauthor=M.+K.+Bussauthor=S.+E.+Dahlbergauthor=H.+Leeauthor=C.+Whalenauthor=K.+Tyburskiauthor=E.+Winerauthor=P.+Ivyauthor=U.+A.+Matulonis&title=A+phase+1+trial+of+the+poly%28ADP-ribose%29+polymerase+inhibitor+olaparib+%28AZD2281%29+in+combination+with+the+anti-angiogenic+cediranib+%28AZD2171%29+in+recurrent+epithelial+ovarian+or+triple-negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DTolaney%26aufirst%3DS.%2BM.%26aulast%3DBirrer%26aufirst%3DM.%26aulast%3DFleming%26aufirst%3DG.%2BF.%26aulast%3DBuss%26aufirst%3DM.%2BK.%26aulast%3DDahlberg%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DWhalen%26aufirst%3DC.%26aulast%3DTyburski%26aufirst%3DK.%26aulast%3DWiner%26aufirst%3DE.%26aulast%3DIvy%26aufirst%3DP.%26aulast%3DMatulonis%26aufirst%3DU.%2BA.%26atitle%3DA%2520phase%25201%2520trial%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520olaparib%2520%2528AZD2281%2529%2520in%2520combination%2520with%2520the%2520anti-angiogenic%2520cediranib%2520%2528AZD2171%2529%2520in%2520recurrent%2520epithelial%2520ovarian%2520or%2520triple-negative%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D2972%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulonis, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlan, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell-McGuinn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B.</span><span> </span><span class="NLM_article-title">Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer</span> <span class="citation_source-journal">J. Clin.Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2011.36.9215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22203755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=372-379&author=S.+B.+Kayeauthor=J.+Lubinskiauthor=U.+Matulonisauthor=J.+E.+Angauthor=C.+Gourleyauthor=B.+Y.+Karlanauthor=A.+Amnonauthor=K.+M.+Bell-McGuinnauthor=L.+M.+Chenauthor=M.+Friedlanderauthor=T.+Safraauthor=I.+Vergoteauthor=M.+Wickensauthor=E.+S.+Loweauthor=J.+Carmichaelauthor=B.+Kaufman&title=Phase+II%2C+open-label%2C+randomized%2C+multicenter+study+comparing+the+efficacy+and+safety+of+olaparib%2C+a+poly+%28ADP-ribose%29+polymerase+inhibitor%2C+and+pegylated+liposomal+doxorubicin+in+patients+with+BRCA1+or+BRCA2+mutations+and+recurrent+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II, open-label, randomized, multicenter study comparing the efficacy of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 and BRCA2 mutations and recurrent ovarian cancer</span></div><div class="casAuthors">Kaye, Stan B.; Lubinski, Jan; Matulonis, Ursula; Ang, Joo Ern; Gourley, Charlie; Karlan, Beth V.; Amnon, Amit; Bell-McGuinn, Katherine M.; Chen, Lee-May; Friedlander, Michael; Safra, Tamar; Vergote, Ignace; Wickens, Mark; Lowe, Elizabeth S.; Carmichael, James; Kaufman, Bella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Olaparib (AZD2281), an orally active poly (ADP-ribose) polymerase inhibitor that induces synthetic lethality in BRCA1- or BRCA2-deficient cells, has shown promising clin. efficacy in nonrandomized phase II trials in patients with ovarian cancer with BRCA1 or BRCA2 deficiency.  We assessed the comparative efficacy and safety of olaparib and pegylated liposomal doxorubicin (PLD) in this patient population.  Patients and Methods In this multicenter, open-label, randomized, phase II study, patients with ovarian cancer that recurred within 12 mo of prior platinum therapy and with confirmed germline BRCA1 or BRCA2 mutations were enrolled.  Patients were assigned in a 1:1:1 ratio to olaparib 200 mg twice per day or 400 mg twice per day continuously or PLD 50 mg/m2 i.v. every 28 days.  The primary efficacy end point was Response Evaluation Criteria in Solid Tumors (RECIST) -assessed progression-free survival (PFS).  Secondary end points included objective response rate (ORR) and safety.  Results Ninety-seven patients were randomly assigned.  Median PFS was 6.5 mo (95% CI, 5.5 to 10.1 mo), 8.8 mo (95% CI, 5.4 to 9.2 mo), and 7.1 mo (95% CI, 3.7 to 10.7 mo) for the olaparib 200 mg, olaparib 400 mg, and PLD groups, resp.  There was no statistically significant difference in PFS (hazard ratio, 0.88; 95% CI, 0.51 to 1.56; P = .66) for combined olaparib doses vs. PLD.  RECIST-assessed ORRs were 25%, 31 %, and 18% for olaparib 200 mg, olaparib 400 mg, and PLD, resp.; differences were not statistically significant.  Tolerability of both treatments was as expected based on previous trials.  Conclusion The efficacy of olaparib was consistent with previous studies.  However, the efficacy of PLD was greater than expected.  Olaparib 400 mg twice per day is a suitable dose to explore in further studies in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMk-rXAQhaM7Vg90H21EOLACvtfcHk0lhBAWv3rsWmZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKgsr8%253D&md5=4f32a5c28cb1e568687f2d58c19ef885</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.36.9215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.36.9215%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DMatulonis%26aufirst%3DU.%26aulast%3DAng%26aufirst%3DJ.%2BE.%26aulast%3DGourley%26aufirst%3DC.%26aulast%3DKarlan%26aufirst%3DB.%2BY.%26aulast%3DAmnon%26aufirst%3DA.%26aulast%3DBell-McGuinn%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DL.%2BM.%26aulast%3DFriedlander%26aufirst%3DM.%26aulast%3DSafra%26aufirst%3DT.%26aulast%3DVergote%26aufirst%3DI.%26aulast%3DWickens%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DE.%2BS.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DB.%26atitle%3DPhase%2520II%252C%2520open-label%252C%2520randomized%252C%2520multicenter%2520study%2520comparing%2520the%2520efficacy%2520and%2520safety%2520of%2520olaparib%252C%2520a%2520poly%2520%2528ADP-ribose%2529%2520polymerase%2520inhibitor%252C%2520and%2520pegylated%2520liposomal%2520doxorubicin%2520in%2520patients%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520and%2520recurrent%2520ovarian%2520cancer%26jtitle%3DJ.%2520Clin.Oncol.%26date%3D2012%26volume%3D30%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Kummar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speranza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murgo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinders, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parchment, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doroshow, J. H.</span><span> </span><span class="NLM_article-title">Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">5626</span><span class="NLM_x">–</span> <span class="NLM_lpage">5634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=5626-5634&author=S.+Kummarauthor=A.+Chenauthor=J.+Jiauthor=Y.+Zhangauthor=J.+M.+Reidauthor=M.+Amesauthor=L.+Jiaauthor=M.+Weilauthor=G.+Speranzaauthor=A.+J.+Murgoauthor=R.+Kindersauthor=L.+Wangauthor=R.+E.+Parchmentauthor=J.+Carterauthor=H.+Stotlerauthor=L.+Rubinsteinauthor=M.+Hollingsheadauthor=G.+Melilloauthor=Y.+Pommierauthor=W.+Bonnerauthor=J.+E.+Tomaszewskiauthor=J.+H.+Doroshow&title=Phase+I+study+of+PARP+inhibitor+ABT-888+in+combination+with+topotecan+in+adults+with+refractory+solid+tumors+and+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DWeil%26aufirst%3DM.%26aulast%3DSperanza%26aufirst%3DG.%26aulast%3DMurgo%26aufirst%3DA.%2BJ.%26aulast%3DKinders%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DStotler%26aufirst%3DH.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DMelillo%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBonner%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26atitle%3DPhase%2520I%2520study%2520of%2520PARP%2520inhibitor%2520ABT-888%2520in%2520combination%2520with%2520topotecan%2520in%2520adults%2520with%2520refractory%2520solid%2520tumors%2520and%2520lymphomas%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D5626%26epage%3D5634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Sandhu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylands, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riisnaes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreischer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevensleben, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toniatti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenham, R. M.</span><span> </span><span class="NLM_article-title">The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2FS1470-2045%2813%2970240-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23810788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOjtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=882-892&author=S.+K.+Sandhuauthor=W.+R.+Schelmanauthor=G.+Wildingauthor=V.+Morenoauthor=R.+D.+Bairdauthor=S.+Mirandaauthor=L.+Hylandsauthor=R.+Riisnaesauthor=M.+Forsterauthor=A.+Omlinauthor=N.+Kreischerauthor=K.+Thwayauthor=H.+Gevenslebenauthor=L.+Sunauthor=J.+Loughneyauthor=M.+Chatterjeeauthor=C.+Toniattiauthor=C.+L.+Carpenterauthor=R.+Iannoneauthor=S.+B.+Kayeauthor=J.+S.+de+Bonoauthor=R.+M.+Wenham&title=The+poly%28ADP-ribose%29+polymerase+inhibitor+niraparib+%28MK4827%29+in+BRCA+mutation+carriers+and+patients+with+sporadic+cancer%3A+a+phase+1+dose-escalation+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial</span></div><div class="casAuthors">Sandhu, Shahneen K.; Schelman, William R.; Wilding, George; Moreno, Victor; Baird, Richard D.; Miranda, Susana; Hylands, Lucy; Riisnaes, Ruth; Forster, Martin; Omlin, Aurelius; Kreischer, Nathan; Thway, Khin; Gevensleben, Heidrun; Sun, Linda; Loughney, John; Chatterjee, Manash; Toniatti, Carlo; Carpenter, Christopher L.; Iannone, Robert; Kaye, Stan B.; de Bono, Johann S.; Wenham, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">882-892</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP) is implicated in DNA repair and transcription regulation.  Niraparib (MK4827) is an oral potent, selective PARP-1 and PARP-2 inhibitor that induces synthetic lethality in preclin. tumor models with loss of BRCA and PTEN function.  We investigated the safety, tolerability, max. tolerated dose, pharmacokinetic and pharmacodynamic profiles, and preliminary antitumor activity of niraparib.In a phase 1 dose-escalation study, we enrolled patients with advanced solid tumors at one site in the UK and two sites in the USA.  Eligible patients were aged at least 18 years; had a life expectancy of at least 12 wk; had an Eastern Cooperative Oncol. Group performance status of 2 or less; had assessable disease; were not suitable to receive any established treatments; had adequate organ function; and had discontinued any previous anticancer treatments at least 4 wk previously.  In part A, cohorts of three to six patients, enriched for BRCA1 and BRCA2 mutation carriers, received niraparib daily at ten escalating doses from 30 mg to 400 mg in a 21-day cycle to establish the max. tolerated dose.  Dose expansion at the max. tolerated dose was pursued in 15 patients to confirm tolerability.  In part B, we further investigated the max. tolerated dose in patients with sporadic platinum-resistant high-grade serous ovarian cancer and sporadic prostate cancer.  We obtained blood, circulating tumor cells, and optional paired tumor biopsies for pharmacokinetic and pharmacodynamic assessments.  Toxic effects were assessed by common toxicity criteria and tumor responses ascribed by Response Evaluation Criteria in Solid Tumors (RECIST).  Circulating tumor cells and archival tumor tissue in prostate patients were analyzed for exploratory putative predictive biomarkers, such as loss of PTEN expression and ETS rearrangements.  This trial is registered with ClinicalTrials.gov, NCT00749502.Between Sept 15, 2008, and Jan 14, 2011, we enrolled 100 patients: 60 in part A and 40 in part B. 300 mg/day was established as the max. tolerated dose.  Dose-limiting toxic effects reported in the first cycle were grade 3 fatigue (one patient given 30 mg/day), grade 3 pneumonitis (one given 60 mg/day), and grade 4 thrombocytopenia (two given 400 mg/day).  Common treatment-related toxic effects were anemia (48 patients [48%]), nausea (42 [42%]), fatigue (42 [42%]), thrombocytopenia (35 [35%]), anorexia (26 [26%]), neutropenia (24 [24%]), constipation (23 [23%]), and vomiting (20 [20%]), and were predominantly grade 1 or 2.  Pharmacokinetics were dose proportional and the mean terminal elimination half-life was 36·4 h (range 32·8-46·0).  Pharmacodynamic analyses confirmed PARP inhibition exceeded 50% at doses greater than 80 mg/day and antitumor activity was documented beyond doses of 60 mg/day.  Eight (40% [95% CI 19-64]) of 20 BRCA1 or BRCA2 mutation carriers with ovarian cancer had RECIST partial responses, as did two (50% [7-93]) of four mutation carriers with breast cancer.  Antitumor activity was also reported in sporadic high-grade serous ovarian cancer, non-small-cell lung cancer, and prostate cancer.  We recorded no correlation between loss of PTEN expression or ETS rearrangements and measures of antitumor activity in patients with prostate cancer.A recommended phase 2 dose of 300 mg/day niraparib is well tolerated.  Niraparib should be further assessed in inherited and sporadic cancers with homologous recombination DNA repair defects and to target PARP-mediated transcription in cancer.Merck Sharp and Dohme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQBD4DZcJn7Vg90H21EOLACvtfcHk0lhBAWv3rsWmZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOjtLnF&md5=b6f27019bb7887156d1abcf05db2bca3</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970240-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970240-7%26sid%3Dliteratum%253Aachs%26aulast%3DSandhu%26aufirst%3DS.%2BK.%26aulast%3DSchelman%26aufirst%3DW.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DBaird%26aufirst%3DR.%2BD.%26aulast%3DMiranda%26aufirst%3DS.%26aulast%3DHylands%26aufirst%3DL.%26aulast%3DRiisnaes%26aufirst%3DR.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DOmlin%26aufirst%3DA.%26aulast%3DKreischer%26aufirst%3DN.%26aulast%3DThway%26aufirst%3DK.%26aulast%3DGevensleben%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLoughney%26aufirst%3DJ.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWenham%26aufirst%3DR.%2BM.%26atitle%3DThe%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520niraparib%2520%2528MK4827%2529%2520in%2520BRCA%2520mutation%2520carriers%2520and%2520patients%2520with%2520sporadic%2520cancer%253A%2520a%2520phase%25201%2520dose-escalation%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3D882%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdev, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span> </span><span class="NLM_article-title">First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumor</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2012.47.6804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23733753" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2580&author=J.+S.+de+Bonoauthor=L.+A.+Minaauthor=M.+Gonzalezauthor=N.+J.+Curtinauthor=E.+Wangauthor=J.+W.+Henshawauthor=M.+Chadhaauthor=J.+C.+Sachdevauthor=D.+Mateiauthor=G.+S.+Jamesonauthor=M.+Ongauthor=B.+Basuauthor=Z.+A.+Wainbergauthor=L.+A.+Byersauthor=R.+Chughauthor=A.+Dorrauthor=S.+B.+Kayeauthor=R.+K.+Ramanathan&title=First-in-human+trial+of+novel+oral+PARP+inhibitor+BMN+673+in+patients+with+solid+tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.47.6804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.47.6804%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DMina%26aufirst%3DL.%2BA.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DHenshaw%26aufirst%3DJ.%2BW.%26aulast%3DChadha%26aufirst%3DM.%26aulast%3DSachdev%26aufirst%3DJ.%2BC.%26aulast%3DMatei%26aufirst%3DD.%26aulast%3DJameson%26aufirst%3DG.%2BS.%26aulast%3DOng%26aufirst%3DM.%26aulast%3DBasu%26aufirst%3DB.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DByers%26aufirst%3DL.%2BA.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DDorr%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DFirst-in-human%2520trial%2520of%2520novel%2520oral%2520PARP%2520inhibitor%2520BMN%2520673%2520in%2520patients%2520with%2520solid%2520tumor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Banin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smorodinsky, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, Y.</span><span> </span><span class="NLM_article-title">Enhanced phosphorylation of p53 by ATM in response to DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1674</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1674-1677&author=S.+Baninauthor=L.+Moyalauthor=S.+Shiehauthor=Y.+Tayaauthor=C.+W.+Andersonauthor=L.+Chessaauthor=N.+I.+Smorodinskyauthor=C.+Privesauthor=Y.+Reissauthor=Y.+Shilohauthor=Y.+Ziv&title=Enhanced+phosphorylation+of+p53+by+ATM+in+response+to+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanin%26aufirst%3DS.%26aulast%3DMoyal%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DChessa%26aufirst%3DL.%26aulast%3DSmorodinsky%26aufirst%3DN.%2BI.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DReiss%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DZiv%26aufirst%3DY.%26atitle%3DEnhanced%2520phosphorylation%2520of%2520p53%2520by%2520ATM%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1674%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Chehab, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malikzay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazonetis, T. D.</span><span> </span><span class="NLM_article-title">Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=278-288&author=N.+H.+Chehabauthor=A.+Malikzayauthor=M.+Appelauthor=T.+D.+Halazonetis&title=Chk2%2FhCds1+functions+as+a+DNA+damage+checkpoint+in+G%281%29+by+stabilizing+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChehab%26aufirst%3DN.%2BH.%26aulast%3DMalikzay%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DChk2%252FhCds1%2520functions%2520as%2520a%2520DNA%2520damage%2520checkpoint%2520in%2520G%25281%2529%2520by%2520stabilizing%2520p53%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D278%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Tibbetts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumbaugh, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliby, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">A role for ATR in the DNA damage-induced phosphorylation of p53</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1101%2Fgad.13.2.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9925639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVOmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=152-157&author=R.+S.+Tibbettsauthor=K.+M.+Brumbaughauthor=J.+M.+Williamsauthor=J.+N.+Sarkariaauthor=W.+A.+Clibyauthor=S.+Y.+Shiehauthor=Y.+Tayaauthor=C.+Privesauthor=R.+T.+Abraham&title=A+role+for+ATR+in+the+DNA+damage-induced+phosphorylation+of+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A role for ATR in the DNA damage-induced phosphorylation of p53</span></div><div class="casAuthors">Tibbetts, Randal S.; Brumbaugh, Kathryn M.; Williams, Josie M.; Sarkaria, Jann N.; Cliby, William A.; Shieh, Sheau-Yann; Taya, Yoichi; Prives, Carol; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Phosphorylation at Ser-15 may be a crit. event in the up-regulation and functional activation of p53 during cellular stress.  In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells.  Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to γ-irradn. and UV light.  In γ-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner.  ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR9Ikma3VGlrVg90H21EOLACvtfcHk0lgSbeIcS8Rxtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVOmt7c%253D&md5=9219d983beec8d5e6523ceb2493fe1f8</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.2.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.2.152%26sid%3Dliteratum%253Aachs%26aulast%3DTibbetts%26aufirst%3DR.%2BS.%26aulast%3DBrumbaugh%26aufirst%3DK.%2BM.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DCliby%26aufirst%3DW.%2BA.%26aulast%3DShieh%26aufirst%3DS.%2BY.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DA%2520role%2520for%2520ATR%2520in%2520the%2520DNA%2520damage-induced%2520phosphorylation%2520of%2520p53%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D152%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Donzelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span> </span><span class="NLM_article-title">Regulating mammalian checkpoints through Cdc25 inactivation</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=671-677&author=M.+Donzelliauthor=G.+F.+Draetta&title=Regulating+mammalian+checkpoints+through+Cdc25+inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonzelli%26aufirst%3DM.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26atitle%3DRegulating%2520mammalian%2520checkpoints%2520through%2520Cdc25%2520inactivation%26jtitle%3DEMBO%2520Rep.%26date%3D2003%26volume%3D4%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Cliby, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimprich, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=159-169&author=W.+A.+Clibyauthor=C.+J.+Robertsauthor=K.+A.+Cimprichauthor=C.+M.+Stringerauthor=J.+R.+Lambauthor=S.+L.+Schreiberauthor=S.+H.+Friend&title=Overexpression+of+a+kinase-inactive+ATR+protein+causes+sensitivity+to+DNA-damaging+agents+and+defects+in+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCliby%26aufirst%3DW.%2BA.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DCimprich%26aufirst%3DK.%2BA.%26aulast%3DStringer%26aufirst%3DC.%2BM.%26aulast%3DLamb%26aufirst%3DJ.%2BR.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DOverexpression%2520of%2520a%2520kinase-inactive%2520ATR%2520protein%2520causes%2520sensitivity%2520to%2520DNA-damaging%2520agents%2520and%2520defects%2520in%2520cell%2520cycle%2520checkpoints%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Uto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagata, N.</span><span> </span><span class="NLM_article-title">Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3386</span><span class="NLM_x">–</span> <span class="NLM_lpage">3396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3386-3396&author=K.+Utoauthor=D.+Inoueauthor=K.+Shimutaauthor=N.+Nakajoauthor=N.+Sagata&title=Chk1%2C+but+not+Chk2%2C+inhibits+Cdc25+phosphatases+by+a+novel+common+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUto%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DShimuta%26aufirst%3DK.%26aulast%3DNakajo%26aufirst%3DN.%26aulast%3DSagata%26aufirst%3DN.%26atitle%3DChk1%252C%2520but%2520not%2520Chk2%252C%2520inhibits%2520Cdc25%2520phosphatases%2520by%2520a%2520novel%2520common%2520mechanism%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D3386%26epage%3D3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Innocente, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogswell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span> </span><span class="NLM_article-title">p53 regulates a G2 checkpoint through cyclin B1</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">–</span> <span class="NLM_lpage">2152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=2147-2152&author=S.+A.+Innocenteauthor=J.+L.+Abrahamsonauthor=J.+P.+Cogswellauthor=J.+M.+Lee&title=p53+regulates+a+G2+checkpoint+through+cyclin+B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInnocente%26aufirst%3DS.%2BA.%26aulast%3DAbrahamson%26aufirst%3DJ.%2BL.%26aulast%3DCogswell%26aufirst%3DJ.%2BP.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26atitle%3Dp53%2520regulates%2520a%2520G2%2520checkpoint%2520through%2520cyclin%2520B1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D2147%26epage%3D2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Reinhardt, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span> </span><span class="NLM_article-title">p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=175-189&author=H.+C.+Reinhardtauthor=A.+S.+Aslanianauthor=J.+A.+Leesauthor=M.+B.+Yaffe&title=p53-deficient+cells+rely+on+ATM-+and+ATR-mediated+checkpoint+signaling+through+the+p38MAPK%2FMK2+pathway+for+survival+after+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DH.%2BC.%26aulast%3DAslanian%26aufirst%3DA.%2BS.%26aulast%3DLees%26aufirst%3DJ.%2BA.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26atitle%3Dp53-deficient%2520cells%2520rely%2520on%2520ATM-%2520and%2520ATR-mediated%2520checkpoint%2520signaling%2520through%2520the%2520p38MAPK%252FMK2%2520pathway%2520for%2520survival%2520after%2520DNA%2520damage%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D175%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommiska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemann, M. T.</span><span> </span><span class="NLM_article-title">The combined status of ATM and p53 link tumor development with therapeutic response</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1895-1909&author=H.+Jiangauthor=H.+C.+Reinhardtauthor=J.+Bartkovaauthor=J.+Tommiskaauthor=C.+Blomqvistauthor=H.+Nevanlinnaauthor=J.+Bartekauthor=M.+B.+Yaffeauthor=M.+T.+Hemann&title=The+combined+status+of+ATM+and+p53+link+tumor+development+with+therapeutic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DReinhardt%26aufirst%3DH.%2BC.%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DTommiska%26aufirst%3DJ.%26aulast%3DBlomqvist%26aufirst%3DC.%26aulast%3DNevanlinna%26aufirst%3DH.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26aulast%3DHemann%26aufirst%3DM.%2BT.%26atitle%3DThe%2520combined%2520status%2520of%2520ATM%2520and%2520p53%2520link%2520tumor%2520development%2520with%2520therapeutic%2520response%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D1895%26epage%3D1909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Sullivan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla-Just, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGregori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, J. M.</span><span> </span><span class="NLM_article-title">ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnchembio.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22660439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=646-654&author=K.+D.+Sullivanauthor=N.+Padilla-Justauthor=R.+E.+Henryauthor=C.+C.+Porterauthor=J.+Kimauthor=J.+J.+Tentlerauthor=S.+G.+Eckhardtauthor=A.+C.+Tanauthor=J.+DeGregoriauthor=J.+M.+Espinosa&title=ATM+and+MET+kinases+are+synthetic+lethal+with+nongenotoxic+activation+of+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53</span></div><div class="casAuthors">Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Porter, Christopher C.; Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon; DeGregori, James; Espinosa, Joaquin M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">646-654</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p53 tumor suppressor orchestrates alternative stress responses including cell cycle arrest and apoptosis, but the mechanisms defining cell fate upon p53 activation are poorly understood.  Several small-mol. activators of p53 have been developed, including Nutlin-3, but their therapeutic potential is limited by the fact that they induce reversible cell cycle arrest in most cancer cell types.  We report here the results of a genome-wide short hairpin RNA screen for genes that are lethal in combination with p53 activation by Nutlin-3, which showed that the ATM and MET kinases govern cell fate choice upon p53 activation.  Genetic or pharmacol. interference with ATM or MET activity converts the cellular response from cell cycle arrest into apoptosis in diverse cancer cell types without affecting expression of key p53 target genes.  ATM and MET inhibitors also enable Nutlin-3 to kill tumor spheroids.  These results identify new pathways controlling the cellular response to p53 activation and aid in the design of p53-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdE_gnwFlQXLVg90H21EOLACvtfcHk0ljlKKIR9uArqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymtrk%253D&md5=dac083b616ff06a85c46d33346f17593</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.965%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DK.%2BD.%26aulast%3DPadilla-Just%26aufirst%3DN.%26aulast%3DHenry%26aufirst%3DR.%2BE.%26aulast%3DPorter%26aufirst%3DC.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTentler%26aufirst%3DJ.%2BJ.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DDeGregori%26aufirst%3DJ.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26atitle%3DATM%2520and%2520MET%2520kinases%2520are%2520synthetic%2520lethal%2520with%2520nongenotoxic%2520activation%2520of%2520p53%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D646%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-12-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23512991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=959-967&author=M.+A.+Bateyauthor=Y.+Zhaoauthor=S.+Kyleauthor=C.+Richardsonauthor=A.+Sladeauthor=N.+M.+Martinauthor=A.+Lauauthor=D.+R.+Newellauthor=N.+J.+Curtin&title=Preclinical+evaluation+of+a+novel+ATM+inhibitor%2C+KU59403%2C+in+vitro+and+in+vivo+in+p53+functional+and+dysfunctional+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer</span></div><div class="casAuthors">Batey, Michael A.; Zhao, Yan; Kyle, Suzanne; Richardson, Caroline; Slade, Andrew; Martin, Niall M. B.; Lau, Alan; Newell, David R.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia mutated (ATM) kinase signals DNA double-strand breaks (DSB) to cell-cycle arrest via p53 and DNA repair.  ATM-defective cells are sensitive to DSB-inducing agents, making ATM an attractive target for anticancer chemo- and radiosensitization.  KU59403 is an ATM inhibitor with the potency, selectivity, and soly. for advanced preclin. evaluation.  KU59403 was not cytotoxic to human cancer cell lines (SW620, LoVo, HCT116, and MDA-MB-231) per se but significantly increased the cytotoxicity of topoisomerase I and II poisons: camptothecin, etoposide, and doxorubicin.  Chemo- and radiosensitization by ATM inhibition was not p53-dependent.  Following administration to mice, KU59403 distributed to tissues and concns. exceeding those required for in vitro activity were maintained for at least 4 h in tumor xenografts.  KU59403 significantly enhanced the antitumor activity of topoisomerase poisons in mice bearing human colon cancer xenografts (SW620 and HCT116) at doses that were nontoxic alone and well-tolerated in combination.  Chemosensitization was both dose- and schedule-dependent.  KU59403 represents a major advance in ATM inhibitor development, being the 1st compd. to show good tissue distribution and significant chemosensitization in in vivo models of human cancer, without major toxicity.  KU59403 provides the 1st proof-of-principle preclin. data to support the future clin. development of ATM inhibitors.  Mol Cancer Ther; 12(6); 959-67. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlMwHzEdbQrVg90H21EOLACvtfcHk0ljlKKIR9uArqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D&md5=82771364eb5cd8a3baf13e5cd48b5389</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520novel%2520ATM%2520inhibitor%252C%2520KU59403%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520p53%2520functional%2520and%2520dysfunctional%2520models%2520of%2520human%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Nghiem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaziri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">9092</span><span class="NLM_x">–</span> <span class="NLM_lpage">9097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=9092-9097&author=P.+Nghiemauthor=P.+K.+Parkauthor=Y.+Kimauthor=C.+Vaziriauthor=S.+L.+Schreiber&title=ATR+inhibition+selectively+sensitizes+G1+checkpoint-deficient+cells+to+lethal+premature+chromatin+condensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNghiem%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DVaziri%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DATR%2520inhibition%2520selectively%2520sensitizes%2520G1%2520checkpoint-deficient%2520cells%2520to%2520lethal%2520premature%2520chromatin%2520condensation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D9092%26epage%3D9097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Sangster-Guity, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunz, F.</span><span> </span><span class="NLM_article-title">ATR mediates cisplatin resistance in a p53 genotype-specific manner</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2526</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2526-2533&author=N.+Sangster-Guityauthor=B.+H.+Conradauthor=N.+Papadopoulosauthor=F.+Bunz&title=ATR+mediates+cisplatin+resistance+in+a+p53+genotype-specific+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangster-Guity%26aufirst%3DN.%26aulast%3DConrad%26aufirst%3DB.%2BH.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DBunz%26aufirst%3DF.%26atitle%3DATR%2520mediates%2520cisplatin%2520resistance%2520in%2520a%2520p53%2520genotype-specific%2520manner%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Murga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campaner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Contreras, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Artista, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Capetillo, O.</span><span> </span><span class="NLM_article-title">Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22120667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1331-1335&author=M.+Murgaauthor=S.+Campanerauthor=A.+J.+Lopez-Contrerasauthor=L.+I.+Toledoauthor=R.+Soriaauthor=M.+F.+Montanaauthor=L.+D%E2%80%99Artistaauthor=T.+Schlekerauthor=C.+Guerraauthor=E.+Garciaauthor=M.+Barbacidauthor=M.+Hidalgoauthor=B.+Amatiauthor=O.+Fernandez-Capetillo&title=Exploiting+oncogene-induced+replicative+stress+for+the+selective+killing+of+Myc-driven+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors</span></div><div class="casAuthors">Murga, Matilde; Campaner, Stefano; Lopez-Contreras, Andres J.; Toledo, Luis I.; Soria, Rebeca; Montana, Maria F.; D'Artista, Luana; Schleker, Thomas; Guerra, Carmen; Garcia, Elena; Barbacid, Mariano; Hidalgo, Manuel; Amati, Bruno; Fernandez-Capetillo, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1331-1335</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene-induced replicative stress activates an Atr- and Chk1-dependent response, which has been proposed to be widespread in tumors.  We explored whether the presence of replicative stress could be exploited for the selective elimination of cancer cells.  To this end, we evaluated the impact of targeting the replicative stress-response on cancer development.  In mice (Mus musculus), the reduced levels of Atr found on a mouse model of the Atr-Seckel syndrome completely prevented the development of Myc-induced lymphomas or pancreatic tumors, both of which showed abundant levels of replicative stress.  Moreover, Chk1 inhibitors were highly effective in killing Myc-driven lymphomas.  By contrast, pancreatic adenocarcinomas initiated by K-RasG12V showed no detectable evidence of replicative stress and were nonresponsive to this therapy.  Besides its impact on cancer, Myc overexpression aggravated the phenotypes of Atr-Seckel mice, revealing that oncogenes can modulate the severity of replicative stress-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZk3HjRl2oVLVg90H21EOLACvtfcHk0ljbMtAqKgqSxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7vN&md5=95824452f88f115f90129c088d120e56</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2189%26sid%3Dliteratum%253Aachs%26aulast%3DMurga%26aufirst%3DM.%26aulast%3DCampaner%26aufirst%3DS.%26aulast%3DLopez-Contreras%26aufirst%3DA.%2BJ.%26aulast%3DToledo%26aufirst%3DL.%2BI.%26aulast%3DSoria%26aufirst%3DR.%26aulast%3DMontana%26aufirst%3DM.%2BF.%26aulast%3DD%25E2%2580%2599Artista%26aufirst%3DL.%26aulast%3DSchleker%26aufirst%3DT.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DE.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DAmati%26aufirst%3DB.%26aulast%3DFernandez-Capetillo%26aufirst%3DO.%26atitle%3DExploiting%2520oncogene-induced%2520replicative%2520stress%2520for%2520the%2520selective%2520killing%2520of%2520Myc-driven%2520tumors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D1331%26epage%3D1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Kawasumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibodeau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angle-Zahn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conney, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nghiem, P.</span><span> </span><span class="NLM_article-title">Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">13716</span><span class="NLM_x">–</span> <span class="NLM_lpage">13721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=13716-13721&author=M.+Kawasumiauthor=B.+Lemosauthor=J.+E.+Bradnerauthor=R.+Thibodeauauthor=Y.+S.+Kimauthor=M.+Schmidtauthor=E.+Higginsauthor=S.+W.+Kooauthor=A.+Angle-Zahnauthor=A.+Chenauthor=D.+Levineauthor=L.+Nguyenauthor=T.+P.+Heffernanauthor=I.+Longoauthor=A.+Mandinovaauthor=Y.+P.+Luauthor=A.+H.+Conneyauthor=P.+Nghiem&title=Protection+from+UV-induced+skin+carcinogenesis+by+genetic+inhibition+of+the+ataxia+telangiectasia+and+Rad3-related+%28ATR%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawasumi%26aufirst%3DM.%26aulast%3DLemos%26aufirst%3DB.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DThibodeau%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DHiggins%26aufirst%3DE.%26aulast%3DKoo%26aufirst%3DS.%2BW.%26aulast%3DAngle-Zahn%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DLongo%26aufirst%3DI.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%2BP.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DNghiem%26aufirst%3DP.%26atitle%3DProtection%2520from%2520UV-induced%2520skin%2520carcinogenesis%2520by%2520genetic%2520inhibition%2520of%2520the%2520ataxia%2520telangiectasia%2520and%2520Rad3-related%2520%2528ATR%2529%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D13716%26epage%3D13721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Fatah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moseley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarakti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedhouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhusudan, S.</span><span> </span><span class="NLM_article-title">Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e57098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e57098&author=R.+Sultanaauthor=T.+Abdel-Fatahauthor=C.+Perryauthor=P.+Moseleyauthor=N.+Albaraktiauthor=V.+Mohanauthor=C.+Seedhouseauthor=S.+Chanauthor=S.+Madhusudan&title=Ataxia+telangiectasia+mutated+and+Rad3+related+%28ATR%29+protein+kinase+inhibition+is+synthetically+lethal+in+XRCC1+deficient+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DAbdel-Fatah%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DC.%26aulast%3DMoseley%26aufirst%3DP.%26aulast%3DAlbarakti%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DV.%26aulast%3DSeedhouse%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DMadhusudan%26aufirst%3DS.%26atitle%3DAtaxia%2520telangiectasia%2520mutated%2520and%2520Rad3%2520related%2520%2528ATR%2529%2520protein%2520kinase%2520inhibition%2520is%2520synthetically%2520lethal%2520in%2520XRCC1%2520deficient%2520ovarian%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De57098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Huntoon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatten, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahner Hendrickson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huehls, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnitz, L. M.</span><span> </span><span class="NLM_article-title">ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3683</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3683-3691&author=C.+J.+Huntoonauthor=K.+S.+Flattenauthor=A.+E.+Wahner+Hendricksonauthor=A.+M.+Huehlsauthor=S.+L.+Sutorauthor=S.+H.+Kaufmannauthor=L.+M.+Karnitz&title=ATR+inhibition+broadly+sensitizes+ovarian+cancer+cells+to+chemotherapy+independent+of+BRCA+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuntoon%26aufirst%3DC.%2BJ.%26aulast%3DFlatten%26aufirst%3DK.%2BS.%26aulast%3DWahner%2BHendrickson%26aufirst%3DA.%2BE.%26aulast%3DHuehls%26aufirst%3DA.%2BM.%26aulast%3DSutor%26aufirst%3DS.%2BL.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DKarnitz%26aufirst%3DL.%2BM.%26atitle%3DATR%2520inhibition%2520broadly%2520sensitizes%2520ovarian%2520cancer%2520cells%2520to%2520chemotherapy%2520independent%2520of%2520BRCA%2520status%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3683%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">bdel-Fatah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbotts, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarakati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedhouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakha, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhusudan, S.</span><span> </span><span class="NLM_article-title">Targeting XRCC1 deficiency in breast cancer for personalized therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1621-1634&author=R.+Sultanaauthor=T.+bdel-Fatahauthor=R.+Abbottsauthor=C.+Hawkesauthor=N.+Albarakatiauthor=C.+Seedhouseauthor=G.+Ballauthor=S.+Chanauthor=E.+A.+Rakhaauthor=I.+O.+Ellisauthor=S.+Madhusudan&title=Targeting+XRCC1+deficiency+in+breast+cancer+for+personalized+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3Dbdel-Fatah%26aufirst%3DT.%26aulast%3DAbbotts%26aufirst%3DR.%26aulast%3DHawkes%26aufirst%3DC.%26aulast%3DAlbarakati%26aufirst%3DN.%26aulast%3DSeedhouse%26aufirst%3DC.%26aulast%3DBall%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DRakha%26aufirst%3DE.%2BA.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DMadhusudan%26aufirst%3DS.%26atitle%3DTargeting%2520XRCC1%2520deficiency%2520in%2520breast%2520cancer%2520for%2520personalized%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D1621%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Toledo, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Capetillo, O.</span><span> </span><span class="NLM_article-title">A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21552262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=721-727&author=L.+I.+Toledoauthor=M.+Murgaauthor=R.+Zurauthor=R.+Soriaauthor=A.+Rodriguezauthor=S.+Martinezauthor=J.+Oyarzabalauthor=J.+Pastorauthor=J.+R.+Bischoffauthor=O.+Fernandez-Capetillo&title=A+cell-based+screen+identifies+ATR+inhibitors+with+synthetic+lethal+properties+for+cancer-associated+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations</span></div><div class="casAuthors">Toledo, Luis I.; Murga, Matilde; Zur, Rafal; Soria, Rebeca; Rodriguez, Antonio; Martinez, Sonia; Oyarzabal, Julen; Pastor, Joaquin; Bischoff, James R.; Fernandez-Capetillo, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-727</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene activation has been shown to generate replication-born DNA damage, also known as replicative stress.  The primary responder to replicative stress is not Ataxia-Telangiectasia Mutated (ATM) but rather the kinase ATM and Rad3-related (ATR).  One limitation for the study of ATR is the lack of potent inhibitors.  We here describe a cell-based screening strategy that has allowed us to identify compds. with ATR inhibitory activity in the nanomolar range.  Pharmacol. inhibition of ATR generates replicative stress, leading to chromosomal breakage in the presence of conditions that stall replication forks.  Moreover, ATR inhibition is particularly toxic for p53-deficient cells, this toxicity being exacerbated by replicative stress-generating conditions such as the overexpression of cyclin E.  Notably, one of the compds. we identified is NVP-BEZ235, a dual phosphatidylinositol-3-OH kinase (PI3K) and mTOR inhibitor that is being tested for cancer chemotherapy but that we now show is also very potent against ATM, ATR and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8JQaK-RtJQLVg90H21EOLACvtfcHk0liI9xVzPRtjrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVagsr0%253D&md5=3a639ade432083e3665d290c516f2fb0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2076%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DL.%2BI.%26aulast%3DMurga%26aufirst%3DM.%26aulast%3DZur%26aufirst%3DR.%26aulast%3DSoria%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DS.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DFernandez-Capetillo%26aufirst%3DO.%26atitle%3DA%2520cell-based%2520screen%2520identifies%2520ATR%2520inhibitors%2520with%2520synthetic%2520lethal%2520properties%2520for%2520cancer-associated%2520mutations%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D721%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacq, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissink, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thommes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhurst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, C.</span><span> </span><span class="NLM_article-title">Discovery of 4-{4-[(3<i>R</i>)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1<i>H</i>-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2125</span><span class="NLM_x">–</span> <span class="NLM_lpage">2138</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2125-2138&author=K.+M.+Footeauthor=K.+Bladesauthor=A.+Croninauthor=S.+Filleryauthor=S.+S.+Guichardauthor=L.+Hassallauthor=I.+Hicksonauthor=X.+Jacqauthor=P.+J.+Jewsburyauthor=T.+M.+McGuireauthor=J.+W.+Nissinkauthor=R.+Odedraauthor=K.+Pageauthor=P.+Perkinsauthor=A.+Sulemanauthor=K.+Tamauthor=P.+Thommesauthor=R.+Broadhurstauthor=C.+Wood&title=Discovery+of+4-%7B4-%5B%283R%29-3-methylmorpholin-4-yl%5D-6-%5B1-%28methylsulfonyl%29cyclopropyl%5Dpyrimidin-2-yl%7D-1H-indole+%28AZ20%29%3A+a+potent+and+selective+inhibitor+of+ATR+protein+kinase+with+monotherapy+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm301859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301859s%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGuichard%26aufirst%3DS.%2BS.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSuleman%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DK.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DBroadhurst%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25204-%257B4-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-6-%255B1-%2528methylsulfonyl%2529cyclopropyl%255Dpyrimidin-2-yl%257D-1H-indole%2520%2528AZ20%2529%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520ATR%2520protein%2520kinase%2520with%2520monotherapy%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2125%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCormick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2320</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101488z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2320-2330&author=J.+D.+Charrierauthor=S.+J.+Durrantauthor=J.+M.+Golecauthor=D.+P.+Kayauthor=R.+M.+Knegtelauthor=S.+MacCormickauthor=M.+Mortimoreauthor=M.+E.+O%E2%80%99Donnellauthor=J.+L.+Pinderauthor=P.+M.+Reaperauthor=A.+P.+Rutherfordauthor=P.+S.+Wangauthor=S.+C.+Youngauthor=J.+R.+Pollard&title=Discovery+of+potent+and+selective+inhibitors+of+ataxia+telangiectasia+mutated+and+Rad3+related+%28ATR%29+protein+kinase+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents</span></div><div class="casAuthors">Charrier, Jean-Damien; Durrant, Steven J.; Golec, Julian M. C.; Kay, David P.; Knegtel, Ronald M. A.; MacCormick, Somhairle; Mortimore, Michael; O'Donnell, Michael E.; Pinder, Joanne L.; Reaper, Philip M.; Rutherford, Alistair P.; Wang, Paul S. H.; Young, Stephen C.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2320-2330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DNA-damaging agents are among the most frequently used anticancer drugs.  However, they provide only modest benefit in most cancers.  This may be attributed to a genome maintenance network, the DNA damage response (DDR), that recognizes and repairs damaged DNA.  ATR is a major regulator of the DDR and an attractive anticancer target.  Herein, we describe the discovery of a series of aminopyrazines with potent and selective ATR inhibition.  Compd. (I) inhibits ATR with a Ki of 6 nM, shows >600-fold selectivity over related kinases ATM or DNA-PK, and blocks ATR signaling in cells with an IC50 of 0.42 μM.  Using I, here it is shown that ATR inhibition markedly enhances death induced by DNA-damaging agents in certain cancers but not normal cells.  This differential response between cancer and normal cells highlights the great potential for ATR inhibition as a novel mechanism to dramatically increase the efficacy of many established drugs and ionizing radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp56O6NNQ8JNbVg90H21EOLACvtfcHk0liI9xVzPRtjrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCksbc%253D&md5=4f17e7c44fc6c7bdc32886e3415722c8</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm101488z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101488z%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DMacCormick%26aufirst%3DS.%26aulast%3DMortimore%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BE.%26aulast%3DPinder%26aufirst%3DJ.%2BL.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DRutherford%26aufirst%3DA.%2BP.%26aulast%3DWang%26aufirst%3DP.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BC.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ataxia%2520telangiectasia%2520mutated%2520and%2520Rad3%2520related%2520%2528ATR%2529%2520protein%2520kinase%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2320%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCormick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnchembio.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21490603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=428-430&author=P.+M.+Reaperauthor=M.+R.+Griffithsauthor=J.+M.+Longauthor=J.+D.+Charrierauthor=S.+MacCormickauthor=P.+A.+Charltonauthor=J.+M.+Golecauthor=J.+R.+Pollard&title=Selective+killing+of+ATM-+or+p53-deficient+cancer+cells+through+inhibition+of+ATR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR</span></div><div class="casAuthors">Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">428-430</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we report a comprehensive biol. characterization of a potent and selective small-mol. inhibitor of the DNA damage response (DDR) kinase ATR.  We show a profound synthetic lethal interaction between ATR and the ATM-p53 tumor suppressor pathway in cells treated with DNA-damaging agents and establish ATR inhibition as a way to transform the outcome for patients with cancer treated with ionizing radiation or genotoxic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRYth09UxMbVg90H21EOLACvtfcHk0lihtBwUjDwTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1agtrs%253D&md5=58c63122b550b1ca5e9064c4bbf3d68f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.573%26sid%3Dliteratum%253Aachs%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DGriffiths%26aufirst%3DM.%2BR.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DMacCormick%26aufirst%3DS.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DSelective%2520killing%2520of%2520ATM-%2520or%2520p53-deficient%2520cancer%2520cells%2520through%2520inhibition%2520of%2520ATR%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D428%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Fokas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillies, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, T. B.</span><span> </span><span class="NLM_article-title">Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fcddis.2012.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23222511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e441&author=E.+Fokasauthor=R.+Prevoauthor=J.+R.+Pollardauthor=P.+M.+Reaperauthor=P.+A.+Charltonauthor=B.+Cornelissenauthor=K.+A.+Vallisauthor=E.+M.+Hammondauthor=M.+M.+Olcinaauthor=M.+W.+Gilliesauthor=R.+J.+Muschelauthor=T.+B.+Brunner&title=Targeting+ATR+in+vivo+using+the+novel+inhibitor+VE-822+results+in+selective+sensitization+of+pancreatic+tumors+to+radiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation</span></div><div class="casAuthors">Fokas, E.; Prevo, R.; Pollard, J. R.; Reaper, P. M.; Charlton, P. A.; Cornelissen, B.; Vallis, K. A.; Hammond, E. M.; Olcina, M. M.; McKenna, W. Gillies; Muschel, R. J.; Brunner, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e441, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Combined radiochemotherapy is the currently used therapy for locally advanced pancreatic ductal adenocarcinoma (PDAC), but normal tissue toxicity limits its application.  Here we test the hypothesis that inhibition of ATR (ATM-Rad3-related) could increase the sensitivity of the cancer cells to radiation or chemotherapy without affecting normal cells.  We tested VE-822, an ATR inhibitor, for in vitro and in vivo radiosensitization.  Chk1 phosphorylation was used to indicate ATR activity, γH2AX and 53BP1 foci as evidence of DNA damage and Rad51 foci for homologous recombination activity.  Sensitivity to radiation (XRT) and gemcitabine was measured with clonogenic assays in vitro and tumor growth delay in vivo.  Murine intestinal damage was evaluated after abdominal XRT.  VE-822 inhibited ATR in vitro and in vivo.  VE-822 decreased maintenance of cell-cycle checkpoints, increased persistent DNA damage and decreased homologous recombination in irradiated cancer cells.  VE-822 decreased survival of pancreatic cancer cells but not normal cells in response to XRT or gemcitabine.  VE-822 markedly prolonged growth delay of pancreatic cancer xenografts after XRT and gemcitabine-based chemoradiation without augmenting normal cell or tissue toxicity.  These findings support ATR inhibition as a promising new approach to improve the therapeutic ration of radiochemotherapy for patients with PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp66nE6ZdMorVg90H21EOLACvtfcHk0lhitbfXjp_-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWnsA%253D%253D&md5=7223df6ec5dbca8c50889b5df8e4cce6</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.181%26sid%3Dliteratum%253Aachs%26aulast%3DFokas%26aufirst%3DE.%26aulast%3DPrevo%26aufirst%3DR.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DCornelissen%26aufirst%3DB.%26aulast%3DVallis%26aufirst%3DK.%2BA.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DGillies%26aufirst%3DM.%2BW.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DBrunner%26aufirst%3DT.%2BB.%26atitle%3DTargeting%2520ATR%2520in%2520vivo%2520using%2520the%2520novel%2520inhibitor%2520VE-822%2520results%2520in%2520selective%2520sensitization%2520of%2520pancreatic%2520tumors%2520to%2520radiation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Stracker, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrini, J. H.</span><span> </span><span class="NLM_article-title">Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1047-1054&author=T.+H.+Strackerauthor=T.+Usuiauthor=J.+H.+Petrini&title=Taking+the+time+to+make+important+decisions%3A+the+checkpoint+effector+kinases+Chk1+and+Chk2+and+the+DNA+damage+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStracker%26aufirst%3DT.%2BH.%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DPetrini%26aufirst%3DJ.%2BH.%26atitle%3DTaking%2520the%2520time%2520to%2520make%2520important%2520decisions%253A%2520the%2520checkpoint%2520effector%2520kinases%2520Chk1%2520and%2520Chk2%2520and%2520the%2520DNA%2520damage%2520response%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D1047%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Ferrao, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukczynska, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span> </span><span class="NLM_article-title">Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1661-1672&author=P.+T.+Ferraoauthor=E.+P.+Bukczynskaauthor=R.+W.+Johnstoneauthor=G.+A.+McArthur&title=Efficacy+of+CHK+inhibitors+as+single+agents+in+MYC-driven+lymphoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrao%26aufirst%3DP.%2BT.%26aulast%3DBukczynska%26aufirst%3DE.%2BP.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26atitle%3DEfficacy%2520of%2520CHK%2520inhibitors%2520as%2520single%2520agents%2520in%2520MYC-driven%2520lymphoma%2520cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1661%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Landau, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeely, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comenzo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhanwar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-11-0949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22653969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1781-1788&author=H.+J.+Landauauthor=S.+C.+McNeelyauthor=J.+S.+Nairauthor=R.+L.+Comenzoauthor=T.+Asaiauthor=H.+Friedmanauthor=S.+C.+Jhanwarauthor=S.+D.+Nimerauthor=G.+K.+Schwartz&title=The+checkpoint+kinase+inhibitor+AZD7762+potentiates+chemotherapy-induced+apoptosis+of+p53-mutated+multiple+myeloma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53-Mutated Multiple Myeloma Cells</span></div><div class="casAuthors">Landau, Heather J.; McNeely, Samuel C.; Nair, Jayasree S.; Comenzo, Raymond L.; Asai, Takashi; Friedman, Hillel; Jhanwar, Suresh C.; Nimer, Stephen D.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1781-1788</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">DNA crosslinking agents are frequently used in the treatment of multiple myeloma-generating lesions, which activate checkpoint kinase 1 (Chk1), a crit. transducer of the DNA damage response.  Chk1 activation promotes cell survival by regulating cell-cycle arrest and DNA repair following genotoxic stress.  The ability of AZD7762, an ATP-competitive Chk1/2 inhibitor to increase the efficacy of the DNA-damaging agents bendamustine, melphalan, and doxorubicin was examd. using four human myeloma cell lines, KMS-12-BM, KMS-12-PE, RPMI-8226, and U266B1.  The in vitro activity of AZD7762 as monotherapy and combined with alkylating agents and the "novel" drug bortezomib was evaluated by studying its effects on cytotoxicity, signaling, and apoptotic pathways.  The Chk1/2 inhibitor AZD7762 potentiated the antiproliferative effects of bendamustine, melphalan, and doxorubicin but not bortezomib in multiple myeloma cell lines that were p53-deficient.  Increased γH2AX staining in cells treated with bendamustine or melphalan plus AZD7762 indicates a greater degree of DNA damage with combined therapy.  Abrogation of the G2-M checkpoint by AZD7762 resulted in mitotic catastrophe with ensuing apoptosis evidenced by PARP and caspase-3 cleavage.  In summary, the cytotoxic effects of bendamustine, melphalan and doxorubicin on p53-deficient multiple myeloma cell lines were enhanced by the coadministration of AZD7762.  These data provide a rationale for testing these combinations in patients with relapsed and/or refractory multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphppiytZoas7Vg90H21EOLACvtfcHk0lihiNrObF-ZwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisLrP&md5=349ec19d319f74ffca2414c2ebd8a9f9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0949%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DH.%2BJ.%26aulast%3DMcNeely%26aufirst%3DS.%2BC.%26aulast%3DNair%26aufirst%3DJ.%2BS.%26aulast%3DComenzo%26aufirst%3DR.%2BL.%26aulast%3DAsai%26aufirst%3DT.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DJhanwar%26aufirst%3DS.%2BC.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DThe%2520checkpoint%2520kinase%2520inhibitor%2520AZD7762%2520potentiates%2520chemotherapy-induced%2520apoptosis%2520of%2520p53-mutated%2520multiple%2520myeloma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1781%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Origanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munir, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=577-588&author=S.+Origantiauthor=S.+R.+Caiauthor=A.+Z.+Munirauthor=L.+S.+Whiteauthor=H.+Piwnica-Worms&title=Synthetic+lethality+of+Chk1+inhibition+combined+with+p53+and%2For+p21+loss+during+a+DNA+damage+response+in+normal+and+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOriganti%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BR.%26aulast%3DMunir%26aufirst%3DA.%2BZ.%26aulast%3DWhite%26aufirst%3DL.%2BS.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DSynthetic%2520lethality%2520of%2520Chk1%2520inhibition%2520combined%2520with%2520p53%2520and%252For%2520p21%2520loss%2520during%2520a%2520DNA%2520damage%2520response%2520in%2520normal%2520and%2520tumor%2520cells%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D577%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugarajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylander-Gans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normolle, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maybaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, T. S.</span><span> </span><span class="NLM_article-title">Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">4972</span><span class="NLM_x">–</span> <span class="NLM_lpage">4981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=4972-4981&author=M.+A.+Morganauthor=L.+A.+Parselsauthor=L.+Zhaoauthor=J.+D.+Parselsauthor=M.+A.+Davisauthor=M.+C.+Hassanauthor=S.+Arumugarajahauthor=L.+Hylander-Gansauthor=D.+Morosiniauthor=D.+M.+Simeoneauthor=C.+E.+Canmanauthor=D.+P.+Normolleauthor=S.+D.+Zabludoffauthor=J.+Maybaumauthor=T.+S.+Lawrence&title=Mechanism+of+radiosensitization+by+the+Chk1%2F2+inhibitor+AZD7762+involves+abrogation+of+the+G2+checkpoint+and+inhibition+of+homologous+recombinational+DNA+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DParsels%26aufirst%3DJ.%2BD.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DHassan%26aufirst%3DM.%2BC.%26aulast%3DArumugarajah%26aufirst%3DS.%26aulast%3DHylander-Gans%26aufirst%3DL.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26aulast%3DCanman%26aufirst%3DC.%2BE.%26aulast%3DNormolle%26aufirst%3DD.%2BP.%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DMaybaum%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26atitle%3DMechanism%2520of%2520radiosensitization%2520by%2520the%2520Chk1%252F2%2520inhibitor%2520AZD7762%2520involves%2520abrogation%2520of%2520the%2520G2%2520checkpoint%2520and%2520inhibition%2520of%2520homologous%2520recombinational%2520DNA%2520repair%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D4972%26epage%3D4981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">DNA damage-induced activation of p53 by the checkpoint kinase Chk2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1824</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1824-1827&author=A.+Hiraoauthor=Y.+Y.+Kongauthor=S.+Matsuokaauthor=A.+Wakehamauthor=J.+Rulandauthor=H.+Yoshidaauthor=D.+Liuauthor=S.+J.+Elledgeauthor=T.+W.+Mak&title=DNA+damage-induced+activation+of+p53+by+the+checkpoint+kinase+Chk2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%2BY.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DDNA%2520damage-induced%2520activation%2520of%2520p53%2520by%2520the%2520checkpoint%2520kinase%2520Chk2%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1824%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carattini-Rivera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMayo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donehower, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=1448-1459&author=Q.+Liuauthor=S.+Guntukuauthor=X.+S.+Cuiauthor=S.+Matsuokaauthor=D.+Cortezauthor=K.+Tamaiauthor=G.+Luoauthor=S.+Carattini-Riveraauthor=F.+DeMayoauthor=A.+Bradleyauthor=L.+A.+Donehowerauthor=S.+J.+Elledge&title=Chk1+is+an+essential+kinase+that+is+regulated+by+Atr+and+required+for+the+G%282%29%2FM+DNA+damage+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGuntuku%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DX.%2BS.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DCortez%26aufirst%3DD.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DCarattini-Rivera%26aufirst%3DS.%26aulast%3DDeMayo%26aufirst%3DF.%26aulast%3DBradley%26aufirst%3DA.%26aulast%3DDonehower%26aufirst%3DL.%2BA.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DChk1%2520is%2520an%2520essential%2520kinase%2520that%2520is%2520regulated%2520by%2520Atr%2520and%2520required%2520for%2520the%2520G%25282%2529%252FM%2520DNA%2520damage%2520checkpoint%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D1448%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainerd, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltimore, D.</span><span> </span><span class="NLM_article-title">Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=2411-2422&author=Y.+Xuauthor=T.+Ashleyauthor=E.+E.+Brainerdauthor=R.+T.+Bronsonauthor=M.+S.+Meynauthor=D.+Baltimore&title=Targeted+disruption+of+ATM+leads+to+growth+retardation%2C+chromosomal+fragmentation+during+meiosis%2C+immune+defects%2C+and+thymic+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAshley%26aufirst%3DT.%26aulast%3DBrainerd%26aufirst%3DE.%2BE.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DMeyn%26aufirst%3DM.%2BS.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DTargeted%2520disruption%2520of%2520ATM%2520leads%2520to%2520growth%2520retardation%252C%2520chromosomal%2520fragmentation%2520during%2520meiosis%252C%2520immune%2520defects%252C%2520and%2520thymic%2520lymphoma%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Takai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoyama, N.</span><span> </span><span class="NLM_article-title">Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5195</span><span class="NLM_x">–</span> <span class="NLM_lpage">5205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=5195-5205&author=H.+Takaiauthor=K.+Nakaauthor=Y.+Okadaauthor=M.+Watanabeauthor=N.+Haradaauthor=S.+Saitoauthor=C.+W.+Andersonauthor=E.+Appellaauthor=M.+Nakanishiauthor=H.+Suzukiauthor=K.+Nagashimaauthor=H.+Sawaauthor=K.+Ikedaauthor=N.+Motoyama&title=Chk2-deficient+mice+exhibit+radioresistance+and+defective+p53-mediated+transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DH.%26aulast%3DNaka%26aufirst%3DK.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DNakanishi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DSawa%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DMotoyama%26aufirst%3DN.%26atitle%3DChk2-deficient%2520mice%2520exhibit%2520radioresistance%2520and%2520defective%2520p53-mediated%2520transcription%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D5195%26epage%3D5205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Brown, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltimore, D.</span><span> </span><span class="NLM_article-title">ATR disruption leads to chromosomal fragmentation and early embryonic lethality</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=397-402&author=E.+J.+Brownauthor=D.+Baltimore&title=ATR+disruption+leads+to+chromosomal+fragmentation+and+early+embryonic+lethality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BJ.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DATR%2520disruption%2520leads%2520to%2520chromosomal%2520fragmentation%2520and%2520early%2520embryonic%2520lethality%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D397%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Azorsa, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisanz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousses, S.</span><span> </span><span class="NLM_article-title">Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1479-5876-7-43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19519883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvkvVersg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=43&author=D.+O.+Azorsaauthor=I.+M.+Gonzalesauthor=G.+D.+Basuauthor=A.+Choudharyauthor=S.+Aroraauthor=K.+M.+Bisanzauthor=J.+A.+Kieferauthor=M.+C.+Hendersonauthor=J.+M.+Trentauthor=D.+D.+Von+Hoffauthor=S.+Mousses&title=Synthetic+lethal+RNAi+screening+identifies+sensitizing+targets+for+gemcitabine+therapy+in+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer</span></div><div class="casAuthors">Azorsa David O; Gonzales Irma M; Basu Gargi D; Choudhary Ashish; Arora Shilpi; Bisanz Kristen M; Kiefer Jeffrey A; Henderson Meredith C; Trent Jeffrey M; Von Hoff Daniel D; Mousses Spyro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer retains a poor prognosis among the gastrointestinal cancers.  It affects 230,000 individuals worldwide, has a very high mortality rate, and remains one of the most challenging malignancies to treat successfully.  Treatment with gemcitabine, the most widely used chemotherapeutic against pancreatic cancer, is not curative and resistance may occur.  Combinations of gemcitabine with other chemotherapeutic drugs or biological agents have resulted in limited improvement.  METHODS:  In order to improve gemcitabine response in pancreatic cancer cells, we utilized a synthetic lethal RNAi screen targeting 572 known kinases to identify genes that when silenced would sensitize pancreatic cancer cells to gemcitabine.  RESULTS:  Results from the RNAi screens identified several genes that, when silenced, potentiated the growth inhibitory effects of gemcitabine in pancreatic cancer cells.  The greatest potentiation was shown by siRNA targeting checkpoint kinase 1 (CHK1).  Validation of the screening results was performed in MIA PaCa-2 and BxPC3 pancreatic cancer cells by examining the dose response of gemcitabine treatment in the presence of either CHK1 or CHK2 siRNA.  These results showed a three to ten-fold decrease in the EC50 for CHK1 siRNA-treated cells versus control siRNA-treated cells while treatment with CHK2 siRNA resulted in no change compared to controls.  CHK1 was further targeted with specific small molecule inhibitors SB 218078 and PD 407824 in combination with gemcitabine.  Results showed that treatment of MIA PaCa-2 cells with either of the CHK1 inhibitors SB 218078 or PD 407824 led to sensitization of the pancreatic cancer cells to gemcitabine.  CONCLUSION:  These findings demonstrate the effectiveness of synthetic lethal RNAi screening as a tool for identifying sensitizing targets to chemotherapeutic agents.  These results also indicate that CHK1 could serve as a putative therapeutic target for sensitizing pancreatic cancer cells to gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSewyviITeFf7BItaL1WaVAfW6udTcc2eaXcTRbN4HQm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvkvVersg%253D%253D&md5=400b6eb75a8ee86d3376a056e57a6df5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-7-43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-7-43%26sid%3Dliteratum%253Aachs%26aulast%3DAzorsa%26aufirst%3DD.%2BO.%26aulast%3DGonzales%26aufirst%3DI.%2BM.%26aulast%3DBasu%26aufirst%3DG.%2BD.%26aulast%3DChoudhary%26aufirst%3DA.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBisanz%26aufirst%3DK.%2BM.%26aulast%3DKiefer%26aufirst%3DJ.%2BA.%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DMousses%26aufirst%3DS.%26atitle%3DSynthetic%2520lethal%2520RNAi%2520screening%2520identifies%2520sensitizing%2520targets%2520for%2520gemcitabine%2520therapy%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2009%26volume%3D7%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Seto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span> </span><span class="NLM_article-title">Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1007%2Fs00280-013-2234-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23892959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2013&pages=619-627&author=T.+Setoauthor=T.+Esakiauthor=F.+Hiraiauthor=S.+Aritaauthor=K.+Nosakiauthor=A.+Makiyamaauthor=T.+Kometaniauthor=C.+Fujimotoauthor=M.+Hamatakeauthor=H.+Takeokaauthor=F.+Agboauthor=X.+Shi&title=Phase+I%2C+dose-escalation+study+of+AZD7762+alone+and+in+combination+with+gemcitabine+in+Japanese+patients+with+advanced+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours</span></div><div class="casAuthors">Seto, Takashi; Esaki, Taito; Hirai, Fumihiko; Arita, Shuji; Nosaki, Kaname; Makiyama, Akitaka; Kometani, Takuro; Fujimoto, Chinatsu; Hamatake, Motoharu; Takeoka, Hiroaki; Agbo, Felix; Shi, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: AZD7762, a potent Chk1/Chk2 inhibitor, has shown chemosensitizing activity with gemcitabine in xenograft models.  Methods: This open-label, Phase I, dose-escalation study evaluated the safety, pharmacokinetics (PK) and preliminary efficacy (RECIST) of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumors (NCT00937664).  Patients received i.v. AZD7762 alone on days 1 and 8 of a 14-day cycle (cycle 0), followed by AZD7762 plus gemcitabine 1,000 mg/m2 on days 1 and 8 of 22-day cycles, in ascending AZD7762 dose cohorts.  Results: Twenty patients received AZD7762 at doses of 6 mg (n = 3), 9 mg (n = 3), 21 mg (n = 6) and 30 mg (n = 8).  Dose-limiting toxicities occurred in 2/6 evaluable patients in the 30-mg cohort: one, CTCAE grade 3 elevated troponin T (cycle 0: AZD7762 monotherapy); one, neutropenia, thrombocytopenia, and elevated aspartate aminotransferase and alanine aminotransferase (cycle 1: combination therapy).  The 30 mg dose was therefore regarded as non-tolerable.  The most common adverse events (AEs) in cycle 0 (AZD7762 monotherapy) were bradycardia (50 %), hypertension (25 %) and fatigue (15 %).  Overall, the most common AEs were bradycardia (55 %), neutropenia (45 %) and hypertension, fatigue and rash (30 % each).  Grade ≥3 AEs were reported in 11 patients, the most common being neutropenia (45 %) and leukopenia (25 %).  AZD7762 exposure increased approx. linearly.  Gemcitabine did not appear to affect AZD7762 PK.  There were no objective responses; five patients (all lung cancer) had stable disease.  Conclusions: The max. tolerated dose of AZD7762 in combination with gemcitabine, 1,000 mg/m2 was detd. as 21 mg in Japanese patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWxvmjbQe4HbVg90H21EOLACvtfcHk0lhbHpU-C6_5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOrtbnJ&md5=249621625eab6c9d7e0a85d4f4f47977</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1007%2Fs00280-013-2234-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-013-2234-6%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DT.%26aulast%3DEsaki%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DF.%26aulast%3DArita%26aufirst%3DS.%26aulast%3DNosaki%26aufirst%3DK.%26aulast%3DMakiyama%26aufirst%3DA.%26aulast%3DKometani%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DC.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DTakeoka%26aufirst%3DH.%26aulast%3DAgbo%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DX.%26atitle%3DPhase%2520I%252C%2520dose-escalation%2520study%2520of%2520AZD7762%2520alone%2520and%2520in%2520combination%2520with%2520gemcitabine%2520in%2520Japanese%2520patients%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D72%26spage%3D619%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worland, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P. M.</span><span> </span><span class="NLM_article-title">UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2F88.14.956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=8667426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK28XkvV2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1996&pages=956-965&author=Q.+Wangauthor=S.+Fanauthor=A.+Eastmanauthor=P.+J.+Worlandauthor=E.+A.+Sausvilleauthor=P.+M.+O%E2%80%99Connor&title=UCN-01%3A+a+potent+abrogator+of+G2+checkpoint+function+in+cancer+cells+with+disrupted+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01: A potent abrogator of G2 checkpoint function in cancer cells with disrupted p53</span></div><div class="casAuthors">Wang, Qizhi; Fan, Saijun; Eastman, Alan; Worland, Peter J.; Sausville, Edward A.; O'Connor, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">956-965</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">National Cancer Institute</span>)
        </div><div class="casAbstract">Arrest of the cell cycle in G2 phase following DNA damage helps protect cell viability by allowing time for DNA repair before entry into mitosis (M phase).  Abrogation of G2 arrest sensitizes cells to the effects of DNA-damaging agents.  UCN-01 (7-hydroxystaurosporine), a protein kinase C inhibitor that may block G2 checkpoint regulation, has been reported to enhance the cytotoxicity of mitomycin C, a known DNA-damaging agent.  We studied the effect of UCN-01 on G2 checkpoint control in human lymphoma CA46 cells, whose sensitivity to various DNA-damaging agents and G2 response to DNA damage have been characterized.  We also assessed the ability of UCN-01 to enhance the cytotoxicity of γ irradn. in CA46 cells and human colon carcinoma HT-29 cells, both of which are mutant for p53 function.  The influence of p53 function on UCN-01-mediated abrogation of the G2 checkpoint and enhancement of DNA-damaging agent cytotoxicity was studied, in transfected human breast carcinoma MCF-7 cells that either expressed or did not express the human papillomavirus type-16 E6 protein.  MCF-7 cells have normal p53 function, and the E6 protein binds p53 protein and promotes its destruction.  The effect of UCN-01 on cell cycle arrest induced by γ irradn. was studied in CA46 cells and in transfected MCF-7 cells by use of flow cytometry.  A histone H1 phosphorylation assay was employed to measure cyclin B1/Cdc2 kinase activity in exts. derived from irradiated and nonirradiated CA46 cells that had been either treated or not treated with UCN-01; the phosphorylation status of Cdc2 kinase protein in the same exts. was detd. by use of western blotting.  The effect of UCN-01 on the cytotoxicity of γ irradn. in CA46 and HT-29 cells was detd. by use of MTT (thiazolyl blue) and clonogenic (colony-forming) assays, resp.; a clonogenic assay was also used to measure the effect of UCN-01 on the cytotoxicity of cisplatin in transfected and nontransfected MCF-7 cells.  G2 arrest induced in CA46 cells by γ irradn. was inhibited by treatment with UCN-01 in a dose-dependent manner; arrest in G2 was completely abrogated by exposure to 300 nM UCN-01.  Biochem. markers indicative of the G2/M transition, including the activation of cyclin B1/Cdc2 kinase and the suppression of Cdc2 threonine-14 and tyrosine-15 phosphorylation, were detected in irradiated cells treated with UCN-01.  UCN-01 enhanced the cytotoxicity of γ irradn. in CA46 and HT-29 cells.  MCF-7 cells with functional p53 protein were more resistant to G2 checkpoint abrogation by UCN-01 than MCF-7 cells with disrupted p53 function.  UCN-01 markedly enhanced the cell-killing activity of cisplatin in MCF-7 cells defective for p53 function.  UCN-01 is a potent abrogator of G2 checkpoint control in cancer cells with disrupted p53 function.  UCN-01 might be capable of enhancing the effectiveness of DNA-damaging agents in the treatment of tumors with cells lacking normal p53 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqxwzeE4ynrVg90H21EOLACvtfcHk0lhbHpU-C6_5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvV2qt7g%253D&md5=9bfd08779e874cfb0f8b5429d2420e77</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F88.14.956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F88.14.956%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DEastman%26aufirst%3DA.%26aulast%3DWorland%26aufirst%3DP.%2BJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DUCN-01%253A%2520a%2520potent%2520abrogator%2520of%2520G2%2520checkpoint%2520function%2520in%2520cancer%2520cells%2520with%2520disrupted%2520p53%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1996%26volume%3D88%26spage%3D956%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Gojo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norsworthy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1217-1227&author=I.+Gojoauthor=A.+Perlauthor=S.+Lugerauthor=M.+R.+Baerauthor=K.+J.+Norsworthyauthor=K.+S.+Bauerauthor=M.+Tidwellauthor=S.+Fleckingerauthor=M.+Carrollauthor=E.+A.+Sausville&title=Phase+I+study+of+UCN-01+and+perifosine+in+patients+with+relapsed+and+refractory+acute+leukemias+and+high-risk+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGojo%26aufirst%3DI.%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DLuger%26aufirst%3DS.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DBauer%26aufirst%3DK.%2BS.%26aulast%3DTidwell%26aufirst%3DM.%26aulast%3DFleckinger%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DPhase%2520I%2520study%2520of%2520UCN-01%2520and%2520perifosine%2520in%2520patients%2520with%2520relapsed%2520and%2520refractory%2520acute%2520leukemias%2520and%2520high-risk%2520myelodysplastic%2520syndrome%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwala, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandara, D. R.</span><span> </span><span class="NLM_article-title">A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=741-748&author=T.+Liauthor=S.+D.+Christensenauthor=P.+H.+Frankelauthor=K.+A.+Margolinauthor=S.+S.+Agarwalaauthor=T.+Luuauthor=P.+C.+Mackauthor=P.+N.+Laraauthor=D.+R.+Gandara&title=A+phase+II+study+of+cell+cycle+inhibitor+UCN-01+in+patients+with+metastatic+melanoma%3A+a+California+Cancer+Consortium+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DS.%2BD.%26aulast%3DFrankel%26aufirst%3DP.%2BH.%26aulast%3DMargolin%26aufirst%3DK.%2BA.%26aulast%3DAgarwala%26aufirst%3DS.%2BS.%26aulast%3DLuu%26aufirst%3DT.%26aulast%3DMack%26aufirst%3DP.%2BC.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DGandara%26aufirst%3DD.%2BR.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520cell%2520cycle%2520inhibitor%2520UCN-01%2520in%2520patients%2520with%2520metastatic%2520melanoma%253A%2520a%2520California%2520Cancer%2520Consortium%2520trial%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D741%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taricani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penaflor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-10-0928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21321066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=591-602&author=T.+J.+Guziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=M.+Labroliauthor=F.+Shanahanauthor=N.+Davisauthor=L.+Taricaniauthor=D.+Wiswellauthor=W.+Seghezziauthor=E.+Penaflorauthor=B.+Bhagwatauthor=W.+Wangauthor=D.+Guauthor=Y.+Hsiehauthor=S.+Leeauthor=M.+Liuauthor=D.+Parry&title=Targeting+the+replication+checkpoint+using+SCH+900776%2C+a+potent+and+functionally+selective+CHK1+inhibitor+identified+via+high+content+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening</span></div><div class="casAuthors">Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Labroli, Marc; Shanahan, Frances; Davis, Nicole; Taricani, Lorena; Wiswell, Derek; Seghezzi, Wolfgang; Penaflor, Ervin; Bhagwat, Bhagyashree; Wang, Wei; Gu, Danling; Hsieh, Yunsheng; Lee, Suining; Liu, Ming; Parry, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (CHK1) is an essential serine/threonine kinase that responds to DNA damage and stalled DNA replication.  CHK1 is essential for maintenance of replication fork viability during exposure to DNA antimetabolites.  In human tumor cell lines, ablation of CHK1 function during antimetabolite exposure led to accumulation of double-strand DNA breaks and cell death.  Here, we extend these observations and confirm ablation of CHK2 does not contribute to these phenotypes and may diminish them.  Furthermore, concomitant suppression of cyclin-dependent kinase (CDK) activity is sufficient to completely antagonize the desired CHK1 ablation phenotypes.  These mechanism-based observations prompted the development of a high-content, cell-based screen for γ-H2AX induction, a surrogate marker for double-strand DNA breaks.  This mechanism-based functional approach was used to optimize small mol. inhibitors of CHK1.  Specifically, the assay was used to mechanistically define the optimal in-cell profile with compds. exhibiting varying degrees of CHK1, CHK2, and CDK selectivity.  Using this approach, SCH 900776 was identified as a highly potent and functionally optimal CHK1 inhibitor with minimal intrinsic antagonistic properties.  SCH 900776 exposure phenocopies short interfering RNA-mediated CHK1 ablation and interacts synergistically with DNA antimetabolite agents in vitro and in vivo to selectively induce dsDNA breaks and cell death in tumor cell backgrounds.  Mol Cancer Ther; 10(4); 591-602.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_DnP2RPokHLVg90H21EOLACvtfcHk0liSEJwI2zZ8AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D&md5=884137ebd69d0959b583a6338a89b87a</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0928%26sid%3Dliteratum%253Aachs%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DPenaflor%26aufirst%3DE.%26aulast%3DBhagwat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520using%2520SCH%2520900776%252C%2520a%2520potent%2520and%2520functionally%2520selective%2520CHK1%2520inhibitor%2520identified%2520via%2520high%2520content%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisanz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peralta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azorsa, D. O.</span><span> </span><span class="NLM_article-title">RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.ygyno.2010.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20722101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=220-227&author=S.+Aroraauthor=K.+M.+Bisanzauthor=L.+A.+Peraltaauthor=G.+D.+Basuauthor=A.+Choudharyauthor=R.+Tibesauthor=D.+O.+Azorsa&title=RNAi+screening+of+the+kinome+identifies+modulators+of+cisplatin+response+in+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells</span></div><div class="casAuthors">Arora, Shilpi; Bisanz, Kristen M.; Peralta, Lourdes A.; Basu, Gargi D.; Choudhary, Ashish; Tibes, Raoul; Azorsa, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objective: Ovarian cancer retains a poor prognosis among the female gynaecol. malignancies.  It constitutes about 3% of all malignancies in women and accounts for 5% of all female cancer related deaths.  A std. treatment is cytoreductive surgery followed by adjuvant chemotherapy, and re-treatment with platinum based chemotherapy at the time of relapse.  In order to improve cisplatin response in ovarian cancer cells, we utilized a high-throughput RNAi screening to identify kinase modulators.  Methods: A high-throughput RNAi screen was performed using a siRNA library targeting 572 kinases to identify potentiators of cisplatin response in the ovarian cancer cell line SKOV3.  Results: RNAi screening identified at least 55 siRNAs that potentiated the growth inhibitory effects of cisplatin in SKOV3 cells.  Inhibition of ATR and CHK1 resulted in the greatest modulation of cisplatin response.  Drug dose response of cisplatin in the presence of siRNA validated the effects of these target genes.  To show that the siRNA data could be successfully translated into potential therapeutic strategies, CHK1 was further targeted with small mol. inhibitor PD 407824 in combination with cisplatin.  Results showed that treatment of SKOV3 and OVCAR3 cells with CHK1 inhibitor PD 407824 led to sensitization of ovarian cancer cells to cisplatin.  Conclusions: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients.  We also demonstrate the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIt3Fi8as5FrVg90H21EOLACvtfcHk0liSEJwI2zZ8AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFWltrc%253D&md5=f965ffe1e3f99395f437048b0a2d4bdb</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2010.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2010.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBisanz%26aufirst%3DK.%2BM.%26aulast%3DPeralta%26aufirst%3DL.%2BA.%26aulast%3DBasu%26aufirst%3DG.%2BD.%26aulast%3DChoudhary%26aufirst%3DA.%26aulast%3DTibes%26aufirst%3DR.%26aulast%3DAzorsa%26aufirst%3DD.%2BO.%26atitle%3DRNAi%2520screening%2520of%2520the%2520kinome%2520identifies%2520modulators%2520of%2520cisplatin%2520response%2520in%2520ovarian%2520cancer%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2010%26volume%3D118%26spage%3D220%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Karp, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatten, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freshwater, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraway, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladstone, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showel, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loechner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span> </span><span class="NLM_article-title">Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6723</span><span class="NLM_x">–</span> <span class="NLM_lpage">6731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-12-2442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23092873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6723-6731&author=J.+E.+Karpauthor=B.+M.+Thomasauthor=J.+M.+Greerauthor=C.+Sorgeauthor=S.+D.+Goreauthor=K.+W.+Pratzauthor=B.+D.+Smithauthor=K.+S.+Flattenauthor=K.+Petersonauthor=P.+Schneiderauthor=K.+Mackeyauthor=T.+Freshwaterauthor=M.+J.+Levisauthor=M.+A.+McDevittauthor=H.+E.+Carrawayauthor=D.+E.+Gladstoneauthor=M.+M.+Showelauthor=S.+Loechnerauthor=D.+A.+Parryauthor=J.+A.+Horowitzauthor=R.+Isaacsauthor=S.+H.+Kaufmann&title=Phase+I+and+pharmacologic+trial+of+cytosine+arabinoside+with+the+selective+checkpoint+1+inhibitor+Sch+900776+in+refractory+acute+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias</span></div><div class="casAuthors">Karp, Judith E.; Thomas, Brian M.; Greer, Jacqueline M.; Sorge, Christopher; Gore, Steven D.; Pratz, Keith W.; Smith, B. Douglas; Flatten, Karen S.; Peterson, Kevin; Schneider, Paula; Mackey, Karen; Freshwater, Tomoko; Levis, Mark J.; McDevitt, Michael A.; Carraway, Hetty E.; Gladstone, Douglas E.; Showel, Margaret M.; Loechner, Sabine; Parry, David A.; Horowitz, Jo Ann; Isaacs, Randi; Kaufmann, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6723-6731</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Incorporation of cytarabine into DNA activates checkpoint kinase 1 (Chk1), which stabilizes stalled replication forks, induces S-phase slowing, and diminishes cytarabine cytotoxicity.  The selective Chk1 inhibitor SCH 900776 abrogates cytarabine-induced S-phase arrest and enhances cytarabine cytotoxicity in acute leukemia cell lines and leukemic blasts in vitro.  To extend these findings to the clin. setting, we have conducted a phase I study of cytarabine and SCH 900776.  Exptl. Design: Twenty-four adults with relapsed and refractory acute leukemias received timed sequential, continuous infusion cytarabine 2 g/m2 over 72 h (667 mg/m2/24 h) beginning on day 1 and again on day 10.  SCH 900776 was administered as a 15- to 30-min infusion on days 2, 3, 11, and 12.  The starting dose of SCH 900776 was 10 mg/m2/dose.  Results: Dose-limiting toxicities consisting of cor. QT interval prolongation and grade 3 palmar-plantar erythrodysesthesia occurred at 140 mg flat dosing (dose level 5, equiv. to 80 mg/m2).  Complete remissions occurred in 8 of 24 (33%) patients, with 7 of 8 at 40 mg/m2 or higher.  SCH 900776 did not accumulate at any dose level.  Marrow blasts obtained pretreatment and during therapy showed increased phosphorylation of H2Ax after SCH 900776 beginning at 40 mg/m2, consistent with unrepaired DNA damage.  Conclusions: These data support a randomized phase II trial of cytarabine +/- SCH 900776 at a recommended flat dose of 100 mg (equiv. to 56 mg/m2) for adults with poor-risk leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1eiYItPvAYrVg90H21EOLACvtfcHk0li_pI1Lny9oIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSiu77N&md5=27c4b385c0ecaf78a7194cd3b2371b62</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2442%26sid%3Dliteratum%253Aachs%26aulast%3DKarp%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DB.%2BM.%26aulast%3DGreer%26aufirst%3DJ.%2BM.%26aulast%3DSorge%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DS.%2BD.%26aulast%3DPratz%26aufirst%3DK.%2BW.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DFlatten%26aufirst%3DK.%2BS.%26aulast%3DPeterson%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMackey%26aufirst%3DK.%26aulast%3DFreshwater%26aufirst%3DT.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DM.%2BA.%26aulast%3DCarraway%26aufirst%3DH.%2BE.%26aulast%3DGladstone%26aufirst%3DD.%2BE.%26aulast%3DShowel%26aufirst%3DM.%2BM.%26aulast%3DLoechner%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DD.%2BA.%26aulast%3DHorowitz%26aufirst%3DJ.%2BA.%26aulast%3DIsaacs%26aufirst%3DR.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520I%2520and%2520pharmacologic%2520trial%2520of%2520cytosine%2520arabinoside%2520with%2520the%2520selective%2520checkpoint%25201%2520inhibitor%2520Sch%2520900776%2520in%2520refractory%2520acute%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D6723%26epage%3D6731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Weiss, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donehower, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKane, S.</span><span> </span><span class="NLM_article-title">Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500mg/m(2) every 21 days in patients with cancer</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=136-144&author=G.+J.+Weissauthor=R.+C.+Donehowerauthor=T.+Iyengarauthor=R.+K.+Ramanathanauthor=K.+Lewandowskiauthor=E.+Westinauthor=K.+Hurtauthor=S.+M.+Hynesauthor=S.+P.+Anthonyauthor=S.+McKane&title=Phase+I+dose-escalation+study+to+examine+the+safety+and+tolerability+of+LY2603618%2C+a+checkpoint+1+kinase+inhibitor%2C+administered+1+day+after+pemetrexed+500mg%2Fm%282%29+every+21+days+in+patients+with+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DDonehower%26aufirst%3DR.%2BC.%26aulast%3DIyengar%26aufirst%3DT.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DLewandowski%26aufirst%3DK.%26aulast%3DWestin%26aufirst%3DE.%26aulast%3DHurt%26aufirst%3DK.%26aulast%3DHynes%26aufirst%3DS.%2BM.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DMcKane%26aufirst%3DS.%26atitle%3DPhase%2520I%2520dose-escalation%2520study%2520to%2520examine%2520the%2520safety%2520and%2520tolerability%2520of%2520LY2603618%252C%2520a%2520checkpoint%25201%2520kinase%2520inhibitor%252C%2520administered%25201%2520day%2520after%2520pemetrexed%2520500mg%252Fm%25282%2529%2520every%252021%2520days%2520in%2520patients%2520with%2520cancer%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Maugeri-Sacca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maria, R.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=525-533&author=M.+Maugeri-Saccaauthor=M.+Bartucciauthor=R.+De+Maria&title=Checkpoint+kinase+1+inhibitors+for+potentiating+systemic+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaugeri-Sacca%26aufirst%3DM.%26aulast%3DBartucci%26aufirst%3DM.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26atitle%3DCheckpoint%2520kinase%25201%2520inhibitors%2520for%2520potentiating%2520systemic%2520anticancer%2520therapy%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2013%26volume%3D39%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Jobson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lountos, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llamas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondapaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardellina, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1<i>H</i>-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1124%2Fjpet.109.154997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19741151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=816-826&author=A.+G.+Jobsonauthor=G.+T.+Lountosauthor=P.+L.+Lorenziauthor=J.+Llamasauthor=J.+Connellyauthor=D.+Cernaauthor=J.+E.+Tropeaauthor=A.+Ondaauthor=G.+Zoppoliauthor=S.+Kondapakaauthor=G.+Zhangauthor=N.+J.+Caplenauthor=J.+H.+Cardellinaauthor=S.+S.+Yooauthor=A.+Monksauthor=C.+Selfauthor=D.+S.+Waughauthor=R.+H.+Shoemakerauthor=Y.+Pommier&title=Cellular+inhibition+of+checkpoint+kinase+2+%28Chk2%29+and+potentiation+of+camptothecins+and+radiation+by+the+novel+Chk2+inhibitor+PV1019+%5B7-nitro-1H-indole-2-carboxylic+acid+%7B4-%5B1-%28guanidinohydrazone%29-ethyl%5D-phenyl%7D-amide%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]</span></div><div class="casAuthors">Jobson, Andrew G.; Lountos, George T.; Lorenzi, Philip L.; Llamas, Jenny; Connelly, John; Cerna, David; Tropea, Joseph E.; Onda, Akikazu; Zoppoli, Gabriele; Kondapaka, Sudhir; Zhang, Guangtao; Caplen, Natasha J.; Cardellina, John H., II; Yoo, Stephen S.; Monks, Anne; Self, Christopher; Waugh, David S.; Shoemaker, Robert H.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Chk2 is a checkpoint kinase involved in the ataxia telangiectasia mutated pathway, which is activated by genomic instability and DNA damage, leading to either cell death (apoptosis) or cell cycle arrest.  Chk2 provides an unexplored therapeutic target against cancer cells.  We recently reported 4,4'-diacetyldiphenylurea-bis(guanylhydrazone) (NSC 109555) as a novel chemotype Chk2 inhibitor.  We have now synthesized a deriv. of NSC 109555, PV1019 (NSC 744039) [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide], which is a selective submicromolar inhibitor of Chk2 in vitro.  The cocrystal structure of PV1019 bound in the ATP binding pocket of Chk2 confirmed enzymic/biochem. observations that PV1019 acts as a competitive inhibitor of Chk2 with respect to ATP.  PV1019 was found to inhibit Chk2 in cells.  It inhibits Chk2 autophosphorylation (which represents the cellular kinase activation of Chk2), Cdc25C phosphorylation, and HDMX degrdn. in response to DNA damage.  PV1019 also protects normal mouse thymocytes against ionizing radiation-induced apoptosis, and it shows synergistic antiproliferative activity with topotecan, camptothecin, and radiation in human tumor cell lines.  We also show that PV1019 and Chk2 small interfering RNAs can exert antiproliferative activity themselves in the cancer cells with high Chk2 expression in the NCl-60 screen.  These data indicate that PV1019 is a potent and selective inhibitor of Chk2 with chemotherapeutic and radiosensitization potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoekmxYz7hWN7Vg90H21EOLACvtfcHk0li_pI1Lny9oIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLzF&md5=904829f9a750c67489e2e90cddd94205</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154997%26sid%3Dliteratum%253Aachs%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DLountos%26aufirst%3DG.%2BT.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLlamas%26aufirst%3DJ.%26aulast%3DConnelly%26aufirst%3DJ.%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DOnda%26aufirst%3DA.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DKondapaka%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DCaplen%26aufirst%3DN.%2BJ.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DSelf%26aufirst%3DC.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCellular%2520inhibition%2520of%2520checkpoint%2520kinase%25202%2520%2528Chk2%2529%2520and%2520potentiation%2520of%2520camptothecins%2520and%2520radiation%2520by%2520the%2520novel%2520Chk2%2520inhibitor%2520PV1019%2520%255B7-nitro-1H-indole-2-carboxylic%2520acid%2520%257B4-%255B1-%2528guanidinohydrazone%2529-ethyl%255D-phenyl%257D-amide%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D816%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101150b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=580-590&author=J.+J.+Caldwellauthor=E.+J.+Welshauthor=C.+Matijssenauthor=V.+E.+Andersonauthor=L.+Antoniauthor=K.+Boxallauthor=F.+Urbanauthor=A.+Hayesauthor=F.+I.+Raynaudauthor=L.+J.+Rigoreauauthor=T.+Raynhamauthor=G.+W.+Aherneauthor=L.+H.+Pearlauthor=A.+W.+Oliverauthor=M.+D.+Garrettauthor=I.+Collins&title=Structure-based+design+of+potent+and+selective+2-%28quinazolin-2-yl%29phenol+inhibitors+of+checkpoint+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm101150b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101150b%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DWelsh%26aufirst%3DE.%2BJ.%26aulast%3DMatijssen%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DV.%2BE.%26aulast%3DAntoni%26aufirst%3DL.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DOliver%26aufirst%3DA.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520selective%25202-%2528quinazolin-2-yl%2529phenol%2520inhibitors%2520of%2520checkpoint%2520kinase%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D580%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Fernandez-Medarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, E.</span><span> </span><span class="NLM_article-title">Ras in cancer and developmental diseases</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1177%2F1947601911411084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21779504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=344-358&author=A.+Fernandez-Medardeauthor=E.+Santos&title=Ras+in+cancer+and+developmental+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ras in cancer and developmental diseases</span></div><div class="casAuthors">Fernandez-Medarde, Alberto; Santos, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-358</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations identified in human cancer about 3 decades ago.  Studies during the last quarter century have characterized the Ras proteins as essential components of signaling networks controlling cellular proliferation, differentiation, or survival.  The oncogenic mutations of the H-ras, N-ras, or K-ras genes frequently found in human tumors are known to throw off balance the normal outcome of those signaling pathways, thus leading to tumor development.  Oncogenic mutations in a no. of other upstream or downstream components of Ras signaling pathways (including membrane RTKs or cytosolic kinases) have been detected more recently in assocn. with a variety of cancers.  Interestingly, the oncogenic Ras mutations and the mutations in other components of Ras/MAPK signaling pathways appear to be mutually exclusive events in most tumors, indicating that deregulation of Ras-dependent signaling is the essential requirement for tumorigenesis.  In contrast to sporadic tumors, sep. studies have identified germline mutations in Ras and various other components of Ras signaling pathways that occur in specific assocn. with a no. of different familial, developmental syndromes frequently sharing common phenotypic cardiofaciocutaneous features.  Finally, even without being a causative force, defective Ras signaling has been cited as a contributing factor to many other human illnesses, including diabetes and immunol. and inflammatory disorders.  We aim this review at summarizing and updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development of various tumoral and nontumoral pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8FC347lm6bVg90H21EOLACvtfcHk0li-6QbBF29YbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D&md5=048ad92dd5959250e4a2b8e0319ff225</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1177%2F1947601911411084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911411084%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Medarde%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DE.%26atitle%3DRas%2520in%2520cancer%2520and%2520developmental%2520diseases%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D344%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Pells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divjak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span> </span><span class="NLM_article-title">Developmentally-regulated expression of murine K-ras isoforms</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=1781-1786&author=S.+Pellsauthor=M.+Divjakauthor=P.+Romanowskiauthor=H.+Impeyauthor=N.+J.+Hawkinsauthor=A.+R.+Clarkeauthor=M.+L.+Hooperauthor=D.+J.+Williamson&title=Developmentally-regulated+expression+of+murine+K-ras+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPells%26aufirst%3DS.%26aulast%3DDivjak%26aufirst%3DM.%26aulast%3DRomanowski%26aufirst%3DP.%26aulast%3DImpey%26aufirst%3DH.%26aulast%3DHawkins%26aufirst%3DN.%2BJ.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DHooper%26aufirst%3DM.%2BL.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26atitle%3DDevelopmentally-regulated%2520expression%2520of%2520murine%2520K-ras%2520isoforms%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D1781%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Bar-Sagi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span> </span><span class="NLM_article-title">Ras and Rho GTPases: a family reunion</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=227-238&author=D.+Bar-Sagiauthor=A.+Hall&title=Ras+and+Rho+GTPases%3A+a+family+reunion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DA.%26atitle%3DRas%2520and%2520Rho%2520GTPases%253A%2520a%2520family%2520reunion%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D227%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Hoa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjaard, R. A.</span><span> </span><span class="NLM_article-title">Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7154</span><span class="NLM_x">–</span> <span class="NLM_lpage">7156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=7154-7156&author=M.+Hoaauthor=S.+L.+Davisauthor=S.+J.+Amesauthor=R.+A.+Spanjaard&title=Amplification+of+wild-type+K-ras+promotes+growth+of+head+and+neck+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoa%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DS.%2BL.%26aulast%3DAmes%26aufirst%3DS.%2BJ.%26aulast%3DSpanjaard%26aufirst%3DR.%2BA.%26atitle%3DAmplification%2520of%2520wild-type%2520K-ras%2520promotes%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D7154%26epage%3D7156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Coleman, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throneburg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisham, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. J.</span><span> </span><span class="NLM_article-title">Overexpression of c-K-ras, c-N-ras and transforming growth factor beta co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=1005-1012&author=W.+B.+Colemanauthor=D.+B.+Throneburgauthor=J.+W.+Grishamauthor=G.+J.+Smith&title=Overexpression+of+c-K-ras%2C+c-N-ras+and+transforming+growth+factor+beta+co-segregate+with+tumorigenicity+in+morphologically+transformed+C3H+10T1%2F2+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DW.%2BB.%26aulast%3DThroneburg%26aufirst%3DD.%2BB.%26aulast%3DGrisham%26aufirst%3DJ.%2BW.%26aulast%3DSmith%26aufirst%3DG.%2BJ.%26atitle%3DOverexpression%2520of%2520c-K-ras%252C%2520c-N-ras%2520and%2520transforming%2520growth%2520factor%2520beta%2520co-segregate%2520with%2520tumorigenicity%2520in%2520morphologically%2520transformed%2520C3H%252010T1%252F2%2520cell%2520lines%26jtitle%3DCarcinogenesis%26date%3D1994%26volume%3D15%26spage%3D1005%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Buday, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downward, J.</span><span> </span><span class="NLM_article-title">Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=611-620&author=L.+Budayauthor=J.+Downward&title=Epidermal+growth+factor+regulates+p21ras+through+the+formation+of+a+complex+of+receptor%2C+Grb2+adapter+protein%2C+and+Sos+nucleotide+exchange+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuday%26aufirst%3DL.%26aulast%3DDownward%26aufirst%3DJ.%26atitle%3DEpidermal%2520growth%2520factor%2520regulates%2520p21ras%2520through%2520the%2520formation%2520of%2520a%2520complex%2520of%2520receptor%252C%2520Grb2%2520adapter%2520protein%252C%2520and%2520Sos%2520nucleotide%2520exchange%2520factor%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D611%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosshans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labourier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinert, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, F. J.</span><span> </span><span class="NLM_article-title">RAS is regulated by the let-7 microRNA family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2005.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15766527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1yhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=635-647&author=S.+M.+Johnsonauthor=H.+Grosshansauthor=J.+Shingaraauthor=M.+Byromauthor=R.+Jarvisauthor=A.+Chengauthor=E.+Labourierauthor=K.+L.+Reinertauthor=D.+Brownauthor=F.+J.+Slack&title=RAS+is+regulated+by+the+let-7+microRNA+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">RAS is regulated by the let-7 microRNA family</span></div><div class="casAuthors">Johnson, Steven M.; Grosshans, Helge; Shingara, Jaclyn; Byrom, Mike; Jarvis, Rich; Cheng, Angie; Labourier, Emmanuel; Reinert, Kristy L.; Brown, David; Slack, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">635-647</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including humans, where they are implicated in cancer.  The let-7 miRNA times seam cell terminal differentiation in C. elegans.  Here the authors show that the let-7 family neg. regulates let-60/RAS.  Loss of let-60/RAS suppresses let-7, and the let-60/RAS 3'UTR contains multiple let-7 complementary sites (LCSs), restricting reporter gene expression in a let-7-dependent manner.  Mir-84, a let-7 family member, is largely absent in vulval precursor cell P6.p at the time that let-60/RAS specifies the 1° vulval fate in that cell, and mir-84 overexpression suppresses the multivulva phenotype of activating let-60/RAS mutations.  The 3'UTRs of the human RAS genes contain multiple LCSs, allowing let-7 to regulate RAS expression.  Let-7 expression is lower in lung tumors than in normal lung tissue, while RAS protein is significantly higher in lung tumors, providing a possible mechanism for let-7 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEwsudQP-3rVg90H21EOLACvtfcHk0li8ycY4aBOAPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1yhsbs%253D&md5=d651c7df1048b5f664e3da3fa0357066</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DGrosshans%26aufirst%3DH.%26aulast%3DShingara%26aufirst%3DJ.%26aulast%3DByrom%26aufirst%3DM.%26aulast%3DJarvis%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DLabourier%26aufirst%3DE.%26aulast%3DReinert%26aufirst%3DK.%2BL.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DSlack%26aufirst%3DF.%2BJ.%26atitle%3DRAS%2520is%2520regulated%2520by%2520the%2520let-7%2520microRNA%2520family%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D635%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Bernhard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanbridge, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakanauskas, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerniglia, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, W. G.</span><span> </span><span class="NLM_article-title">Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6597-6600&author=E.+J.+Bernhardauthor=E.+J.+Stanbridgeauthor=S.+Guptaauthor=A.+K.+Guptaauthor=D.+Sotoauthor=V.+J.+Bakanauskasauthor=G.+J.+Cernigliaauthor=R.+J.+Muschelauthor=W.+G.+McKenna&title=Direct+evidence+for+the+contribution+of+activated+N-ras+and+K-ras+oncogenes+to+increased+intrinsic+radiation+resistance+in+human+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernhard%26aufirst%3DE.%2BJ.%26aulast%3DStanbridge%26aufirst%3DE.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DSoto%26aufirst%3DD.%26aulast%3DBakanauskas%26aufirst%3DV.%2BJ.%26aulast%3DCerniglia%26aufirst%3DG.%2BJ.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DMcKenna%26aufirst%3DW.%2BG.%26atitle%3DDirect%2520evidence%2520for%2520the%2520contribution%2520of%2520activated%2520N-ras%2520and%2520K-ras%2520oncogenes%2520to%2520increased%2520intrinsic%2520radiation%2520resistance%2520in%2520human%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6597%26epage%3D6600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=537-540&author=L.+A.+Diazauthor=R.+T.+Williamsauthor=J.+Wuauthor=I.+Kindeauthor=J.+R.+Hechtauthor=J.+Berlinauthor=B.+Allenauthor=I.+Bozicauthor=J.+G.+Reiterauthor=M.+A.+Nowakauthor=K.+W.+Kinzlerauthor=K.+S.+Olinerauthor=B.+Vogelstein&title=The+molecular+evolution+of+acquired+resistance+to+targeted+EGFR+blockade+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DKinde%26aufirst%3DI.%26aulast%3DHecht%26aufirst%3DJ.%2BR.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DBozic%26aufirst%3DI.%26aulast%3DReiter%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DM.%2BA.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DOliner%26aufirst%3DK.%2BS.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DThe%2520molecular%2520evolution%2520of%2520acquired%2520resistance%2520to%2520targeted%2520EGFR%2520blockade%2520in%2520colorectal%2520cancers%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Hancock, J. F.</span><span> </span><span class="NLM_article-title">Ras proteins: different signals from different locations</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12728271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=373-384&author=J.+F.+Hancock&title=Ras+proteins%3A+different+signals+from+different+locations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Ras proteins: different signals from different locations</span></div><div class="casAuthors">Hancock, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-385</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ras signaling has classically been thought to occur exclusively at the inner surface of a relatively uniform plasma membrane.  Recent studies have shown that Ras proteins interact dynamically with specific microdomains of the plasma membrane as well as with other internal cell membranes.  These different membrane microenvironments modulate Ras signal output and highlight the complex interplay between Ras location and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIio6gLe-jnbVg90H21EOLACvtfcHk0lgLHTLdNqCCFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7g%253D&md5=f72470c5749f4db56f7db5397df86742</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fnrm1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1105%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DJ.%2BF.%26atitle%3DRas%2520proteins%253A%2520different%2520signals%2520from%2520different%2520locations%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D373%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Farnesyltransferase inhibitors</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1053%2Fj.seminoncol.2003.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14981578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFelsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=28-39&author=S.+M.+Sebtiauthor=A.+A.+Adjei&title=Farnesyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Farnesyltransferase inhibitors</span></div><div class="casAuthors">Sebti, Said M.; Adjei, Alex A.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1, Suppl. 1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  The farnesyltransferase inhibitors (FTIs) were designed to inhibit the post-translational processing of Ras proteins, which are mutated in 30% of all human cancers.  Recent studies suggest, however, that the target of FTIs may be a protein other than Ras, and that these agents may be more appropriately used to treat tumors with activated wild-type ras signaling.  Preliminary results from several phase II and phase III studies have been reported.  The FTIs fail to show significant single-agent activity in non-small cell lung cancer, small cell lung cancer, pancreatic cancer, refractory colorectal cancer, and bladder cancer.  Activity has been shown in hematol. malignancies (acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome), breast cancer, and glioma.  Several combination studies of FTIs and std. cytotoxic agents are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-ex_kxKCurVg90H21EOLACvtfcHk0lgLHTLdNqCCFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFelsbw%253D&md5=8c5f181e40f7d504e13eb0a9f05922fe</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2003.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2003.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DFarnesyltransferase%2520inhibitors%26jtitle%3DSemin.%2520Oncol.%26date%3D2004%26volume%3D31%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Targeting protein prenylation for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22020205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=775-791&author=N.+Berndtauthor=A.+D.+Hamiltonauthor=S.+M.+Sebti&title=Targeting+protein+prenylation+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein prenylation for cancer therapy</span></div><div class="casAuthors">Berndt, Norbert; Hamilton, Andrew D.; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid post-translational modifications that are required for the transforming activity of many oncogenic proteins, including some RAS family members.  This observation prompted the development of inhibitors of farnesyltransferase (FT) and geranylgeranyltransferase 1 (GGT1) as potential anticancer drugs.  In this Review, we discuss the mechanisms by which FT and GGT1 inhibitors (FTIs and GGTIs, resp.) affect signal transduction pathways, cell cycle progression, proliferation and cell survival.  In contrast to their preclin. efficacy, only a small subset of patients responds to FTIs.  Identifying tumors that depend on farnesylation for survival remains a challenge, and strategies to overcome this are discussed.  One GGTI has recently entered the clinic, and the safety and efficacy of GGTIs await results from clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmj2vv2fG4gLVg90H21EOLACvtfcHk0lhWdsRr0FjbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF&md5=c98505df79a037234fb260801c9b97aa</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnrc3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3151%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DTargeting%2520protein%2520prenylation%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D775%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Winter-Vann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dela Cruz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergo, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toone, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, P. J.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4336</span><span class="NLM_x">–</span> <span class="NLM_lpage">4341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.0408107102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15784746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4336-4341&author=A.+M.+Winter-Vannauthor=R.+A.+Baronauthor=W.+Wongauthor=J.+dela+Cruzauthor=J.+D.+Yorkauthor=D.+M.+Goodenauthor=M.+O.+Bergoauthor=S.+G.+Youngauthor=E.+J.+Tooneauthor=P.+J.+Casey&title=A+small-molecule+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase+with+antitumor+activity+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span></div><div class="casAuthors">Winter-Vann, Ann M.; Baron, Rudi A.; Wong, Waihay; dela Cruz, June; York, John D.; Gooden, David M.; Bergo, Martin O.; Young, Stephen G.; Toone, Eric J.; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4336-4341</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Many key regulatory proteins, including members of the Ras family of GTPases, are modified at their C terminus by a process termed prenylation.  This processing is initiated by the addn. of an isoprenoid lipid, and the proteins are further modified by a proteolytic event and methylation of the C-terminal prenylcysteine.  Although the biol. consequences of prenylation have been characterized extensively, the contributions of prenylcysteine methylation to the functions of the modified proteins are not well understood.  This reaction is catalyzed by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt).  Recent genetic disruption studies have provided strong evidence that blocking Icmt activity has profound consequences on oncogenic transformation.  Here, we report the identification of a selective small-mol. inhibitor of Icmt, 2-[5-(3-methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil).  Cysmethynil treatment results in inhibition of cell growth in an Icmt-dependent fashion, demonstrating mechanism-based activity of the compd.  Treatment of cancer cells with cysmethynil results in mislocalization of Ras and impaired epidermal growth factor signaling.  In a human colon cancer cell line, cysmethynil treatment blocks anchorage-independent growth, and this effect is reversed by overexpression of Icmt.  These findings provide a compelling rationale for development of Icmt inhibitors as another approach to anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-1GtT0roj7Vg90H21EOLACvtfcHk0lhWdsRr0FjbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D&md5=8cbe478e0911934e2868d5b5eb376a58</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408107102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408107102%26sid%3Dliteratum%253Aachs%26aulast%3DWinter-Vann%26aufirst%3DA.%2BM.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DW.%26aulast%3Ddela%2BCruz%26aufirst%3DJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DToone%26aufirst%3DE.%2BJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520with%2520antitumor%2520activity%2520in%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D4336%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Ostrem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+inhibitors+allosterically+control+GTP+affinity+and+effector+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lhWdsRr0FjbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520inhibitors%2520allosterically%2520control%2520GTP%2520affinity%2520and%2520effector%2520interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Shima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijiri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, T.</span><span> </span><span class="NLM_article-title">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">8182</span><span class="NLM_x">–</span> <span class="NLM_lpage">8187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.1217730110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23630290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8182-8187&author=F.+Shimaauthor=Y.+Yoshikawaauthor=M.+Yeauthor=M.+Arakiauthor=S.+Matsumotoauthor=J.+Liaoauthor=L.+Huauthor=T.+Sugimotoauthor=Y.+Ijiriauthor=A.+Takedaauthor=Y.+Nishiyamaauthor=C.+Satoauthor=S.+Muraokaauthor=A.+Tamuraauthor=T.+Osodaauthor=K.+Tsudaauthor=T.+Miyakawaauthor=H.+Fukunishiauthor=J.+Shimadaauthor=T.+Kumasakaauthor=M.+Yamamotoauthor=T.+Kataoka&title=In+silico+discovery+of+small-molecule+Ras+inhibitors+that+display+antitumor+activity+by+blocking+the+Ras-effector+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span></div><div class="casAuthors">Shima, Fumi; Yoshikawa, Yoko; Ye, Min; Araki, Mitsugu; Matsumoto, Shigeyuki; Liao, Jingling; Hu, Lizhi; Sugimoto, Takeshi; Ijiri, Yuichi; Takeda, Azusa; Nishiyama, Yuko; Sato, Chie; Muraoka, Shin; Tamura, Atsuo; Osoda, Tsutomu; Tsuda, Ken-ichiro; Miyakawa, Tomoya; Fukunishi, Hiroaki; Shimada, Jiro; Kumasaka, Takashi; Yamamoto, Masaki; Kataoka, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8187, S8182/1-S8182/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently obsd. in human cancers, making them promising anticancer drug targets.  Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-defined surface pockets suitable for drug binding.  Only recently, such pockets have been found in the crystal structures of a unique conformation of Ras·GTP.  Here we report the successful development of small-mol. Ras inhibitors by an in silico screen targeting a pocket found in the crystal structure of M-Ras·GTP carrying an H-Ras-type substitution P40D.  The selected compd. Kobe0065 and its analog Kobe2602 exhibit inhibitory activity toward H-Ras·GTP-c-Raf-1 binding both in vivo and in vitro.  They effectively inhibit both anchorage-dependent and -independent growth and induce apoptosis of H-rasG12V-transformed NIH 3T3 cells, which is accompanied by down-regulation of downstream mols. such as MEK/ERK, Akt, and RalA as well as an upstream mol., Son of sevenless.  Moreover, they exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-rasG12V gene by oral administration.  The NMR structure of a complex of the compd. with H-Ras·GTPT355, exclusively adopting the unique conformation, confirms its insertion into one of the surface pockets and provides a mol. basis for binding inhibition toward multiple RasGTP-interacting mols.  This study proves the effectiveness of our strategy for structure-based drug design to target Ras·GTP, and the resulting Kobe0065-family compds. may serve as a scaffold for the development of Ras inhibitors with higher potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk-yi5md5AbVg90H21EOLACvtfcHk0linuOjS8pm7-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K&md5=aa6569874162595cf17825f2528b4cd3</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217730110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217730110%26sid%3Dliteratum%253Aachs%26aulast%3DShima%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DIjiri%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DMuraoka%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DOsoda%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DK.%26aulast%3DMiyakawa%26aufirst%3DT.%26aulast%3DFukunishi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DT.%26atitle%3DIn%2520silico%2520discovery%2520of%2520small-molecule%2520Ras%2520inhibitors%2520that%2520display%2520antitumor%2520activity%2520by%2520blocking%2520the%2520Ras-effector%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D8182%26epage%3D8187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Rusconi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caiola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span> </span><span class="NLM_article-title">RAS/RAF/MEK inhibitors in oncology</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.2174%2F092986712799320510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22257058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Kktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1164-1176&author=P.+Rusconiauthor=E.+Caiolaauthor=M.+Broggini&title=RAS%2FRAF%2FMEK+inhibitors+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">RAS/RAF/MEK inhibitors in oncology</span></div><div class="casAuthors">Rusconi, P.; Caiola, E.; Broggini, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1164-1176</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The RAS/RAF/MEK signaling pathway plays a central role in mediating both proliferation and survival of cancer cells.  These proteins are a group of serine/threonine kinases activated in response to a variety of extracellular stimuli and mediate signal transduction from the cell surface towards both nuclear and cytosolic targets.  In combination with several other signaling pathways, they can differentially alter phosphorylation status of the transcription factors.  A controlled regulation of these cascades is involved in cell proliferation and differentiation, whereas an unregulated activation of these kinases can result in oncogenesis.  Dysregulation of the RAS/RAF/MEK pathway was detected in > 30% of human tumors, however mutations in the MEK1 and MEK2 genes are seldom, so that hyperactivation of MEK1/2 usually results from gain-of-function mutations in RAS and/or B-RAF.  In addn., alteration of the pathways is often assocd. with drug resistance in the clinic, such as the case of K-RAS mutant expressing tumors.  Since RAS protein is a difficult target, alternative ways altering post-translational modifications using farnesyl transferase inhibitors were adopted.  Drug discovery programs have therefore largely focused on B-RAF and MEK.  In this review we will discuss the most promising strategies developed to target these kinases and the most recent inhibitors facing the preclin. and clin. setting, also considering their structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPn09xagNe5rVg90H21EOLACvtfcHk0linuOjS8pm7-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Kktro%253D&md5=8f035e72d81b5703de0e5782102726e9</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F092986712799320510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320510%26sid%3Dliteratum%253Aachs%26aulast%3DRusconi%26aufirst%3DP.%26aulast%3DCaiola%26aufirst%3DE.%26aulast%3DBroggini%26aufirst%3DM.%26atitle%3DRAS%252FRAF%252FMEK%2520inhibitors%2520in%2520oncology%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1164%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Kim, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wistuba, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenschein, G. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erasmus, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alden, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kies, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitrakopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. K.</span><span> </span><span class="NLM_article-title">The BATTLE trial: personalizing therapy for lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=44-53&author=E.+S.+Kimauthor=R.+S.+Herbstauthor=I.+I.+Wistubaauthor=J.+J.+Leeauthor=G.+R.+Blumenscheinauthor=A.+Tsaoauthor=D.+J.+Stewartauthor=M.+E.+Hicksauthor=J.+Erasmusauthor=S.+Guptaauthor=C.+M.+Aldenauthor=S.+Liuauthor=X.+Tangauthor=F.+R.+Khuriauthor=H.+T.+Tranauthor=B.+E.+Johnsonauthor=J.+V.+Heymachauthor=L.+Maoauthor=F.+Fossellaauthor=M.+S.+Kiesauthor=V.+Papadimitrakopoulouauthor=S.+E.+Davisauthor=S.+M.+Lippmanauthor=W.+K.+Hong&title=The+BATTLE+trial%3A+personalizing+therapy+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlumenschein%26aufirst%3DG.%2BR.%26aulast%3DTsao%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DD.%2BJ.%26aulast%3DHicks%26aufirst%3DM.%2BE.%26aulast%3DErasmus%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DAlden%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DTran%26aufirst%3DH.%2BT.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DFossella%26aufirst%3DF.%26aulast%3DKies%26aufirst%3DM.%2BS.%26aulast%3DPapadimitrakopoulou%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DS.%2BE.%26aulast%3DLippman%26aufirst%3DS.%2BM.%26aulast%3DHong%26aufirst%3DW.%2BK.%26atitle%3DThe%2520BATTLE%2520trial%253A%2520personalizing%2520therapy%2520for%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D44%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Heidorn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milagre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhomen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2009.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20141835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVWitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=209-221&author=S.+J.+Heidornauthor=C.+Milagreauthor=S.+Whittakerauthor=A.+Nourryauthor=I.+Niculescu-Duvasauthor=N.+Dhomenauthor=J.+Hussainauthor=J.+S.+Reis-Filhoauthor=C.+J.+Springerauthor=C.+Pritchardauthor=R.+Marais&title=Kinase-dead+BRAF+and+oncogenic+RAS+cooperate+to+drive+tumor+progression+through+CRAF"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF</span></div><div class="casAuthors">Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Nourry, Arnaud; Niculescu-Duvas, Ion; Dhomen, Nathalie; Hussain, Jahan; Reis-Filho, Jorge S.; Springer, Caroline J.; Pritchard, Catrin; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-221</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We describe a mechanism of tumorigenesis mediated by kinase-dead BRAF in the presence of oncogenic RAS.  We show that drugs that selectively inhibit BRAF drive RAS-dependent BRAF binding to CRAF, CRAF activation, and MEK-ERK signaling.  This does not occur when oncogenic BRAF is inhibited, demonstrating that BRAF inhibition per se does not drive pathway activation; it only occurs when BRAF is inhibited in the presence of oncogenic RAS.  Kinase-dead BRAF mimics the effects of the BRAF-selective drugs and kinase-dead Braf and oncogenic Ras cooperate to induce melanoma in mice.  Our data reveal another paradigm of BRAF-mediated signaling that promotes tumor progression.  They highlight the importance of understanding pathway signaling in clin. practice and of genotyping tumors prior to administering BRAF-selective drugs, to identify patients who are likely to respond and also to identify patients who may experience adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMSb6ckHpR07Vg90H21EOLACvtfcHk0lhPNBVGHk7yWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVWitL0%253D&md5=80af840cb978f5956b3d998b185115f4</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DHeidorn%26aufirst%3DS.%2BJ.%26aulast%3DMilagre%26aufirst%3DC.%26aulast%3DWhittaker%26aufirst%3DS.%26aulast%3DNourry%26aufirst%3DA.%26aulast%3DNiculescu-Duvas%26aufirst%3DI.%26aulast%3DDhomen%26aufirst%3DN.%26aulast%3DHussain%26aufirst%3DJ.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26aulast%3DPritchard%26aufirst%3DC.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DKinase-dead%2520BRAF%2520and%2520oncogenic%2520RAS%2520cooperate%2520to%2520drive%2520tumor%2520progression%2520through%2520CRAF%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D209%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Callahan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimek, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merghoub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span> </span><span class="NLM_article-title">Progression of RAS-mutant leukemia during RAF inhibitor treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">2316</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1056%2FNEJMoa1208958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23134356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=2316-2321&author=M.+K.+Callahanauthor=R.+Rampalauthor=J.+J.+Hardingauthor=V.+M.+Klimekauthor=Y.+R.+Chungauthor=T.+Merghoubauthor=J.+D.+Wolchokauthor=D.+B.+Solitauthor=N.+Rosenauthor=O.+Abdel-Wahabauthor=R.+L.+Levineauthor=P.+B.+Chapman&title=Progression+of+RAS-mutant+leukemia+during+RAF+inhibitor+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Progression of RAS-mutant leukemia during RAF inhibitor treatment</span></div><div class="casAuthors">Callahan, Margaret K.; Rampal, Raajit; Harding, James J.; Klimek, Virginia M.; Chung, Young Rock; Merghoub, Taha; Wolchok, Jedd D.; Solit, David B.; Rosen, Neal; Abdel-Wahab, Omar; Levine, Ross L.; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2316-2321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Vemurafenib, a selective RAF inhibitor, extends survival among patients with BRAF V600E-mutant melanoma.  Vemurafenib inhibits ERK signaling in BRAF V600E-mutant cells but activates ERK signaling in BRAF wild-type cells.  This paradoxical activation of ERK signaling is the mechanistic basis for the development of RAS-mutant squamous-cell skin cancers in patients treated with RAF inhibitors.  We report the accelerated growth of a previously unsuspected RAS-mutant leukemia in a patient with melanoma who was receiving vemurafenib.  Exposure to vemurafenib induced hyperactivation of ERK signaling and proliferation of the leukemic cell population, an effect that was reversed on drug withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLDR-0oiU3L7Vg90H21EOLACvtfcHk0ljyX3gmJQk9hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKmt77K&md5=82e34747b22f505104ce8ebb8d197144</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1208958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1208958%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DM.%2BK.%26aulast%3DRampal%26aufirst%3DR.%26aulast%3DHarding%26aufirst%3DJ.%2BJ.%26aulast%3DKlimek%26aufirst%3DV.%2BM.%26aulast%3DChung%26aufirst%3DY.%2BR.%26aulast%3DMerghoub%26aufirst%3DT.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DProgression%2520of%2520RAS-mutant%2520leukemia%2520during%2520RAF%2520inhibitor%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D2316%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamphier, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span> </span><span class="NLM_article-title">Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=829-839&author=N.+Tanakaauthor=M.+Ishiharaauthor=M.+Kitagawaauthor=H.+Haradaauthor=T.+Kimuraauthor=T.+Matsuyamaauthor=M.+S.+Lamphierauthor=S.+Aizawaauthor=T.+W.+Makauthor=T.+Taniguchi&title=Cellular+commitment+to+oncogene-induced+transformation+or+apoptosis+is+dependent+on+the+transcription+factor+IRF-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DMatsuyama%26aufirst%3DT.%26aulast%3DLamphier%26aufirst%3DM.%2BS.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DCellular%2520commitment%2520to%2520oncogene-induced%2520transformation%2520or%2520apoptosis%2520is%2520dependent%2520on%2520the%2520transcription%2520factor%2520IRF-1%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D829%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Serrano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurrach, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2FS0092-8674%2800%2981902-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9054499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=593-602&author=M.+Serranoauthor=A.+W.+Linauthor=M.+E.+McCurrachauthor=D.+Beachauthor=S.+W.+Lowe&title=Oncogenic+ras+provokes+premature+cell+senescence+associated+with+accumulation+of+p53+and+p16INK4a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</span></div><div class="casAuthors">Serrano, Manuel; Lin, Athena W.; Mccurrach, Mila E.; Beach, David; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-602</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Oncogenic ras can transform most immortal rodent cells to a tumorigenic state.  However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.  Here the authors show that expression of oncogenic ras in primary human or rodent cells results in a permanent G1 arrest.  The arrest induced by ras is accompanied by accumulation of p53 and p16, and is phenotypically indistinguishable from cellular senescence.  Inactivation of either p53 or p16 prevents ras-induced arrest in rodent cells, and E1A achieves a similar effect in human cells.  These observations suggest that the onset of cellular senescence does not simply reflect the accumulation of cell divisions, but can be prematurely activated in response to an oncogenic stimulus.  Negation of ras-induced senescence may be relevant during multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTv0YzGcJpLVg90H21EOLACvtfcHk0ljyX3gmJQk9hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSit7k%253D&md5=6856c4d670f34b65635da4ee11abc498</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981902-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981902-9%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%2BW.%26aulast%3DMcCurrach%26aufirst%3DM.%2BE.%26aulast%3DBeach%26aufirst%3DD.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DOncogenic%2520ras%2520provokes%2520premature%2520cell%2520senescence%2520associated%2520with%2520accumulation%2520of%2520p53%2520and%2520p16INK4a%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D593%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Cox, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Der, C. J.</span><span> </span><span class="NLM_article-title">The dark side of Ras: regulation of apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8999</span><span class="NLM_x">–</span> <span class="NLM_lpage">9006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fsj.onc.1207111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14663478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=8999-9006&author=A.+D.+Coxauthor=C.+J.+Der&title=The+dark+side+of+Ras%3A+regulation+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The dark side of Ras: regulation of apoptosis</span></div><div class="casAuthors">Cox, Adrienne D.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">56</span>),
    <span class="NLM_cas:pages">8999-9006</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutational activation of Ras promotes oncogenesis by disrupting a multitude of normal cellular processes.  Perhaps, best characterized and understood are the mechanisms by which oncogenic Ras promotes deregulated cell cycle progression and uncontrolled cellular proliferation.  However, it is now clear that oncogenic Ras can also deregulate processes that control apoptosis.  In light of the diversity of downstream effector targets known to facilitate Ras function, it is perhaps not surprising that Ras regulation of cell survival is complex, involving the balance and interplay of multiple signaling networks.  While our understanding of these events is still far from complete, and is complicated by cell type and signaling context differences, several important mechanisms have begun to emerge.  We review the role and mechanism of specific effectors in regulating the antiapoptotic (Raf, phosphatidylinositol 3-kinase and Tiam1) and apoptotic (Nore1 and RASSF1) actions of oncogenic Ras, and discuss the possibility that the effector actions of p120RasGAP make a significant contribution to Ras regulation of apoptotic events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFAJRj7yjhbVg90H21EOLACvtfcHk0lhCeloMpNt7MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOmsro%253D&md5=9b1b257ddc3638c187ea260c4817ca98</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207111%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520dark%2520side%2520of%2520Ras%253A%2520regulation%2520of%2520apoptosis%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D8999%26epage%3D9006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Vicent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayles, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet-Cordero, E. A.</span><span> </span><span class="NLM_article-title">Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3940</span><span class="NLM_x">–</span> <span class="NLM_lpage">3952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=3940-3952&author=S.+Vicentauthor=R.+Chenauthor=L.+C.+Saylesauthor=C.+Linauthor=R.+G.+Walkerauthor=A.+K.+Gillespieauthor=A.+Subramanianauthor=G.+Hinkleauthor=X.+Yangauthor=S.+Saifauthor=D.+E.+Rootauthor=V.+Huffauthor=W.+C.+Hahnauthor=E.+A.+Sweet-Cordero&title=Wilms+tumor+1+%28WT1%29+regulates+KRAS-driven+oncogenesis+and+senescence+in+mouse+and+human+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVicent%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSayles%26aufirst%3DL.%2BC.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DR.%2BG.%26aulast%3DGillespie%26aufirst%3DA.%2BK.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DHinkle%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSaif%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHuff%26aufirst%3DV.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSweet-Cordero%26aufirst%3DE.%2BA.%26atitle%3DWilms%2520tumor%25201%2520%2528WT1%2529%2520regulates%2520KRAS-driven%2520oncogenesis%2520and%2520senescence%2520in%2520mouse%2520and%2520human%2520models%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D3940%26epage%3D3952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koopman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=489-500&author=A.+Singhauthor=P.+Greningerauthor=D.+Rhodesauthor=L.+Koopmanauthor=S.+Violetteauthor=N.+Bardeesyauthor=J.+Settleman&title=A+gene+expression+signature+associated+with+%E2%80%9CK-Ras+addiction%E2%80%9D+reveals+regulators+of+EMT+and+tumor+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DRhodes%26aufirst%3DD.%26aulast%3DKoopman%26aufirst%3DL.%26aulast%3DViolette%26aufirst%3DS.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DA%2520gene%2520expression%2520signature%2520associated%2520with%2520%25E2%2580%259CK-Ras%2520addiction%25E2%2580%259D%2520reveals%2520regulators%2520of%2520EMT%2520and%2520tumor%2520cell%2520survival%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26spage%3D489%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampkin, T.</span><span> </span><span class="NLM_article-title">Targeting Polo-like kinase in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-09-1380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20068088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=384-389&author=Y.+Degenhardtauthor=T.+Lampkin&title=Targeting+Polo-like+kinase+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting polo-like kinase in cancer therapy</span></div><div class="casAuthors">Degenhardt, Yan; Lampkin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plk) function in mitosis and maintaining DNA integrity.  There are four family members, of which Plk1 represents a target for anticancer therapy.  Plk1 is only expressed in dividing cells with peak expression during G2/M.  Plk1 functions in multiple steps of mitosis, and is overexpressed in many tumor types.  Mitotic arrest and inhibition of proliferation, apoptosis, and tumor growth inhibition have been obsd. in preclin. studies using small interfering RNAs (siRNA) or small mols. that inhibit Plk1.  Preclin. studies also show that Plk1 inhibitors may be active against tumors with RAS mutations and that tumor cells with mutations in TP53 are more sensitive to inhibition of Plk1.  Several Plk inhibitors are in phase I or II clin. studies.  As expected, hematol. toxicity is the primary dose-limiting toxicity.  Some patients have achieved clin. response, although in some studies only at doses above the max. tolerated dose defined in the study.  Further evaluation is necessary to discern the clin. utility of Plk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-WiWxvJiS7Vg90H21EOLACvtfcHk0liB8bqy0lhYzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D&md5=94d00dd707dc1ca59ed9d58b0099ba89</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1380%26sid%3Dliteratum%253Aachs%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DLampkin%26aufirst%3DT.%26atitle%3DTargeting%2520Polo-like%2520kinase%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D384%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tap, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gounder, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ustoyev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2024</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2012.46.5476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23569312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2024-2028&author=M.+A.+Dicksonauthor=W.+D.+Tapauthor=M.+L.+Keohanauthor=S.+P.+D%E2%80%99Angeloauthor=M.+M.+Gounderauthor=C.+R.+Antonescuauthor=J.+Landaauthor=L.+X.+Qinauthor=D.+D.+Rathboneauthor=M.+M.+Condyauthor=Y.+Ustoyevauthor=A.+M.+Cragoauthor=S.+Singerauthor=G.+K.+Schwartz&title=Phase+II+trial+of+the+CDK4+inhibitor+PD0332991+in+patients+with+advanced+CDK4-amplified+well-differentiated+or+dedifferentiated+liposarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span></div><div class="casAuthors">Dickson, Mark A.; Tap, William D.; Keohan, Mary Louise; D'Angelo, Sandra P.; Gounder, Mrinal M.; Antonescu, Cristina R.; Landa, Jonathan; Qin, Li-Xuan; Rathbone, Dustin D.; Condy, Mercedes M.; Ustoyev, Yelena; Crago, Aimee M.; Singer, Samuel; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2024-2028</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose CDK4 is amplified in > 90% of well-differentiated (WDLS) and dedifferentiated liposarcomas (DDLS).  The selective cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitor PD0332991 inhibits growth and induces senescence in cell lines and xenografts.  In a phase I trial of PD0332991, several patients with WDLS or DDLS experienced prolonged stable disease.  We performed an open-label phase II study to det. the safety and efficacy of PD0332991 in patients with advanced WDLS/DDLS.  Patients and Methods Patients age ≥ 18 years experiencing disease progression while receiving systemic therapy before enrollment received PD0332991 200 mg orally once per day for 14 consecutive days in 21-day cycles.  All were required to have CDK4 amplification by fluorescence in situ hybridization and retinoblastoma protein (RB) expression by immunohistochem. (≥ 1 +).  The primary end point was progression-free survival (PFS) at 12 wk, with 12-wk PFS of ≥ 40% considered promising and ≤ 20% not promising.  If ≥ nine of 28 patients were progression free at 12 wk, PD0332991 would be considered active.  Results We screened 48 patients (44 of 48 had CDK4 amplification; 41 of 44 were RB pos.).  Of those, 30 were enrolled, and 29 were evaluable for the primary end point.  Grade 3 to 4 events included anemia (17%), thrombocytopenia (30%), neutropenia (50%), and febrile neutropenia (3%).  At 12 wk, PFS was 66% (90% CI, 51 % to 100%), significantly exceeding the primary end point.  The median PFS was 18 wk.  There was one partial response.  Conclusion Treatment with the CDK4 inhibitor PD0332991 was assocd. with a favorable progression-free rate in patients with CDK4-amplified and RB-expressing WDLS/DDLS who had progressive disease despite systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNBEhZMJmyrVg90H21EOLACvtfcHk0lgoXQP9CMXHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL&md5=d0c2be513ba6cda5014428939c7ec975</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.5476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.5476%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DKeohan%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DS.%2BP.%26aulast%3DGounder%26aufirst%3DM.%2BM.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLanda%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.%2BX.%26aulast%3DRathbone%26aufirst%3DD.%2BD.%26aulast%3DCondy%26aufirst%3DM.%2BM.%26aulast%3DUstoyev%26aufirst%3DY.%26aulast%3DCrago%26aufirst%3DA.%2BM.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DPhase%2520II%2520trial%2520of%2520the%2520CDK4%2520inhibitor%2520PD0332991%2520in%2520patients%2520with%2520advanced%2520CDK4-amplified%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2024%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">Use of isogenic human cancer cells for high-throughput screening and drug discovery</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=940-945&author=C.+J.+Torranceauthor=V.+Agrawalauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=Use+of+isogenic+human+cancer+cells+for+high-throughput+screening+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DAgrawal%26aufirst%3DV.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DUse%2520of%2520isogenic%2520human%2520cancer%2520cells%2520for%2520high-throughput%2520screening%2520and%2520drug%2520discovery%26jtitle%3DNat.%2520Biotechnol.%26date%3D2001%26volume%3D19%26spage%3D940%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winslow, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magendantz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolliday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span> </span><span class="NLM_article-title">Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">8773</span><span class="NLM_x">–</span> <span class="NLM_lpage">8778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8773-8778&author=A.+T.+Shawauthor=M.+M.+Winslowauthor=M.+Magendantzauthor=C.+Ouyangauthor=J.+Dowdleauthor=A.+Subramanianauthor=T.+A.+Lewisauthor=R.+L.+Maglathinauthor=N.+Tollidayauthor=T.+Jacks&title=Selective+killing+of+K-ras+mutant+cancer+cells+by+small+molecule+inducers+of+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DWinslow%26aufirst%3DM.%2BM.%26aulast%3DMagendantz%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DC.%26aulast%3DDowdle%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DT.%2BA.%26aulast%3DMaglathin%26aufirst%3DR.%2BL.%26aulast%3DTolliday%26aufirst%3DN.%26aulast%3DJacks%26aufirst%3DT.%26atitle%3DSelective%2520killing%2520of%2520K-ras%2520mutant%2520cancer%2520cells%2520by%2520small%2520molecule%2520inducers%2520of%2520oxidative%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D8773%26epage%3D8778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Yagoda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Rechenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaganjor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolpaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smukste, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessnick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=864-868&author=N.+Yagodaauthor=M.+von+Rechenbergauthor=E.+Zaganjorauthor=A.+J.+Bauerauthor=W.+S.+Yangauthor=D.+J.+Fridmanauthor=A.+J.+Wolpawauthor=I.+Smuksteauthor=J.+M.+Peltierauthor=J.+J.+Bonifaceauthor=R.+Smithauthor=S.+L.+Lessnickauthor=S.+Sahasrabudheauthor=B.+R.+Stockwell&title=RAS-RAF-MEK-dependent+oxidative+cell+death+involving+voltage-dependent+anion+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYagoda%26aufirst%3DN.%26aulast%3Dvon%2BRechenberg%26aufirst%3DM.%26aulast%3DZaganjor%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DFridman%26aufirst%3DD.%2BJ.%26aulast%3DWolpaw%26aufirst%3DA.%2BJ.%26aulast%3DSmukste%26aufirst%3DI.%26aulast%3DPeltier%26aufirst%3DJ.%2BM.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DSahasrabudhe%26aufirst%3DS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRAS-RAF-MEK-dependent%2520oxidative%2520cell%2520death%2520involving%2520voltage-dependent%2520anion%2520channels%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D864%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">649</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.ejphar.2010.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20854805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=649&publication_year=2010&pages=51-58&author=W.+Guoauthor=X.+Weiauthor=S.+Wuauthor=L.+Wangauthor=H.+Pengauthor=J.+Wangauthor=B.+Fang&title=Antagonistic+effect+of+flavonoids+on+NSC-741909-mediated+antitumor+activity+via+scavenging+of+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species</span></div><div class="casAuthors">Guo, Wei; Wei, Xiaoli; Wu, Shuhong; Wang, Li; Peng, Henry; Wang, Ji; Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">649</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NSC-741909 (1-[(4-chlorophenyl)methyl]-1H-Indole-3-methanol) is a novel anticancer agent that is highly active against several NCI-60 cancer cell lines.  This agent induces sustained activation of mitogen-activated protein kinases (MAPK), including JNK and p38 MAP kinases.  However, the mechanisms of its selective antitumor activity in some cancer cell lines remain unknown.  We tested the combined effects of NSC-741909 and several kinase inhibitors that target the Raf/MEK/ERK1/2 or PI3K/AKT pathways in two sensitive lung cancer cells.  We found that PD98059 (2'-amino-3'-methoxyflavone), a flavone deriv. and a selective MEK inhibitor, can dramatically block the cell killing effect of NSC-741909.  To det. whether this inhibitory effect is assocd. with MEK inhibition or other mechanisms, we evaluated the effects of other MEK inhibitors with different chem. structures and flavone derivs. that do not have an effect on MEK.  We found that several flavonoids can markedly block NSC-741909-induced apoptosis and JNK activation in a time-dependent manner, regardless of whether they inhibit MEK or not.  In contrast, NSC-741909-induced JNK activation and apoptosis were not blocked by other MEK-specific inhibitors U0126 and CI1040.  Our results also showed that NSC-741909 induced a dramatic increase of reactive oxygen species in sensitive cells and that flavonoids effectively blocked the NSC-741909-induced reactive oxygen species prodn. which are assocd. with flavonoids antagonistic effects on NSC-741909-induced JNK activation and apoptosis.  Those results demonstrated that flavonoids-mediated antagonist effect is through scavenging of reactive oxygen species.  Our results may have implication on the design of clin. evaluation of antitumor activity of NSC-741909 or its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHaPky_XrXo7Vg90H21EOLACvtfcHk0li8S_bSCq_lIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbjM&md5=b4025b9029b51ee322cb58f6e67c8abc</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntagonistic%2520effect%2520of%2520flavonoids%2520on%2520NSC-741909-mediated%2520antitumor%2520activity%2520via%2520scavenging%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D649%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Oxidative stress in NSC-741909-induced apoptosis of cancer cells</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1479-5876-8-37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20398386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BC3czjslakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=37&author=X.+Weiauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=P.+Huangauthor=J.+Liuauthor=B.+Fang&title=Oxidative+stress+in+NSC-741909-induced+apoptosis+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in NSC-741909-induced apoptosis of cancer cells</span></div><div class="casAuthors">Wei Xiaoli; Guo Wei; Wu Shuhong; Wang Li; Huang Peng; Liu Jinsong; Fang Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  NSC-741909 is a novel anticancer agent that can effectively suppress the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers.  We recently showed that NSC-741909-induced antitumor activity is associated with sustained Jun N-terminal kinase (JNK) activation, resulting from suppression of JNK dephosphorylation associated with decreased protein levels of MAPK phosphatase-1.  However, the mechanisms of NSC-741909-induced antitumor activity remain unclear.  Because JNK is frequently activated by oxidative stress in cells, we hypothesized that reactive oxygen species (ROS) may be involved in the suppression of JNK dephosphorylation and the cytotoxicity of NSC-741909.  METHODS:  The generation of ROS was measured by using the cell-permeable nonfluorescent compound H2DCF-DA and flow cytometry analysis.  Cell viability was determined by sulforhodamine B assay.  Western blot analysis, immunofluorescent staining and flow cytometry assays were used to determine apoptosis and molecular changes induced by NSC-741909.  RESULTS:  Treatment with NSC-741909 induced robust ROS generation and marked MAPK phosphatase-1 and -7 clustering in NSC-741909-sensitive, but not resistant cell lines, in a dose- and time-dependent manner.  The generation of ROS was detectable as early as 30 min and ROS levels were as high as 6- to 8-fold above basal levels after treatment.  Moreover, the NSC-741909-induced ROS generation could be blocked by pretreatment with antioxidants, such as nordihydroguaiaretic acid, aesculetin, baicalein, and caffeic acid, which in turn, inhibited the NSC-741909-induced JNK activation and apoptosis.  CONCLUSION:  Our results demonstrate that the increased ROS production was associated with NSC-741909-induced antitumor activity and that ROS generation and subsequent JNK activation is one of the primary mechanisms of NSC-741909-mediated antitumor cell activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5uKg0iJiIOP_I8Jvzw4xCfW6udTcc2eZL_R2wudl_17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czjslakug%253D%253D&md5=2764d03fa3d1c25a6e5b47beb9ce4ad3</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-8-37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-8-37%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DOxidative%2520stress%2520in%2520NSC-741909-induced%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2010%26volume%3D8%26spage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Interruption of RNA processing machinery by a small compound 1-[(4-chlorophenyl)methyl]-1<i>H</i>-indole-3-carboxaldehyde (oncrasin-1)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-08-0839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19208825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=441-448&author=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=R.+Wangauthor=L.+Weiauthor=J.+Liuauthor=B.+Fang&title=Interruption+of+RNA+processing+machinery+by+a+small+compound+1-%5B%284-chlorophenyl%29methyl%5D-1H-indole-3-carboxaldehyde+%28oncrasin-1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)</span></div><div class="casAuthors">Guo, Wei; Wu, Shuhong; Wang, Li; Wang, Rui-Yu; Wei, Xiaoli; Liu, Jinsong; Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein kinase Cι (PKCι) is activated by oncogenic Ras proteins and is required for K-Ras-induced transformation and colonic carcinogenesis in vivo.  However, the role of PKCι in signal transduction and oncogenesis is not clear.  We recently identified a small mol., designated 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1), that can selectively kill K-Ras mutant cancer cells and induce abnormal nuclear aggregation of PKCι in sensitive cells but not in resistant cells.  To det. the causes and biol. consequences of PKCι aggregates in the nucleus, we analyzed the effect of oncrasin-1 on proteins involved in DNA repair and RNA processing.  Our results showed that oncrasin-1 treatment led to co-aggregation of PKCι and splicing factors into mega-spliceosomes but had no obvious effects on the DNA repair mol. Rad51.  Moreover, oncrasin-1 treatment suppressed the phosphorylation of the largest subunit of RNA polymerase II and the expression of intron-less reporter genes in sensitive cells but not in resistant cells, suggesting that suppression of RNA transcription is a major effect of oncrasin-1 treatment.  Studies with cultured cells or with recombinant proteins showed that oncrasin-1 can disrupt the interaction of PKCι and cyclin-dependent protein kinase 9/cyclin T1 complex, which is known to phosphorylate the largest subunit of RNA polymerase II and is required for RNA transcription.  Together, our results suggest that oncrasin-1 suppresses the function of RNA processing machinery and that PKCι might be involved in the biol. function of RNA processing complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTkzIuYMfNPLVg90H21EOLACvtfcHk0ljN_O3JEjfMNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFamsbg%253D&md5=282a8af2e04fe0ffd70bc416d6002201</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0839%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DInterruption%2520of%2520RNA%2520processing%2520machinery%2520by%2520a%2520small%2520compound%25201-%255B%25284-chlorophenyl%2529methyl%255D-1H-indole-3-carboxaldehyde%2520%2528oncrasin-1%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D441%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e28487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e28487&author=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=X.+Weiauthor=X.+Liuauthor=J.+Wangauthor=Z.+Luauthor=M.+Hollingsheadauthor=B.+Fang&title=Antitumor+activity+of+a+novel+oncrasin+analogue+is+mediated+by+JNK+activation+and+STAT3+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520novel%2520oncrasin%2520analogue%2520is%2520mediated%2520by%2520JNK%2520activation%2520and%2520STAT3%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De28487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swisher, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1456-1464&author=X.+Liuauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=J.+Wangauthor=B.+Daiauthor=E.+S.+Kimauthor=J.+V.+Heymachauthor=M.+Wangauthor=L.+Girardauthor=J.+Minnaauthor=J.+A.+Rothauthor=S.+G.+Swisherauthor=B.+Fang&title=Antitumor+activity+of+a+novel+STAT3+inhibitor+and+redox+modulator+in+non-small+cell+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DSwisher%26aufirst%3DS.%2BG.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520novel%2520STAT3%2520inhibitor%2520and%2520redox%2520modulator%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1456%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Jaspers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersbergen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sol, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drost, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wientjens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doroshow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottenberg, S.</span><span> </span><span class="NLM_article-title">Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=68-81&author=J.+E.+Jaspersauthor=A.+Kersbergenauthor=U.+Boonauthor=W.+Solauthor=D.+L.+vanauthor=S.+A.+Zanderauthor=R.+Drostauthor=E.+Wientjensauthor=J.+Jiauthor=A.+Alyauthor=J.+H.+Doroshowauthor=A.+Cranstonauthor=N.+M.+Martinauthor=A.+Lauauthor=M.+J.+O%E2%80%99Connorauthor=S.+Ganesanauthor=P.+Borstauthor=J.+Jonkersauthor=S.+Rottenberg&title=Loss+of+53BP1+causes+PARP+inhibitor+resistance+in+Brca1-mutated+mouse+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaspers%26aufirst%3DJ.%2BE.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DSol%26aufirst%3DW.%26aulast%3Dvan%26aufirst%3DD.%2BL.%26aulast%3DZander%26aufirst%3DS.%2BA.%26aulast%3DDrost%26aufirst%3DR.%26aulast%3DWientjens%26aufirst%3DE.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DAly%26aufirst%3DA.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DGanesan%26aufirst%3DS.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DRottenberg%26aufirst%3DS.%26atitle%3DLoss%2520of%252053BP1%2520causes%2520PARP%2520inhibitor%2520resistance%2520in%2520Brca1-mutated%2520mouse%2520mammary%2520tumors%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">16948</span><span class="NLM_x">–</span> <span class="NLM_lpage">16955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16948-16955&author=X.+Weiauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=Y.+Luauthor=B.+Xuauthor=J.+Liuauthor=B.+Fang&title=Inhibiting+JNK+dephosphorylation+and+induction+of+apoptosis+by+novel+anticancer+agent+NSC-741909+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DInhibiting%2520JNK%2520dephosphorylation%2520and%2520induction%2520of%2520apoptosis%2520by%2520novel%2520anticancer%2520agent%2520NSC-741909%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16948%26epage%3D16955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2668</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101417n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2668-2679&author=S.+Wuauthor=L.+Wangauthor=W.+Guoauthor=X.+Liuauthor=J.+Liuauthor=X.+Weiauthor=B.+Fang&title=Analogues+and+derivatives+of+oncrasin-1%2C+a+novel+inhibitor+of+the+C-terminal+domain+of+RNA+polymerase+II+and+their+antitumor+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm101417n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101417n%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAnalogues%2520and%2520derivatives%2520of%2520oncrasin-1%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520C-terminal%2520domain%2520of%2520RNA%2520polymerase%2520II%2520and%2520their%2520antitumor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2668%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chen-Xi Wang, Zi-Lin Zhang, Qi-Kun Yin, Jia-Li Tu, Jia-En Wang, Yao-Hao Xu, Yong Rao, Tian-Miao Ou, Shi-Liang Huang, Ding Li, Hong-Gen Wang, Qing-Jiang Li, Jia-Heng Tan, Shuo-Bin Chen, <span class="NLM_string-name hlFld-ContribAuthor">Zhi-Shu Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9752-9772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00917" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BNew%252BQuinazolinone%252BDerivatives%252Bthat%252BInhibit%252BBloom%252BSyndrome%252BProtein%252B%252528BLM%252529%252BHelicase%25252C%252BTrigger%252BDNA%252BDamage%252Bat%252Bthe%252BTelomere%252BRegion%25252C%252Band%252BSynergize%252Bwith%252BPARP%252BInhibitors%26aulast%3DWang%26aufirst%3DChen-Xi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30052020%26date%3D07082020%26date%3D22072020%26volume%3D63%26issue%3D17%26spage%3D9752%26epage%3D9772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Falchi</span>, <span class="hlFld-ContribAuthor ">Elisa  Giacomini</span>, <span class="hlFld-ContribAuthor ">Tiziana  Masini</span>, <span class="hlFld-ContribAuthor ">Nicolas  Boutard</span>, <span class="hlFld-ContribAuthor ">Lorenza  Di Ianni</span>, <span class="hlFld-ContribAuthor ">Marcella  Manerba</span>, <span class="hlFld-ContribAuthor ">Fulvia  Farabegoli</span>, <span class="hlFld-ContribAuthor ">Lara  Rossini</span>, <span class="hlFld-ContribAuthor ">Janet  Robertson</span>, <span class="hlFld-ContribAuthor ">Saverio  Minucci</span>, <span class="hlFld-ContribAuthor ">Isabella  Pallavicini</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Di Stefano</span>, <span class="hlFld-ContribAuthor ">Marinella  Roberti</span>, <span class="hlFld-ContribAuthor ">Roberto  Pellicciari</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthetic Lethality Triggered by Combining Olaparib with BRCA2–Rad51 Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (10)
                                     , 2491-2497. <a href="https://doi.org/10.1021/acschembio.7b00707" title="DOI URL">https://doi.org/10.1021/acschembio.7b00707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00707%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSynthetic%252BLethality%252BTriggered%252Bby%252BCombining%252BOlaparib%252Bwith%252BBRCA2%2525E2%252580%252593Rad51%252BDisruptors%26aulast%3DFalchi%26aufirst%3DFederico%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D25082017%26date%3D01092017%26date%3D20102017%26date%3D25082017%26volume%3D12%26issue%3D10%26spage%3D2491%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shijie  Li</span>, <span class="hlFld-ContribAuthor ">Win  Topatana</span>, <span class="hlFld-ContribAuthor ">Sarun  Juengpanich</span>, <span class="hlFld-ContribAuthor ">Jiasheng  Cao</span>, <span class="hlFld-ContribAuthor ">Jiahao  Hu</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Diana  Ma</span>, <span class="hlFld-ContribAuthor ">Xiujun  Cai</span>, <span class="hlFld-ContribAuthor ">Mingyu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of synthetic lethality in cancer: molecular and cellular classification. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00358-6" title="DOI URL">https://doi.org/10.1038/s41392-020-00358-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00358-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00358-6%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DDevelopment%252Bof%252Bsynthetic%252Blethality%252Bin%252Bcancer%25253A%252Bmolecular%252Band%252Bcellular%252Bclassification%26aulast%3DLi%26aufirst%3DShijie%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Rizza</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Filomeni</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting S-nitrosylation for cancer therapy: facts and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (19)
                                     , 3649-3672. <a href="https://doi.org/10.1042/BCJ20200064" title="DOI URL">https://doi.org/10.1042/BCJ20200064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200064%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DExploiting%252BS-nitrosylation%252Bfor%252Bcancer%252Btherapy%25253A%252Bfacts%252Band%252Bperspectives%26aulast%3DRizza%26aufirst%3DSalvatore%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D19%26spage%3D3649%26epage%3D3672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huanbo  Zhu</span>, <span class="hlFld-ContribAuthor ">Umang  Swami</span>, <span class="hlFld-ContribAuthor ">Ranjan  Preet</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing DNA Replication Stress for Novel Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 990. <a href="https://doi.org/10.3390/genes11090990" title="DOI URL">https://doi.org/10.3390/genes11090990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes11090990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes11090990%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DHarnessing%252BDNA%252BReplication%252BStress%252Bfor%252BNovel%252BCancer%252BTherapy%26aulast%3DZhu%26aufirst%3DHuanbo%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaviarasan  Lakshmanan</span>, <span class="hlFld-ContribAuthor ">Gowramma  Byran</span>, <span class="hlFld-ContribAuthor ">Manal  Mohammed</span>. </span><span class="cited-content_cbyCitation_article-title">A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception. </span><span class="cited-content_cbyCitation_journal-name">Current Enzyme Inhibition</span><span> <strong>2020,</strong> <em>16 </em>
                                    (2)
                                     , 115-134. <a href="https://doi.org/10.2174/1573408016666200316114209" title="DOI URL">https://doi.org/10.2174/1573408016666200316114209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573408016666200316114209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573408016666200316114209%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Enzyme%2520Inhibition%26atitle%3DA%252BBrief%252BReview%252Bon%252BDual%252BTarget%252Bof%252BPARP1%252Band%252BSTAT3%252Bfor%252BCancer%252BTherapy%25253A%252BA%252BNovel%252BPerception%26aulast%3DLakshmanan%26aufirst%3DKaviarasan%26date%3D2020%26volume%3D16%26issue%3D2%26spage%3D115%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sima  Lev</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2020,</strong> <em>48 </em>
                                    (2)
                                     , 657-665. <a href="https://doi.org/10.1042/BST20191055" title="DOI URL">https://doi.org/10.1042/BST20191055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20191055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20191055%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DTargeted%252Btherapy%252Band%252Bdrug%252Bresistance%252Bin%252Btriple-negative%252Bbreast%252Bcancer%25253A%252Bthe%252BEGFR%252Baxis%26aulast%3DLev%26aufirst%3DSima%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D2%26spage%3D657%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rakesh  Paul</span>, <span class="hlFld-ContribAuthor ">Tania  Das</span>, <span class="hlFld-ContribAuthor ">Manish  Debnath</span>, <span class="hlFld-ContribAuthor ">Ajay  Chauhan</span>, <span class="hlFld-ContribAuthor ">Jyotirmayee  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">G‐Quadruplex‐Binding Small Molecule Induces Synthetic Lethality in Breast Cancer Cells by Inhibiting
              c‐MYC
              and
              BCL2
              Expression. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (7)
                                     , 963-970. <a href="https://doi.org/10.1002/cbic.201900534" title="DOI URL">https://doi.org/10.1002/cbic.201900534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900534%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DG%2525E2%252580%252590Quadruplex%2525E2%252580%252590Binding%252BSmall%252BMolecule%252BInduces%252BSynthetic%252BLethality%252Bin%252BBreast%252BCancer%252BCells%252Bby%252BInhibiting%252Bc%2525E2%252580%252590MYC%252Band%252BBCL2%252BExpression%26aulast%3DPaul%26aufirst%3DRakesh%26date%3D2020%26volume%3D21%26issue%3D7%26spage%3D963%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariko  Sasaki</span>, <span class="hlFld-ContribAuthor ">Hideaki  Ogiwara</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex‐deficient cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2020,</strong> <em>111 </em>
                                    (3)
                                     , 774-782. <a href="https://doi.org/10.1111/cas.14311" title="DOI URL">https://doi.org/10.1111/cas.14311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14311%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DSynthetic%252Blethal%252Btherapy%252Bbased%252Bon%252Btargeting%252Bthe%252Bvulnerability%252Bof%252BSWI%25252FSNF%252Bchromatin%252Bremodeling%252Bcomplex%2525E2%252580%252590deficient%252Bcancers%26aulast%3DSasaki%26aufirst%3DMariko%26date%3D2020%26date%3D2020%26volume%3D111%26issue%3D3%26spage%3D774%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian R.  Lahue</span>, <span class="hlFld-ContribAuthor ">Meir  Glick</span>, <span class="hlFld-ContribAuthor ">Matthew  Tudor</span>, <span class="hlFld-ContribAuthor ">Scott Arne  Johnson</span>, <span class="hlFld-ContribAuthor ">Janet  Diratsouian</span>, <span class="hlFld-ContribAuthor ">Mary Jo  Wildey</span>, <span class="hlFld-ContribAuthor ">Marybeth  Burton</span>, <span class="hlFld-ContribAuthor ">Robert  Mazzola</span>, <span class="hlFld-ContribAuthor ">Anne Mai  Wassermann</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity & tractability revisited in collaborative small molecule phenotypic screening library design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115192. <a href="https://doi.org/10.1016/j.bmc.2019.115192" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115192%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiversity%252B%252526%252Btractability%252Brevisited%252Bin%252Bcollaborative%252Bsmall%252Bmolecule%252Bphenotypic%252Bscreening%252Blibrary%252Bdesign%26aulast%3DLahue%26aufirst%3DBrian%2BR.%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clémence  Dubois</span>, <span class="hlFld-ContribAuthor ">Fanny  Martin</span>, <span class="hlFld-ContribAuthor ">Chervin  Hassel</span>, <span class="hlFld-ContribAuthor ">Florian  Magnier</span>, <span class="hlFld-ContribAuthor ">Pierre  Daumar</span>, <span class="hlFld-ContribAuthor ">Corinne  Aubel</span>, <span class="hlFld-ContribAuthor ">Sylvie  Guerder</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Mounetou</span>, <span class="hlFld-ContribAuthor ">Frédérique  Penault-Lorca</span>, <span class="hlFld-ContribAuthor ">Mahchid  Bamdad</span>. </span><span class="cited-content_cbyCitation_article-title">Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     , 64. <a href="https://doi.org/10.3390/jcm9010064" title="DOI URL">https://doi.org/10.3390/jcm9010064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9010064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9010064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DLow-Dose%252Band%252BLong-Term%252BOlaparib%252BTreatment%252BSensitizes%252BMDA-MB-231%252Band%252BSUM1315%252BTriple-Negative%252BBreast%252BCancers%252BSpheroids%252Bto%252BFractioned%252BRadiotherapy%26aulast%3DDubois%26aufirst%3DCl%25C3%25A9mence%26date%3D2020%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L Cristobal  Monraz Gomez</span>, <span class="hlFld-ContribAuthor ">Maria  Kondratova</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Ravel</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Barillot</span>, <span class="hlFld-ContribAuthor ">Andrei  Zinovyev</span>, <span class="hlFld-ContribAuthor ">Inna  Kuperstein</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Atlas of Cancer Signalling Network in preclinical studies. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Bioinformatics</span><span> <strong>2019,</strong> <em>20 </em>
                                    (2)
                                     , 701-716. <a href="https://doi.org/10.1093/bib/bby031" title="DOI URL">https://doi.org/10.1093/bib/bby031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bib/bby031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbib%2Fbby031%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Bioinformatics%26atitle%3DApplication%252Bof%252BAtlas%252Bof%252BCancer%252BSignalling%252BNetwork%252Bin%252Bpreclinical%252Bstudies%26aulast%3DMonraz%2BGomez%26aufirst%3DL%2BCristobal%26date%3D2019%26date%3D2018%26volume%3D20%26issue%3D2%26spage%3D701%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Rizza</span>, <span class="hlFld-ContribAuthor ">Paola  Giglio</span>, <span class="hlFld-ContribAuthor ">Fiorella  Faienza</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Filomeni</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Aspects of Protein Denitrosylation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 173-189. <a href="https://doi.org/10.1016/B978-0-12-816545-4.00009-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816545-4.00009-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816545-4.00009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816545-4.00009-8%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BAspects%252Bof%252BProtein%252BDenitrosylation%26aulast%3DRizza%26aufirst%3DSalvatore%26date%3D2019%26spage%3D173%26epage%3D189%26pub%3DElsevier%26atitle%3DTherapeutic%252BApplication%252Bof%252BNitric%252BOxide%252Bin%252BCancer%252Band%252BInflammatory%252BDisorders%26date%3D2019%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Yan</span>, <span class="hlFld-ContribAuthor ">Xiaoshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Ran  Zhang</span>, <span class="hlFld-ContribAuthor ">Xingxiang  Pu</span>, <span class="hlFld-ContribAuthor ">Shuhong  Wu</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Pan  Tong</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Qing H.  Meng</span>, <span class="hlFld-ContribAuthor ">Vanessa B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Luc  Girard</span>, <span class="hlFld-ContribAuthor ">John D.  Minna</span>, <span class="hlFld-ContribAuthor ">Jack A.  Roth</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Swisher</span>, <span class="hlFld-ContribAuthor ">John V.  Heymach</span>, <span class="hlFld-ContribAuthor ">Bingliang  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (1)
                                     , 125-132. <a href="https://doi.org/10.1158/0008-5472.CAN-18-1938" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-1938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-1938%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DInhibition%252Bof%252BThioredoxin%25252FThioredoxin%252BReductase%252BInduces%252BSynthetic%252BLethality%252Bin%252BLung%252BCancers%252Bwith%252BCompromised%252BGlutathione%252BHomeostasis%26aulast%3DYan%26aufirst%3DXiang%26date%3D2019%26date%3D2018%26volume%3D79%26issue%3D1%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyan  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Luo</span>, <span class="hlFld-ContribAuthor ">Mengqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chunlan  Pu</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-(1,3,4-oxadiazol-2-yl)-1,8-naphthyridin-4(1
              H
              )-ones as cisplatin sensitizers. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1949-1960. <a href="https://doi.org/10.1039/C8MD00464A" title="DOI URL">https://doi.org/10.1039/C8MD00464A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00464A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00464A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-%2525281%25252C3%25252C4-oxadiazol-2-yl%252529-1%25252C8-naphthyridin-4%2525281%252BH%252B%252529-ones%252Bas%252Bcisplatin%252Bsensitizers%26aulast%3DHou%26aufirst%3DXueyan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D1949%26epage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K  Veskimäe</span>, <span class="hlFld-ContribAuthor ">M  Scaravilli</span>, <span class="hlFld-ContribAuthor ">W  Niininen</span>, <span class="hlFld-ContribAuthor ">H  Karvonen</span>, <span class="hlFld-ContribAuthor ">S  Jaatinen</span>, <span class="hlFld-ContribAuthor ">M  Nykter</span>, <span class="hlFld-ContribAuthor ">T  Visakorpi</span>, <span class="hlFld-ContribAuthor ">J  Mäenpää</span>, <span class="hlFld-ContribAuthor ">D  Ungureanu</span>, <span class="hlFld-ContribAuthor ">S  Staff</span>. </span><span class="cited-content_cbyCitation_article-title">Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2018,</strong> <em>11 </em>
                                    (5)
                                     , 1160-1170. <a href="https://doi.org/10.1016/j.tranon.2018.07.010" title="DOI URL">https://doi.org/10.1016/j.tranon.2018.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2018.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2018.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DExpression%252BAnalysis%252Bof%252BPlatinum%252BSensitive%252Band%252BResistant%252BEpithelial%252BOvarian%252BCancer%252BPatient%252BSamples%252BReveals%252BNew%252BCandidates%252Bfor%252BTargeted%252BTherapies%26aulast%3DVeskim%25C3%25A4e%26aufirst%3DK%26date%3D2018%26volume%3D11%26issue%3D5%26spage%3D1160%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Naoki  Kawahara</span>, <span class="hlFld-ContribAuthor ">Kenji  Ogawa</span>, <span class="hlFld-ContribAuthor ">Yuki  Yamada</span>, <span class="hlFld-ContribAuthor ">Kana  Iwai</span>, <span class="hlFld-ContribAuthor ">Emiko  Niiro</span>, <span class="hlFld-ContribAuthor ">Sachiko  Morioka</span>. </span><span class="cited-content_cbyCitation_article-title">Conceptual frameworks of synthetic lethality in clear cell carcinoma of the ovary (Review). </span><span class="cited-content_cbyCitation_journal-name">Biomedical Reports</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/br.2018.1114" title="DOI URL">https://doi.org/10.3892/br.2018.1114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/br.2018.1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fbr.2018.1114%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Reports%26atitle%3DConceptual%252Bframeworks%252Bof%252Bsynthetic%252Blethality%252Bin%252Bclear%252Bcell%252Bcarcinoma%252Bof%252Bthe%252Bovary%252B%252528Review%252529%26aulast%3DKobayashi%26aufirst%3DHiroshi%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaojun  Qiu</span>, <span class="hlFld-ContribAuthor ">Nancy L.  Oleinick</span>, <span class="hlFld-ContribAuthor ">Junran  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">ATR/CHK1 inhibitors and cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Radiotherapy and Oncology</span><span> <strong>2018,</strong> <em>126 </em>
                                    (3)
                                     , 450-464. <a href="https://doi.org/10.1016/j.radonc.2017.09.043" title="DOI URL">https://doi.org/10.1016/j.radonc.2017.09.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.radonc.2017.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.radonc.2017.09.043%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiotherapy%2520and%2520Oncology%26atitle%3DATR%25252FCHK1%252Binhibitors%252Band%252Bcancer%252Btherapy%26aulast%3DQiu%26aufirst%3DZhaojun%26date%3D2018%26volume%3D126%26issue%3D3%26spage%3D450%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahnoosh  Rashidi</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Islami</span>, <span class="hlFld-ContribAuthor ">Saeed  Esmaeili-Mahani</span>. </span><span class="cited-content_cbyCitation_article-title">Design and stereoselective synthesis of novel β-lactone and β-lactams as potent anticancer agents on breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (8)
                                     , 835-841. <a href="https://doi.org/10.1016/j.tet.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.tet.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDesign%252Band%252Bstereoselective%252Bsynthesis%252Bof%252Bnovel%252B%2525CE%2525B2-lactone%252Band%252B%2525CE%2525B2-lactams%252Bas%252Bpotent%252Banticancer%252Bagents%252Bon%252Bbreast%252Bcancer%252Bcells%26aulast%3DRashidi%26aufirst%3DMahnoosh%26date%3D2018%26volume%3D74%26issue%3D8%26spage%3D835%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raksha  Ghanghoria</span>, <span class="hlFld-ContribAuthor ">Prashant  Kesharwani</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Tekade</span>, <span class="hlFld-ContribAuthor ">Narendra K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2018,</strong> <em>269 </em>, 277-301. <a href="https://doi.org/10.1016/j.jconrel.2016.11.002" title="DOI URL">https://doi.org/10.1016/j.jconrel.2016.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2016.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DTargeting%252Bluteinizing%252Bhormone-releasing%252Bhormone%25253A%252BA%252Bpotential%252Btherapeutics%252Bto%252Btreat%252Bgynecological%252Band%252Bother%252Bcancers%26aulast%3DGhanghoria%26aufirst%3DRaksha%26date%3D2018%26volume%3D269%26spage%3D277%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiufeng  Pang</span>, <span class="hlFld-ContribAuthor ">Mingyao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Defeat mutant
              KRAS
              with synthetic lethality. </span><span class="cited-content_cbyCitation_journal-name">Small GTPases</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 212-219. <a href="https://doi.org/10.1080/21541248.2016.1213783" title="DOI URL">https://doi.org/10.1080/21541248.2016.1213783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21541248.2016.1213783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21541248.2016.1213783%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall%2520GTPases%26atitle%3DDefeat%252Bmutant%252BKRAS%252Bwith%252Bsynthetic%252Blethality%26aulast%3DPang%26aufirst%3DXiufeng%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D212%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elzbieta  Pawłowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Szczepanska</span>, <span class="hlFld-ContribAuthor ">Janusz  Blasiak</span>. </span><span class="cited-content_cbyCitation_article-title">DNA2—An Important Player in DNA Damage Response or Just Another DNA Maintenance Protein?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (7)
                                     , 1562. <a href="https://doi.org/10.3390/ijms18071562" title="DOI URL">https://doi.org/10.3390/ijms18071562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18071562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18071562%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDNA2%2525E2%252580%252594An%252BImportant%252BPlayer%252Bin%252BDNA%252BDamage%252BResponse%252Bor%252BJust%252BAnother%252BDNA%252BMaintenance%252BProtein%25253F%26aulast%3DPaw%25C5%2582owska%26aufirst%3DElzbieta%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D7%26spage%3D1562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María  Sánchez-Peris</span>, <span class="hlFld-ContribAuthor ">Juan  Murga</span>, <span class="hlFld-ContribAuthor ">Eva  Falomir</span>, <span class="hlFld-ContribAuthor ">Miguel  Carda</span>, <span class="hlFld-ContribAuthor ">Juan Alberto  Marco</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of honokiol analogues and evaluation of their modulating action on VEGF protein secretion and telomerase-related gene expressions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>89 </em>
                                    (4)
                                     , 577-584. <a href="https://doi.org/10.1111/cbdd.12880" title="DOI URL">https://doi.org/10.1111/cbdd.12880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12880%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Bof%252Bhonokiol%252Banalogues%252Band%252Bevaluation%252Bof%252Btheir%252Bmodulating%252Baction%252Bon%252BVEGF%252Bprotein%252Bsecretion%252Band%252Btelomerase-related%252Bgene%252Bexpressions%26aulast%3DS%25C3%25A1nchez-Peris%26aufirst%3DMar%25C3%25ADa%26date%3D2017%26date%3D2016%26volume%3D89%26issue%3D4%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elliot  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Zhor  Senhaji Mouhri</span>, <span class="hlFld-ContribAuthor ">Christopher  Williams</span>, <span class="hlFld-ContribAuthor ">Bertrand J.  Jean-Claude</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity of novel molecules designed to target PARP and DNA. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (3)
                                     , 688-694. <a href="https://doi.org/10.1016/j.bmcl.2016.09.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.09.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.09.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bnovel%252Bmolecules%252Bdesigned%252Bto%252Btarget%252BPARP%252Band%252BDNA%26aulast%3DGoodfellow%26aufirst%3DElliot%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D688%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sreekanth A.  Ramachandran</span>, <span class="hlFld-ContribAuthor ">Pradeep S.  Jadhavar</span>, <span class="hlFld-ContribAuthor ">Manvendra P.  Singh</span>, <span class="hlFld-ContribAuthor ">Ankesh  Sharma</span>, <span class="hlFld-ContribAuthor ">Gaurav N.  Bagle</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Quinn</span>, <span class="hlFld-ContribAuthor ">Po-yin  Wong</span>, <span class="hlFld-ContribAuthor ">Andrew A.  Protter</span>, <span class="hlFld-ContribAuthor ">Roopa  Rai</span>, <span class="hlFld-ContribAuthor ">Son M.  Pham</span>, <span class="hlFld-ContribAuthor ">Jeffrey N.  Lindquist</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 750-754. <a href="https://doi.org/10.1016/j.bmcl.2017.01.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolopyrimidine%252Bderivatives%252Bas%252Bnovel%252Binhibitors%252Bof%252Bataxia%252Btelangiectasia%252Band%252Brad3%252Brelated%252Bprotein%252B%252528ATR%252529%26aulast%3DRamachandran%26aufirst%3DSreekanth%2BA.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D750%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suzannah  Harnor</span>, <span class="hlFld-ContribAuthor ">James  Pickles</span>, <span class="hlFld-ContribAuthor ">Celine  Cano</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the DNA-Damage Response by Inhibitors of the Phosphatidylinositol 3-Kinase Related Kinase (PIKK) Family. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 189-189. <a href="https://doi.org/10.1007/7355_2017_26" title="DOI URL">https://doi.org/10.1007/7355_2017_26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_26%26sid%3Dliteratum%253Aachs%26atitle%3DModulation%252Bof%252Bthe%252BDNA-Damage%252BResponse%252Bby%252BInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BRelated%252BKinase%252B%252528PIKK%252529%252BFamily%26aulast%3DHarnor%26aufirst%3DSuzannah%26date%3D2017%26spage%3D189%26epage%3D189%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Wang</span>, <span class="hlFld-ContribAuthor ">R.  Zhang</span>, <span class="hlFld-ContribAuthor ">B.  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Patient-Derived Xenografts From Lung Cancer and Their Potential Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 273-289. <a href="https://doi.org/10.1016/B978-0-12-804010-2.00020-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-804010-2.00020-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-804010-2.00020-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-804010-2.00020-5%26sid%3Dliteratum%253Aachs%26atitle%3DPatient-Derived%252BXenografts%252BFrom%252BLung%252BCancer%252Band%252BTheir%252BPotential%252BApplications%26aulast%3DWang%26aufirst%3DL.%26date%3D2017%26spage%3D273%26epage%3D289%26pub%3DElsevier%26atitle%3DPatient%252BDerived%252BTumor%252BXenograft%252BModels%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuo  Jiang</span>, <span class="hlFld-ContribAuthor ">Shane  Starr</span>, <span class="hlFld-ContribAuthor ">Fuxue  Chen</span>, <span class="hlFld-ContribAuthor ">Jiaxi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (16)
                                     , 1897-1910. <a href="https://doi.org/10.2217/fon-2016-0066" title="DOI URL">https://doi.org/10.2217/fon-2016-0066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2016-0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2016-0066%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DLow-fidelity%252Balternative%252BDNA%252Brepair%252Bcarcinogenesis%252Btheory%252Bmay%252Binterpret%252Bmany%252Bcancer%252Bfeatures%252Band%252Banticancer%252Bstrategies%26aulast%3DJiang%26aufirst%3DChuo%26date%3D2016%26volume%3D12%26issue%3D16%26spage%3D1897%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Kelley</span>, <span class="hlFld-ContribAuthor ">Jonathan  Knisely</span>, <span class="hlFld-ContribAuthor ">Marc  Symons</span>, <span class="hlFld-ContribAuthor ">Rosamaria  Ruggieri</span>. </span><span class="cited-content_cbyCitation_article-title">Radioresistance of Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2016,</strong> <em>8 </em>
                                    (4)
                                     , 42. <a href="https://doi.org/10.3390/cancers8040042" title="DOI URL">https://doi.org/10.3390/cancers8040042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers8040042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers8040042%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRadioresistance%252Bof%252BBrain%252BTumors%26aulast%3DKelley%26aufirst%3DKevin%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swathi V.  Iyer</span>, <span class="hlFld-ContribAuthor ">Alejandro  Parrales</span>, <span class="hlFld-ContribAuthor ">Priya  Begani</span>, <span class="hlFld-ContribAuthor ">Akshay  Narkar</span>, <span class="hlFld-ContribAuthor ">Amit S.  Adhikari</span>, <span class="hlFld-ContribAuthor ">Luis A.  Martinez</span>, <span class="hlFld-ContribAuthor ">Tomoo  Iwakuma</span>. </span><span class="cited-content_cbyCitation_article-title">Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 5401-5415. <a href="https://doi.org/10.18632/oncotarget.6634" title="DOI URL">https://doi.org/10.18632/oncotarget.6634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.6634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.6634%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DAllele-specific%252Bsilencing%252Bof%252Bmutant%252Bp53%252Battenuates%252Bdominant-negative%252Band%252Bgain-of-function%252Bactivities%26aulast%3DIyer%26aufirst%3DSwathi%2BV.%26date%3D2016%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D5401%26epage%3D5415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. N. Visweswara  Sastry</span>, <span class="hlFld-ContribAuthor ">Sunitha Rani  Routhu</span>, <span class="hlFld-ContribAuthor ">Soma Gupta  Datta</span>, <span class="hlFld-ContribAuthor ">Narayana  Nagesh</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>, <span class="hlFld-ContribAuthor ">Jagadeesh Babu  Nanubolu</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Ram Awatar  Maurya</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (39)
                                     , 9294-9305. <a href="https://doi.org/10.1039/C6OB01077F" title="DOI URL">https://doi.org/10.1039/C6OB01077F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01077F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01077F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%25252C%252BDNA%252Bbinding%252Baffinity%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252B4H-benzo%25255Bg%25255D%25255B1%25252C2%25252C3%25255Dtriazolo%25255B5%25252C1-c%25255D%25255B1%25252C4%25255Doxazocines%26aulast%3DSastry%26aufirst%3DK.%2BN.%2BVisweswara%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D39%26spage%3D9294%26epage%3D9305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingliang  Fang</span>, <span class="hlFld-ContribAuthor ">Reza J  Mehran</span>, <span class="hlFld-ContribAuthor ">John V  Heymach</span>, <span class="hlFld-ContribAuthor ">Stephen G  Swisher</span>. </span><span class="cited-content_cbyCitation_article-title">Predictive biomarkers in precision medicine and drug development against lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Cancer</span><span> <strong>2015,</strong> <em>34 </em>
                                    (3)
                                     <a href="https://doi.org/10.1186/s40880-015-0028-4" title="DOI URL">https://doi.org/10.1186/s40880-015-0028-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40880-015-0028-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40880-015-0028-4%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Cancer%26atitle%3DPredictive%252Bbiomarkers%252Bin%252Bprecision%252Bmedicine%252Band%252Bdrug%252Bdevelopment%252Bagainst%252Blung%252Bcancer%26aulast%3DFang%26aufirst%3DBingliang%26date%3D2015%26date%3D2015%26volume%3D34%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa  Rosso</span>, <span class="hlFld-ContribAuthor ">Alla  Polotskaia</span>, <span class="hlFld-ContribAuthor ">Jill  Bargonetti</span>. </span><span class="cited-content_cbyCitation_article-title">Homozygous
              mdm2
              SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (33)
                                     , 34573-34591. <a href="https://doi.org/10.18632/oncotarget.5312" title="DOI URL">https://doi.org/10.18632/oncotarget.5312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.5312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.5312%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DHomozygous%252Bmdm2%252BSNP309%252Bcancer%252Bcells%252Bwith%252Bcompromised%252Btranscriptional%252Belongation%252Bat%252Bp53%252Btarget%252Bgenes%252Bare%252Bsensitive%252Bto%252Binduction%252Bof%252Bp53-independent%252Bcell%252Bdeath%26aulast%3DRosso%26aufirst%3DMelissa%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D33%26spage%3D34573%26epage%3D34591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingliang  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies. </span><span class="cited-content_cbyCitation_journal-name">Acta Biochimica et Biophysica Sinica</span><span> <strong>2015,</strong> <em>62 </em>, gmv090. <a href="https://doi.org/10.1093/abbs/gmv090" title="DOI URL">https://doi.org/10.1093/abbs/gmv090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/abbs/gmv090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fabbs%2Fgmv090%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biochimica%2520et%2520Biophysica%2520Sinica%26atitle%3DRAS%252Bsignaling%252Band%252Banti-RAS%252Btherapy%25253A%252Blessons%252Blearned%252Bfrom%252Bgenetically%252Bengineered%252Bmouse%252Bmodels%25252C%252Bhuman%252Bcancer%252Bcells%25252C%252Band%252Bpatient-related%252Bstudies%26aulast%3DFang%26aufirst%3DBingliang%26date%3D2015%26date%3D2015%26volume%3D62%26spage%3Dgmv090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Wermke</span>, <span class="hlFld-ContribAuthor ">Aylin  Camgoz</span>, <span class="hlFld-ContribAuthor ">Maciej  Paszkowski-Rogacz</span>, <span class="hlFld-ContribAuthor ">Sebastian  Thieme</span>, <span class="hlFld-ContribAuthor ">Malte  von Bonin</span>, <span class="hlFld-ContribAuthor ">Andreas  Dahl</span>, <span class="hlFld-ContribAuthor ">Uwe  Platzbecker</span>, <span class="hlFld-ContribAuthor ">Mirko  Theis</span>, <span class="hlFld-ContribAuthor ">Gerhard  Ehninger</span>, <span class="hlFld-ContribAuthor ">Sebastian  Brenner</span>, <span class="hlFld-ContribAuthor ">Martin  Bornhäuser</span>, <span class="hlFld-ContribAuthor ">Frank  Buchholz</span>. </span><span class="cited-content_cbyCitation_article-title">RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2015,</strong> <em>125 </em>
                                    (24)
                                     , 3760-3768. <a href="https://doi.org/10.1182/blood-2014-07-590646" title="DOI URL">https://doi.org/10.1182/blood-2014-07-590646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2014-07-590646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2014-07-590646%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DRNAi%252Bprofiling%252Bof%252Bprimary%252Bhuman%252BAML%252Bcells%252Bidentifies%252BROCK1%252Bas%252Ba%252Btherapeutic%252Btarget%252Band%252Bnominates%252Bfasudil%252Bas%252Ban%252Bantileukemic%252Bdrug%26aulast%3DWermke%26aufirst%3DMartin%26date%3D2015%26volume%3D125%26issue%3D24%26spage%3D3760%26epage%3D3768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura L.  Romero-Hernández</span>, <span class="hlFld-ContribAuthor ">Penélope  Merino-Montiel</span>, <span class="hlFld-ContribAuthor ">Sara  Montiel-Smith</span>, <span class="hlFld-ContribAuthor ">Socorro  Meza-Reyes</span>, <span class="hlFld-ContribAuthor ">José Luis  Vega-Báez</span>, <span class="hlFld-ContribAuthor ">Ibane  Abasolo</span>, <span class="hlFld-ContribAuthor ">Simó  Schwartz</span>, <span class="hlFld-ContribAuthor ">Óscar  López</span>, <span class="hlFld-ContribAuthor ">José G.  Fernández-Bolaños</span>. </span><span class="cited-content_cbyCitation_article-title">Diosgenin-based thio(seleno)ureas and triazolyl glycoconjugates as hybrid drugs. Antioxidant and antiproliferative profile. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>99 </em>, 67-81. <a href="https://doi.org/10.1016/j.ejmech.2015.05.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiosgenin-based%252Bthio%252528seleno%252529ureas%252Band%252Btriazolyl%252Bglycoconjugates%252Bas%252Bhybrid%252Bdrugs.%252BAntioxidant%252Band%252Bantiproliferative%252Bprofile%26aulast%3DRomero-Hern%25C3%25A1ndez%26aufirst%3DLaura%2BL.%26date%3D2015%26volume%3D99%26spage%3D67%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Motonobu  Saito</span>, <span class="hlFld-ContribAuthor ">Yoko  Shimada</span>, <span class="hlFld-ContribAuthor ">Kouya  Shiraishi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Koji  Tsuta</span>, <span class="hlFld-ContribAuthor ">Hirohiko  Totsuka</span>, <span class="hlFld-ContribAuthor ">Suenori  Chiku</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Ichikawa</span>, <span class="hlFld-ContribAuthor ">Mamoru  Kato</span>, <span class="hlFld-ContribAuthor ">Shun-ichi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Teruhiko  Yoshida</span>, <span class="hlFld-ContribAuthor ">Jun  Yokota</span>, <span class="hlFld-ContribAuthor ">Takashi  Kohno</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2015,</strong> <em>75 </em>
                                    (11)
                                     , 2264-2271. <a href="https://doi.org/10.1158/0008-5472.CAN-14-3282" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-14-3282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-14-3282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-14-3282%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DDevelopment%252Bof%252BLung%252BAdenocarcinomas%252Bwith%252BExclusive%252BDependence%252Bon%252BOncogene%252BFusions%26aulast%3DSaito%26aufirst%3DMotonobu%26date%3D2015%26date%3D2015%26volume%3D75%26issue%3D11%26spage%3D2264%26epage%3D2271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie K.  Stock</span>, <span class="hlFld-ContribAuthor ">Neil P.  Jones</span>, <span class="hlFld-ContribAuthor ">Tim  Hammonds</span>, <span class="hlFld-ContribAuthor ">Jon  Roffey</span>, <span class="hlFld-ContribAuthor ">Christian  Dillon</span>. </span><span class="cited-content_cbyCitation_article-title">Addressing the Right Targets in Oncology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2015,</strong> <em>20 </em>
                                    (3)
                                     , 305-317. <a href="https://doi.org/10.1177/1087057114564349" title="DOI URL">https://doi.org/10.1177/1087057114564349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057114564349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057114564349%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DAddressing%252Bthe%252BRight%252BTargets%252Bin%252BOncology%26aulast%3DStock%26aufirst%3DJulie%2BK.%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D3%26spage%3D305%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Huang</span>, <span class="hlFld-ContribAuthor ">Mengru  Cao</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Shuhong  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Liu</span>, <span class="hlFld-ContribAuthor ">Hongyu  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Sun</span>, <span class="hlFld-ContribAuthor ">Caimiao  Wei</span>, <span class="hlFld-ContribAuthor ">Keith A.  Baggerly</span>, <span class="hlFld-ContribAuthor ">Jack A.  Roth</span>, <span class="hlFld-ContribAuthor ">Michael  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Swisher</span>, <span class="hlFld-ContribAuthor ">Bingliang  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 345-354. <a href="https://doi.org/10.18632/oncotarget.2814" title="DOI URL">https://doi.org/10.18632/oncotarget.2814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2814%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DExpression%252Bof%252Bsulfotransferase%252BSULT1A1%252Bin%252Bcancer%252Bcells%252Bpredicts%252Bsusceptibility%252Bto%252Bthe%252Bnovel%252Banticancer%252Bagent%252BNSC-743380%26aulast%3DHuang%26aufirst%3DXiao%26date%3D2015%26date%3D2014%26volume%3D6%26issue%3D1%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxia  Cui</span>, <span class="hlFld-ContribAuthor ">Stela S  Palii</span>, <span class="hlFld-ContribAuthor ">Cynthia L  Innes</span>, <span class="hlFld-ContribAuthor ">Richard S  Paules</span>. </span><span class="cited-content_cbyCitation_article-title">Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2014,</strong> <em>13 </em>
                                    (22)
                                     , 3541-3550. <a href="https://doi.org/10.4161/15384101.2014.960729" title="DOI URL">https://doi.org/10.4161/15384101.2014.960729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/15384101.2014.960729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2F15384101.2014.960729%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DDepletion%252Bof%252BATR%252Bselectively%252Bsensitizes%252BATM-deficient%252Bhuman%252Bmammary%252Bepithelial%252Bcells%252Bto%252Bionizing%252Bradiation%252Band%252BDNA-damaging%252Bagents%26aulast%3DCui%26aufirst%3DYuxia%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D22%26spage%3D3541%26epage%3D3550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0010.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concept and models of synthetic lethal interactions. (A) Synthetic lethality between genes <i>A</i> and <i>B</i>. <i>A</i><sup><i>+</i></sup> and <i>B</i><sup><i>+</i></sup> represent wild types, while <i>A</i><sup><i>–</i></sup> and <i>B</i><sup><i>–</i></sup> represent mutants. Synthetic lethality refers to a lethal phenotype observed only in the combination group of <i>A</i><sup><i>–</i></sup> and <i>B</i><sup><i>–</i></sup>. (B) An essential survival function is regulated by two pathways conducted by A, B, C and X, Y, X, respectively. A functional change in either of these pathways is insufficient to induce viability changes. However, the simultaneous presence of mutations or dysfunctions in both pathways, such as a mutation in A and any mutation in X, Y, or Z, induces lethal phenotype. Thus, A is synthetic lethal with X, Y, and Z, and vice versa. (C) An essential survival function is regulated by pathway A alone, in which A2 is a multiprotein complex composed of X, Y, and Z; and A3 has homologues of α, β and γ. Synthetic lethality may exist among X, Y, and Z and among A3α, β, and γ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. DNA damage repair pathways. Single-strand break (SSB), double-strand break (DSB), and single strand DNA derived from DNA damage or stalled replication fork are recognized by various sensor molecules (marked yellow), leading to activation of signal transducers (marked green), which in turn activate different DNA repair pathways and checkpoint pathways, thereby preventing transmission of the genetic lesion to the daughter cells. Those parallel pathways provide opportunities of eliminating some cancer cells with mutations in those pathways through synthetic lethality.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of PARP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Checkpoint pathways and cell cycle regulations. DNA damage caused by physical, chemical, and biological factors, such as oncogene activation, activates phosphatidylinositol 3-kinase related kinases ATM and ATR, leading to the activation of CHK2, CHK1, and p38/MK2, which further regulate activity and stability of cell cycle regulators, including p53 and CDC25. p53/p21 is the major regulator of G1/S checkpoint. The loss of p53 function in cancer cells makes the cells addicting to the S and/or G2/M checkpoints for DNA repaire and survival. Inhibiting S and/or G2/M checkpoint regulators may induce synthetic lethality in p53 mutant cells when DNA is damaged. Arrow indicates activation, and the line terminating with a black circle indicates suppression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of nutlin-3 and inhibitors of ATM/ATR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of CHK1/2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Ras signaling pathways and synthetic lethal interactions. Receptor tyrosine kinases (RTK) activate RAS and PI3K/AKT/mTOR pathways. RAS in turn activates RAF/MEK/ERK, PI3K/AKT/mTOR, and RalGEF/Ral pathways and crosstalks with RTK, WNT, c-Jun N-terminal kinases (JNK), reactive oxidative species (ROS), STAT3, and tumor necrosis factor α (TNFα)/NFκB pathways. Several key nodes in those signaling networks, such as TBK1, PLK1, CDK4, SYK, and WT1 (colored tan), have been reported to have synthetic lethal interactions with oncogenic RAS. In contrast, activation of p53 and JNK may lead to apoptosis. Arrow indicates activation, and the line terminating with a black circle indicates suppression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/medium/jm-2014-00415t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of oncogenic Ras synthetic lethal agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500415t/20150603/images/large/jm-2014-00415t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500415t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i12">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 168 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">Cancer genome landscapes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1235122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23539594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=1546-1558&author=B.+Vogelsteinauthor=N.+Papadopoulosauthor=V.+E.+Velculescuauthor=S.+Zhouauthor=L.+A.+Diazauthor=K.+W.+Kinzler&title=Cancer+genome+landscapes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer genome landscapes</span></div><div class="casAuthors">Vogelstein, Bert; Papadopoulos, Nickolas; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6127</span>),
    <span class="NLM_cas:pages">1546-1558</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer.  For most cancer types, this landscape consists of a small no. of "mountains" (genes altered in a high percentage of tumors) and a much larger no. of "hills" (genes altered infrequently).  To date, these studies have revealed ~140 genes that, when altered by intragenic mutations, can promote or "drive" tumorigenesis.  A typical tumor contains two to eight of these "driver gene" mutations; the remaining mutations are passengers that confer no selective growth advantage.  Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance.  A better understanding of these pathways is one of the most pressing needs in basic cancer research.  Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXBcf6dWj0bVg90H21EOLACvtfcHk0lgu5NNNfjGrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOhsb0%253D&md5=da190782f210873557cbf15441540ee7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1235122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1235122%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DCancer%2520genome%2520landscapes%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D1546%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Patel, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halling-Brown, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tym, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span> </span><span class="NLM_article-title">Objective assessment of cancer genes for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=35-50&author=M.+N.+Patelauthor=M.+D.+Halling-Brownauthor=J.+E.+Tymauthor=P.+Workmanauthor=B.+Al-Lazikani&title=Objective+assessment+of+cancer+genes+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BN.%26aulast%3DHalling-Brown%26aufirst%3DM.%2BD.%26aulast%3DTym%26aufirst%3DJ.%2BE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26atitle%3DObjective%2520assessment%2520of%2520cancer%2520genes%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D35%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hartwell, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szankasi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Integrating genetic approaches into the discovery of anticancer drugs</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.278.5340.1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9353181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Wju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1064-1068&author=L.+H.+Hartwellauthor=P.+Szankasiauthor=C.+J.+Robertsauthor=A.+W.+Murrayauthor=S.+H.+Friend&title=Integrating+genetic+approaches+into+the+discovery+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating genetic approaches into the discovery of anticancer drugs</span></div><div class="casAuthors">Hartwell, Leland H.; Szankasi, Philippe; Roberts, Christopher J.; Murray, Andrew W.; Friend, Stephen H.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5340</span>),
    <span class="NLM_cas:pages">1064-1068</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 48 refs. The discovery of anticancer drugs is now driven by the numerous mol. alterations identified in tumor cells over the past decade.  To exploit these alterations, it is necessary to understand how they define a mol. context that allows increased sensitivity to particular compds.  Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies by which drugs can be profiled for their ability to selectively kill cells in a mol. context that matches those found in tumors.  Similarly, it may be possible to identify and validate new targets for drugs that would selectively kill tumor cells with a particular mol. context.  This article outlines some of the ways that yeast genetics can be used to streamline anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbQLv4QwxtZrVg90H21EOLACvtfcHk0lgUbwyFvk2nfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Wju7k%253D&md5=6bd5b219e8b5f5dd28b400003a9e4edb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5340.1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5340.1064%26sid%3Dliteratum%253Aachs%26aulast%3DHartwell%26aufirst%3DL.%2BH.%26aulast%3DSzankasi%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DMurray%26aufirst%3DA.%2BW.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DIntegrating%2520genetic%2520approaches%2520into%2520the%2520discovery%2520of%2520anticancer%2520drugs%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1064%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dobzhansky, T. H.</span><span> </span><span class="NLM_article-title">Genetics of natural populations. XIII. Recombination and variability and populations of drosophila pseudoobscura</span> <span class="citation_source-journal">Genetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1946&pages=269-290&author=T.+H.+Dobzhansky&title=Genetics+of+natural+populations.+XIII.+Recombination+and+variability+and+populations+of+drosophila+pseudoobscura"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobzhansky%26aufirst%3DT.%2BH.%26atitle%3DGenetics%2520of%2520natural%2520populations.%2520XIII.%2520Recombination%2520and%2520variability%2520and%2520populations%2520of%2520drosophila%2520pseudoobscura%26jtitle%3DGenetics%26date%3D1946%26volume%3D31%26spage%3D269%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lucchesi, J. C.</span><span> </span><span class="NLM_article-title">Synthetic lethality and semi-lethality among functionally related mutants of <i>Drosophila melanfgaster</i></span> <span class="citation_source-journal">Genetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fgenetics%2F59.1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=5683639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADyaF1M%252FhtFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1968&pages=37-44&author=J.+C.+Lucchesi&title=Synthetic+lethality+and+semi-lethality+among+functionally+related+mutants+of+Drosophila+melanfgaster"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality and semi-lethality among functionally related mutants of Drosophila melanfgaster</span></div><div class="casAuthors">Lucchesi J C</div><div class="citationInfo"><span class="NLM_cas:title">Genetics</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>
        ISSN:<span class="NLM_cas:issn">0016-6731</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXM96_03HVQCO2kE7krGOBfW6udTcc2eacdu6Qlhij27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1M%252FhtFyrtg%253D%253D&md5=0a74c995f844634c47a35e6a5b39b90a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fgenetics%2F59.1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgenetics%252F59.1.37%26sid%3Dliteratum%253Aachs%26aulast%3DLucchesi%26aufirst%3DJ.%2BC.%26atitle%3DSynthetic%2520lethality%2520and%2520semi-lethality%2520among%2520functionally%2520related%2520mutants%2520of%2520Drosophila%2520melanfgaster%26jtitle%3DGenetics%26date%3D1968%26volume%3D59%26spage%3D37%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Farmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarosa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature03445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15829967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=917-921&author=H.+Farmerauthor=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+Tuttauthor=D.+A.+Johnsonauthor=T.+B.+Richardsonauthor=M.+Santarosaauthor=K.+J.+Dillonauthor=I.+Hicksonauthor=C.+Knightsauthor=N.+M.+Martinauthor=S.+P.+Jacksonauthor=G.+C.+Smithauthor=A.+Ashworth&title=Targeting+the+DNA+repair+defect+in+BRCA+mutant+cells+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span></div><div class="casAuthors">Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian; Knights, Charlotte; Martin, Niall M. B.; Jackson, Stephen P.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">917-921</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers.  Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks.  The authors show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis.  This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination.  These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVTKE4mFwfrVg90H21EOLACvtfcHk0lg1h6AoGZwsjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D&md5=03b5ba0adc21a5627fe17ae535f45078</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03445%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DH.%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BB.%26aulast%3DSantarosa%26aufirst%3DM.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520DNA%2520repair%2520defect%2520in%2520BRCA%2520mutant%2520cells%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dolma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessnick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=285-296&author=S.+Dolmaauthor=S.+L.+Lessnickauthor=W.+C.+Hahnauthor=B.+R.+Stockwell&title=Identification+of+genotype-selective+antitumor+agents+using+synthetic+lethal+chemical+screening+in+engineered+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolma%26aufirst%3DS.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DIdentification%2520of%2520genotype-selective%2520antitumor%2520agents%2520using%2520synthetic%2520lethal%2520chemical%2520screening%2520in%2520engineered%2520human%2520tumor%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D285%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7403</span><span class="NLM_x">–</span> <span class="NLM_lpage">7408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7403-7408&author=W.+Guoauthor=S.+Wuauthor=J.+Liuauthor=B.+Fang&title=Identification+of+a+small+molecule+with+synthetic+lethality+for+K-ras+and+protein+kinase+C+iota"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520with%2520synthetic%2520lethality%2520for%2520K-ras%2520and%2520protein%2520kinase%2520C%2520iota%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7403%26epage%3D7408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Barbie, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meylan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiling, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadlow, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoersch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittner, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span> </span><span class="NLM_article-title">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature08460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19847166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=108-112&author=D.+A.+Barbieauthor=P.+Tamayoauthor=J.+S.+Boehmauthor=S.+Y.+Kimauthor=S.+E.+Moodyauthor=I.+F.+Dunnauthor=A.+C.+Schinzelauthor=P.+Sandyauthor=E.+Meylanauthor=C.+Schollauthor=S.+Frohlingauthor=E.+M.+Chanauthor=M.+L.+Sosauthor=K.+Michelauthor=C.+Mermelauthor=S.+J.+Silverauthor=B.+A.+Weirauthor=J.+H.+Reilingauthor=Q.+Shengauthor=P.+B.+Guptaauthor=R.+C.+Wadlowauthor=H.+Leauthor=S.+Hoerschauthor=B.+S.+Wittnerauthor=S.+Ramaswamyauthor=D.+M.+Livingstonauthor=D.+M.+Sabatiniauthor=M.+Meyersonauthor=R.+K.+Thomasauthor=E.+S.+Landerauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=D.+G.+Gillilandauthor=T.+Jacksauthor=W.+C.+Hahn&title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span></div><div class="casAuthors">Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7269</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to std. therapies.  Although the identification of specific oncogenes has led to the development of clin. effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach.  A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele.  Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IκB kinase TBK1 was selectively essential in cells that contain mutant KRAS.  Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression.  In these cells, TBK1 activated NF-κB anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction.  These observations indicate that TBK1 and NF-κB signaling are essential in KRAS mutant tumors, and establish a general approach for the rational identification of co-dependent pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlw2rhGywK0bVg90H21EOLACvtfcHk0lgfQQwdqx1tVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL&md5=aab467de18805a08c3b1484f432ea64a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature08460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08460%26sid%3Dliteratum%253Aachs%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DDunn%26aufirst%3DI.%2BF.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMeylan%26aufirst%3DE.%26aulast%3DScholl%26aufirst%3DC.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DMichel%26aufirst%3DK.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DReiling%26aufirst%3DJ.%2BH.%26aulast%3DSheng%26aufirst%3DQ.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DWadlow%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DHoersch%26aufirst%3DS.%26aulast%3DWittner%26aufirst%3DB.%2BS.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DSystematic%2520RNA%2520interference%2520reveals%2520that%2520oncogenic%2520KRAS-driven%2520cancers%2520require%2520TBK1%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D108%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuele, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlabach, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2009.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19490893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=835-848&author=J.+Luoauthor=M.+J.+Emanueleauthor=D.+Liauthor=C.+J.+Creightonauthor=M.+R.+Schlabachauthor=T.+F.+Westbrookauthor=K.+K.+Wongauthor=S.+J.+Elledge&title=A+genome-wide+RNAi+screen+identifies+multiple+synthetic+lethal+interactions+with+the+Ras+oncogene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene</span></div><div class="casAuthors">Luo, Ji; Emanuele, Michael J.; Li, Danan; Creighton, Chad J.; Schlabach, Michael R.; Westbrook, Thomas F.; Wong, Kwok-Kin; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">835-848</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Oncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understanding of the vulnerabilities of these cancers is lacking.  We undertook a genome-wide RNAi screen to identify synthetic lethal interactions with the KRAS oncogene.  We discovered a diverse set of proteins whose depletion selectively impaired the viability of Ras mutant cells.  Among these we obsd. a strong enrichment for genes with mitotic functions.  We describe a pathway involving the mitotic kinase PLK1, the anaphase-promoting complex/cyclosome, and the proteasome that, when inhibited, results in prometaphase accumulation and the subsequent death of Ras mutant cells.  Gene expression anal. indicates that reduced expression of genes in this pathway correlates with increased survival of patients bearing tumors with a Ras transcriptional signature.  Our results suggest a previously underappreciated role for Ras in mitotic progression and demonstrate a pharmacol. tractable pathway for the potential treatment of cancers harboring Ras mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmWFKW3XYaabVg90H21EOLACvtfcHk0lgfQQwdqx1tVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCltb4%253D&md5=f06fd1f1c469495489ad2ac7f0cab090</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DEmanuele%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DWestbrook%26aufirst%3DT.%2BF.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520genome-wide%2520RNAi%2520screen%2520identifies%2520multiple%2520synthetic%2520lethal%2520interactions%2520with%2520the%2520Ras%2520oncogene%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D835%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Puyol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizcueta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=63-73&author=M.+Puyolauthor=A.+Martinauthor=P.+Dubusauthor=F.+Muleroauthor=P.+Pizcuetaauthor=G.+Khanauthor=C.+Guerraauthor=D.+Santamariaauthor=M.+Barbacid&title=A+synthetic+lethal+interaction+between+K-Ras+oncogenes+and+Cdk4+unveils+a+therapeutic+strategy+for+non-small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuyol%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMulero%26aufirst%3DF.%26aulast%3DPizcueta%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DA%2520synthetic%2520lethal%2520interaction%2520between%2520K-Ras%2520oncogenes%2520and%2520Cdk4%2520unveils%2520a%2520therapeutic%2520strategy%2520for%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D63%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Astsaturov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratushny, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnyukova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhmyanova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skobeleva, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecherskaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasto, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebriiskii, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golemis, E. A.</span><span> </span><span class="NLM_article-title">Synthetic lethal screen of an EGFR-centered network to improve targeted therapies</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscisignal.2001083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20858866" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=ra67&author=I.+Astsaturovauthor=V.+Ratushnyauthor=A.+Sukhanovaauthor=M.+B.+Einarsonauthor=T.+Bagnyukovaauthor=Y.+Zhouauthor=K.+Devarajanauthor=J.+S.+Silvermanauthor=N.+Tikhmyanovaauthor=N.+Skobelevaauthor=A.+Pecherskayaauthor=R.+E.+Nastoauthor=C.+Sharmaauthor=S.+A.+Jablonskiauthor=I.+G.+Serebriiskiiauthor=L.+M.+Weinerauthor=E.+A.+Golemis&title=Synthetic+lethal+screen+of+an+EGFR-centered+network+to+improve+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2001083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2001083%26sid%3Dliteratum%253Aachs%26aulast%3DAstsaturov%26aufirst%3DI.%26aulast%3DRatushny%26aufirst%3DV.%26aulast%3DSukhanova%26aufirst%3DA.%26aulast%3DEinarson%26aufirst%3DM.%2BB.%26aulast%3DBagnyukova%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DSilverman%26aufirst%3DJ.%2BS.%26aulast%3DTikhmyanova%26aufirst%3DN.%26aulast%3DSkobeleva%26aufirst%3DN.%26aulast%3DPecherskaya%26aufirst%3DA.%26aulast%3DNasto%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DC.%26aulast%3DJablonski%26aufirst%3DS.%2BA.%26aulast%3DSerebriiskii%26aufirst%3DI.%2BG.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DGolemis%26aufirst%3DE.%2BA.%26atitle%3DSynthetic%2520lethal%2520screen%2520of%2520an%2520EGFR-centered%2520network%2520to%2520improve%2520targeted%2520therapies%26jtitle%3DSci.%2520Signaling%26date%3D2010%26volume%3D3%26spage%3Dra67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Whitehurst, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodemann, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardenas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michnoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. A.</span><span> </span><span class="NLM_article-title">Synthetic lethal screen identification of chemosensitizer loci in cancer cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=815-819&author=A.+W.+Whitehurstauthor=B.+O.+Bodemannauthor=J.+Cardenasauthor=D.+Fergusonauthor=L.+Girardauthor=M.+Peytonauthor=J.+D.+Minnaauthor=C.+Michnoffauthor=W.+Haoauthor=M.+G.+Rothauthor=X.+J.+Xieauthor=M.+A.+White&title=Synthetic+lethal+screen+identification+of+chemosensitizer+loci+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitehurst%26aufirst%3DA.%2BW.%26aulast%3DBodemann%26aufirst%3DB.%2BO.%26aulast%3DCardenas%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMichnoff%26aufirst%3DC.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DSynthetic%2520lethal%2520screen%2520identification%2520of%2520chemosensitizer%2520loci%2520in%2520cancer%2520cells%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D815%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomeusz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span> </span><span class="NLM_article-title">KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5532</span><span class="NLM_x">–</span> <span class="NLM_lpage">5543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5532-5543&author=B.+Daiauthor=S.+Y.+Yooauthor=G.+Bartholomeuszauthor=R.+A.+Grahamauthor=M.+Majidiauthor=S.+Yanauthor=J.+Mengauthor=L.+Jiauthor=K.+Coombesauthor=J.+D.+Minnaauthor=B.+Fangauthor=J.+A.+Roth&title=KEAP1-dependent+synthetic+lethality+induced+by+AKT+and+TXNRD1+inhibitors+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DS.%2BY.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DGraham%26aufirst%3DR.%2BA.%26aulast%3DMajidi%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DCoombes%26aufirst%3DK.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DKEAP1-dependent%2520synthetic%2520lethality%2520induced%2520by%2520AKT%2520and%2520TXNRD1%2520inhibitors%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5532%26epage%3D5543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">The concept of synthetic lethality in the context of anticancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=16110319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=689-698&author=W.+G.+Kaelin&title=The+concept+of+synthetic+lethality+in+the+context+of+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Concept of Synthetic Lethality in the Context of Anticancer Therapy</span></div><div class="casAuthors">Kaelin, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">689-698</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Two genes are synthetic lethal if mutation of either alone is compatible with viability but mutation of both leads to death.  So, targeting a gene that is synthetic lethal to a cancer-relevant mutation should kill only cancer cells and spare normal cells.  Synthetic lethality therefore provides a conceptual framework for the development of cancer-specific cytotoxic agents.  This paradigm has not been exploited in the past because there were no robust methods for systematically identifying synthetic lethal genes.  This is changing as a result of the increased availability of chem. and genetic tools for perturbing gene function in somatic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf4V-KQ6I5ILVg90H21EOLACvtfcHk0ljgjKmuR5nmtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleks7c%253D&md5=4d5e38282cd8a3d2c3451d56ca88ac8b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1691%26sid%3Dliteratum%253Aachs%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DThe%2520concept%2520of%2520synthetic%2520lethality%2520in%2520the%2520context%2520of%2520anticancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D689%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Le Meur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentleman, R.</span><span> </span><span class="NLM_article-title">Modeling synthetic lethality</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=R135&author=N.+Le+Meurauthor=R.+Gentleman&title=Modeling+synthetic+lethality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BMeur%26aufirst%3DN.%26aulast%3DGentleman%26aufirst%3DR.%26atitle%3DModeling%2520synthetic%2520lethality%26jtitle%3DGenome%2520Biol.%26date%3D2008%26volume%3D9%26spage%3DR135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berriz, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brost, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levinson, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munyana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonikian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sdicu, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burd, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretscher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, C.</span><span> </span><span class="NLM_article-title">Global mapping of the yeast genetic interaction network</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1091317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14764870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=808-813&author=A.+H.+Tongauthor=G.+Lesageauthor=G.+D.+Baderauthor=H.+Dingauthor=H.+Xuauthor=X.+Xinauthor=J.+Youngauthor=G.+F.+Berrizauthor=R.+L.+Brostauthor=M.+Changauthor=Y.+Chenauthor=X.+Chengauthor=G.+Chuaauthor=H.+Friesenauthor=D.+S.+Goldbergauthor=J.+Haynesauthor=C.+Humphriesauthor=G.+Heauthor=S.+Husseinauthor=L.+Keauthor=N.+Kroganauthor=Z.+Liauthor=J.+N.+Levinsonauthor=H.+Luauthor=P.+Menardauthor=C.+Munyanaauthor=A.+B.+Parsonsauthor=O.+Ryanauthor=R.+Tonikianauthor=T.+Robertsauthor=A.+M.+Sdicuauthor=J.+Shapiroauthor=B.+Sheikhauthor=B.+Suterauthor=S.+L.+Wongauthor=L.+V.+Zhangauthor=H.+Zhuauthor=C.+G.+Burdauthor=S.+Munroauthor=C.+Sanderauthor=J.+Rineauthor=J.+Greenblattauthor=M.+Peterauthor=A.+Bretscherauthor=G.+Bellauthor=F.+P.+Rothauthor=G.+W.+Brownauthor=B.+Andrewsauthor=H.+Busseyauthor=C.+Boone&title=Global+mapping+of+the+yeast+genetic+interaction+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of the yeast genetic interaction network</span></div><div class="casAuthors">Tong, Amy Hin Yan; Lesage, Guillaume; Bader, Gary D.; Ding, Huiming; Xu, Hong; Xin, Xiaofeng; Young, James; Berriz, Gabriel F.; Brost, Renee L.; Chang, Michael; Chen, YiQun; Cheng, Xin; Chua, Gordon; Friesen, Helena; Goldberg, Debra S.; Haynes, Jennifer; Humphries, Christine; He, Grace; Hussein, Shamiza; Ke, Lizhu; Krogan, Nevan; Li, Zhijian; Levinson, Joshua N.; Lu, Hong; Menard, Patrice; Munyana, Christella; Parsons, Ainslie B.; Ryan, Owen; Tonikian, Raffi; Roberts, Tania; Sdicu, Anne-Marie; Shapiro, Jesse; Sheikh, Bilal; Suter, Bernhard; Wong, Sharyl L.; Zhang, Lan V.; Zhu, Hongwei; Burd, Christopher G.; Munro, Sean; Sander, Chris; Rine, Jasper; Greenblatt, Jack; Peter, Matthias; Bretscher, Anthony; Bell, Graham; Roth, Frederick P.; Brown, Grant W.; Andrews, Brenda; Bussey, Howard; Boone, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A genetic interaction network contg. ∼1000 genes and ∼4000 interactions was mapped by crossing mutations in 132 different query genes into a set of ∼4700 viable gene yeast deletion mutants and scoring the double mutant progeny for fitness defects.  Network connectivity was predictive of function because interactions often occurred among functionally related genes, and similar patterns of interactions tended to identify components of the same pathway.  The genetic network exhibited dense local neighborhoods; therefore, the position of a gene on a partially mapped network is predictive of other genetic interactions.  Because digenic interactions are common in yeast, similar networks may underlie the complex genetics assocd. with inherited phenotypes in other organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbAm9UJCYBrLVg90H21EOLACvtfcHk0liTehALgycs5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKntg%253D%253D&md5=2bff102d32c6a0218ac6f110b6a4486d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1091317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1091317%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DA.%2BH.%26aulast%3DLesage%26aufirst%3DG.%26aulast%3DBader%26aufirst%3DG.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXin%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DBerriz%26aufirst%3DG.%2BF.%26aulast%3DBrost%26aufirst%3DR.%2BL.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DChua%26aufirst%3DG.%26aulast%3DFriesen%26aufirst%3DH.%26aulast%3DGoldberg%26aufirst%3DD.%2BS.%26aulast%3DHaynes%26aufirst%3DJ.%26aulast%3DHumphries%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHussein%26aufirst%3DS.%26aulast%3DKe%26aufirst%3DL.%26aulast%3DKrogan%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLevinson%26aufirst%3DJ.%2BN.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMenard%26aufirst%3DP.%26aulast%3DMunyana%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DA.%2BB.%26aulast%3DRyan%26aufirst%3DO.%26aulast%3DTonikian%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DSdicu%26aufirst%3DA.%2BM.%26aulast%3DShapiro%26aufirst%3DJ.%26aulast%3DSheikh%26aufirst%3DB.%26aulast%3DSuter%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DL.%2BV.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurd%26aufirst%3DC.%2BG.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DRine%26aufirst%3DJ.%26aulast%3DGreenblatt%26aufirst%3DJ.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DBretscher%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DF.%2BP.%26aulast%3DBrown%26aufirst%3DG.%2BW.%26aulast%3DAndrews%26aufirst%3DB.%26aulast%3DBussey%26aufirst%3DH.%26aulast%3DBoone%26aufirst%3DC.%26atitle%3DGlobal%2520mapping%2520of%2520the%2520yeast%2520genetic%2520interaction%2520network%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D808%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidransky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">p53 mutations in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=49-53&author=M.+Hollsteinauthor=D.+Sidranskyauthor=B.+Vogelsteinauthor=C.+C.+Harris&title=p53+mutations+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3Dp53%2520mutations%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Olivier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainaut, P.</span><span> </span><span class="NLM_article-title">TP53 mutations in human cancers: origins, consequences, and clinical use</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a001008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=a001008&author=M.+Olivierauthor=M.+Hollsteinauthor=P.+Hainaut&title=TP53+mutations+in+human+cancers%3A+origins%2C+consequences%2C+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlivier%26aufirst%3DM.%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DHainaut%26aufirst%3DP.%26atitle%3DTP53%2520mutations%2520in%2520human%2520cancers%253A%2520origins%252C%2520consequences%252C%2520and%2520clinical%2520use%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26spage%3Da001008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horejsi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koed, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tort, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guldberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orntoft, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=864-870&author=J.+Bartkovaauthor=Z.+Horejsiauthor=K.+Koedauthor=A.+Kraemerauthor=F.+Tortauthor=K.+Ziegerauthor=P.+Guldbergauthor=M.+Sehestedauthor=J.+M.+Neslandauthor=C.+Lukasauthor=T.+Orntoftauthor=J.+Lukasauthor=J.+Bartek&title=DNA+damage+response+as+a+candidate+anti-cancer+barrier+in+early+human+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DHorejsi%26aufirst%3DZ.%26aulast%3DKoed%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DTort%26aufirst%3DF.%26aulast%3DZieger%26aufirst%3DK.%26aulast%3DGuldberg%26aufirst%3DP.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNesland%26aufirst%3DJ.%2BM.%26aulast%3DLukas%26aufirst%3DC.%26aulast%3DOrntoft%26aufirst%3DT.%26aulast%3DLukas%26aufirst%3DJ.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DDNA%2520damage%2520response%2520as%2520a%2520candidate%2520anti-cancer%2520barrier%2520in%2520early%2520human%2520tumorigenesis%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D864%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span> </span><span class="NLM_article-title">Genome maintenance mechanisms for preventing cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2F35077232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=11357144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=366-374&author=J.+H.+Hoeijmakers&title=Genome+maintenance+mechanisms+for+preventing+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Genome maintenance mechanisms for preventing cancer</span></div><div class="casAuthors">Hoeijmakers, Jan H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">366-374</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 67 refs.  The early notion that cancer is caused by mutations in genes crit. for the control of cell growth implied that genome stability is important for preventing oncogenesis.  During the past decade, knowledge about the mechanisms by which genes erode and the mol. machinery designed to counteract this time-dependent genetic degeneration has increased markedly.  At the same time, it has become apparent that inherited or acquired deficiencies in genome maintenance systems contribute significantly to the onset of cancer.  This review summarizes the main DNA caretaking systems and their impact on genome stability and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLg3z9y6ZD7Vg90H21EOLACvtfcHk0lhPo9TCx-6gig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D&md5=7ef77f478c786849b0ec44a9d3c5bd28</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2F35077232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077232%26sid%3Dliteratum%253Aachs%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26atitle%3DGenome%2520maintenance%2520mechanisms%2520for%2520preventing%2520cancer%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D366%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Langelier, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, J. M.</span><span> </span><span class="NLM_article-title">Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1216338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22582261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=728-732&author=M.+F.+Langelierauthor=J.+L.+Planckauthor=S.+Royauthor=J.+M.+Pascal&title=Structural+basis+for+DNA+damage-dependent+poly%28ADP-ribosyl%29ation+by+human+PARP-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1</span></div><div class="casAuthors">Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6082</span>),
    <span class="NLM_cas:pages">728-732</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase-1 (PARP-1) (ADP) has a modular domain architecture that couples DNA damage detection to poly(ADP-ribosyl)ation activity through a poorly understood mechanism.  Here, the authors report the crystal structure of a DNA double-strand break in complex with human PARP-1 domains essential for activation (Zn1, Zn3, WGR-CAT).  PARP-1 engages DNA as a monomer, and the interaction with DNA damage organizes PARP-1 domains into a collapsed conformation that can explain the strong preference for automodification.  The Zn1, Zn3, and WGR domains collectively bind to DNA, forming a network of interdomain contacts that links the DNA damage interface to the catalytic domain (CAT).  The DNA damage-induced conformation of PARP-1 results in structural distortions that destabilize the CAT.  The results suggest that an increase in CAT protein dynamics underlies the DNA-dependent activation mechanism of PARP-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdGq__cCoyMLVg90H21EOLACvtfcHk0lhPo9TCx-6gig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFymurk%253D&md5=27070d2b1f5801ed1ce258a4ff545d5e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1216338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1216338%26sid%3Dliteratum%253Aachs%26aulast%3DLangelier%26aufirst%3DM.%2BF.%26aulast%3DPlanck%26aufirst%3DJ.%2BL.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPascal%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520basis%2520for%2520DNA%2520damage-dependent%2520poly%2528ADP-ribosyl%2529ation%2520by%2520human%2520PARP-1%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D728%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ali, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timinszky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas-Bosacoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladurner, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. W.</span><span> </span><span class="NLM_article-title">The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22683995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlCrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=685-692&author=A.+A.+Aliauthor=G.+Timinszkyauthor=R.+Arribas-Bosacomaauthor=M.+Kozlowskiauthor=P.+O.+Hassaauthor=M.+Hasslerauthor=A.+G.+Ladurnerauthor=L.+H.+Pearlauthor=A.+W.+Oliver&title=The+zinc-finger+domains+of+PARP1+cooperate+to+recognize+DNA+strand+breaks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks</span></div><div class="casAuthors">Ali, Ammar A. E.; Timinszky, Gyula; Arribas-Bosacoma, Raquel; Kozlowski, Marek; Hassa, Paul O.; Hassler, Markus; Ladurner, Andreas G.; Pearl, Laurence H.; Oliver, Antony W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase 1 (PARP1) is a primary DNA damage sensor whose (ADP-ribose) polymerase activity is acutely regulated by interaction with DNA breaks.  Upon activation at sites of DNA damage, PARP1 modifies itself and other proteins by covalent addn. of long, branched polymers of ADP-ribose, which in turn recruit downstream DNA repair and chromatin remodeling factors.  PARP1 recognizes DNA damage through its N-terminal DNA-binding domain (DBD), which consists of a tandem repeat of an unusual zinc-finger (ZnF) domain.  We have detd. the crystal structure of the human PARP1-DBD bound to a DNA break.  Along with functional anal. of PARP1 recruitment to sites of DNA damage in vivo, the structure reveals a dimeric assembly whereby ZnF1 and ZnF2 domains from sep. PARP1 mols. form a strand-break recognition module that helps activate PARP1 by facilitating its dimerization and consequent trans-automodification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuObmZ8n9SLVg90H21EOLACvtfcHk0lg2tG2wPv7LVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlCrurs%253D&md5=38dfc87a8543158bbf4ddfaf8241f691</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2335%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DA.%2BA.%26aulast%3DTiminszky%26aufirst%3DG.%26aulast%3DArribas-Bosacoma%26aufirst%3DR.%26aulast%3DKozlowski%26aufirst%3DM.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHassler%26aufirst%3DM.%26aulast%3DLadurner%26aufirst%3DA.%2BG.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DOliver%26aufirst%3DA.%2BW.%26atitle%3DThe%2520zinc-finger%2520domains%2520of%2520PARP1%2520cooperate%2520to%2520recognize%2520DNA%2520strand%2520breaks%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Luijsterburg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrouwe, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullenders, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantuma, N. P.</span><span> </span><span class="NLM_article-title">DDB2 promotes chromatin decondensation at UV-induced DNA damage</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2012&pages=267-281&author=M.+S.+Luijsterburgauthor=M.+Lindhauthor=K.+Acsauthor=M.+G.+Vrouweauthor=A.+Pinesauthor=A.+H.+vanauthor=L.+H.+Mullendersauthor=N.+P.+Dantuma&title=DDB2+promotes+chromatin+decondensation+at+UV-induced+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuijsterburg%26aufirst%3DM.%2BS.%26aulast%3DLindh%26aufirst%3DM.%26aulast%3DAcs%26aufirst%3DK.%26aulast%3DVrouwe%26aufirst%3DM.%2BG.%26aulast%3DPines%26aufirst%3DA.%26aulast%3Dvan%26aufirst%3DA.%2BH.%26aulast%3DMullenders%26aufirst%3DL.%2BH.%26aulast%3DDantuma%26aufirst%3DN.%2BP.%26atitle%3DDDB2%2520promotes%2520chromatin%2520decondensation%2520at%2520UV-induced%2520DNA%2520damage%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2012%26volume%3D197%26spage%3D267%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Goodarzi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, P. A.</span><span> </span><span class="NLM_article-title">The repair and signaling responses to DNA double-strand breaks</span> <span class="citation_source-journal">Adv. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=1-45&author=A.+A.+Goodarziauthor=P.+A.+Jeggo&title=The+repair+and+signaling+responses+to+DNA+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodarzi%26aufirst%3DA.%2BA.%26aulast%3DJeggo%26aufirst%3DP.%2BA.%26atitle%3DThe%2520repair%2520and%2520signaling%2520responses%2520to%2520DNA%2520double-strand%2520breaks%26jtitle%3DAdv.%2520Genet.%26date%3D2013%26volume%3D82%26spage%3D1%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sperka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, K. L.</span><span> </span><span class="NLM_article-title">DNA damage checkpoints in stem cells, ageing and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm3420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22914294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=579-590&author=T.+Sperkaauthor=J.+Wangauthor=K.+L.+Rudolph&title=DNA+damage+checkpoints+in+stem+cells%2C+ageing+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage checkpoints in stem cells, ageing and cancer</span></div><div class="casAuthors">Sperka, Tobias; Wang, Jianwei; Rudolph, K. Lenhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA damage induces cell-intrinsic checkpoints, including p53 and retinoblastoma (RB), as well as upstream regulators (exonuclease 1 (EXO1), ataxia telangiectasia mutated (ATM), ATR, p16INK4a and p19ARF) and downstream targets (p21, PUMA (p53 upregulated modulator of apoptosis) and sestrins).  Clearance of damaged cells by cell-intrinsic checkpoints suppresses carcinogenesis but as a downside may impair stem cell and tissue maintenance during ageing.  Modulating the activity of DNA damage checkpoints can either accelerate or decelerate tissue ageing and age-related carcinogenesis.  The outcome depends on cell-intrinsic and cell-extrinsic mechanisms that regulate the clearance of damaged cells and on the mol. context in ageing tissues, including the level of DNA damage accumulation itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHH5hhJRv5LVg90H21EOLACvtfcHk0libUSD6sOiixA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbjN&md5=10ecb3400938bda8c5954ff075743cdd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm3420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3420%26sid%3Dliteratum%253Aachs%26aulast%3DSperka%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DK.%2BL.%26atitle%3DDNA%2520damage%2520checkpoints%2520in%2520stem%2520cells%252C%2520ageing%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D579%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballif, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smogorzewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E. R.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalarski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerenthal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1126%2Fscience.1140321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17525332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Kit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1160-1166&author=S.+Matsuokaauthor=B.+A.+Ballifauthor=A.+Smogorzewskaauthor=E.+R.+McDonaldauthor=K.+E.+Hurovauthor=J.+Luoauthor=C.+E.+Bakalarskiauthor=Z.+Zhaoauthor=N.+Soliminiauthor=Y.+Lerenthalauthor=Y.+Shilohauthor=S.+P.+Gygiauthor=S.+J.+Elledge&title=ATM+and+ATR+substrate+analysis+reveals+extensive+protein+networks+responsive+to+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage</span></div><div class="casAuthors">Matsuoka, Shuhei; Ballif, Bryan A.; Smogorzewska, Agata; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Bakalarski, Corey E.; Zhao, Zhenming; Solimini, Nicole; Lerenthal, Yaniv; Shiloh, Yosef; Gygi, Steven P.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5828</span>),
    <span class="NLM_cas:pages">1160-1166</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular responses to DNA damage are mediated by a no. of protein kinases, including ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related).  The outlines of the signal transduction portion of this pathway are known, but little is known about the physiol. scope of the DNA damage response (DDR).  We performed a large-scale proteomic anal. of proteins phosphorylated in response to DNA damage on consensus sites recognized by ATM and ATR and identified more than 900 regulated phosphorylation sites encompassing over 700 proteins.  Functional anal. of a subset of this data set indicated that this list is highly enriched for proteins involved in the DDR.  This set of proteins is highly interconnected, and we identified a large no. of protein modules and networks not previously linked to the DDR.  This database paints a much broader landscape for the DDR than was previously appreciated and opens new avenues of investigation into the responses to DNA damage in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZIQna2pqRWrVg90H21EOLACvtfcHk0libUSD6sOiixA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Kit7o%253D&md5=ee6ee3a4a06556f457c8efabc2fe62be</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1140321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1140321%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DBallif%26aufirst%3DB.%2BA.%26aulast%3DSmogorzewska%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%2BR.%26aulast%3DHurov%26aufirst%3DK.%2BE.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DBakalarski%26aufirst%3DC.%2BE.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DSolimini%26aufirst%3DN.%26aulast%3DLerenthal%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DATM%2520and%2520ATR%2520substrate%2520analysis%2520reveals%2520extensive%2520protein%2520networks%2520responsive%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1160%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantor, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, R.</span><span> </span><span class="NLM_article-title">Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=317-328&author=J.+Chenauthor=D.+P.+Silverauthor=D.+Walpitaauthor=S.+B.+Cantorauthor=A.+F.+Gazdarauthor=G.+Tomlinsonauthor=F.+J.+Couchauthor=B.+L.+Weberauthor=T.+Ashleyauthor=D.+M.+Livingstonauthor=R.+Scully&title=Stable+interaction+between+the+products+of+the+BRCA1+and+BRCA2+tumor+suppressor+genes+in+mitotic+and+meiotic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSilver%26aufirst%3DD.%2BP.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DCantor%26aufirst%3DS.%2BB.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DTomlinson%26aufirst%3DG.%26aulast%3DCouch%26aufirst%3DF.%2BJ.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26aulast%3DAshley%26aufirst%3DT.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DScully%26aufirst%3DR.%26atitle%3DStable%2520interaction%2520between%2520the%2520products%2520of%2520the%2520BRCA1%2520and%2520BRCA2%2520tumor%2520suppressor%2520genes%2520in%2520mitotic%2520and%2520meiotic%2520cells%26jtitle%3DMol.%2520Cell%26date%3D1998%26volume%3D2%26spage%3D317%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pellegrini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkitaraman, A. R.</span><span> </span><span class="NLM_article-title">Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature01230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12442171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2002&pages=287-293&author=L.+Pellegriniauthor=D.+S.+Yuauthor=T.+Loauthor=S.+Anandauthor=M.+Leeauthor=T.+L.+Blundellauthor=A.+R.+Venkitaraman&title=Insights+into+DNA+recombination+from+the+structure+of+a+RAD51-BRCA2+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</span></div><div class="casAuthors">Pellegrini, Luca; Yu, David S.; Lo, Thomas; Anand, Shubha; Lee, MiYoung; Blundell, Tom L.; Venkitaraman, Ashok R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">6913</span>),
    <span class="NLM_cas:pages">287-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The breast cancer susceptibility protein BRCA2 controls the function of RAD51, a recombinase enzyme, in pathways for DNA repair by homologous recombination.  We report here the structure of a complex between an evolutionarily conserved sequence in BRCA2 (the BRC repeat) and the RecA-homol. domain of RAD51.  The BRC repeat mimics a motif in RAD51 that serves as an interface for oligomerization between individual RAD51 monomers, thus enabling BRCA2 to control the assembly of the RAD51 nucleoprotein filament, which is essential for strand-pairing reactions during DNA recombination.  The RAD51 oligomerization motif is highly conserved among RecA-like recombinases, highlighting a common evolutionary origin for the mechanism of nucleoprotein filament formation, mirrored in the BRC repeat.  Cancer-assocd. mutations that affect the BRC repeat disrupt its predicted interaction with RAD51, yielding structural insight into mechanisms for cancer susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo44KTdJmBb5rVg90H21EOLACvtfcHk0lhdUw6YK4Yoyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVektLY%253D&md5=5dc084f8efb75cf95bc31d4f5b1797e3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature01230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01230%26sid%3Dliteratum%253Aachs%26aulast%3DPellegrini%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%2BS.%26aulast%3DLo%26aufirst%3DT.%26aulast%3DAnand%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26atitle%3DInsights%2520into%2520DNA%2520recombination%2520from%2520the%2520structure%2520of%2520a%2520RAD51-BRCA2%2520complex%26jtitle%3DNature%26date%3D2002%26volume%3D420%26spage%3D287%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ramsden, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellert, M.</span><span> </span><span class="NLM_article-title">Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=609-614&author=D.+A.+Ramsdenauthor=M.+Gellert&title=Ku+protein+stimulates+DNA+end+joining+by+mammalian+DNA+ligases%3A+a+direct+role+for+Ku+in+repair+of+DNA+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DD.%2BA.%26aulast%3DGellert%26aufirst%3DM.%26atitle%3DKu%2520protein%2520stimulates%2520DNA%2520end%2520joining%2520by%2520mammalian%2520DNA%2520ligases%253A%2520a%2520direct%2520role%2520for%2520Ku%2520in%2520repair%2520of%2520DNA%2520double-strand%2520breaks%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D609%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Simsek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasin, M.</span><span> </span><span class="NLM_article-title">Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.1773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20208544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=410-416&author=D.+Simsekauthor=M.+Jasin&title=Alternative+end-joining+is+suppressed+by+the+canonical+NHEJ+component+Xrcc4-ligase+IV+during+chromosomal+translocation+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation</span></div><div class="casAuthors">Simsek, Deniz; Jasin, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-416</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chromosomal translocations in hematol. and mesenchymal tumors form overwhelmingly by nonhomologous end-joining (NHEJ).  Canonical NHEJ, essential for the repair of radiation-induced and some programmed double-strand breaks (DSBs), requires the Xrcc4-ligase IV complex.  For other DSBs, the requirement for Xrcc4-ligase IV is less stringent, suggesting the existence of alternative end-joining (alt-NHEJ) pathways.  To understand the contributions of the canonical NHEJ and alt-NHEJ pathways, translocation formation was examd. in cells deficient in Xrcc4-ligase IV.  Xrcc4-ligase IV was not required for but rather suppressed translocations.  Translocation breakpoint junctions had similar characteristics in wild-type cells and cells deficient in Xrcc4-ligase IV, including an unchanged bias toward microhomol., unlike what was obsd. for intrachromosomal DSB repair.  Complex insertions in some junctions showed that joining can be iterative, encompassing successive processing steps before joining.  The results imply that alt-NHEJ is the primary mediator of translocation formation in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNk90asZ_3LVg90H21EOLACvtfcHk0lhdUw6YK4Yoyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVCitLs%253D&md5=790ec53459d49d015b8bea66a8636192</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1773%26sid%3Dliteratum%253Aachs%26aulast%3DSimsek%26aufirst%3DD.%26aulast%3DJasin%26aufirst%3DM.%26atitle%3DAlternative%2520end-joining%2520is%2520suppressed%2520by%2520the%2520canonical%2520NHEJ%2520component%2520Xrcc4-ligase%2520IV%2520during%2520chromosomal%2520translocation%2520formation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D410%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gibson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, W. L.</span><span> </span><span class="NLM_article-title">New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm3376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22713970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=411-424&author=B.+A.+Gibsonauthor=W.+L.+Kraus&title=New+insights+into+the+molecular+and+cellular+functions+of+poly%28ADP-ribose%29+and+PARPs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs</span></div><div class="casAuthors">Gibson, Bryan A.; Kraus, W. Lee</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes.  The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signaling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signaling responses.  PARPs act in a complex response network that is driven by the cellular, mol. and chem. biol. of poly(ADP-ribose) (PAR).  This PAR-dependent response network is crucial for a broad array of physiol. and pathol. responses and thus is a good target for chem. therapeutics for several diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIm3s5z-XFELVg90H21EOLACvtfcHk0lhJlVplqfe3vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVaht70%253D&md5=b72f18e950b804fed13258a3930fe004</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrm3376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3376%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DB.%2BA.%26aulast%3DKraus%26aufirst%3DW.%2BL.%26atitle%3DNew%2520insights%2520into%2520the%2520molecular%2520and%2520cellular%2520functions%2520of%2520poly%2528ADP-ribose%2529%2520and%2520PARPs%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, W. L.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribosyl)ation by PARP-1: “PAR-laying” NAD+ into a nuclear signal</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1951</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1951-1967&author=M.+Y.+Kimauthor=T.+Zhangauthor=W.+L.+Kraus&title=Poly%28ADP-ribosyl%29ation+by+PARP-1%3A+%E2%80%9CPAR-laying%E2%80%9D+NAD%2B+into+a+nuclear+signal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DKraus%26aufirst%3DW.%2BL.%26atitle%3DPoly%2528ADP-ribosyl%2529ation%2520by%2520PARP-1%253A%2520%25E2%2580%259CPAR-laying%25E2%2580%259D%2520NAD%252B%2520into%2520a%2520nuclear%2520signal%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1951%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ruscetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehnert, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trong, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. R.</span><span> </span><span class="NLM_article-title">Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">14461</span><span class="NLM_x">–</span> <span class="NLM_lpage">14467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=14461-14467&author=T.+Ruscettiauthor=B.+E.+Lehnertauthor=J.+Halbrookauthor=H.+L.+Trongauthor=M.+F.+Hoekstraauthor=D.+J.+Chenauthor=S.+R.+Peterson&title=Stimulation+of+the+DNA-dependent+protein+kinase+by+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuscetti%26aufirst%3DT.%26aulast%3DLehnert%26aufirst%3DB.%2BE.%26aulast%3DHalbrook%26aufirst%3DJ.%26aulast%3DTrong%26aufirst%3DH.%2BL.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DD.%2BJ.%26aulast%3DPeterson%26aufirst%3DS.%2BR.%26atitle%3DStimulation%2520of%2520the%2520DNA-dependent%2520protein%2520kinase%2520by%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D14461%26epage%3D14467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ahel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=81-85&author=I.+Ahelauthor=D.+Ahelauthor=T.+Matsusakaauthor=A.+J.+Clarkauthor=J.+Pinesauthor=S.+J.+Boultonauthor=S.+C.+West&title=Poly%28ADP-ribose%29-binding+zinc+finger+motifs+in+DNA+repair%2Fcheckpoint+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhel%26aufirst%3DI.%26aulast%3DAhel%26aufirst%3DD.%26aulast%3DMatsusaka%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DPines%26aufirst%3DJ.%26aulast%3DBoulton%26aufirst%3DS.%2BJ.%26aulast%3DWest%26aufirst%3DS.%2BC.%26atitle%3DPoly%2528ADP-ribose%2529-binding%2520zinc%2520finger%2520motifs%2520in%2520DNA%2520repair%252Fcheckpoint%2520proteins%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Haince, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, G. G.</span><span> </span><span class="NLM_article-title">Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">16441</span><span class="NLM_x">–</span> <span class="NLM_lpage">16453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1074%2Fjbc.M608406200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17428792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVajtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16441-16453&author=J.+F.+Hainceauthor=S.+Kozlovauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=M.+J.+Hendzelauthor=M.+F.+Lavinauthor=G.+G.+Poirier&title=Ataxia+telangiectasia+mutated+%28ATM%29+signaling+network+is+modulated+by+a+novel+poly%28ADP-ribose%29-dependent+pathway+in+the+early+response+to+DNA-damaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ataxia Telangiectasia Mutated (ATM) Signaling Network Is Modulated by a Novel Poly(ADP-ribose)-dependent Pathway in the Early Response to DNA-damaging Agents</span></div><div class="casAuthors">Haince, Jean-Francois; Kozlov, Sergei; Dawson, Valina L.; Dawson, Ted M.; Hendzel, Michael J.; Lavin, Martin F.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">16441-16453</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Poly(ADP-ribosyl)ation is a post-translational modification that is instantly stimulated by DNA strand breaks creating a unique signal for the modulation of protein functions in DNA repair and cell cycle checkpoint pathways.  Here we report that lack of poly(ADP-ribose) synthesis leads to a compromised response to DNA damage.  Deficiency in poly(ADP-ribosyl)ation metab. induces profound cellular sensitivity to DNA-damaging agents, particularly in cells deficient for the protein kinase ataxia telangiectasia mutated (ATM).  At the biochem. level, we examd. the significance of poly(ADP-ribose) synthesis on the regulation of early DNA damage-induced signaling cascade initiated by ATM.  Using potent PARP inhibitors and PARP-1 knock-out cells, we demonstrate a functional interplay between ATM and poly(ADP-ribose) that is important for the phosphorylation of p53, SMC1, and H2AX.  For the first time, we demonstrate a functional and phys. interaction between the major DSB signaling kinase, ATM and poly(ADP-ribosyl)ation by PARP-1, a key enzyme of chromatin remodeling.  This study suggests that poly(ADP-ribose) might serve as a DNA damage sensory mol. that is crit. for early DNA damage signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_7jlZ-ppnPbVg90H21EOLACvtfcHk0lhD1Lx0OrN8KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVajtLg%253D&md5=9401678e8556575105acec9f3a84d108</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608406200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608406200%26sid%3Dliteratum%253Aachs%26aulast%3DHaince%26aufirst%3DJ.%2BF.%26aulast%3DKozlov%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DAtaxia%2520telangiectasia%2520mutated%2520%2528ATM%2529%2520signaling%2520network%2520is%2520modulated%2520by%2520a%2520novel%2520poly%2528ADP-ribose%2529-dependent%2520pathway%2520in%2520the%2520early%2520response%2520to%2520DNA-damaging%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D16441%26epage%3D16453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chou, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dephoure, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nottke, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colaiacovo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">18475</span><span class="NLM_x">–</span> <span class="NLM_lpage">18480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18475-18480&author=D.+M.+Chouauthor=B.+Adamsonauthor=N.+E.+Dephoureauthor=X.+Tanauthor=A.+C.+Nottkeauthor=K.+E.+Hurovauthor=S.+P.+Gygiauthor=M.+P.+Colaiacovoauthor=S.+J.+Elledge&title=A+chromatin+localization+screen+reveals+poly+%28ADP+ribose%29-regulated+recruitment+of+the+repressive+polycomb+and+NuRD+complexes+to+sites+of+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DD.%2BM.%26aulast%3DAdamson%26aufirst%3DB.%26aulast%3DDephoure%26aufirst%3DN.%2BE.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DNottke%26aufirst%3DA.%2BC.%26aulast%3DHurov%26aufirst%3DK.%2BE.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DColaiacovo%26aufirst%3DM.%2BP.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520chromatin%2520localization%2520screen%2520reveals%2520poly%2520%2528ADP%2520ribose%2529-regulated%2520recruitment%2520of%2520the%2520repressive%2520polycomb%2520and%2520NuRD%2520complexes%2520to%2520sites%2520of%2520DNA%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D18475%26epage%3D18480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pleschke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleczkowska, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althaus, F. R.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">40974</span><span class="NLM_x">–</span> <span class="NLM_lpage">40980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40974-40980&author=J.+M.+Pleschkeauthor=H.+E.+Kleczkowskaauthor=M.+Strohmauthor=F.+R.+Althaus&title=Poly%28ADP-ribose%29+binds+to+specific+domains+in+DNA+damage+checkpoint+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPleschke%26aufirst%3DJ.%2BM.%26aulast%3DKleczkowska%26aufirst%3DH.%2BE.%26aulast%3DStrohm%26aufirst%3DM.%26aulast%3DAlthaus%26aufirst%3DF.%2BR.%26atitle%3DPoly%2528ADP-ribose%2529%2520binds%2520to%2520specific%2520domains%2520in%2520DNA%2520damage%2520checkpoint%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40974%26epage%3D40980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masutani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span> </span><span class="NLM_article-title">Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1242%2Fjcs.128272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23868975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=4414-4423&author=L.+Weiauthor=S.+Nakajimaauthor=C.+L.+Hsiehauthor=S.+Kannoauthor=M.+Masutaniauthor=A.+S.+Levineauthor=A.+Yasuiauthor=L.+Lan&title=Damage+response+of+XRCC1+at+sites+of+DNA+single+strand+breaks+is+regulated+by+phosphorylation+and+ubiquitylation+after+degradation+of+poly%28ADP-ribose%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose)</span></div><div class="casAuthors">Wei, Leizhen; Nakajima, Satoshi; Hsieh, Ching-Lung; Kanno, Shinichiro; Masutani, Mitsuko; Levine, Arthur S.; Yasui, Akira; Lan, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4414-4423</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Single-strand breaks (SSBs) are the most common type of oxidative DNA damage and they are related to aging and many genetic diseases.  The scaffold protein for repair of SSBs, XRCC1, accumulates at sites of poly(ADP-ribose) (pAR) synthesized by PARP, but it is retained at sites of SSBs after pAR degrdn.  How XRCC1 responds to SSBs after pAR degrdn. and how this affects repair progression are not well understood.  We found that XRCC1 dissocs. from pAR and is translocated to sites of SSBs dependent on its BRCTII domain and the function of PARG.  In addn., phosphorylation of XRCC1 is also required for the proper dissocn. kinetics of XRCC1 because (1) phosphorylation sites mutated in XRCC1 (X1 pm) cause retention of XRCC1 at sites of SSB for a longer time compared to wild type XRCC1; and (2) phosphorylation of XRCC1 is required for efficient polyubiquitylation of XRCC1.  Interestingly, a mutant of XRCC1, LL360/361DD, which abolishes pAR binding, shows significant upregulation of ubiquitylation, indicating that pARylation of XRCC1 prevents the poly-ubiquitylation.  We also found that the dynamics of the repair proteins DNA polymerase beta, PNK, APTX, PCNA and ligase I are regulated by domains of XRCC1.  In summary, the dynamic damage response of XRCC1 is regulated in a manner that depends on modifications of polyADP-ribosylation, phosphorylation and ubiquitylation in live cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPj3VHY4k58bVg90H21EOLACvtfcHk0lh5vKHx-jBuog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSmsL3L&md5=e27808fb25d37ea2c308c9f2ac24333a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1242%2Fjcs.128272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.128272%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DC.%2BL.%26aulast%3DKanno%26aufirst%3DS.%26aulast%3DMasutani%26aufirst%3DM.%26aulast%3DLevine%26aufirst%3DA.%2BS.%26aulast%3DYasui%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DDamage%2520response%2520of%2520XRCC1%2520at%2520sites%2520of%2520DNA%2520single%2520strand%2520breaks%2520is%2520regulated%2520by%2520phosphorylation%2520and%2520ubiquitylation%2520after%2520degradation%2520of%2520poly%2528ADP-ribose%2529%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26spage%3D4414%26epage%3D4423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Prasad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrik, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Berg, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span> </span><span class="NLM_article-title">DNA polymerase beta-mediated long patch base excision repair. Poly(ADP-ribose)polymerase-1 stimulates strand displacement DNA synthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">32411</span><span class="NLM_x">–</span> <span class="NLM_lpage">32414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=32411-32414&author=R.+Prasadauthor=O.+I.+Lavrikauthor=S.+J.+Kimauthor=P.+Kedarauthor=X.+P.+Yangauthor=B.+J.+Vande+Bergauthor=S.+H.+Wilson&title=DNA+polymerase+beta-mediated+long+patch+base+excision+repair.+Poly%28ADP-ribose%29polymerase-1+stimulates+strand+displacement+DNA+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DR.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DKedar%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%2BP.%26aulast%3DVande%2BBerg%26aufirst%3DB.%2BJ.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26atitle%3DDNA%2520polymerase%2520beta-mediated%2520long%2520patch%2520base%2520excision%2520repair.%2520Poly%2528ADP-ribose%2529polymerase-1%2520stimulates%2520strand%2520displacement%2520DNA%2520synthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D32411%26epage%3D32414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Sukhanova, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodyreva, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedeva, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrik, O. I.</span><span> </span><span class="NLM_article-title">Human base excision repair enzymes apurinic/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1222-1229&author=M.+V.+Sukhanovaauthor=S.+N.+Khodyrevaauthor=N.+A.+Lebedevaauthor=R.+Prasadauthor=S.+H.+Wilsonauthor=O.+I.+Lavrik&title=Human+base+excision+repair+enzymes+apurinic%2Fapyrimidinic+endonuclease1+%28APE1%29%2C+DNA+polymerase+beta+and+poly%28ADP-ribose%29+polymerase+1%3A+interplay+between+strand-displacement+DNA+synthesis+and+proofreading+exonuclease+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukhanova%26aufirst%3DM.%2BV.%26aulast%3DKhodyreva%26aufirst%3DS.%2BN.%26aulast%3DLebedeva%26aufirst%3DN.%2BA.%26aulast%3DPrasad%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DHuman%2520base%2520excision%2520repair%2520enzymes%2520apurinic%252Fapyrimidinic%2520endonuclease1%2520%2528APE1%2529%252C%2520DNA%2520polymerase%2520beta%2520and%2520poly%2528ADP-ribose%2529%2520polymerase%25201%253A%2520interplay%2520between%2520strand-displacement%2520DNA%2520synthesis%2520and%2520proofreading%2520exonuclease%2520activity%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D1222%26epage%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ahel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horejsi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiechens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Wilson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen-Hughes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, S. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1240-1243&author=D.+Ahelauthor=Z.+Horejsiauthor=N.+Wiechensauthor=S.+E.+Poloauthor=E.+Garcia-Wilsonauthor=I.+Ahelauthor=H.+Flynnauthor=M.+Skehelauthor=S.+C.+Westauthor=S.+P.+Jacksonauthor=T.+Owen-Hughesauthor=S.+J.+Boulton&title=Poly%28ADP-ribose%29-dependent+regulation+of+DNA+repair+by+the+chromatin+remodeling+enzyme+ALC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhel%26aufirst%3DD.%26aulast%3DHorejsi%26aufirst%3DZ.%26aulast%3DWiechens%26aufirst%3DN.%26aulast%3DPolo%26aufirst%3DS.%2BE.%26aulast%3DGarcia-Wilson%26aufirst%3DE.%26aulast%3DAhel%26aufirst%3DI.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%2BC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DOwen-Hughes%26aufirst%3DT.%26aulast%3DBoulton%26aufirst%3DS.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529-dependent%2520regulation%2520of%2520DNA%2520repair%2520by%2520the%2520chromatin%2520remodeling%2520enzyme%2520ALC1%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1240%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Couto, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiely, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddaway, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pears, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakin, N. D.</span><span> </span><span class="NLM_article-title">PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2011&pages=367-375&author=C.+A.+Coutoauthor=H.+Y.+Wangauthor=J.+C.+Greenauthor=R.+Kielyauthor=R.+Siddawayauthor=C.+Borerauthor=C.+J.+Pearsauthor=N.+D.+Lakin&title=PARP+regulates+nonhomologous+end+joining+through+retention+of+Ku+at+double-strand+breaks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCouto%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DGreen%26aufirst%3DJ.%2BC.%26aulast%3DKiely%26aufirst%3DR.%26aulast%3DSiddaway%26aufirst%3DR.%26aulast%3DBorer%26aufirst%3DC.%26aulast%3DPears%26aufirst%3DC.%2BJ.%26aulast%3DLakin%26aufirst%3DN.%2BD.%26atitle%3DPARP%2520regulates%2520nonhomologous%2520end%2520joining%2520through%2520retention%2520of%2520Ku%2520at%2520double-strand%2520breaks%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D194%26spage%3D367%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mansour, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikomey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahm-Daphi, J.</span><span> </span><span class="NLM_article-title">The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1134-1142&author=W.+Y.+Mansourauthor=K.+Borgmannauthor=C.+Petersenauthor=E.+Dikomeyauthor=J.+Dahm-Daphi&title=The+absence+of+Ku+but+not+defects+in+classical+non-homologous+end-joining+is+required+to+trigger+PARP1-dependent+end-joining"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DW.%2BY.%26aulast%3DBorgmann%26aufirst%3DK.%26aulast%3DPetersen%26aufirst%3DC.%26aulast%3DDikomey%26aufirst%3DE.%26aulast%3DDahm-Daphi%26aufirst%3DJ.%26atitle%3DThe%2520absence%2520of%2520Ku%2520but%2520not%2520defects%2520in%2520classical%2520non-homologous%2520end-joining%2520is%2520required%2520to%2520trigger%2520PARP1-dependent%2520end-joining%26jtitle%3DDNA%2520Repair%26date%3D2013%26volume%3D12%26spage%3D1134%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Aguilar-Quesada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Gamez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Oliva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peralta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matinez-Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiles-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menissier-de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz de Almodovar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span> </span><span class="NLM_article-title">Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition</span> <span class="citation_source-journal">BMC Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1471-2199-8-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=17459151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BD2s3nt1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=29&author=R.+Aguilar-Quesadaauthor=J.+A.+Munoz-Gamezauthor=D.+Martin-Olivaauthor=A.+Peraltaauthor=M.+T.+Valenzuelaauthor=R.+Matinez-Romeroauthor=R.+Quiles-Perezauthor=J.+Menissier-de+Murciaauthor=G.+de+Murciaauthor=M.+Ruiz+de+Almodovarauthor=F.+J.+Oliver&title=Interaction+between+ATM+and+PARP-1+in+response+to+DNA+damage+and+sensitization+of+ATM+deficient+cells+through+PARP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition</span></div><div class="casAuthors">Aguilar-Quesada Rocio; Munoz-Gamez Jose Antonio; Martin-Oliva David; Peralta Andreina; Valenzuela Maria Teresa; Matinez-Romero Ruben; Quiles-Perez Rosa; Menissier-de Murcia Josiane; de Murcia Gilbert; Ruiz de Almodovar Mariano; Oliver F Javier</div><div class="citationInfo"><span class="NLM_cas:title">BMC molecular biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">ATM and PARP-1 are two of the most important players in the cell's response to DNA damage.  PARP-1 and ATM recognize and bound to both single and double strand DNA breaks in response to different triggers.  Here we report that ATM and PARP-1 form a molecular complex in vivo in undamaged cells and this association increases after gamma-irradiation.  ATM is also modified by PARP-1 during DNA damage.  We have also evaluated the impact of PARP-1 absence or inhibition on ATM-kinase activity and have found that while PARP-1 deficient cells display a defective ATM-kinase activity and reduced gamma-H2AX foci formation in response to gamma-irradiation, PARP inhibition on itself is able to activate ATM-kinase.  PARP inhibition induced gamma H2AX foci accumulation, in an ATM-dependent manner.  Inhibition of PARP also induces DNA double strand breaks which were dependent on the presence of ATM.  As consequence ATM deficient cells display an increased sensitivity to PARP inhibition.  In summary our results show that while PARP-1 is needed in the response of ATM to gamma irradiation, the inhibition of PARP induces DNA double strand breaks (which are resolved in and ATM-dependent pathway) and activates ATM kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfw2r-L7o8tt0Q2ypr7jHkfW6udTcc2ebBX4I9ppDn4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3nt1ajsg%253D%253D&md5=d8c4d51698467602c0cc817ca4b77ad8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1471-2199-8-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2199-8-29%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar-Quesada%26aufirst%3DR.%26aulast%3DMunoz-Gamez%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Oliva%26aufirst%3DD.%26aulast%3DPeralta%26aufirst%3DA.%26aulast%3DValenzuela%26aufirst%3DM.%2BT.%26aulast%3DMatinez-Romero%26aufirst%3DR.%26aulast%3DQuiles-Perez%26aufirst%3DR.%26aulast%3DMenissier-de%2BMurcia%26aufirst%3DJ.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DRuiz%2Bde%2BAlmodovar%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26atitle%3DInteraction%2520between%2520ATM%2520and%2520PARP-1%2520in%2520response%2520to%2520DNA%2520damage%2520and%2520sensitization%2520of%2520ATM%2520deficient%2520cells%2520through%2520PARP%2520inhibition%26jtitle%3DBMC%2520Mol.%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Yang, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3872</span><span class="NLM_x">–</span> <span class="NLM_lpage">3882</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fsj.onc.1207491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15021907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3872-3882&author=Y.+G.+Yangauthor=U.+Cortesauthor=S.+Patnaikauthor=M.+Jasinauthor=Z.+Q.+Wang&title=Ablation+of+PARP-1+does+not+interfere+with+the+repair+of+DNA+double-strand+breaks%2C+but+compromises+the+reactivation+of+stalled+replication+forks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks</span></div><div class="casAuthors">Yang, Yun-Gui; Cortes, Ulrich; Patnaik, Srinivas; Jasin, Maria; Wang, Zhao-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3872-3882</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant DNA end-sensing and binding mol.  Inactivation of PARP-1 by chems. and genetic mutations slows cell proliferation, increases sister chromatid exchange (SCE), micronuclei formation and chromosome instability, and shortens telomeres.  Given its affinity to DNA breaks and temporal occupation on DNA strand break sites, PARP-1 is proposed to prevent inappropriate DNA recombination.  The authors investigated the potential role of PARP-1 in repair of DNA double-strand breaks (DSBs) and stalled replication forks.  PARP-1-/- embryonic stem cells and embryonic fibroblast cells exhibited normal repair of DNA DSBs by either homologous recombination (HR) or nonhomologous end-joining (NHEJ) pathways.  Inactivation of PARP-1 did not interfere with gene-targeting efficiency in ES cells.  However, PARP-1-/- cells were hypersensitive to the replication damage agent hydroxyurea (HU)-induced cell death and exhibited enhanced SCE formation.  Ablation of PARP-1 delayed reactivation of stalled replication forks imposed by HU and re-entry into the G2-M phase after HU release.  These data indicate that PARP-1 is dispensable in HR induced by DSBs, but is involved in the repair and reactivation of stalled replication forks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob45UCqZt86rVg90H21EOLACvtfcHk0liVUZe-_sSWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ylt78%253D&md5=8336ccce02aae385138c7061c713b4b3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207491%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%2BG.%26aulast%3DCortes%26aufirst%3DU.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DJasin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DAblation%2520of%2520PARP-1%2520does%2520not%2520interfere%2520with%2520the%2520repair%2520of%2520DNA%2520double-strand%2520breaks%252C%2520but%2520compromises%2520the%2520reactivation%2520of%2520stalled%2520replication%2520forks%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D3872%26epage%3D3882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Shibata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohmi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teraoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masutani, M.</span><span> </span><span class="NLM_article-title">PARP-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1328</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1328-1337&author=A.+Shibataauthor=N.+Kamadaauthor=K.+Masumuraauthor=T.+Nohmiauthor=S.+Kobayashiauthor=H.+Teraokaauthor=H.+Nakagamaauthor=T.+Sugimuraauthor=H.+Suzukiauthor=M.+Masutani&title=PARP-1+deficiency+causes+an+increase+of+deletion+mutations+and+insertions%2Frearrangements+in+vivo+after+treatment+with+an+alkylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DMasumura%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTeraoka%26aufirst%3DH.%26aulast%3DNakagama%26aufirst%3DH.%26aulast%3DSugimura%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DMasutani%26aufirst%3DM.%26atitle%3DPARP-1%2520deficiency%2520causes%2520an%2520increase%2520of%2520deletion%2520mutations%2520and%2520insertions%252Frearrangements%2520in%2520vivo%2520after%2520treatment%2520with%2520an%2520alkylating%2520agent%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D1328%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Menissier de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ame, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Femboj%2Fcdg206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12727891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVKmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=2255-2263&author=J.+Menissier+de+Murciaauthor=M.+Ricoulauthor=L.+Tartierauthor=C.+Niedergangauthor=A.+Huberauthor=F.+Dantzerauthor=V.+Schreiberauthor=J.+C.+Ameauthor=A.+Dierichauthor=M.+LeMeurauthor=L.+Sabatierauthor=P.+Chambonauthor=G.+de+Murcia&title=Functional+interaction+between+PARP-1+and+PARP-2+in+chromosome+stability+and+embryonic+development+in+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Ricoul, Michelle; Tartier, Laurence; Niedergang, Claude; Huber, Aline; Dantzer, Francoise; Schreiber, Valerie; Ame, Jean-Christophe; Dierich, Andree; LeMeur, Marianne; Sabatier, Laure; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2255-2263</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The DNA damage-dependent poly(ADP-ribose) polymerases, PARP-1 and PARP-2, homo- and heterodimerize and are both involved in the base excision repair (BER) pathway.  Here, we report that mice carrying a targeted disruption of the PARP-2 gene are sensitive to ionizing radiation.  Following alkylating agent treatment, parp-2-/--derived mouse embryonic fibroblasts exhibit increased post-replicative genomic instability, G2/M accumulation and chromosome mis-segregation accompanying kinetochore defects.  Moreover, parp-1-/-parp-2-/- double mutant mice are not viable and die at the onset of gastrulation, demonstrating that the expression of both PARP-1 and PARP-2 and/or DNA-dependent poly(ADP-ribosyl) ation is essential during early embryogenesis.  Interestingly, specific female embryonic lethality is obsd. in parp-1+/-parp-2-/- mutants at E9.5.  Meta phase analyses of E8.5 embryonic fibroblasts highlight a specific instability of the X chromosome in those females, but not in males.  Together, these results support the notion that PARP-1 and PARP-2 possess both overlapping and non-redundant functions in the maintenance of genomic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFm6QExlZgjrVg90H21EOLACvtfcHk0lgDMXrEhwEXKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVKmu7w%253D&md5=4f881464925f74a16724321bb9b1d107</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg206%26sid%3Dliteratum%253Aachs%26aulast%3DMenissier%2Bde%2BMurcia%26aufirst%3DJ.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DTartier%26aufirst%3DL.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DA.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DAme%26aufirst%3DJ.%2BC.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DSabatier%26aufirst%3DL.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DFunctional%2520interaction%2520between%2520PARP-1%2520and%2520PARP-2%2520in%2520chromosome%2520stability%2520and%2520embryonic%2520development%2520in%2520mouse%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D2255%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutrillaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walztinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">7303</span><span class="NLM_x">–</span> <span class="NLM_lpage">7307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.94.14.7303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9207086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=7303-7307&author=J.+M.+de+Murciaauthor=C.+Niedergangauthor=C.+Truccoauthor=M.+Ricoulauthor=B.+Dutrillauxauthor=M.+Markauthor=F.+J.+Oliverauthor=M.+Massonauthor=A.+Dierichauthor=M.+LeMeurauthor=C.+Walztingerauthor=P.+Chambonauthor=G.+de+Murcia&title=Requirement+of+poly%28ADP-ribose%29+polymerase+in+recovery+from+DNA+damage+in+mice+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Niedergang, Claude; Trucco, Carlotta; Ricoul, Michele; Dutrillaux, Bernard; Mark, Manuel; Oliver, F. Javier; Masson, Murielle; Dierich, Andree; LeMeur, Marianne; Walztinger, Caroline; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7303-7307</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase [PARP; NAD+ ADP-ribosyltransferase; NAD+:poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyltransferase, EC 2.4.2.30] is a zinc-finger DNA-binding protein that detects specifically DNA strand breaks generated by genotoxic agents.  To det. its biol. function, the authors have inactivated both alleles by gene targeting in mice.  Treatment of PARP-/- mice either by the alkylating agent N-methyl-N-nitrosourea (MNU) or by γ-irradn. revealed an extreme sensitivity and a high genomic instability to both agents.  Following whole body γ-irradn. (8 Gy) mutant mice died rapidly from acute radiation toxicity to the small intestine.  Mice-derived PARP-/- cells displayed a high sensitivity to MNU exposure: a G2/M arrest in mouse embryonic fibroblasts and a rapid apoptotic response and a p53 accumulation were obsd. in splenocytes.  Altogether these results demonstrate that PARP is a survival factor playing an essential and pos. role during DNA damage recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwmTBk-nHc7Vg90H21EOLACvtfcHk0lgDMXrEhwEXKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D&md5=a652d7d877fa0c29ff1aeb9769fbd86f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.14.7303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.14.7303%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DTrucco%26aufirst%3DC.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DDutrillaux%26aufirst%3DB.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DWalztinger%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DRequirement%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520recovery%2520from%2520DNA%2520damage%2520in%2520mice%2520and%2520in%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D7303%26epage%3D7307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><div class="note"><p class="first last">(Erratum appears in  <cite>Nature</cite> <span class="NLM_year">2007</span>, <em>447</em>, 346)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature03443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15829966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=913-917&author=H.+E.+Bryantauthor=N.+Schultzauthor=H.+D.+Thomasauthor=K.+M.+Parkerauthor=D.+Flowerauthor=E.+Lopezauthor=S.+Kyleauthor=M.+Meuthauthor=N.+J.+Curtinauthor=T.+Helleday&title=Specific+killing+of+BRCA2-deficient+tumours+with+inhibitors+of+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase</span></div><div class="casAuthors">Bryant, Helen E.; Schultz, Niklas; Thomas, Huw D.; Parker, Kayan M.; Flower, Dan; Lopez, Elena; Kyle, Suzanne; Meuth, Mark; Curtin, Nicola J.; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">913-917</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage.  Nevertheless, PARP1-/- mice are viable, fertile and do not develop early onset tumors.  Here, the authors show that PARP inhibitors trigger γ-H2AX and RAD51 foci formation.  The authors propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair.  Furthermore, the authors show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired.  Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells.  The authors exploit this requirement in order to kill BRCA2-deficient tumors by PARP inhibition alone.  Treatment with PARP inhibitors is likely to be highly tumor specific, because only the tumors (which are BRCA2-/-) in BRCA2+/- patients are defective in homologous recombination.  The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumor, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJ6B7d7dB77Vg90H21EOLACvtfcHk0lh-1AsUs9u5AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D&md5=44631eba667cf75ef99c31d011d6db44</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnature03443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03443%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BM.%26aulast%3DFlower%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMeuth%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DSpecific%2520killing%2520of%2520BRCA2-deficient%2520tumours%2520with%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D913%26epage%3D917%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Patel, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span> </span><span class="NLM_article-title">Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">3406</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=3406-3411&author=A.+G.+Patelauthor=J.+N.+Sarkariaauthor=S.+H.+Kaufmann&title=Nonhomologous+end+joining+drives+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+lethality+in+homologous+recombination-deficient+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BG.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DNonhomologous%2520end%2520joining%2520drives%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%2520lethality%2520in%2520homologous%2520recombination-deficient%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D3406%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1685-1691&author=H.+E.+Bryantauthor=T.+Helleday&title=Inhibition+of+poly+%28ADP-ribose%29+polymerase+activates+ATM+which+is+required+for+subsequent+homologous+recombination+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520poly%2520%2528ADP-ribose%2529%2520polymerase%2520activates%2520ATM%2520which%2520is%2520required%2520for%2520subsequent%2520homologous%2520recombination%2520repair%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D1685%26epage%3D1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hegan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachelek, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindra, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, P. M.</span><span> </span><span class="NLM_article-title">Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2201</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2201-2206&author=D.+C.+Heganauthor=Y.+Luauthor=G.+C.+Stachelekauthor=M.+E.+Crosbyauthor=R.+S.+Bindraauthor=P.+M.+Glazer&title=Inhibition+of+poly%28ADP-ribose%29+polymerase+down-regulates+BRCA1+and+RAD51+in+a+pathway+mediated+by+E2F4+and+p130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegan%26aufirst%3DD.%2BC.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DStachelek%26aufirst%3DG.%2BC.%26aulast%3DCrosby%26aufirst%3DM.%2BE.%26aulast%3DBindra%26aufirst%3DR.%2BS.%26aulast%3DGlazer%26aufirst%3DP.%2BM.%26atitle%3DInhibition%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520down-regulates%2520BRCA1%2520and%2520RAD51%2520in%2520a%2520pathway%2520mediated%2520by%2520E2F4%2520and%2520p130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2201%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Antoniou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pharoah, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narod, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risch, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyfjord, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radice, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoukian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton-Culver, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronwald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinius, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorlacius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eerola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrjakoski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, D. F.</span><span> </span><span class="NLM_article-title">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span><div class="note"><p class="first last">(Erratum appears in  <cite>Am. J. Hum. Genet.</cite> <span class="NLM_year">2003</span>, <em>73</em>, 709)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1086%2F375033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12677558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=1117-1130&author=A.+Antoniouauthor=P.+D.+Pharoahauthor=S.+Narodauthor=H.+A.+Rischauthor=J.+E.+Eyfjordauthor=J.+L.+Hopperauthor=N.+Lomanauthor=H.+Olssonauthor=O.+Johannssonauthor=A.+Borgauthor=B.+Pasiniauthor=P.+Radiceauthor=S.+Manoukianauthor=D.+M.+Ecclesauthor=N.+Tangauthor=E.+Olahauthor=H.+Anton-Culverauthor=E.+Warnerauthor=J.+Lubinskiauthor=J.+Gronwaldauthor=B.+Gorskiauthor=H.+Tuliniusauthor=S.+Thorlaciusauthor=H.+Eerolaauthor=H.+Nevanlinnaauthor=K.+Syrjakoskiauthor=O.+P.+Kallioniemiauthor=D.+Thompsonauthor=C.+Evansauthor=J.+Petoauthor=F.+Lallooauthor=D.+G.+Evansauthor=D.+F.+Easton&title=Average+risks+of+breast+and+ovarian+cancer+associated+with+BRCA1+or+BRCA2+mutations+detected+in+case+Series+unselected+for+family+history%3A+a+combined+analysis+of+22+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies</span></div><div class="casAuthors">Antoniou, A.; Pharoah, P. D. P.; Narod, S.; Risch, H. A.; Eyfjord, J. E.; Hopper, J. L.; Loman, N.; Olsson, H.; Johannsson, O.; Borg, A.; Pasini, B.; Radice, P.; Manoukian, S.; Eccles, D. M.; Tang, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tulinius, H.; Thorlacius, S.; Eerola, H.; Nevanlinna, H.; Syrjakoski, K.; Kallioniemi, O.-P.; Thompson, D.; Evans, C.; Peto, J.; Lalloo, F.; Evans, D. G.; Easton, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1117-1130</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the av. magnitude of these risks is uncertain and may depend on the context.  Ests. based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk ests. from studies based on cases unselected for family history have been imprecise.  We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2.  Breast and ovarian cancer incidence rates for mutation carriers were estd. using a modified segregation anal., based on the occurrence of these cancers in the relatives of mutation-carrying index case patients.  The av. cumulative risks in BRCA1-mutation carriers by age 70 yr were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer.  The corresponding ests. for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%).  Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers (P trend.0012) but not for BRCA2-mutation carriers.  Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 yr of age.  We found some evidence for a redn. in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes.  The pattern of cancer risks was similar to those found in multiple-case families, but their abs. magnitudes were lower, particularly for BRCA2.  The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNfcConjQ5W7Vg90H21EOLACvtfcHk0lhg6_JnPbJXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslagtbg%253D&md5=97dea4dccdd6e57c4dd1120640090c21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1086%2F375033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F375033%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniou%26aufirst%3DA.%26aulast%3DPharoah%26aufirst%3DP.%2BD.%26aulast%3DNarod%26aufirst%3DS.%26aulast%3DRisch%26aufirst%3DH.%2BA.%26aulast%3DEyfjord%26aufirst%3DJ.%2BE.%26aulast%3DHopper%26aufirst%3DJ.%2BL.%26aulast%3DLoman%26aufirst%3DN.%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DJohannsson%26aufirst%3DO.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DPasini%26aufirst%3DB.%26aulast%3DRadice%26aufirst%3DP.%26aulast%3DManoukian%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DD.%2BM.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DE.%26aulast%3DAnton-Culver%26aufirst%3DH.%26aulast%3DWarner%26aufirst%3DE.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DGronwald%26aufirst%3DJ.%26aulast%3DGorski%26aufirst%3DB.%26aulast%3DTulinius%26aufirst%3DH.%26aulast%3DThorlacius%26aufirst%3DS.%26aulast%3DEerola%26aufirst%3DH.%26aulast%3DNevanlinna%26aufirst%3DH.%26aulast%3DSyrjakoski%26aufirst%3DK.%26aulast%3DKallioniemi%26aufirst%3DO.%2BP.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DPeto%26aufirst%3DJ.%26aulast%3DLalloo%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DD.%2BG.%26aulast%3DEaston%26aufirst%3DD.%2BF.%26atitle%3DAverage%2520risks%2520of%2520breast%2520and%2520ovarian%2520cancer%2520associated%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520detected%2520in%2520case%2520Series%2520unselected%2520for%2520family%2520history%253A%2520a%2520combined%2520analysis%2520of%252022%2520studies%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D72%26spage%3D1117%26epage%3D1130%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D73%26spage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breast Cancer Linkage Consortium</span><span> </span><span class="NLM_article-title">Cancer incidence in BRCA1 mutation carriers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2F94.18.1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12237281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt1Gnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1358-1365&author=D.+Thompsonauthor=D.+F.+Eastonauthor=Breast+Cancer+Linkage+Consortium&title=Cancer+incidence+in+BRCA1+mutation+carriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Incidence in BRCA1 Mutation Carriers</span></div><div class="casAuthors">Thompson, Deborah; Easton, Douglas F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1358-1365</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Germline BRCA1 mutations confer a substantial lifetime risk of breast and ovarian cancer, but whether cancer at other sites is increased is less clear.  To evaluate the risks of other cancers in BRCA1 mutation carriers, we conducted a cohort study of 11 847 individuals from 699 families segregating a BRCA1 mutation that were ascertained in 30 centers across Europe and North America.  The obsd. cancer incidence was compared with the expected cancer incidence based on population cancer rates.  Relative risks (RRs) of each cancer type in BRCA1 carriers relative to risks for the general population were estd. by weighting individuals according to their estd. probability of being a mutation carrier.  All statistical tests were two-sided.  BRCA1 mutation carriers were at a statistically significantly increased risk for several cancers, including pancreatic cancer (RR = 2.26, 95% confidence interval [CI] = 1.26 to 4.06, P =.004) and cancer of the uterine body and cervix (uterine body RR = 2.65, 95% CI = 1.69 to 4.16, P<.001; cervix RR = 3.72, 95% CI = 2.26 to 6.10, P<.001).  There was some evidence of an elevated risk of prostate cancer in mutation carriers younger than 65 yr old (RR = 1.82, 95% CI = 1.01 to 3.29, P =.05) but not in those 65 yr old or older (RR = 0.84, 95% CI = 0.53 to 1.33, P =.45).  Overall, increases in the risk for cancer at sites other than the breast or ovary were small and evident in women (RR = 2.30, 95% CI = 1.93 to 2.75, P =.001) but not in men (RR = 0.95, 95% CI = 0.81 to 1.12, P =.58).  In carriers of BRCA1 mutations, the overall increased risk of cancer at sites other than breast and ovary is small and is obsd. in women but generally not in men.  BRCA1 mutations may confer increased risks of other abdominal cancers in women and increased risks of pancreatic cancer in men and women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKlOCJQe1CvbVg90H21EOLACvtfcHk0lhg6_JnPbJXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt1Gnurs%253D&md5=04e4d8a355b2dace5d0ba41c18dd54d7</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F94.18.1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F94.18.1358%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DEaston%26aufirst%3DD.%2BF.%26aulast%3D%26atitle%3DCancer%2520incidence%2520in%2520BRCA1%2520mutation%2520carriers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1358%26epage%3D1365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Roy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. N.</span><span> </span><span class="NLM_article-title">BRCA1 and BRCA2: different roles in a common pathway of genome protection</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc3181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Gksb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=68-78&author=R.+Royauthor=J.+Chunauthor=S.+N.+Powell&title=BRCA1+and+BRCA2%3A+different+roles+in+a+common+pathway+of+genome+protection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA1 and BRCA2: different roles in a common pathway of genome protection</span></div><div class="casAuthors">Roy, Rohini; Chun, Jarin; Powell, Simon N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The proteins encoded by the two major breast cancer susceptibility genes, BRCA1 and BRCA2, work in a common pathway of genome protection.  However, the two proteins work at different stages in the DNA damage response (DDR) and in DNA repair.  BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination.  The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes.  As discussed here, the proteins work in concert to protect the genome from double-strand DNA damage during DNA replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-oyZ81uPqU7Vg90H21EOLACvtfcHk0lhg6_JnPbJXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Gksb7M&md5=97d95a505fdbf7859e3a62e456021c72</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrc3181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3181%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DS.%2BN.%26atitle%3DBRCA1%2520and%2520BRCA2%253A%2520different%2520roles%2520in%2520a%2520common%2520pathway%2520of%2520genome%2520protection%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Thiemermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myint, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia–reperfusion injury in the heart and skeletal muscle</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=679-683&author=C.+Thiemermannauthor=J.+Bowesauthor=F.+P.+Myintauthor=J.+R.+Vane&title=Inhibition+of+the+activity+of+poly%28ADP+ribose%29+synthetase+reduces+ischemia%E2%80%93reperfusion+injury+in+the+heart+and+skeletal+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DMyint%26aufirst%3DF.%2BP.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520the%2520activity%2520of%2520poly%2528ADP%2520ribose%2529%2520synthetase%2520reduces%2520ischemia%25E2%2580%2593reperfusion%2520injury%2520in%2520the%2520heart%2520and%2520skeletal%2520muscle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D679%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Eliasson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandir, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurn, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traystman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnm1097-1089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9334719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1089-1095&author=M.+J.+Eliassonauthor=K.+Sampeiauthor=A.+S.+Mandirauthor=P.+D.+Hurnauthor=R.+J.+Traystmanauthor=J.+Baoauthor=A.+Pieperauthor=Z.+Q.+Wangauthor=T.+M.+Dawsonauthor=S.+H.+Snyderauthor=V.+L.+Dawson&title=Poly%28ADP-ribose%29+polymerase+gene+disruption+renders+mice+resistant+to+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia</span></div><div class="casAuthors">Eliasson, Mikael J. L.; Sampei, Kenji; Mandir, Allen S.; Hurn, Patricia D.; Traystman, Richard J.; Bao, Jun; Pieper, Andrew; Wang, Zhao-Qi; Dawson, Ted M.; Snyder, Solomon H.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1089-1095</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Nitric oxide (NO) and peroxynitrite, formed from NO and superoxide anion, have been implicated as mediators of neuronal damage following focal ischemia, but their mol. targets have not been defined.  One candidate pathway is DNA damage leading to activation of the nuclear enzyme, poly(ADP-ribose) polymerase (PARP), which catalyzes attachment of ADP ribose units from NAD to nuclear proteins following DNA damage.  Excessive activation of PARP can deplete NAD and ATP, which is consumed in regeneration of NAD, leading to cell death by energy depletion.  The authors show that genetic disruption of PARP provides profound protection against glutamate-NO-mediated ischemic insults in vitro and major decreases in infarct vol. after reversible middle cerebral artery occlusion.  These results provide compelling evidence for a primary involvement of PARP activation in neuronal damage following focal ischemia and suggest that therapies designed towards inhibiting PARP may provide benefit in the treatment of cerebrovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSq-7dMGKE7Vg90H21EOLACvtfcHk0lhVrSBJhK5c5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFyqtb8%253D&md5=d83a2bb75e066d20b415119fb4452e21</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnm1097-1089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1097-1089%26sid%3Dliteratum%253Aachs%26aulast%3DEliasson%26aufirst%3DM.%2BJ.%26aulast%3DSampei%26aufirst%3DK.%26aulast%3DMandir%26aufirst%3DA.%2BS.%26aulast%3DHurn%26aufirst%3DP.%2BD.%26aulast%3DTraystman%26aufirst%3DR.%2BJ.%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520gene%2520disruption%2520renders%2520mice%2520resistant%2520to%2520cerebral%2520ischemia%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1089%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ha, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hester, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3270</span><span class="NLM_x">–</span> <span class="NLM_lpage">3275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=3270-3275&author=H.+C.+Haauthor=L.+D.+Hesterauthor=S.+H.+Snyder&title=Poly%28ADP-ribose%29+polymerase-1+dependence+of+stress-induced+transcription+factors+and+associated+gene+expression+in+glia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DH.%2BC.%26aulast%3DHester%26aufirst%3DL.%2BD.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520dependence%2520of%2520stress-induced%2520transcription%2520factors%2520and%2520associated%2520gene%2520expression%2520in%2520glia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D3270%26epage%3D3275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Calabrese, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canan-Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkacz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalitzky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2Fdjh005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14709739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=56-67&author=C.+R.+Calabreseauthor=R.+Almassyauthor=S.+Bartonauthor=M.+A.+Bateyauthor=A.+H.+Calvertauthor=S.+Canan-Kochauthor=B.+W.+Durkaczauthor=Z.+Hostomskyauthor=R.+A.+Kumpfauthor=S.+Kyleauthor=J.+Liauthor=K.+Maegleyauthor=D.+R.+Newellauthor=E.+Notarianniauthor=I.+J.+Stratfordauthor=D.+Skalitzkyauthor=H.+D.+Thomasauthor=L.+Z.+Wangauthor=S.+E.+Webberauthor=K.+J.+Williamsauthor=N.+J.+Curtin&title=Anticancer+chemosensitization+and+radiosensitization+by+the+novel+poly%28ADP-ribose%29+polymerase-1+inhibitor+AG14361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361</span></div><div class="casAuthors">Calabrese, Christopher R.; Almassy, Robert; Barton, Stephanie; Batey, Michael A.; Calvert, A. Hilary; Canan-Koch, Stacie; Durkacz, Barbara W.; Hostomsky, Zdenek; Kumpf, Robert A.; Kyle, Suzanne; Li, Jianke; Maegley, Karen; Newell, David R.; Notarianni, Elena; Stratford, Ian J.; Skalitzky, Donald; Thomas, Huw D.; Wang, Lan-Zhen; Webber, Stephen E.; Williams, Kaye J.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) facilitates the repair of DNA strand breaks.  Inhibiting PARP-1 increases the cytotoxicity of DNA-damaging chemotherapy and radiation therapy in vitro.  Because classical PARP-1 inhibitors have limited clin. utility, we investigated whether AG14361, a novel potent PARP-1 inhibitor (inhibition const. <5 nM), enhances the effects of chemotherapy and radiation therapy in human cancer cell cultures and xenografts.  Methods: The effect of AG14361 on the antitumor activity of the DNA alkylating agent temozolomide, topoisomerase I poisons topotecan or irinotecan, or x-irradn. or γ-radiation was investigated in human cancer cell lines A549, LoVo, and SW620 by proliferation and survival assays and in xenografts in mice by tumor vol. detn.  The specificity of AG14361 for PARP-1 was investigated by microarray anal. and by antiproliferation and acute toxicity assays in PARP-1-/- and PARP-1+/+ cells and mice.  After i.p. administration, the concn. of AG14361 was detd. in mouse plasma and tissues, and its effect on PARP-1 activity was detd. in tumor homogenates.  All statistical tests were two-sided.  Results: AG14361 at 0.4 μM did not affect cancer cell gene expression or growth, but it did increase the antiproliferative activity of temozolomide (e.g., in LoVo cells by 5.5-fold, 95% confidence interval [CI] = 4.9-fold to 5.9-fold; P = .004) and topotecan (e.g., in LoVo cells by 1.6-fold, 95% CI = 1.3-fold to 1.9-fold; P = .002) and inhibited recovery from potentially lethal γ-radiation damage in LoVo cells by 73% (95% CI = 48% to 98%).  In vivo, nontoxic doses of AG14361 increased the delay of LoVo xenograft growth induced by irinotecan, x-irradn., or temozolomide by two- to threefold.  The combination of AG14361 and temozolomide caused complete regression of SW620 xenograft tumors.  AG14361 was retained in xenografts in which PARP-1 activity was inhibited by more than 75% for at least 4 h.  Conclusion: AG14361 is, to our knowledge, the first high-potency PARP-1 inhibitor with the specificity and in vivo activity to enhance chemotherapy and radiation therapy of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpwvo2sC6rVg90H21EOLACvtfcHk0lhVrSBJhK5c5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislarsw%253D%253D&md5=1b14488c625431de24ba11fad79ad9e5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjh005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjh005%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DBarton%26aufirst%3DS.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCanan-Koch%26aufirst%3DS.%26aulast%3DDurkacz%26aufirst%3DB.%2BW.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNotarianni%26aufirst%3DE.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWilliams%26aufirst%3DK.%2BJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DAnticancer%2520chemosensitization%2520and%2520radiosensitization%2520by%2520the%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520inhibitor%2520AG14361%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2004%26volume%3D96%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrd1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15864271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&author=P.+Jagtapauthor=C.+Szabo&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span></div><div class="casAuthors">Jagtap, Prakash; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-440</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are involved in the regulation of many cellular functions.  Three consequences of the activation of PARP1, which is the main isoform of the PARP family, are particularly important for drug development: first, its role in DNA repair; second, its capacity to deplete cellular energetic pools, which culminates in cell dysfunction and necrosis; and third, its capacity to promote the transcription of pro-inflammatory genes.  Consequently, pharmacol. inhibitors of PARP have the potential to enhance the cytotoxicity of certain DNA-damaging anticancer drugs, reduce parenchymal cell necrosis (for example, in stroke or myocardial infarction) and downregulate multiple simultaneous pathways of inflammation and tissue injury (for example, in circulatory shock, colitis or diabetic complications).  The first ultrapotent novel PARP inhibitors have now entered human clin. trials.  This article presents an overview of the principal pathophysiol. pathways and mechanisms that are governed by PARP, followed by the main structures and therapeutic actions of various classes of novel PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDsrfd_xv8g7Vg90H21EOLACvtfcHk0lhMO5z-ahnfbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D&md5=1dfd177b8064b017efb5dd7779655d55</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrd1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1718%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Rouleau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, G. G.</span><span> </span><span class="NLM_article-title">PARP inhibition: PARP1 and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc2812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20200537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=293-301&author=M.+Rouleauauthor=A.+Patelauthor=M.+J.+Hendzelauthor=S.+H.+Kaufmannauthor=G.+G.+Poirier&title=PARP+inhibition%3A+PARP1+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">PARP inhibition: PARP1 and beyond</span></div><div class="casAuthors">Rouleau, Michele; Patel, Anand; Hendzel, Michael J.; Kaufmann, Scott H.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-301</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent findings have thrust poly(ADP-ribose) polymerases (PARPs) into the limelight as potential chemotherapeutic targets.  To provide a framework for understanding these recent observations, the authors have reviewed what is known about the structures and functions of the family of PARP enzymes, and then outlined a series of questions that should be addressed to guide the rational development of PARP inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOiY_n1IClmbVg90H21EOLACvtfcHk0lhMO5z-ahnfbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D&md5=fa3e3964e84229317dadbd505f11ad86</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc2812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2812%26sid%3Dliteratum%253Aachs%26aulast%3DRouleau%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DPARP%2520inhibition%253A%2520PARP1%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Ferraris, D. V.</span><span> </span><span class="NLM_article-title">Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4561</span><span class="NLM_x">–</span> <span class="NLM_lpage">4584</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100012m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1WksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4561-4584&author=D.+V.+Ferraris&title=Evolution+of+poly%28ADP-ribose%29+polymerase-1+%28PARP-1%29+inhibitors.+From+concept+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic</span></div><div class="casAuthors">Ferraris, Dana V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4561-4584</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1) has been an actively pursued drug discovery target for almost 3 decades.  Often referred to as the "guardian angel of DNA", this abundant nuclear enzyme has been the focus of over 20 medicinal chem. programs in a wide range of therapeutic areas encompassing stroke, cardiac ischemia, cancer, inflammation, and diabetes.  Despite the great therapeutic potential for this target and the tremendous academic and industrial efforts dedicated to it, only recently have PARP-1 inhibitors made headway in clin. trials.  Recent results from several PARP-1 inhibitors in phase II clin. trials for cancer therapy have attracted the attention of national media.  Of the several potential therapeutic indications for PARP-1 inhibitors, the two major areas that hold the most promise are ischemia and cancer.  This review is structured to provide the readers with a brief summary of the rationale for PARP-1 as a therapeutic target, to explain the PARP-1 inhibitor pharmacophore, and to provide an update on the progress of the PARP-1 drug discovery programs.  This Perspective will offer a historical account of the crit. PARP-1 publications that instilled the interest of the biopharmaceutical industry in the late 1980s and early 1990s.  Furthermore, I will discuss why PARP- 1 received so much attention in the late 1990s and early 2000s followed by the slight decline in the medicinal chem. efforts today.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPhFTTs4raarVg90H21EOLACvtfcHk0lhMO5z-ahnfbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1WksLs%253D&md5=6c093238562c908d45dfcd2f3055457d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm100012m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100012m%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26atitle%3DEvolution%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520%2528PARP-1%2529%2520inhibitors.%2520From%2520concept%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4561%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Wahlberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frostell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, J.</span><span> </span><span class="NLM_article-title">Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=283-288&author=E.+Wahlbergauthor=T.+Karlbergauthor=E.+Kouznetsovaauthor=N.+Markovaauthor=A.+Macchiaruloauthor=A.+G.+Thorsellauthor=E.+Polauthor=A.+Frostellauthor=T.+Ekbladauthor=D.+Oncuauthor=B.+Kullauthor=G.+M.+Robertsonauthor=R.+Pellicciariauthor=H.+Schulerauthor=J.+Weigelt&title=Family-wide+chemical+profiling+and+structural+analysis+of+PARP+and+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlberg%26aufirst%3DE.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DKouznetsova%26aufirst%3DE.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DThorsell%26aufirst%3DA.%2BG.%26aulast%3DPol%26aufirst%3DE.%26aulast%3DFrostell%26aufirst%3DA.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DOncu%26aufirst%3DD.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DRobertson%26aufirst%3DG.%2BM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DWeigelt%26aufirst%3DJ.%26atitle%3DFamily-wide%2520chemical%2520profiling%2520and%2520structural%2520analysis%2520of%2520PARP%2520and%2520tankyrase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D283%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Skalitzky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marakovits, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0255769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=210-213&author=D.+J.+Skalitzkyauthor=J.+T.+Marakovitsauthor=K.+A.+Maegleyauthor=A.+Ekkerauthor=X.+H.+Yuauthor=Z.+Hostomskyauthor=S.+E.+Webberauthor=B.+W.+Eastmanauthor=R.+Almassyauthor=J.+Liauthor=N.+J.+Curtinauthor=D.+R.+Newellauthor=A.+H.+Calvertauthor=R.+J.+Griffinauthor=B.+T.+Golding&title=Tricyclic+benzimidazoles+as+potent+poly%28ADP-ribose%29+polymerase-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm0255769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255769%26sid%3Dliteratum%253Aachs%26aulast%3DSkalitzky%26aufirst%3DD.%2BJ.%26aulast%3DMarakovits%26aufirst%3DJ.%2BT.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DEkker%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DEastman%26aufirst%3DB.%2BW.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DTricyclic%2520benzimidazoles%2520as%2520potent%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D210%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Weston, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldreive, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skowronska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudzki, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankovic, T.</span><span> </span><span class="NLM_article-title">The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=4578-4587&author=V.+J.+Westonauthor=C.+E.+Oldreiveauthor=A.+Skowronskaauthor=D.+G.+Oscierauthor=G.+Prattauthor=M.+J.+Dyerauthor=G.+Smithauthor=J.+E.+Powellauthor=Z.+Rudzkiauthor=P.+Kearnsauthor=P.+A.+Mossauthor=A.+M.+Taylorauthor=T.+Stankovic&title=The+PARP+inhibitor+olaparib+induces+significant+killing+of+ATM-deficient+lymphoid+tumor+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeston%26aufirst%3DV.%2BJ.%26aulast%3DOldreive%26aufirst%3DC.%2BE.%26aulast%3DSkowronska%26aufirst%3DA.%26aulast%3DOscier%26aufirst%3DD.%2BG.%26aulast%3DPratt%26aufirst%3DG.%26aulast%3DDyer%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DJ.%2BE.%26aulast%3DRudzki%26aufirst%3DZ.%26aulast%3DKearns%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DP.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DStankovic%26aufirst%3DT.%26atitle%3DThe%2520PARP%2520inhibitor%2520olaparib%2520induces%2520significant%2520killing%2520of%2520ATM-deficient%2520lymphoid%2520tumor%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D4578%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Vilar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartnik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniesta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, S. B.</span><span> </span><span class="NLM_article-title">MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2632</span><span class="NLM_x">–</span> <span class="NLM_lpage">2642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2632-2642&author=E.+Vilarauthor=C.+M.+Bartnikauthor=S.+L.+Stenzelauthor=L.+Raskinauthor=J.+Ahnauthor=V.+Morenoauthor=B.+Mukherjeeauthor=M.+D.+Iniestaauthor=M.+A.+Morganauthor=G.+Rennertauthor=S.+B.+Gruber&title=MRE11+deficiency+increases+sensitivity+to+poly%28ADP-ribose%29+polymerase+inhibition+in+microsatellite+unstable+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilar%26aufirst%3DE.%26aulast%3DBartnik%26aufirst%3DC.%2BM.%26aulast%3DStenzel%26aufirst%3DS.%2BL.%26aulast%3DRaskin%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DIniesta%26aufirst%3DM.%2BD.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DRennert%26aufirst%3DG.%26aulast%3DGruber%26aufirst%3DS.%2BB.%26atitle%3DMRE11%2520deficiency%2520increases%2520sensitivity%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%2520in%2520microsatellite%2520unstable%2520colorectal%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2632%26epage%3D2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Postel-Vinay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friboulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontebasso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorvault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olaussen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5377</span><span class="NLM_x">–</span> <span class="NLM_lpage">5387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=5377-5387&author=S.+Postel-Vinayauthor=I.+Bajramiauthor=L.+Fribouletauthor=R.+Elliottauthor=Y.+Fontebassoauthor=N.+Dorvaultauthor=K.+A.+Olaussenauthor=F.+Andreauthor=J.+C.+Soriaauthor=C.+J.+Lordauthor=A.+Ashworth&title=A+high-throughput+screen+identifies+PARP1%2F2+inhibitors+as+a+potential+therapy+for+ERCC1-deficient+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostel-Vinay%26aufirst%3DS.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DFriboulet%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DFontebasso%26aufirst%3DY.%26aulast%3DDorvault%26aufirst%3DN.%26aulast%3DOlaussen%26aufirst%3DK.%2BA.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DA%2520high-throughput%2520screen%2520identifies%2520PARP1%252F2%2520inhibitors%2520as%2520a%2520potential%2520therapy%2520for%2520ERCC1-deficient%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D5377%26epage%3D5387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Williamson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliocco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebb, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees-Miller, S. P.</span><span> </span><span class="NLM_article-title">Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1002%2Femmm.201200229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22416035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=515-527&author=C.+T.+Williamsonauthor=E.+Kubotaauthor=J.+D.+Hamillauthor=A.+Klimowiczauthor=R.+Yeauthor=H.+Muzikauthor=M.+Deanauthor=L.+Tuauthor=D.+Gilleyauthor=A.+M.+Maglioccoauthor=B.+C.+McKayauthor=D.+G.+Bebbauthor=S.+P.+Lees-Miller&title=Enhanced+cytotoxicity+of+PARP+inhibition+in+mantle+cell+lymphoma+harbouring+mutations+in+both+ATM+and+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53</span></div><div class="casAuthors">Williamson, Chris T.; Kubota, Eiji; Hamill, Jeffrey D.; Klimowicz, Alexander; Ye, Ruiqiong; Muzik, Huong; Dean, Michelle; Tu, LiRen; Gilley, David; Magliocco, Anthony M.; McKay, Bruce C.; Bebb, D. Gwyn; Lees-Miller, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Poly-ADP ribose polymerase (PARP) inhibitors have shown promise in the treatment of human malignancies characterized by deficiencies in the DNA damage repair proteins BRCA1 and BRCA2 and preclin. studies have demonstrated the potential effectiveness of PARP inhibitors in targeting ataxia-telangiectasia mutated (ATM)-deficient tumors.  Here, we show that mantle cell lymphoma (MCL) cells deficient in both ATM and p53 are more sensitive to the PARP inhibitor olaparib than cells lacking ATM function alone.  In ATM-deficient MCL cells, olaparib induced DNA-PK-dependent phosphorylation and stabilization of p53 as well as expression of p53-responsive cell cycle checkpoint regulators, and inhibition of DNA-PK reduced the toxicity of olaparib in ATM-deficient MCL cells.  Thus, both DNA-PK and p53 regulate the response of ATM-deficient MCL cells to olaparib.  In addn., small mol. inhibition of both ATM and PARP was cytotoxic in normal human fibroblasts with disruption of p53, implying that the combination of ATM and PARP inhibitors may have utility in targeting p53-deficient malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc8TNr6X4i5rVg90H21EOLACvtfcHk0lhrOcZ1QMZE7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOnu7Y%253D&md5=73d6fadf9301ba2e9f8a7ccf58665abc</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Femmm.201200229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201200229%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DC.%2BT.%26aulast%3DKubota%26aufirst%3DE.%26aulast%3DHamill%26aufirst%3DJ.%2BD.%26aulast%3DKlimowicz%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DMuzik%26aufirst%3DH.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DL.%26aulast%3DGilley%26aufirst%3DD.%26aulast%3DMagliocco%26aufirst%3DA.%2BM.%26aulast%3DMcKay%26aufirst%3DB.%2BC.%26aulast%3DBebb%26aufirst%3DD.%2BG.%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26atitle%3DEnhanced%2520cytotoxicity%2520of%2520PARP%2520inhibition%2520in%2520mantle%2520cell%2520lymphoma%2520harbouring%2520mutations%2520in%2520both%2520ATM%2520and%2520p53%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1002%2Femmm.200900041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20049735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=315-322&author=A.+M.+Mendes-Pereiraauthor=S.+A.+Martinauthor=R.+Broughauthor=A.+McCarthyauthor=J.+R.+Taylorauthor=J.+S.+Kimauthor=T.+Waldmanauthor=C.+J.+Lordauthor=A.+Ashworth&title=Synthetic+lethal+targeting+of+PTEN+mutant+cells+with+PARP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors</span></div><div class="casAuthors">Mendes-Pereira, Ana M.; Martin, Sarah A.; Brough, Rachel; McCarthy, Afshan; Taylor, Jessica R.; Kim, Jung-Sik; Waldman, Todd; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">315-322</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The tumor suppressor gene, phosphatase and tensin homolog (PTEN), is one of the most commonly mutated genes in human cancers.  Recent evidence suggests that PTEN is important for the maintenance of genome stability.  Here, we show that PTEN deficiency causes a homologous recombination (HR) defect in human tumor cells.  The HR deficiency caused by PTEN deficiency, sensitizes tumor cells to potent inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP), both in vitro and in vivo.  PARP inhibitors are now showing considerable promise in the clinic, specifically in patients with mutations in either of the breast cancer susceptibility genes BRCA1 or BRCA2.  The data we present here now suggests that the clin. assessment of PARP inhibitors should be extended beyond those with BRCA mutations to a larger group of patients with PTEN mutant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqq6kbXT_l7Vg90H21EOLACvtfcHk0lhrOcZ1QMZE7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL%252FK&md5=c14c7e0d1ae6a753deabbfb125dcc5a2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Femmm.200900041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.200900041%26sid%3Dliteratum%253Aachs%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DS.%2BA.%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DSynthetic%2520lethal%2520targeting%2520of%2520PTEN%2520mutant%2520cells%2520with%2520PARP%2520inhibitors%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D315%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2010-2019&author=C.+J.+Lordauthor=S.+McDonaldauthor=S.+Swiftauthor=N.+C.+Turnerauthor=A.+Ashworth&title=A+high-throughput+RNA+interference+screen+for+DNA+repair+determinants+of+PARP+inhibitor+sensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DMcDonald%26aufirst%3DS.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DA%2520high-throughput%2520RNA%2520interference%2520screen%2520for%2520DNA%2520repair%2520determinants%2520of%2520PARP%2520inhibitor%2520sensitivity%26jtitle%3DDNA%2520Repair%26date%3D2008%26volume%3D7%26spage%3D2010%26epage%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Cardnell, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masrorpour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, L. A.</span><span> </span><span class="NLM_article-title">Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6322</span><span class="NLM_x">–</span> <span class="NLM_lpage">6328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-13-1975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=24077350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6322-6328&author=R.+J.+Cardnellauthor=Y.+Fengauthor=L.+Diaoauthor=Y.+H.+Fanauthor=F.+Masrorpourauthor=J.+Wangauthor=Y.+Shenauthor=G.+B.+Millsauthor=J.+D.+Minnaauthor=J.+V.+Heymachauthor=L.+A.+Byers&title=Proteomic+markers+of+DNA+repair+and+PI3K+pathway+activation+predict+response+to+the+PARP+inhibitor+BMN+673+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer</span></div><div class="casAuthors">Cardnell, Robert J.; Feng, Ying; Diao, Lixia; Fan, You-Hong; Masrorpour, Fatemah; Wang, Jing; Shen, Yuqiao; Mills, Gordon B.; Minna, John D.; Heymach, John V.; Byers, Lauren A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6322-6328</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Small cell lung carcinoma (SCLC) is an aggressive malignancy affecting nearly 30,000 people annually in the United States.  We have previously identified elevated PARP1 levels in SCLC and demonstrated in vitro sensitivity to the PARP inhibitors AZD 2281 and AG014699.  Here, we evaluate activity of a novel, potent PARP inhibitor, BMN 673, and identify markers of response as a basis for developing predictive markers for clin. application.  Exptl. Design: Inhibition of SCLC proliferation by BMN 673 was assayed in vitro and effects on tumor growth were measured in SCLC xenograft models.  Protein expression and pathway activation was assessed by reverse phase protein array and western blot anal.  PARP inhibition was confirmed using a PAR ELISA.  Results: We demonstrate striking, single agent activity of BMN 673 in SCLC cell lines and xenografts, with single agent BMN 673 exhibiting in vivo activity similar to cisplatin.  Sensitivity to BMN 673 was assocd. with elevated baseline expression levels of several DNA repair proteins, whereas greater drug resistance was obsd. in SCLC models with baseline activation of the PI3K/mTOR pathway.  Furthermore, we developed and confirmed these data with a novel "DNA repair score" consisting of a group of 17 DNA repair proteins.  Conclusions: Elevated expression of multiple DNA repair proteins, as well as a corresponding "DNA repair protein score," predict response to BMN 673 in in vitro SCLC models.  These observations complement recent work in which PI3K inhibition sensitizes breast cancer models to PARP inhibition, suggesting cooperation between DNA repair and PI3K pathways.  Clin Cancer Res; 19(22); 6322-8. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjX1GczmvrarVg90H21EOLACvtfcHk0lg4JVWdoE4dQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7bJ&md5=b801c3e12708b8fc5014bdc0bfbd20e8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1975%26sid%3Dliteratum%253Aachs%26aulast%3DCardnell%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DDiao%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DMasrorpour%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DByers%26aufirst%3DL.%2BA.%26atitle%3DProteomic%2520markers%2520of%2520DNA%2520repair%2520and%2520PI3K%2520pathway%2520activation%2520predict%2520response%2520to%2520the%2520PARP%2520inhibitor%2520BMN%2520673%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6322%26epage%3D6328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Brenner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ateeq, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanisamy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabolch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basrur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonigro, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenitoba-Johnson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navone, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=664-678&author=J.+C.+Brennerauthor=B.+Ateeqauthor=Y.+Liauthor=A.+K.+Yocumauthor=Q.+Caoauthor=I.+A.+Asanganiauthor=S.+Patelauthor=X.+Wangauthor=H.+Liangauthor=J.+Yuauthor=N.+Palanisamyauthor=J.+Siddiquiauthor=W.+Yanauthor=X.+Caoauthor=R.+Mehraauthor=A.+Sabolchauthor=V.+Basrurauthor=R.+J.+Lonigroauthor=J.+Yangauthor=S.+A.+Tomlinsauthor=C.+A.+Maherauthor=K.+S.+Elenitoba-Johnsonauthor=M.+Hussainauthor=N.+M.+Navoneauthor=K.+J.+Pientaauthor=S.+Varamballyauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Mechanistic+rationale+for+inhibition+of+poly%28ADP-ribose%29+polymerase+in+ETS+gene+fusion-positive+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DAteeq%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYocum%26aufirst%3DA.%2BK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DPalanisamy%26aufirst%3DN.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DSabolch%26aufirst%3DA.%26aulast%3DBasrur%26aufirst%3DV.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DMaher%26aufirst%3DC.%2BA.%26aulast%3DElenitoba-Johnson%26aufirst%3DK.%2BS.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DNavone%26aufirst%3DN.%2BM.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMechanistic%2520rationale%2520for%2520inhibition%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520ETS%2520gene%2520fusion-positive%2520prostate%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D664%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Nowsheen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e46614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46614&author=S.+Nowsheenauthor=T.+Cooperauthor=J.+A.+Stanleyauthor=E.+S.+Yang&title=Synthetic+lethal+interactions+between+EGFR+and+PARP+inhibition+in+human+triple+negative+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNowsheen%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DT.%26aulast%3DStanley%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DSynthetic%2520lethal%2520interactions%2520between%2520EGFR%2520and%2520PARP%2520inhibition%2520in%2520human%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De46614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinfeldt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, H.</span><span> </span><span class="NLM_article-title">Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7917</span><span class="NLM_x">–</span> <span class="NLM_lpage">7923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-08-1223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19047122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7917-7923&author=R.+Plummerauthor=C.+Jonesauthor=M.+Middletonauthor=R.+Wilsonauthor=J.+Evansauthor=A.+Olsenauthor=N.+Curtinauthor=A.+Boddyauthor=P.+McHughauthor=D.+Newellauthor=A.+Harrisauthor=P.+Johnsonauthor=H.+Steinfeldtauthor=R.+Dewjiauthor=D.+Wangauthor=L.+Robsonauthor=H.+Calvert&title=Phase+I+study+of+the+poly%28ADP-ribose%29+polymerase+inhibitor%2C+AG014699%2C+in+combination+with+temozolomide+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Plummer, Ruth; Jones, Christopher; Middleton, Mark; Wilson, Richard; Evans, Jeffrey; Olsen, Anna; Curtin, Nicola; Boddy, Alan; McHugh, Peter; Newell, David; Harris, Adrian; Johnson, Patrick; Steinfeldt, Heidi; Dewji, Raz; Wang, Diane; Robson, Lesley; Calvert, Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7917-7923</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: One mechanism of tumor resistance to cytotoxic therapy is repair of damaged DNA.  Poly(ADP-ribose) polymerase (PARP)-1 is a nuclear enzyme involved in base excision repair, one of the five major repair pathways.  PARP inhibitors are emerging as a new class of agents that can potentiate chemotherapy and radiotherapy.  The article reports safety, efficacy, pharmacokinetic, and pharmacodynamic results of the first-in-class trial of a PARP inhibitor, AG014699, combined with temozolomide in adults with advanced malignancy.  Exptl. Design: Initially, patients with solid tumors received escalating doses of AG014699 with 100 mg/m2/d temozolomide x 5 every 28 days to establish the PARP ID (PID).  Subsequently, AG014699 dose was fixed at PID and temozolomide escalated to max. tolerated dose or 200 mg/m2 in metastatic melanoma patients whose tumors were biopsied.  AG014699 and temozolomide pharmacokinetics, PARP activity, DNA strand single-strand breaks, response, and toxicity were evaluated.  RESULTS: Thirty-three patients were enrolled.  PARP inhibition was seen at all doses; PID was 12 mg/m2 based on 74% to 97% inhibition of peripheral blood lymphocyte PARP activity.  Recommended doses were 12 mg/m2 AG014699 and 200 mg/m2 temozolomide.  Mean tumor PARP inhibition at 5 h was 92% (range, 46-97%).  No toxicity attributable to AG014699 alone was obsd.  AG014699 showed linear pharmacokinetics with no interaction with temozolomide.  All patients treated at PID showed increases in DNA single-strand breaks and encouraging evidence of activity was seen.  CONCLUSIONS: The combination of AG014699 and temozolomide is well tolerated, pharmacodynamic assessments showing proof of principle of the mode of action of this new class of agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3DGcSbf45bVg90H21EOLACvtfcHk0lgr3kPlGQNFmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegt7%252FM&md5=76b77d0a31dcb652c31e049a7f6163c2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1223%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DMiddleton%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DA.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DBoddy%26aufirst%3DA.%26aulast%3DMcHugh%26aufirst%3DP.%26aulast%3DNewell%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DSteinfeldt%26aufirst%3DH.%26aulast%3DDewji%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRobson%26aufirst%3DL.%26aulast%3DCalvert%26aufirst%3DH.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%252C%2520AG014699%252C%2520in%2520combination%2520with%2520temozolomide%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7917%26epage%3D7923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steven, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbattista, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, H.</span><span> </span><span class="NLM_article-title">A phase II study of the potent PARP inhibitor, rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1007%2Fs00280-013-2113-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23423489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=1191-1199&author=R.+Plummerauthor=P.+Loriganauthor=N.+Stevenauthor=L.+Scottauthor=M.+R.+Middletonauthor=R.+H.+Wilsonauthor=E.+Mulliganauthor=N.+Curtinauthor=D.+Wangauthor=R.+Dewjiauthor=A.+Abbattistaauthor=J.+Galloauthor=H.+Calvert&title=A+phase+II+study+of+the+potent+PARP+inhibitor%2C+rucaparib+%28PF-01367338%2C+AG014699%29%2C+with+temozolomide+in+patients+with+metastatic+melanoma+demonstrating+evidence+of+chemopotentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation</span></div><div class="casAuthors">Plummer, Ruth; Lorigan, Paul; Steven, Neil; Scott, Lucy; Middleton, Mark R.; Wilson, Richard H.; Mulligan, Evan; Curtin, Nicola; Wang, Diane; Dewji, Raz; Abbattista, Antonello; Gallo, Jorge; Calvert, Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1191-1199</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose poly(ADP ribose) polymerase inhibition has been shown to potentiate the cytotoxicity of DNA damaging agents.  A phase I study of rucaparib and temozolomide showed that full-dose temozolomide could be given during PARP inhibition.  We report the results of a phase II study of i.v. rucaparib 12 mg/m2 and oral temozolomide 200 mg/m2 on days 1-5 every 28 days in patients with advanced metastatic melanoma.  Methods Patients with chemotherapy naive measurable metastatic melanoma, performance status ≤2 and good end-organ function were recruited.  Treatment was given until progression.  A two stage phase II design was used, with response rate the primary endpoint.  Population pharmacokinetics and pharmacodynamics were also explored.  Results Forty-six patients were recruited with 37 patients receiving at least 2 cycles and 17 patients at least 6 cycles.  Myelosuppression occurred with 25 patients (54 %) requiring a 25 % dose redn. in temozolomide.  The response rate was 17.4 %, median time to progression 3.5 mo, median overall survival 9.9 mo, and 36 % of patients were progression-free at 6 mo.  Conclusions This study showed that temozolomide (150-200 mg/m2/day) can safely be given with a PARP ID of rucaparib, increasing progression-free survival over historical controls in metastatic melanoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBJwDTgW-YGLVg90H21EOLACvtfcHk0lgr3kPlGQNFmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVemsLw%253D&md5=ae12a942aeec5c9443327f28472fa943</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00280-013-2113-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-013-2113-1%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DLorigan%26aufirst%3DP.%26aulast%3DSteven%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DE.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDewji%26aufirst%3DR.%26aulast%3DAbbattista%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%26aulast%3DCalvert%26aufirst%3DH.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520the%2520potent%2520PARP%2520inhibitor%252C%2520rucaparib%2520%2528PF-01367338%252C%2520AG014699%2529%252C%2520with%2520temozolomide%2520in%2520patients%2520with%2520metastatic%2520melanoma%2520demonstrating%2520evidence%2520of%2520chemopotentiation%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26spage%3D1191%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Fong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carden, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergui-Roelvink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messiou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">A’Hern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span> </span><span class="NLM_article-title">Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2512</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2009.26.9589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20406929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVyjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2512-2519&author=P.+C.+Fongauthor=T.+A.+Yapauthor=D.+S.+Bossauthor=C.+P.+Cardenauthor=M.+Mergui-Roelvinkauthor=C.+Gourleyauthor=J.+De+Greveauthor=J.+Lubinskiauthor=S.+Shanleyauthor=C.+Messiouauthor=R.+A%E2%80%99Hernauthor=A.+Tuttauthor=A.+Ashworthauthor=J.+Stoneauthor=J.+Carmichaelauthor=J.+H.+Schellensauthor=J.+S.+de+Bonoauthor=S.+B.+Kaye&title=Poly%28ADP%29-ribose+polymerase+inhibition%3A+frequent+durable+responses+in+BRCA+carrier+ovarian+cancer+correlating+with+platinum-free+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval</span></div><div class="casAuthors">Fong, Peter C.; Yap, Timothy A.; Boss, David S.; Carden, Craig P.; Mergui-Roelvink, Maria; Gourley, Charlie; De Greve, Jacques; Lubinski, Jan; Shanley, Susan; Messiou, Christina; A'Hern, Roger; Tutt, Andrew; Ashworth, Alan; Stone, John; Carmichael, James; Schellens, Jan H. M.; de Bono, Johann S.; Kaye, Stan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2512-2519</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Selective tumor cell cytotoxicity can be achieved through a synthetic lethal strategy using poly(ADP)-ribose polymerase (PARP) inhibitor therapy in BRCA1/2 mutation carriers in whom tumor cells have defective homologous recombination (HR) DNA repair.  Platinum-based chemotherapy responses correlate with HR DNA repair capacity.  Olaparib is a potent, oral PARP inhibitor that is well tolerated, with antitumor activity in BRCA1/2 mutation carriers.  Patients and Methods: Patients with BRCA1/2-mutated ovarian cancer were treated with olaparib within a dose-escalation and single-stage expansion of a phase I trial.  Antitumor activity was subsequently correlated with platinum sensitivity.  Results: Fifty patients were treated: 48 had germline BRCA1/2 mutations; one had a BRCA2 germline sequence change of unknown significance, and another had a strong family history of BRCA1/2-assocd. cancers who declined mutation testing.  Of the 50 patients, 13 had platinum-sensitive disease, 24 had platinum-resistant disease, and 13 had platinum-refractory disease (according to platinum-free interval).  Twenty (40%; 95% CI, 26% to 55%) achieved Response Evaluation Criteria in Solid Tumors (RECIST) complete or partial responses and/or tumor marker (CA125) responses, and three (6.0%) maintained RECIST disease stabilization for more than 4 mo, giving an overall clin. benefit rate of 46% (95% CI, 32% to 61 %).  Median response duration was 28 wk.  There was a significant assocn. between the clin. benefit rate and platinum-free interval across the platinum-sensitive, resistant, and refractory subgroups (69%, 45%, and 23%, resp.).  Post hoc analyses indicated assocns. between platinum sensitivity and extent of olaparib response (radiol. change, P = .001; CA125 change, P = .002).  Conclusion: Olaparib has antitumor activity in BRCA1/2 mutation ovarian cancer, which is assocd. with platinum sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyvj9Ym5yY27Vg90H21EOLACvtfcHk0liojQmjaTt85w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVyjtr4%253D&md5=4198806c2b9d41e7068d26049fd0cd3f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.26.9589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.26.9589%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DP.%2BC.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DBoss%26aufirst%3DD.%2BS.%26aulast%3DCarden%26aufirst%3DC.%2BP.%26aulast%3DMergui-Roelvink%26aufirst%3DM.%26aulast%3DGourley%26aufirst%3DC.%26aulast%3DDe%2BGreve%26aufirst%3DJ.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DShanley%26aufirst%3DS.%26aulast%3DMessiou%26aufirst%3DC.%26aulast%3DA%25E2%2580%2599Hern%26aufirst%3DR.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26atitle%3DPoly%2528ADP%2529-ribose%2520polymerase%2520inhibition%253A%2520frequent%2520durable%2520responses%2520in%2520BRCA%2520carrier%2520ovarian%2520cancer%2520correlating%2520with%2520platinum-free%2520interval%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D2512%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domchek, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audeh, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzel, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmutzler, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span> </span><span class="NLM_article-title">Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=235-244&author=A.+Tuttauthor=M.+Robsonauthor=J.+E.+Garberauthor=S.+M.+Domchekauthor=M.+W.+Audehauthor=J.+N.+Weitzelauthor=M.+Friedlanderauthor=B.+Arunauthor=N.+Lomanauthor=R.+K.+Schmutzlerauthor=A.+Wardleyauthor=G.+Mitchellauthor=H.+Earlauthor=M.+Wickensauthor=J.+Carmichael&title=Oral+poly%28ADP-ribose%29+polymerase+inhibitor+olaparib+in+patients+with+BRCA1+or+BRCA2+mutations+and+advanced+breast+cancer%3A+a+proof-of-concept+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DRobson%26aufirst%3DM.%26aulast%3DGarber%26aufirst%3DJ.%2BE.%26aulast%3DDomchek%26aufirst%3DS.%2BM.%26aulast%3DAudeh%26aufirst%3DM.%2BW.%26aulast%3DWeitzel%26aufirst%3DJ.%2BN.%26aulast%3DFriedlander%26aufirst%3DM.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DLoman%26aufirst%3DN.%26aulast%3DSchmutzler%26aufirst%3DR.%2BK.%26aulast%3DWardley%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DG.%26aulast%3DEarl%26aufirst%3DH.%26aulast%3DWickens%26aufirst%3DM.%26aulast%3DCarmichael%26aufirst%3DJ.%26atitle%3DOral%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520olaparib%2520in%2520patients%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520and%2520advanced%2520breast%2520cancer%253A%2520a%2520proof-of-concept%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D235%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Bundred, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardovskis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglitis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramonov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=949-958&author=N.+Bundredauthor=J.+Gardovskisauthor=J.+Jaskiewiczauthor=J.+Eglitisauthor=V.+Paramonovauthor=P.+McCormackauthor=H.+Swaislandauthor=M.+Cavallinauthor=T.+Parryauthor=J.+Carmichaelauthor=J.+M.+Dixon&title=Evaluation+of+the+pharmacodynamics+and+pharmacokinetics+of+the+PARP+inhibitor+olaparib%3A+a+phase+I+multicentre+trial+in+patients+scheduled+for+elective+breast+cancer+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBundred%26aufirst%3DN.%26aulast%3DGardovskis%26aufirst%3DJ.%26aulast%3DJaskiewicz%26aufirst%3DJ.%26aulast%3DEglitis%26aufirst%3DJ.%26aulast%3DParamonov%26aufirst%3DV.%26aulast%3DMcCormack%26aufirst%3DP.%26aulast%3DSwaisland%26aufirst%3DH.%26aulast%3DCavallin%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDixon%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamics%2520and%2520pharmacokinetics%2520of%2520the%2520PARP%2520inhibitor%2520olaparib%253A%2520a%2520phase%2520I%2520multicentre%2520trial%2520in%2520patients%2520scheduled%2520for%2520elective%2520breast%2520cancer%2520surgery%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nokihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahina, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span> </span><span class="NLM_article-title">A phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1111%2Fj.1349-7006.2011.02179.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22145984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2012&pages=504-509&author=N.+Yamamotoauthor=H.+Nokiharaauthor=Y.+Yamadaauthor=Y.+Gotoauthor=M.+Taniokaauthor=T.+Shibataauthor=K.+Yamadaauthor=H.+Asahinaauthor=T.+Kawataauthor=X.+Shiauthor=T.+Tamura&title=A+phase+I%2C+dose-finding+and+pharmacokinetic+study+of+olaparib+%28AZD2281%29+in+Japanese+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors</span></div><div class="casAuthors">Yamamoto, Noboru; Nokihara, Hiroshi; Yamada, Yasuhide; Goto, Yasushi; Tanioka, Maki; Shibata, Takashi; Yamada, Kazuhiko; Asahina, Hajime; Kawata, Toshio; Shi, Xiaojin; Tamura, Tomohide</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Olaparib (AZD2281) is an orally active Poly(ADP-ribose) polymerase (PARP) inhibitor with favorable antitumor activity in advanced ovarian and breast cancers with BRCA1/2 mutations in Western (USA and European) studies.  This Phase I dose-finding study evaluated the tolerability, pharmacokinetics, PARP inhibitory activity, and antitumor activity of olaparib in Japanese patients with solid tumors.  Olaparib was administered as a single-dose on day 1, followed by twice-daily dosing for 28 days from 48 h after a single dose.  Doses were escalated from 100 mg b.i.d. in successive cohorts, up to a max. of 400 mg b.i.d.  The present study enrolled 12 patients (n = 3, 3, and 6 in 100, 200 and 400-mg b.i.d. levels, resp.).  The most common adverse events were nausea, increased blood creatinine, decreased hematocrit, leukopenia and lymphopenia; dose-limiting toxicities were not obsd. up to and including the 400-mg b.i.d. dose level.  Following twice-daily dosing, olaparib showed no marked increase in exposure at steady state over that expected from the single-dose pharmacokinetics.  PARP-1 inhibition was obsd. from the 100-mg b.i.d. dose level in peripheral blood mononuclear cells from 6 h post-dose on day 1 during the multiple-dosing period.  A patient with metastatic breast cancer (100 mg b.i.d.) had a partial response for 13 mo and four patients (two each in the 200 and 400-mg b.i.d. levels) had stable disease >8 wk.  Olaparib was well tolerated up to the 400-mg b.i.d. dose in Japanese patients with solid tumors.  Preliminary evidence of antitumor activity was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnA3Dxz9hnbVg90H21EOLACvtfcHk0lg27_orP7AGAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1eru7k%253D&md5=56706a86e4388164e010ea363bd1524c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.02179.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.02179.x%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNokihara%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DTanioka%26aufirst%3DM.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DAsahina%26aufirst%3DH.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTamura%26aufirst%3DT.%26atitle%3DA%2520phase%2520I%252C%2520dose-finding%2520and%2520pharmacokinetic%2520study%2520of%2520olaparib%2520%2528AZD2281%2529%2520in%2520Japanese%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Sci.%26date%3D2012%26volume%3D103%26spage%3D504%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Rajan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kummar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannargudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span> </span><span class="NLM_article-title">A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-11-2425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22371451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2344-2351&author=A.+Rajanauthor=C.+A.+Carterauthor=R.+J.+Kellyauthor=M.+Gutierrezauthor=S.+Kummarauthor=E.+Szaboauthor=M.+A.+Yanceyauthor=J.+Jiauthor=B.+Mannargudiauthor=S.+Wooauthor=S.+Spencerauthor=W.+D.+Figgauthor=G.+Giaccone&title=A+phase+I+combination+study+of+olaparib+with+cisplatin+and+gemcitabine+in+adults+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors</span></div><div class="casAuthors">Rajan, Arun; Carter, Corey A.; Kelly, Ronan J.; Gutierrez, Martin; Kummar, Shivaani; Szabo, Eva; Yancey, Mary Ann; Ji, Jiuping; Mannargudi, Baskar; Woo, Sukyung; Spencer, Shawn; Figg, William Douglas; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2351</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the safety and tolerability of olaparib with cisplatin and gemcitabine, establish the max. tolerated dose (MTD), and evaluate the pharmacodynamic and pharmacokinetic profile of the combination.  Exptl. Design: We conducted a phase I study of olaparib with cisplatin and gemcitabine in patients with advanced solid tumors.  Treatment at dose level 1 (DL1) consisted of olaparib 100 mg orally every 12 h on days 1 to 4, gemcitabine 500 mg/m2 on days 3 and 10, and cisplatin 60 mg/m2 on day 3.  PAR levels were measured in peripheral blood mononuclear cells (PBMC).  RESULTS: Dose-limiting toxicities (DLT) in two of three patients at DL1 included thrombocytopenia and febrile neutropenia.  The protocol was amended to enroll patients treated with ≤2 prior severely myelosuppressive chemotherapy regimens and treated with olaparib 100 mg once daily on days 1 to 4 (DL-1).  No DLTs were seen in six patients at DL-1.  Because of persistent thrombocytopenia and neutropenia following a return to DL1, patients received 100 mg olaparib every 12 h on day 1 only.  No hematol. DLTs were obsd.; nonhematol. DLTs included gastrointestinal bleed, syncope, and hypoxia.  Of 21 patients evaluable for response, two had partial response.  Olaparib inhibited PARP in PBMCs and tumor tissue, although PAR levels were less effectively inhibited when olaparib was used for a short duration.  CONCLUSIONS: Olaparib in combination with cisplatin and gemcitabine is assocd. with myelosuppression even at relatively low doses.  Modified schedules of olaparib in chemotherapy naive patients will have to be explored with std. doses of chemotherapy.  Clin Cancer Res; 18(8); 2344-51.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI7TqGiAg307Vg90H21EOLACvtfcHk0lg27_orP7AGAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOnu7o%253D&md5=c1b311dfb8abb03ba06b7d5b5a9739b6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2425%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DA.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DKelly%26aufirst%3DR.%2BJ.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DYancey%26aufirst%3DM.%2BA.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DMannargudi%26aufirst%3DB.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DS.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DA%2520phase%2520I%2520combination%2520study%2520of%2520olaparib%2520with%2520cisplatin%2520and%2520gemcitabine%2520in%2520adults%2520with%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D2344%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buss, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyburski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulonis, U. A.</span><span> </span><span class="NLM_article-title">A phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2972</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2972-2978&author=J.+F.+Liuauthor=S.+M.+Tolaneyauthor=M.+Birrerauthor=G.+F.+Flemingauthor=M.+K.+Bussauthor=S.+E.+Dahlbergauthor=H.+Leeauthor=C.+Whalenauthor=K.+Tyburskiauthor=E.+Winerauthor=P.+Ivyauthor=U.+A.+Matulonis&title=A+phase+1+trial+of+the+poly%28ADP-ribose%29+polymerase+inhibitor+olaparib+%28AZD2281%29+in+combination+with+the+anti-angiogenic+cediranib+%28AZD2171%29+in+recurrent+epithelial+ovarian+or+triple-negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DTolaney%26aufirst%3DS.%2BM.%26aulast%3DBirrer%26aufirst%3DM.%26aulast%3DFleming%26aufirst%3DG.%2BF.%26aulast%3DBuss%26aufirst%3DM.%2BK.%26aulast%3DDahlberg%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DWhalen%26aufirst%3DC.%26aulast%3DTyburski%26aufirst%3DK.%26aulast%3DWiner%26aufirst%3DE.%26aulast%3DIvy%26aufirst%3DP.%26aulast%3DMatulonis%26aufirst%3DU.%2BA.%26atitle%3DA%2520phase%25201%2520trial%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520olaparib%2520%2528AZD2281%2529%2520in%2520combination%2520with%2520the%2520anti-angiogenic%2520cediranib%2520%2528AZD2171%2529%2520in%2520recurrent%2520epithelial%2520ovarian%2520or%2520triple-negative%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D2972%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulonis, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlan, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell-McGuinn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B.</span><span> </span><span class="NLM_article-title">Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer</span> <span class="citation_source-journal">J. Clin.Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2011.36.9215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22203755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=372-379&author=S.+B.+Kayeauthor=J.+Lubinskiauthor=U.+Matulonisauthor=J.+E.+Angauthor=C.+Gourleyauthor=B.+Y.+Karlanauthor=A.+Amnonauthor=K.+M.+Bell-McGuinnauthor=L.+M.+Chenauthor=M.+Friedlanderauthor=T.+Safraauthor=I.+Vergoteauthor=M.+Wickensauthor=E.+S.+Loweauthor=J.+Carmichaelauthor=B.+Kaufman&title=Phase+II%2C+open-label%2C+randomized%2C+multicenter+study+comparing+the+efficacy+and+safety+of+olaparib%2C+a+poly+%28ADP-ribose%29+polymerase+inhibitor%2C+and+pegylated+liposomal+doxorubicin+in+patients+with+BRCA1+or+BRCA2+mutations+and+recurrent+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II, open-label, randomized, multicenter study comparing the efficacy of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 and BRCA2 mutations and recurrent ovarian cancer</span></div><div class="casAuthors">Kaye, Stan B.; Lubinski, Jan; Matulonis, Ursula; Ang, Joo Ern; Gourley, Charlie; Karlan, Beth V.; Amnon, Amit; Bell-McGuinn, Katherine M.; Chen, Lee-May; Friedlander, Michael; Safra, Tamar; Vergote, Ignace; Wickens, Mark; Lowe, Elizabeth S.; Carmichael, James; Kaufman, Bella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Olaparib (AZD2281), an orally active poly (ADP-ribose) polymerase inhibitor that induces synthetic lethality in BRCA1- or BRCA2-deficient cells, has shown promising clin. efficacy in nonrandomized phase II trials in patients with ovarian cancer with BRCA1 or BRCA2 deficiency.  We assessed the comparative efficacy and safety of olaparib and pegylated liposomal doxorubicin (PLD) in this patient population.  Patients and Methods In this multicenter, open-label, randomized, phase II study, patients with ovarian cancer that recurred within 12 mo of prior platinum therapy and with confirmed germline BRCA1 or BRCA2 mutations were enrolled.  Patients were assigned in a 1:1:1 ratio to olaparib 200 mg twice per day or 400 mg twice per day continuously or PLD 50 mg/m2 i.v. every 28 days.  The primary efficacy end point was Response Evaluation Criteria in Solid Tumors (RECIST) -assessed progression-free survival (PFS).  Secondary end points included objective response rate (ORR) and safety.  Results Ninety-seven patients were randomly assigned.  Median PFS was 6.5 mo (95% CI, 5.5 to 10.1 mo), 8.8 mo (95% CI, 5.4 to 9.2 mo), and 7.1 mo (95% CI, 3.7 to 10.7 mo) for the olaparib 200 mg, olaparib 400 mg, and PLD groups, resp.  There was no statistically significant difference in PFS (hazard ratio, 0.88; 95% CI, 0.51 to 1.56; P = .66) for combined olaparib doses vs. PLD.  RECIST-assessed ORRs were 25%, 31 %, and 18% for olaparib 200 mg, olaparib 400 mg, and PLD, resp.; differences were not statistically significant.  Tolerability of both treatments was as expected based on previous trials.  Conclusion The efficacy of olaparib was consistent with previous studies.  However, the efficacy of PLD was greater than expected.  Olaparib 400 mg twice per day is a suitable dose to explore in further studies in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMk-rXAQhaM7Vg90H21EOLACvtfcHk0lg_NvyZ3Mq3OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKgsr8%253D&md5=4f32a5c28cb1e568687f2d58c19ef885</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.36.9215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.36.9215%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DLubinski%26aufirst%3DJ.%26aulast%3DMatulonis%26aufirst%3DU.%26aulast%3DAng%26aufirst%3DJ.%2BE.%26aulast%3DGourley%26aufirst%3DC.%26aulast%3DKarlan%26aufirst%3DB.%2BY.%26aulast%3DAmnon%26aufirst%3DA.%26aulast%3DBell-McGuinn%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DL.%2BM.%26aulast%3DFriedlander%26aufirst%3DM.%26aulast%3DSafra%26aufirst%3DT.%26aulast%3DVergote%26aufirst%3DI.%26aulast%3DWickens%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DE.%2BS.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DB.%26atitle%3DPhase%2520II%252C%2520open-label%252C%2520randomized%252C%2520multicenter%2520study%2520comparing%2520the%2520efficacy%2520and%2520safety%2520of%2520olaparib%252C%2520a%2520poly%2520%2528ADP-ribose%2529%2520polymerase%2520inhibitor%252C%2520and%2520pegylated%2520liposomal%2520doxorubicin%2520in%2520patients%2520with%2520BRCA1%2520or%2520BRCA2%2520mutations%2520and%2520recurrent%2520ovarian%2520cancer%26jtitle%3DJ.%2520Clin.Oncol.%26date%3D2012%26volume%3D30%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Kummar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speranza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murgo, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinders, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parchment, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doroshow, J. H.</span><span> </span><span class="NLM_article-title">Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">5626</span><span class="NLM_x">–</span> <span class="NLM_lpage">5634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=5626-5634&author=S.+Kummarauthor=A.+Chenauthor=J.+Jiauthor=Y.+Zhangauthor=J.+M.+Reidauthor=M.+Amesauthor=L.+Jiaauthor=M.+Weilauthor=G.+Speranzaauthor=A.+J.+Murgoauthor=R.+Kindersauthor=L.+Wangauthor=R.+E.+Parchmentauthor=J.+Carterauthor=H.+Stotlerauthor=L.+Rubinsteinauthor=M.+Hollingsheadauthor=G.+Melilloauthor=Y.+Pommierauthor=W.+Bonnerauthor=J.+E.+Tomaszewskiauthor=J.+H.+Doroshow&title=Phase+I+study+of+PARP+inhibitor+ABT-888+in+combination+with+topotecan+in+adults+with+refractory+solid+tumors+and+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DWeil%26aufirst%3DM.%26aulast%3DSperanza%26aufirst%3DG.%26aulast%3DMurgo%26aufirst%3DA.%2BJ.%26aulast%3DKinders%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DStotler%26aufirst%3DH.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DMelillo%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBonner%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26atitle%3DPhase%2520I%2520study%2520of%2520PARP%2520inhibitor%2520ABT-888%2520in%2520combination%2520with%2520topotecan%2520in%2520adults%2520with%2520refractory%2520solid%2520tumors%2520and%2520lymphomas%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D5626%26epage%3D5634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Sandhu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylands, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riisnaes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreischer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevensleben, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toniatti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenham, R. M.</span><span> </span><span class="NLM_article-title">The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2FS1470-2045%2813%2970240-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23810788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOjtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=882-892&author=S.+K.+Sandhuauthor=W.+R.+Schelmanauthor=G.+Wildingauthor=V.+Morenoauthor=R.+D.+Bairdauthor=S.+Mirandaauthor=L.+Hylandsauthor=R.+Riisnaesauthor=M.+Forsterauthor=A.+Omlinauthor=N.+Kreischerauthor=K.+Thwayauthor=H.+Gevenslebenauthor=L.+Sunauthor=J.+Loughneyauthor=M.+Chatterjeeauthor=C.+Toniattiauthor=C.+L.+Carpenterauthor=R.+Iannoneauthor=S.+B.+Kayeauthor=J.+S.+de+Bonoauthor=R.+M.+Wenham&title=The+poly%28ADP-ribose%29+polymerase+inhibitor+niraparib+%28MK4827%29+in+BRCA+mutation+carriers+and+patients+with+sporadic+cancer%3A+a+phase+1+dose-escalation+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial</span></div><div class="casAuthors">Sandhu, Shahneen K.; Schelman, William R.; Wilding, George; Moreno, Victor; Baird, Richard D.; Miranda, Susana; Hylands, Lucy; Riisnaes, Ruth; Forster, Martin; Omlin, Aurelius; Kreischer, Nathan; Thway, Khin; Gevensleben, Heidrun; Sun, Linda; Loughney, John; Chatterjee, Manash; Toniatti, Carlo; Carpenter, Christopher L.; Iannone, Robert; Kaye, Stan B.; de Bono, Johann S.; Wenham, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">882-892</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP) is implicated in DNA repair and transcription regulation.  Niraparib (MK4827) is an oral potent, selective PARP-1 and PARP-2 inhibitor that induces synthetic lethality in preclin. tumor models with loss of BRCA and PTEN function.  We investigated the safety, tolerability, max. tolerated dose, pharmacokinetic and pharmacodynamic profiles, and preliminary antitumor activity of niraparib.In a phase 1 dose-escalation study, we enrolled patients with advanced solid tumors at one site in the UK and two sites in the USA.  Eligible patients were aged at least 18 years; had a life expectancy of at least 12 wk; had an Eastern Cooperative Oncol. Group performance status of 2 or less; had assessable disease; were not suitable to receive any established treatments; had adequate organ function; and had discontinued any previous anticancer treatments at least 4 wk previously.  In part A, cohorts of three to six patients, enriched for BRCA1 and BRCA2 mutation carriers, received niraparib daily at ten escalating doses from 30 mg to 400 mg in a 21-day cycle to establish the max. tolerated dose.  Dose expansion at the max. tolerated dose was pursued in 15 patients to confirm tolerability.  In part B, we further investigated the max. tolerated dose in patients with sporadic platinum-resistant high-grade serous ovarian cancer and sporadic prostate cancer.  We obtained blood, circulating tumor cells, and optional paired tumor biopsies for pharmacokinetic and pharmacodynamic assessments.  Toxic effects were assessed by common toxicity criteria and tumor responses ascribed by Response Evaluation Criteria in Solid Tumors (RECIST).  Circulating tumor cells and archival tumor tissue in prostate patients were analyzed for exploratory putative predictive biomarkers, such as loss of PTEN expression and ETS rearrangements.  This trial is registered with ClinicalTrials.gov, NCT00749502.Between Sept 15, 2008, and Jan 14, 2011, we enrolled 100 patients: 60 in part A and 40 in part B. 300 mg/day was established as the max. tolerated dose.  Dose-limiting toxic effects reported in the first cycle were grade 3 fatigue (one patient given 30 mg/day), grade 3 pneumonitis (one given 60 mg/day), and grade 4 thrombocytopenia (two given 400 mg/day).  Common treatment-related toxic effects were anemia (48 patients [48%]), nausea (42 [42%]), fatigue (42 [42%]), thrombocytopenia (35 [35%]), anorexia (26 [26%]), neutropenia (24 [24%]), constipation (23 [23%]), and vomiting (20 [20%]), and were predominantly grade 1 or 2.  Pharmacokinetics were dose proportional and the mean terminal elimination half-life was 36·4 h (range 32·8-46·0).  Pharmacodynamic analyses confirmed PARP inhibition exceeded 50% at doses greater than 80 mg/day and antitumor activity was documented beyond doses of 60 mg/day.  Eight (40% [95% CI 19-64]) of 20 BRCA1 or BRCA2 mutation carriers with ovarian cancer had RECIST partial responses, as did two (50% [7-93]) of four mutation carriers with breast cancer.  Antitumor activity was also reported in sporadic high-grade serous ovarian cancer, non-small-cell lung cancer, and prostate cancer.  We recorded no correlation between loss of PTEN expression or ETS rearrangements and measures of antitumor activity in patients with prostate cancer.A recommended phase 2 dose of 300 mg/day niraparib is well tolerated.  Niraparib should be further assessed in inherited and sporadic cancers with homologous recombination DNA repair defects and to target PARP-mediated transcription in cancer.Merck Sharp and Dohme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQBD4DZcJn7Vg90H21EOLACvtfcHk0lgiod2RedGO6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOjtLnF&md5=b6f27019bb7887156d1abcf05db2bca3</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970240-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970240-7%26sid%3Dliteratum%253Aachs%26aulast%3DSandhu%26aufirst%3DS.%2BK.%26aulast%3DSchelman%26aufirst%3DW.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DBaird%26aufirst%3DR.%2BD.%26aulast%3DMiranda%26aufirst%3DS.%26aulast%3DHylands%26aufirst%3DL.%26aulast%3DRiisnaes%26aufirst%3DR.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DOmlin%26aufirst%3DA.%26aulast%3DKreischer%26aufirst%3DN.%26aulast%3DThway%26aufirst%3DK.%26aulast%3DGevensleben%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLoughney%26aufirst%3DJ.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWenham%26aufirst%3DR.%2BM.%26atitle%3DThe%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520niraparib%2520%2528MK4827%2529%2520in%2520BRCA%2520mutation%2520carriers%2520and%2520patients%2520with%2520sporadic%2520cancer%253A%2520a%2520phase%25201%2520dose-escalation%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3D882%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdev, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span> </span><span class="NLM_article-title">First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumor</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2012.47.6804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23733753" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2580&author=J.+S.+de+Bonoauthor=L.+A.+Minaauthor=M.+Gonzalezauthor=N.+J.+Curtinauthor=E.+Wangauthor=J.+W.+Henshawauthor=M.+Chadhaauthor=J.+C.+Sachdevauthor=D.+Mateiauthor=G.+S.+Jamesonauthor=M.+Ongauthor=B.+Basuauthor=Z.+A.+Wainbergauthor=L.+A.+Byersauthor=R.+Chughauthor=A.+Dorrauthor=S.+B.+Kayeauthor=R.+K.+Ramanathan&title=First-in-human+trial+of+novel+oral+PARP+inhibitor+BMN+673+in+patients+with+solid+tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.47.6804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.47.6804%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DMina%26aufirst%3DL.%2BA.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DHenshaw%26aufirst%3DJ.%2BW.%26aulast%3DChadha%26aufirst%3DM.%26aulast%3DSachdev%26aufirst%3DJ.%2BC.%26aulast%3DMatei%26aufirst%3DD.%26aulast%3DJameson%26aufirst%3DG.%2BS.%26aulast%3DOng%26aufirst%3DM.%26aulast%3DBasu%26aufirst%3DB.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DByers%26aufirst%3DL.%2BA.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DDorr%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DFirst-in-human%2520trial%2520of%2520novel%2520oral%2520PARP%2520inhibitor%2520BMN%2520673%2520in%2520patients%2520with%2520solid%2520tumor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Banin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smorodinsky, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, Y.</span><span> </span><span class="NLM_article-title">Enhanced phosphorylation of p53 by ATM in response to DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1674</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1674-1677&author=S.+Baninauthor=L.+Moyalauthor=S.+Shiehauthor=Y.+Tayaauthor=C.+W.+Andersonauthor=L.+Chessaauthor=N.+I.+Smorodinskyauthor=C.+Privesauthor=Y.+Reissauthor=Y.+Shilohauthor=Y.+Ziv&title=Enhanced+phosphorylation+of+p53+by+ATM+in+response+to+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanin%26aufirst%3DS.%26aulast%3DMoyal%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DChessa%26aufirst%3DL.%26aulast%3DSmorodinsky%26aufirst%3DN.%2BI.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DReiss%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DZiv%26aufirst%3DY.%26atitle%3DEnhanced%2520phosphorylation%2520of%2520p53%2520by%2520ATM%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1674%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Chehab, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malikzay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazonetis, T. D.</span><span> </span><span class="NLM_article-title">Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=278-288&author=N.+H.+Chehabauthor=A.+Malikzayauthor=M.+Appelauthor=T.+D.+Halazonetis&title=Chk2%2FhCds1+functions+as+a+DNA+damage+checkpoint+in+G%281%29+by+stabilizing+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChehab%26aufirst%3DN.%2BH.%26aulast%3DMalikzay%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DChk2%252FhCds1%2520functions%2520as%2520a%2520DNA%2520damage%2520checkpoint%2520in%2520G%25281%2529%2520by%2520stabilizing%2520p53%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D278%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Tibbetts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumbaugh, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliby, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">A role for ATR in the DNA damage-induced phosphorylation of p53</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1101%2Fgad.13.2.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9925639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVOmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=152-157&author=R.+S.+Tibbettsauthor=K.+M.+Brumbaughauthor=J.+M.+Williamsauthor=J.+N.+Sarkariaauthor=W.+A.+Clibyauthor=S.+Y.+Shiehauthor=Y.+Tayaauthor=C.+Privesauthor=R.+T.+Abraham&title=A+role+for+ATR+in+the+DNA+damage-induced+phosphorylation+of+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A role for ATR in the DNA damage-induced phosphorylation of p53</span></div><div class="casAuthors">Tibbetts, Randal S.; Brumbaugh, Kathryn M.; Williams, Josie M.; Sarkaria, Jann N.; Cliby, William A.; Shieh, Sheau-Yann; Taya, Yoichi; Prives, Carol; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Phosphorylation at Ser-15 may be a crit. event in the up-regulation and functional activation of p53 during cellular stress.  In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells.  Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to γ-irradn. and UV light.  In γ-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner.  ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR9Ikma3VGlrVg90H21EOLACvtfcHk0libQlQ1QDJuSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVOmt7c%253D&md5=9219d983beec8d5e6523ceb2493fe1f8</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.2.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.2.152%26sid%3Dliteratum%253Aachs%26aulast%3DTibbetts%26aufirst%3DR.%2BS.%26aulast%3DBrumbaugh%26aufirst%3DK.%2BM.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DCliby%26aufirst%3DW.%2BA.%26aulast%3DShieh%26aufirst%3DS.%2BY.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DA%2520role%2520for%2520ATR%2520in%2520the%2520DNA%2520damage-induced%2520phosphorylation%2520of%2520p53%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D152%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Donzelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span> </span><span class="NLM_article-title">Regulating mammalian checkpoints through Cdc25 inactivation</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=671-677&author=M.+Donzelliauthor=G.+F.+Draetta&title=Regulating+mammalian+checkpoints+through+Cdc25+inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonzelli%26aufirst%3DM.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26atitle%3DRegulating%2520mammalian%2520checkpoints%2520through%2520Cdc25%2520inactivation%26jtitle%3DEMBO%2520Rep.%26date%3D2003%26volume%3D4%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Cliby, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimprich, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=159-169&author=W.+A.+Clibyauthor=C.+J.+Robertsauthor=K.+A.+Cimprichauthor=C.+M.+Stringerauthor=J.+R.+Lambauthor=S.+L.+Schreiberauthor=S.+H.+Friend&title=Overexpression+of+a+kinase-inactive+ATR+protein+causes+sensitivity+to+DNA-damaging+agents+and+defects+in+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCliby%26aufirst%3DW.%2BA.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DCimprich%26aufirst%3DK.%2BA.%26aulast%3DStringer%26aufirst%3DC.%2BM.%26aulast%3DLamb%26aufirst%3DJ.%2BR.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DOverexpression%2520of%2520a%2520kinase-inactive%2520ATR%2520protein%2520causes%2520sensitivity%2520to%2520DNA-damaging%2520agents%2520and%2520defects%2520in%2520cell%2520cycle%2520checkpoints%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Uto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagata, N.</span><span> </span><span class="NLM_article-title">Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3386</span><span class="NLM_x">–</span> <span class="NLM_lpage">3396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3386-3396&author=K.+Utoauthor=D.+Inoueauthor=K.+Shimutaauthor=N.+Nakajoauthor=N.+Sagata&title=Chk1%2C+but+not+Chk2%2C+inhibits+Cdc25+phosphatases+by+a+novel+common+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUto%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DShimuta%26aufirst%3DK.%26aulast%3DNakajo%26aufirst%3DN.%26aulast%3DSagata%26aufirst%3DN.%26atitle%3DChk1%252C%2520but%2520not%2520Chk2%252C%2520inhibits%2520Cdc25%2520phosphatases%2520by%2520a%2520novel%2520common%2520mechanism%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D3386%26epage%3D3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Innocente, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogswell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span> </span><span class="NLM_article-title">p53 regulates a G2 checkpoint through cyclin B1</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">–</span> <span class="NLM_lpage">2152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=2147-2152&author=S.+A.+Innocenteauthor=J.+L.+Abrahamsonauthor=J.+P.+Cogswellauthor=J.+M.+Lee&title=p53+regulates+a+G2+checkpoint+through+cyclin+B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInnocente%26aufirst%3DS.%2BA.%26aulast%3DAbrahamson%26aufirst%3DJ.%2BL.%26aulast%3DCogswell%26aufirst%3DJ.%2BP.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26atitle%3Dp53%2520regulates%2520a%2520G2%2520checkpoint%2520through%2520cyclin%2520B1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D2147%26epage%3D2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Reinhardt, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span> </span><span class="NLM_article-title">p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=175-189&author=H.+C.+Reinhardtauthor=A.+S.+Aslanianauthor=J.+A.+Leesauthor=M.+B.+Yaffe&title=p53-deficient+cells+rely+on+ATM-+and+ATR-mediated+checkpoint+signaling+through+the+p38MAPK%2FMK2+pathway+for+survival+after+DNA+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DH.%2BC.%26aulast%3DAslanian%26aufirst%3DA.%2BS.%26aulast%3DLees%26aufirst%3DJ.%2BA.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26atitle%3Dp53-deficient%2520cells%2520rely%2520on%2520ATM-%2520and%2520ATR-mediated%2520checkpoint%2520signaling%2520through%2520the%2520p38MAPK%252FMK2%2520pathway%2520for%2520survival%2520after%2520DNA%2520damage%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D175%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommiska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemann, M. T.</span><span> </span><span class="NLM_article-title">The combined status of ATM and p53 link tumor development with therapeutic response</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1895-1909&author=H.+Jiangauthor=H.+C.+Reinhardtauthor=J.+Bartkovaauthor=J.+Tommiskaauthor=C.+Blomqvistauthor=H.+Nevanlinnaauthor=J.+Bartekauthor=M.+B.+Yaffeauthor=M.+T.+Hemann&title=The+combined+status+of+ATM+and+p53+link+tumor+development+with+therapeutic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DReinhardt%26aufirst%3DH.%2BC.%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DTommiska%26aufirst%3DJ.%26aulast%3DBlomqvist%26aufirst%3DC.%26aulast%3DNevanlinna%26aufirst%3DH.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26aulast%3DHemann%26aufirst%3DM.%2BT.%26atitle%3DThe%2520combined%2520status%2520of%2520ATM%2520and%2520p53%2520link%2520tumor%2520development%2520with%2520therapeutic%2520response%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D1895%26epage%3D1909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Sullivan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla-Just, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGregori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, J. M.</span><span> </span><span class="NLM_article-title">ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnchembio.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22660439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=646-654&author=K.+D.+Sullivanauthor=N.+Padilla-Justauthor=R.+E.+Henryauthor=C.+C.+Porterauthor=J.+Kimauthor=J.+J.+Tentlerauthor=S.+G.+Eckhardtauthor=A.+C.+Tanauthor=J.+DeGregoriauthor=J.+M.+Espinosa&title=ATM+and+MET+kinases+are+synthetic+lethal+with+nongenotoxic+activation+of+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53</span></div><div class="casAuthors">Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Porter, Christopher C.; Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon; DeGregori, James; Espinosa, Joaquin M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">646-654</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p53 tumor suppressor orchestrates alternative stress responses including cell cycle arrest and apoptosis, but the mechanisms defining cell fate upon p53 activation are poorly understood.  Several small-mol. activators of p53 have been developed, including Nutlin-3, but their therapeutic potential is limited by the fact that they induce reversible cell cycle arrest in most cancer cell types.  We report here the results of a genome-wide short hairpin RNA screen for genes that are lethal in combination with p53 activation by Nutlin-3, which showed that the ATM and MET kinases govern cell fate choice upon p53 activation.  Genetic or pharmacol. interference with ATM or MET activity converts the cellular response from cell cycle arrest into apoptosis in diverse cancer cell types without affecting expression of key p53 target genes.  ATM and MET inhibitors also enable Nutlin-3 to kill tumor spheroids.  These results identify new pathways controlling the cellular response to p53 activation and aid in the design of p53-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdE_gnwFlQXLVg90H21EOLACvtfcHk0lhxPKF9tSG73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymtrk%253D&md5=dac083b616ff06a85c46d33346f17593</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.965%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DK.%2BD.%26aulast%3DPadilla-Just%26aufirst%3DN.%26aulast%3DHenry%26aufirst%3DR.%2BE.%26aulast%3DPorter%26aufirst%3DC.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTentler%26aufirst%3DJ.%2BJ.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DDeGregori%26aufirst%3DJ.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26atitle%3DATM%2520and%2520MET%2520kinases%2520are%2520synthetic%2520lethal%2520with%2520nongenotoxic%2520activation%2520of%2520p53%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D646%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-12-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23512991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=959-967&author=M.+A.+Bateyauthor=Y.+Zhaoauthor=S.+Kyleauthor=C.+Richardsonauthor=A.+Sladeauthor=N.+M.+Martinauthor=A.+Lauauthor=D.+R.+Newellauthor=N.+J.+Curtin&title=Preclinical+evaluation+of+a+novel+ATM+inhibitor%2C+KU59403%2C+in+vitro+and+in+vivo+in+p53+functional+and+dysfunctional+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer</span></div><div class="casAuthors">Batey, Michael A.; Zhao, Yan; Kyle, Suzanne; Richardson, Caroline; Slade, Andrew; Martin, Niall M. B.; Lau, Alan; Newell, David R.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia mutated (ATM) kinase signals DNA double-strand breaks (DSB) to cell-cycle arrest via p53 and DNA repair.  ATM-defective cells are sensitive to DSB-inducing agents, making ATM an attractive target for anticancer chemo- and radiosensitization.  KU59403 is an ATM inhibitor with the potency, selectivity, and soly. for advanced preclin. evaluation.  KU59403 was not cytotoxic to human cancer cell lines (SW620, LoVo, HCT116, and MDA-MB-231) per se but significantly increased the cytotoxicity of topoisomerase I and II poisons: camptothecin, etoposide, and doxorubicin.  Chemo- and radiosensitization by ATM inhibition was not p53-dependent.  Following administration to mice, KU59403 distributed to tissues and concns. exceeding those required for in vitro activity were maintained for at least 4 h in tumor xenografts.  KU59403 significantly enhanced the antitumor activity of topoisomerase poisons in mice bearing human colon cancer xenografts (SW620 and HCT116) at doses that were nontoxic alone and well-tolerated in combination.  Chemosensitization was both dose- and schedule-dependent.  KU59403 represents a major advance in ATM inhibitor development, being the 1st compd. to show good tissue distribution and significant chemosensitization in in vivo models of human cancer, without major toxicity.  KU59403 provides the 1st proof-of-principle preclin. data to support the future clin. development of ATM inhibitors.  Mol Cancer Ther; 12(6); 959-67. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlMwHzEdbQrVg90H21EOLACvtfcHk0lhxPKF9tSG73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D&md5=82771364eb5cd8a3baf13e5cd48b5389</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520novel%2520ATM%2520inhibitor%252C%2520KU59403%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520p53%2520functional%2520and%2520dysfunctional%2520models%2520of%2520human%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Nghiem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaziri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">9092</span><span class="NLM_x">–</span> <span class="NLM_lpage">9097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=9092-9097&author=P.+Nghiemauthor=P.+K.+Parkauthor=Y.+Kimauthor=C.+Vaziriauthor=S.+L.+Schreiber&title=ATR+inhibition+selectively+sensitizes+G1+checkpoint-deficient+cells+to+lethal+premature+chromatin+condensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNghiem%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DVaziri%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DATR%2520inhibition%2520selectively%2520sensitizes%2520G1%2520checkpoint-deficient%2520cells%2520to%2520lethal%2520premature%2520chromatin%2520condensation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D9092%26epage%3D9097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Sangster-Guity, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunz, F.</span><span> </span><span class="NLM_article-title">ATR mediates cisplatin resistance in a p53 genotype-specific manner</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2526</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2526-2533&author=N.+Sangster-Guityauthor=B.+H.+Conradauthor=N.+Papadopoulosauthor=F.+Bunz&title=ATR+mediates+cisplatin+resistance+in+a+p53+genotype-specific+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangster-Guity%26aufirst%3DN.%26aulast%3DConrad%26aufirst%3DB.%2BH.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DBunz%26aufirst%3DF.%26atitle%3DATR%2520mediates%2520cisplatin%2520resistance%2520in%2520a%2520p53%2520genotype-specific%2520manner%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Murga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campaner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Contreras, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Artista, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Capetillo, O.</span><span> </span><span class="NLM_article-title">Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22120667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1331-1335&author=M.+Murgaauthor=S.+Campanerauthor=A.+J.+Lopez-Contrerasauthor=L.+I.+Toledoauthor=R.+Soriaauthor=M.+F.+Montanaauthor=L.+D%E2%80%99Artistaauthor=T.+Schlekerauthor=C.+Guerraauthor=E.+Garciaauthor=M.+Barbacidauthor=M.+Hidalgoauthor=B.+Amatiauthor=O.+Fernandez-Capetillo&title=Exploiting+oncogene-induced+replicative+stress+for+the+selective+killing+of+Myc-driven+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors</span></div><div class="casAuthors">Murga, Matilde; Campaner, Stefano; Lopez-Contreras, Andres J.; Toledo, Luis I.; Soria, Rebeca; Montana, Maria F.; D'Artista, Luana; Schleker, Thomas; Guerra, Carmen; Garcia, Elena; Barbacid, Mariano; Hidalgo, Manuel; Amati, Bruno; Fernandez-Capetillo, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1331-1335</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene-induced replicative stress activates an Atr- and Chk1-dependent response, which has been proposed to be widespread in tumors.  We explored whether the presence of replicative stress could be exploited for the selective elimination of cancer cells.  To this end, we evaluated the impact of targeting the replicative stress-response on cancer development.  In mice (Mus musculus), the reduced levels of Atr found on a mouse model of the Atr-Seckel syndrome completely prevented the development of Myc-induced lymphomas or pancreatic tumors, both of which showed abundant levels of replicative stress.  Moreover, Chk1 inhibitors were highly effective in killing Myc-driven lymphomas.  By contrast, pancreatic adenocarcinomas initiated by K-RasG12V showed no detectable evidence of replicative stress and were nonresponsive to this therapy.  Besides its impact on cancer, Myc overexpression aggravated the phenotypes of Atr-Seckel mice, revealing that oncogenes can modulate the severity of replicative stress-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZk3HjRl2oVLVg90H21EOLACvtfcHk0lhdd9LXTTgL3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7vN&md5=95824452f88f115f90129c088d120e56</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2189%26sid%3Dliteratum%253Aachs%26aulast%3DMurga%26aufirst%3DM.%26aulast%3DCampaner%26aufirst%3DS.%26aulast%3DLopez-Contreras%26aufirst%3DA.%2BJ.%26aulast%3DToledo%26aufirst%3DL.%2BI.%26aulast%3DSoria%26aufirst%3DR.%26aulast%3DMontana%26aufirst%3DM.%2BF.%26aulast%3DD%25E2%2580%2599Artista%26aufirst%3DL.%26aulast%3DSchleker%26aufirst%3DT.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DE.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DAmati%26aufirst%3DB.%26aulast%3DFernandez-Capetillo%26aufirst%3DO.%26atitle%3DExploiting%2520oncogene-induced%2520replicative%2520stress%2520for%2520the%2520selective%2520killing%2520of%2520Myc-driven%2520tumors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D1331%26epage%3D1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Kawasumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibodeau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angle-Zahn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conney, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nghiem, P.</span><span> </span><span class="NLM_article-title">Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">13716</span><span class="NLM_x">–</span> <span class="NLM_lpage">13721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=13716-13721&author=M.+Kawasumiauthor=B.+Lemosauthor=J.+E.+Bradnerauthor=R.+Thibodeauauthor=Y.+S.+Kimauthor=M.+Schmidtauthor=E.+Higginsauthor=S.+W.+Kooauthor=A.+Angle-Zahnauthor=A.+Chenauthor=D.+Levineauthor=L.+Nguyenauthor=T.+P.+Heffernanauthor=I.+Longoauthor=A.+Mandinovaauthor=Y.+P.+Luauthor=A.+H.+Conneyauthor=P.+Nghiem&title=Protection+from+UV-induced+skin+carcinogenesis+by+genetic+inhibition+of+the+ataxia+telangiectasia+and+Rad3-related+%28ATR%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawasumi%26aufirst%3DM.%26aulast%3DLemos%26aufirst%3DB.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DThibodeau%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DHiggins%26aufirst%3DE.%26aulast%3DKoo%26aufirst%3DS.%2BW.%26aulast%3DAngle-Zahn%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DLongo%26aufirst%3DI.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%2BP.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DNghiem%26aufirst%3DP.%26atitle%3DProtection%2520from%2520UV-induced%2520skin%2520carcinogenesis%2520by%2520genetic%2520inhibition%2520of%2520the%2520ataxia%2520telangiectasia%2520and%2520Rad3-related%2520%2528ATR%2529%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D13716%26epage%3D13721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Fatah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moseley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarakti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedhouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhusudan, S.</span><span> </span><span class="NLM_article-title">Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e57098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e57098&author=R.+Sultanaauthor=T.+Abdel-Fatahauthor=C.+Perryauthor=P.+Moseleyauthor=N.+Albaraktiauthor=V.+Mohanauthor=C.+Seedhouseauthor=S.+Chanauthor=S.+Madhusudan&title=Ataxia+telangiectasia+mutated+and+Rad3+related+%28ATR%29+protein+kinase+inhibition+is+synthetically+lethal+in+XRCC1+deficient+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DAbdel-Fatah%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DC.%26aulast%3DMoseley%26aufirst%3DP.%26aulast%3DAlbarakti%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DV.%26aulast%3DSeedhouse%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DMadhusudan%26aufirst%3DS.%26atitle%3DAtaxia%2520telangiectasia%2520mutated%2520and%2520Rad3%2520related%2520%2528ATR%2529%2520protein%2520kinase%2520inhibition%2520is%2520synthetically%2520lethal%2520in%2520XRCC1%2520deficient%2520ovarian%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De57098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Huntoon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatten, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahner Hendrickson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huehls, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnitz, L. M.</span><span> </span><span class="NLM_article-title">ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3683</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3683-3691&author=C.+J.+Huntoonauthor=K.+S.+Flattenauthor=A.+E.+Wahner+Hendricksonauthor=A.+M.+Huehlsauthor=S.+L.+Sutorauthor=S.+H.+Kaufmannauthor=L.+M.+Karnitz&title=ATR+inhibition+broadly+sensitizes+ovarian+cancer+cells+to+chemotherapy+independent+of+BRCA+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuntoon%26aufirst%3DC.%2BJ.%26aulast%3DFlatten%26aufirst%3DK.%2BS.%26aulast%3DWahner%2BHendrickson%26aufirst%3DA.%2BE.%26aulast%3DHuehls%26aufirst%3DA.%2BM.%26aulast%3DSutor%26aufirst%3DS.%2BL.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DKarnitz%26aufirst%3DL.%2BM.%26atitle%3DATR%2520inhibition%2520broadly%2520sensitizes%2520ovarian%2520cancer%2520cells%2520to%2520chemotherapy%2520independent%2520of%2520BRCA%2520status%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3683%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">bdel-Fatah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbotts, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarakati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedhouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakha, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhusudan, S.</span><span> </span><span class="NLM_article-title">Targeting XRCC1 deficiency in breast cancer for personalized therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1621-1634&author=R.+Sultanaauthor=T.+bdel-Fatahauthor=R.+Abbottsauthor=C.+Hawkesauthor=N.+Albarakatiauthor=C.+Seedhouseauthor=G.+Ballauthor=S.+Chanauthor=E.+A.+Rakhaauthor=I.+O.+Ellisauthor=S.+Madhusudan&title=Targeting+XRCC1+deficiency+in+breast+cancer+for+personalized+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3Dbdel-Fatah%26aufirst%3DT.%26aulast%3DAbbotts%26aufirst%3DR.%26aulast%3DHawkes%26aufirst%3DC.%26aulast%3DAlbarakati%26aufirst%3DN.%26aulast%3DSeedhouse%26aufirst%3DC.%26aulast%3DBall%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DRakha%26aufirst%3DE.%2BA.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DMadhusudan%26aufirst%3DS.%26atitle%3DTargeting%2520XRCC1%2520deficiency%2520in%2520breast%2520cancer%2520for%2520personalized%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D1621%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Toledo, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Capetillo, O.</span><span> </span><span class="NLM_article-title">A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnsmb.2076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21552262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=721-727&author=L.+I.+Toledoauthor=M.+Murgaauthor=R.+Zurauthor=R.+Soriaauthor=A.+Rodriguezauthor=S.+Martinezauthor=J.+Oyarzabalauthor=J.+Pastorauthor=J.+R.+Bischoffauthor=O.+Fernandez-Capetillo&title=A+cell-based+screen+identifies+ATR+inhibitors+with+synthetic+lethal+properties+for+cancer-associated+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations</span></div><div class="casAuthors">Toledo, Luis I.; Murga, Matilde; Zur, Rafal; Soria, Rebeca; Rodriguez, Antonio; Martinez, Sonia; Oyarzabal, Julen; Pastor, Joaquin; Bischoff, James R.; Fernandez-Capetillo, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-727</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene activation has been shown to generate replication-born DNA damage, also known as replicative stress.  The primary responder to replicative stress is not Ataxia-Telangiectasia Mutated (ATM) but rather the kinase ATM and Rad3-related (ATR).  One limitation for the study of ATR is the lack of potent inhibitors.  We here describe a cell-based screening strategy that has allowed us to identify compds. with ATR inhibitory activity in the nanomolar range.  Pharmacol. inhibition of ATR generates replicative stress, leading to chromosomal breakage in the presence of conditions that stall replication forks.  Moreover, ATR inhibition is particularly toxic for p53-deficient cells, this toxicity being exacerbated by replicative stress-generating conditions such as the overexpression of cyclin E.  Notably, one of the compds. we identified is NVP-BEZ235, a dual phosphatidylinositol-3-OH kinase (PI3K) and mTOR inhibitor that is being tested for cancer chemotherapy but that we now show is also very potent against ATM, ATR and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8JQaK-RtJQLVg90H21EOLACvtfcHk0lg5Emv0xt-pDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVagsr0%253D&md5=3a639ade432083e3665d290c516f2fb0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2076%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DL.%2BI.%26aulast%3DMurga%26aufirst%3DM.%26aulast%3DZur%26aufirst%3DR.%26aulast%3DSoria%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DS.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DFernandez-Capetillo%26aufirst%3DO.%26atitle%3DA%2520cell-based%2520screen%2520identifies%2520ATR%2520inhibitors%2520with%2520synthetic%2520lethal%2520properties%2520for%2520cancer-associated%2520mutations%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D721%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacq, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissink, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thommes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhurst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, C.</span><span> </span><span class="NLM_article-title">Discovery of 4-{4-[(3<i>R</i>)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1<i>H</i>-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2125</span><span class="NLM_x">–</span> <span class="NLM_lpage">2138</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2125-2138&author=K.+M.+Footeauthor=K.+Bladesauthor=A.+Croninauthor=S.+Filleryauthor=S.+S.+Guichardauthor=L.+Hassallauthor=I.+Hicksonauthor=X.+Jacqauthor=P.+J.+Jewsburyauthor=T.+M.+McGuireauthor=J.+W.+Nissinkauthor=R.+Odedraauthor=K.+Pageauthor=P.+Perkinsauthor=A.+Sulemanauthor=K.+Tamauthor=P.+Thommesauthor=R.+Broadhurstauthor=C.+Wood&title=Discovery+of+4-%7B4-%5B%283R%29-3-methylmorpholin-4-yl%5D-6-%5B1-%28methylsulfonyl%29cyclopropyl%5Dpyrimidin-2-yl%7D-1H-indole+%28AZ20%29%3A+a+potent+and+selective+inhibitor+of+ATR+protein+kinase+with+monotherapy+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm301859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301859s%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGuichard%26aufirst%3DS.%2BS.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSuleman%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DK.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DBroadhurst%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25204-%257B4-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-6-%255B1-%2528methylsulfonyl%2529cyclopropyl%255Dpyrimidin-2-yl%257D-1H-indole%2520%2528AZ20%2529%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520ATR%2520protein%2520kinase%2520with%2520monotherapy%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2125%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCormick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2320</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101488z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2320-2330&author=J.+D.+Charrierauthor=S.+J.+Durrantauthor=J.+M.+Golecauthor=D.+P.+Kayauthor=R.+M.+Knegtelauthor=S.+MacCormickauthor=M.+Mortimoreauthor=M.+E.+O%E2%80%99Donnellauthor=J.+L.+Pinderauthor=P.+M.+Reaperauthor=A.+P.+Rutherfordauthor=P.+S.+Wangauthor=S.+C.+Youngauthor=J.+R.+Pollard&title=Discovery+of+potent+and+selective+inhibitors+of+ataxia+telangiectasia+mutated+and+Rad3+related+%28ATR%29+protein+kinase+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents</span></div><div class="casAuthors">Charrier, Jean-Damien; Durrant, Steven J.; Golec, Julian M. C.; Kay, David P.; Knegtel, Ronald M. A.; MacCormick, Somhairle; Mortimore, Michael; O'Donnell, Michael E.; Pinder, Joanne L.; Reaper, Philip M.; Rutherford, Alistair P.; Wang, Paul S. H.; Young, Stephen C.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2320-2330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DNA-damaging agents are among the most frequently used anticancer drugs.  However, they provide only modest benefit in most cancers.  This may be attributed to a genome maintenance network, the DNA damage response (DDR), that recognizes and repairs damaged DNA.  ATR is a major regulator of the DDR and an attractive anticancer target.  Herein, we describe the discovery of a series of aminopyrazines with potent and selective ATR inhibition.  Compd. (I) inhibits ATR with a Ki of 6 nM, shows >600-fold selectivity over related kinases ATM or DNA-PK, and blocks ATR signaling in cells with an IC50 of 0.42 μM.  Using I, here it is shown that ATR inhibition markedly enhances death induced by DNA-damaging agents in certain cancers but not normal cells.  This differential response between cancer and normal cells highlights the great potential for ATR inhibition as a novel mechanism to dramatically increase the efficacy of many established drugs and ionizing radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp56O6NNQ8JNbVg90H21EOLACvtfcHk0lg7e3kdtikTuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCksbc%253D&md5=4f17e7c44fc6c7bdc32886e3415722c8</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm101488z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101488z%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DMacCormick%26aufirst%3DS.%26aulast%3DMortimore%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BE.%26aulast%3DPinder%26aufirst%3DJ.%2BL.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DRutherford%26aufirst%3DA.%2BP.%26aulast%3DWang%26aufirst%3DP.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BC.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ataxia%2520telangiectasia%2520mutated%2520and%2520Rad3%2520related%2520%2528ATR%2529%2520protein%2520kinase%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2320%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charrier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCormick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnchembio.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21490603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=428-430&author=P.+M.+Reaperauthor=M.+R.+Griffithsauthor=J.+M.+Longauthor=J.+D.+Charrierauthor=S.+MacCormickauthor=P.+A.+Charltonauthor=J.+M.+Golecauthor=J.+R.+Pollard&title=Selective+killing+of+ATM-+or+p53-deficient+cancer+cells+through+inhibition+of+ATR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR</span></div><div class="casAuthors">Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">428-430</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we report a comprehensive biol. characterization of a potent and selective small-mol. inhibitor of the DNA damage response (DDR) kinase ATR.  We show a profound synthetic lethal interaction between ATR and the ATM-p53 tumor suppressor pathway in cells treated with DNA-damaging agents and establish ATR inhibition as a way to transform the outcome for patients with cancer treated with ionizing radiation or genotoxic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRYth09UxMbVg90H21EOLACvtfcHk0lg7e3kdtikTuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1agtrs%253D&md5=58c63122b550b1ca5e9064c4bbf3d68f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.573%26sid%3Dliteratum%253Aachs%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DGriffiths%26aufirst%3DM.%2BR.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DMacCormick%26aufirst%3DS.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DSelective%2520killing%2520of%2520ATM-%2520or%2520p53-deficient%2520cancer%2520cells%2520through%2520inhibition%2520of%2520ATR%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D428%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Fokas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillies, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, T. B.</span><span> </span><span class="NLM_article-title">Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fcddis.2012.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23222511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e441&author=E.+Fokasauthor=R.+Prevoauthor=J.+R.+Pollardauthor=P.+M.+Reaperauthor=P.+A.+Charltonauthor=B.+Cornelissenauthor=K.+A.+Vallisauthor=E.+M.+Hammondauthor=M.+M.+Olcinaauthor=M.+W.+Gilliesauthor=R.+J.+Muschelauthor=T.+B.+Brunner&title=Targeting+ATR+in+vivo+using+the+novel+inhibitor+VE-822+results+in+selective+sensitization+of+pancreatic+tumors+to+radiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation</span></div><div class="casAuthors">Fokas, E.; Prevo, R.; Pollard, J. R.; Reaper, P. M.; Charlton, P. A.; Cornelissen, B.; Vallis, K. A.; Hammond, E. M.; Olcina, M. M.; McKenna, W. Gillies; Muschel, R. J.; Brunner, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e441, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Combined radiochemotherapy is the currently used therapy for locally advanced pancreatic ductal adenocarcinoma (PDAC), but normal tissue toxicity limits its application.  Here we test the hypothesis that inhibition of ATR (ATM-Rad3-related) could increase the sensitivity of the cancer cells to radiation or chemotherapy without affecting normal cells.  We tested VE-822, an ATR inhibitor, for in vitro and in vivo radiosensitization.  Chk1 phosphorylation was used to indicate ATR activity, γH2AX and 53BP1 foci as evidence of DNA damage and Rad51 foci for homologous recombination activity.  Sensitivity to radiation (XRT) and gemcitabine was measured with clonogenic assays in vitro and tumor growth delay in vivo.  Murine intestinal damage was evaluated after abdominal XRT.  VE-822 inhibited ATR in vitro and in vivo.  VE-822 decreased maintenance of cell-cycle checkpoints, increased persistent DNA damage and decreased homologous recombination in irradiated cancer cells.  VE-822 decreased survival of pancreatic cancer cells but not normal cells in response to XRT or gemcitabine.  VE-822 markedly prolonged growth delay of pancreatic cancer xenografts after XRT and gemcitabine-based chemoradiation without augmenting normal cell or tissue toxicity.  These findings support ATR inhibition as a promising new approach to improve the therapeutic ration of radiochemotherapy for patients with PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp66nE6ZdMorVg90H21EOLACvtfcHk0lg3OryjURcSVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWnsA%253D%253D&md5=7223df6ec5dbca8c50889b5df8e4cce6</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.181%26sid%3Dliteratum%253Aachs%26aulast%3DFokas%26aufirst%3DE.%26aulast%3DPrevo%26aufirst%3DR.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DCornelissen%26aufirst%3DB.%26aulast%3DVallis%26aufirst%3DK.%2BA.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DGillies%26aufirst%3DM.%2BW.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DBrunner%26aufirst%3DT.%2BB.%26atitle%3DTargeting%2520ATR%2520in%2520vivo%2520using%2520the%2520novel%2520inhibitor%2520VE-822%2520results%2520in%2520selective%2520sensitization%2520of%2520pancreatic%2520tumors%2520to%2520radiation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Stracker, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrini, J. H.</span><span> </span><span class="NLM_article-title">Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1047-1054&author=T.+H.+Strackerauthor=T.+Usuiauthor=J.+H.+Petrini&title=Taking+the+time+to+make+important+decisions%3A+the+checkpoint+effector+kinases+Chk1+and+Chk2+and+the+DNA+damage+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStracker%26aufirst%3DT.%2BH.%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DPetrini%26aufirst%3DJ.%2BH.%26atitle%3DTaking%2520the%2520time%2520to%2520make%2520important%2520decisions%253A%2520the%2520checkpoint%2520effector%2520kinases%2520Chk1%2520and%2520Chk2%2520and%2520the%2520DNA%2520damage%2520response%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D1047%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Ferrao, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukczynska, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span> </span><span class="NLM_article-title">Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1661-1672&author=P.+T.+Ferraoauthor=E.+P.+Bukczynskaauthor=R.+W.+Johnstoneauthor=G.+A.+McArthur&title=Efficacy+of+CHK+inhibitors+as+single+agents+in+MYC-driven+lymphoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrao%26aufirst%3DP.%2BT.%26aulast%3DBukczynska%26aufirst%3DE.%2BP.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26atitle%3DEfficacy%2520of%2520CHK%2520inhibitors%2520as%2520single%2520agents%2520in%2520MYC-driven%2520lymphoma%2520cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1661%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Landau, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeely, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comenzo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhanwar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-11-0949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22653969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1781-1788&author=H.+J.+Landauauthor=S.+C.+McNeelyauthor=J.+S.+Nairauthor=R.+L.+Comenzoauthor=T.+Asaiauthor=H.+Friedmanauthor=S.+C.+Jhanwarauthor=S.+D.+Nimerauthor=G.+K.+Schwartz&title=The+checkpoint+kinase+inhibitor+AZD7762+potentiates+chemotherapy-induced+apoptosis+of+p53-mutated+multiple+myeloma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53-Mutated Multiple Myeloma Cells</span></div><div class="casAuthors">Landau, Heather J.; McNeely, Samuel C.; Nair, Jayasree S.; Comenzo, Raymond L.; Asai, Takashi; Friedman, Hillel; Jhanwar, Suresh C.; Nimer, Stephen D.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1781-1788</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">DNA crosslinking agents are frequently used in the treatment of multiple myeloma-generating lesions, which activate checkpoint kinase 1 (Chk1), a crit. transducer of the DNA damage response.  Chk1 activation promotes cell survival by regulating cell-cycle arrest and DNA repair following genotoxic stress.  The ability of AZD7762, an ATP-competitive Chk1/2 inhibitor to increase the efficacy of the DNA-damaging agents bendamustine, melphalan, and doxorubicin was examd. using four human myeloma cell lines, KMS-12-BM, KMS-12-PE, RPMI-8226, and U266B1.  The in vitro activity of AZD7762 as monotherapy and combined with alkylating agents and the "novel" drug bortezomib was evaluated by studying its effects on cytotoxicity, signaling, and apoptotic pathways.  The Chk1/2 inhibitor AZD7762 potentiated the antiproliferative effects of bendamustine, melphalan, and doxorubicin but not bortezomib in multiple myeloma cell lines that were p53-deficient.  Increased γH2AX staining in cells treated with bendamustine or melphalan plus AZD7762 indicates a greater degree of DNA damage with combined therapy.  Abrogation of the G2-M checkpoint by AZD7762 resulted in mitotic catastrophe with ensuing apoptosis evidenced by PARP and caspase-3 cleavage.  In summary, the cytotoxic effects of bendamustine, melphalan and doxorubicin on p53-deficient multiple myeloma cell lines were enhanced by the coadministration of AZD7762.  These data provide a rationale for testing these combinations in patients with relapsed and/or refractory multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphppiytZoas7Vg90H21EOLACvtfcHk0lg3OryjURcSVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisLrP&md5=349ec19d319f74ffca2414c2ebd8a9f9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0949%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DH.%2BJ.%26aulast%3DMcNeely%26aufirst%3DS.%2BC.%26aulast%3DNair%26aufirst%3DJ.%2BS.%26aulast%3DComenzo%26aufirst%3DR.%2BL.%26aulast%3DAsai%26aufirst%3DT.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DJhanwar%26aufirst%3DS.%2BC.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DThe%2520checkpoint%2520kinase%2520inhibitor%2520AZD7762%2520potentiates%2520chemotherapy-induced%2520apoptosis%2520of%2520p53-mutated%2520multiple%2520myeloma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1781%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Origanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munir, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=577-588&author=S.+Origantiauthor=S.+R.+Caiauthor=A.+Z.+Munirauthor=L.+S.+Whiteauthor=H.+Piwnica-Worms&title=Synthetic+lethality+of+Chk1+inhibition+combined+with+p53+and%2For+p21+loss+during+a+DNA+damage+response+in+normal+and+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOriganti%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BR.%26aulast%3DMunir%26aufirst%3DA.%2BZ.%26aulast%3DWhite%26aufirst%3DL.%2BS.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DSynthetic%2520lethality%2520of%2520Chk1%2520inhibition%2520combined%2520with%2520p53%2520and%252For%2520p21%2520loss%2520during%2520a%2520DNA%2520damage%2520response%2520in%2520normal%2520and%2520tumor%2520cells%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D577%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugarajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylander-Gans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normolle, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maybaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, T. S.</span><span> </span><span class="NLM_article-title">Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">4972</span><span class="NLM_x">–</span> <span class="NLM_lpage">4981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=4972-4981&author=M.+A.+Morganauthor=L.+A.+Parselsauthor=L.+Zhaoauthor=J.+D.+Parselsauthor=M.+A.+Davisauthor=M.+C.+Hassanauthor=S.+Arumugarajahauthor=L.+Hylander-Gansauthor=D.+Morosiniauthor=D.+M.+Simeoneauthor=C.+E.+Canmanauthor=D.+P.+Normolleauthor=S.+D.+Zabludoffauthor=J.+Maybaumauthor=T.+S.+Lawrence&title=Mechanism+of+radiosensitization+by+the+Chk1%2F2+inhibitor+AZD7762+involves+abrogation+of+the+G2+checkpoint+and+inhibition+of+homologous+recombinational+DNA+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DParsels%26aufirst%3DJ.%2BD.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DHassan%26aufirst%3DM.%2BC.%26aulast%3DArumugarajah%26aufirst%3DS.%26aulast%3DHylander-Gans%26aufirst%3DL.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26aulast%3DCanman%26aufirst%3DC.%2BE.%26aulast%3DNormolle%26aufirst%3DD.%2BP.%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DMaybaum%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26atitle%3DMechanism%2520of%2520radiosensitization%2520by%2520the%2520Chk1%252F2%2520inhibitor%2520AZD7762%2520involves%2520abrogation%2520of%2520the%2520G2%2520checkpoint%2520and%2520inhibition%2520of%2520homologous%2520recombinational%2520DNA%2520repair%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D4972%26epage%3D4981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">DNA damage-induced activation of p53 by the checkpoint kinase Chk2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1824</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1824-1827&author=A.+Hiraoauthor=Y.+Y.+Kongauthor=S.+Matsuokaauthor=A.+Wakehamauthor=J.+Rulandauthor=H.+Yoshidaauthor=D.+Liuauthor=S.+J.+Elledgeauthor=T.+W.+Mak&title=DNA+damage-induced+activation+of+p53+by+the+checkpoint+kinase+Chk2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%2BY.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DDNA%2520damage-induced%2520activation%2520of%2520p53%2520by%2520the%2520checkpoint%2520kinase%2520Chk2%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1824%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carattini-Rivera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMayo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donehower, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=1448-1459&author=Q.+Liuauthor=S.+Guntukuauthor=X.+S.+Cuiauthor=S.+Matsuokaauthor=D.+Cortezauthor=K.+Tamaiauthor=G.+Luoauthor=S.+Carattini-Riveraauthor=F.+DeMayoauthor=A.+Bradleyauthor=L.+A.+Donehowerauthor=S.+J.+Elledge&title=Chk1+is+an+essential+kinase+that+is+regulated+by+Atr+and+required+for+the+G%282%29%2FM+DNA+damage+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGuntuku%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DX.%2BS.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DCortez%26aufirst%3DD.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DCarattini-Rivera%26aufirst%3DS.%26aulast%3DDeMayo%26aufirst%3DF.%26aulast%3DBradley%26aufirst%3DA.%26aulast%3DDonehower%26aufirst%3DL.%2BA.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DChk1%2520is%2520an%2520essential%2520kinase%2520that%2520is%2520regulated%2520by%2520Atr%2520and%2520required%2520for%2520the%2520G%25282%2529%252FM%2520DNA%2520damage%2520checkpoint%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D1448%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainerd, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltimore, D.</span><span> </span><span class="NLM_article-title">Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=2411-2422&author=Y.+Xuauthor=T.+Ashleyauthor=E.+E.+Brainerdauthor=R.+T.+Bronsonauthor=M.+S.+Meynauthor=D.+Baltimore&title=Targeted+disruption+of+ATM+leads+to+growth+retardation%2C+chromosomal+fragmentation+during+meiosis%2C+immune+defects%2C+and+thymic+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAshley%26aufirst%3DT.%26aulast%3DBrainerd%26aufirst%3DE.%2BE.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DMeyn%26aufirst%3DM.%2BS.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DTargeted%2520disruption%2520of%2520ATM%2520leads%2520to%2520growth%2520retardation%252C%2520chromosomal%2520fragmentation%2520during%2520meiosis%252C%2520immune%2520defects%252C%2520and%2520thymic%2520lymphoma%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Takai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoyama, N.</span><span> </span><span class="NLM_article-title">Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5195</span><span class="NLM_x">–</span> <span class="NLM_lpage">5205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=5195-5205&author=H.+Takaiauthor=K.+Nakaauthor=Y.+Okadaauthor=M.+Watanabeauthor=N.+Haradaauthor=S.+Saitoauthor=C.+W.+Andersonauthor=E.+Appellaauthor=M.+Nakanishiauthor=H.+Suzukiauthor=K.+Nagashimaauthor=H.+Sawaauthor=K.+Ikedaauthor=N.+Motoyama&title=Chk2-deficient+mice+exhibit+radioresistance+and+defective+p53-mediated+transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DH.%26aulast%3DNaka%26aufirst%3DK.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DNakanishi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DSawa%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DMotoyama%26aufirst%3DN.%26atitle%3DChk2-deficient%2520mice%2520exhibit%2520radioresistance%2520and%2520defective%2520p53-mediated%2520transcription%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D5195%26epage%3D5205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Brown, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltimore, D.</span><span> </span><span class="NLM_article-title">ATR disruption leads to chromosomal fragmentation and early embryonic lethality</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=397-402&author=E.+J.+Brownauthor=D.+Baltimore&title=ATR+disruption+leads+to+chromosomal+fragmentation+and+early+embryonic+lethality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BJ.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DATR%2520disruption%2520leads%2520to%2520chromosomal%2520fragmentation%2520and%2520early%2520embryonic%2520lethality%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D397%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Azorsa, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisanz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousses, S.</span><span> </span><span class="NLM_article-title">Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1479-5876-7-43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19519883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvkvVersg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=43&author=D.+O.+Azorsaauthor=I.+M.+Gonzalesauthor=G.+D.+Basuauthor=A.+Choudharyauthor=S.+Aroraauthor=K.+M.+Bisanzauthor=J.+A.+Kieferauthor=M.+C.+Hendersonauthor=J.+M.+Trentauthor=D.+D.+Von+Hoffauthor=S.+Mousses&title=Synthetic+lethal+RNAi+screening+identifies+sensitizing+targets+for+gemcitabine+therapy+in+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer</span></div><div class="casAuthors">Azorsa David O; Gonzales Irma M; Basu Gargi D; Choudhary Ashish; Arora Shilpi; Bisanz Kristen M; Kiefer Jeffrey A; Henderson Meredith C; Trent Jeffrey M; Von Hoff Daniel D; Mousses Spyro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer retains a poor prognosis among the gastrointestinal cancers.  It affects 230,000 individuals worldwide, has a very high mortality rate, and remains one of the most challenging malignancies to treat successfully.  Treatment with gemcitabine, the most widely used chemotherapeutic against pancreatic cancer, is not curative and resistance may occur.  Combinations of gemcitabine with other chemotherapeutic drugs or biological agents have resulted in limited improvement.  METHODS:  In order to improve gemcitabine response in pancreatic cancer cells, we utilized a synthetic lethal RNAi screen targeting 572 known kinases to identify genes that when silenced would sensitize pancreatic cancer cells to gemcitabine.  RESULTS:  Results from the RNAi screens identified several genes that, when silenced, potentiated the growth inhibitory effects of gemcitabine in pancreatic cancer cells.  The greatest potentiation was shown by siRNA targeting checkpoint kinase 1 (CHK1).  Validation of the screening results was performed in MIA PaCa-2 and BxPC3 pancreatic cancer cells by examining the dose response of gemcitabine treatment in the presence of either CHK1 or CHK2 siRNA.  These results showed a three to ten-fold decrease in the EC50 for CHK1 siRNA-treated cells versus control siRNA-treated cells while treatment with CHK2 siRNA resulted in no change compared to controls.  CHK1 was further targeted with specific small molecule inhibitors SB 218078 and PD 407824 in combination with gemcitabine.  Results showed that treatment of MIA PaCa-2 cells with either of the CHK1 inhibitors SB 218078 or PD 407824 led to sensitization of the pancreatic cancer cells to gemcitabine.  CONCLUSION:  These findings demonstrate the effectiveness of synthetic lethal RNAi screening as a tool for identifying sensitizing targets to chemotherapeutic agents.  These results also indicate that CHK1 could serve as a putative therapeutic target for sensitizing pancreatic cancer cells to gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSewyviITeFf7BItaL1WaVAfW6udTcc2ebqIjXL5l_h-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvkvVersg%253D%253D&md5=400b6eb75a8ee86d3376a056e57a6df5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-7-43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-7-43%26sid%3Dliteratum%253Aachs%26aulast%3DAzorsa%26aufirst%3DD.%2BO.%26aulast%3DGonzales%26aufirst%3DI.%2BM.%26aulast%3DBasu%26aufirst%3DG.%2BD.%26aulast%3DChoudhary%26aufirst%3DA.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBisanz%26aufirst%3DK.%2BM.%26aulast%3DKiefer%26aufirst%3DJ.%2BA.%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DMousses%26aufirst%3DS.%26atitle%3DSynthetic%2520lethal%2520RNAi%2520screening%2520identifies%2520sensitizing%2520targets%2520for%2520gemcitabine%2520therapy%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2009%26volume%3D7%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Seto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span> </span><span class="NLM_article-title">Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1007%2Fs00280-013-2234-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23892959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2013&pages=619-627&author=T.+Setoauthor=T.+Esakiauthor=F.+Hiraiauthor=S.+Aritaauthor=K.+Nosakiauthor=A.+Makiyamaauthor=T.+Kometaniauthor=C.+Fujimotoauthor=M.+Hamatakeauthor=H.+Takeokaauthor=F.+Agboauthor=X.+Shi&title=Phase+I%2C+dose-escalation+study+of+AZD7762+alone+and+in+combination+with+gemcitabine+in+Japanese+patients+with+advanced+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours</span></div><div class="casAuthors">Seto, Takashi; Esaki, Taito; Hirai, Fumihiko; Arita, Shuji; Nosaki, Kaname; Makiyama, Akitaka; Kometani, Takuro; Fujimoto, Chinatsu; Hamatake, Motoharu; Takeoka, Hiroaki; Agbo, Felix; Shi, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: AZD7762, a potent Chk1/Chk2 inhibitor, has shown chemosensitizing activity with gemcitabine in xenograft models.  Methods: This open-label, Phase I, dose-escalation study evaluated the safety, pharmacokinetics (PK) and preliminary efficacy (RECIST) of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumors (NCT00937664).  Patients received i.v. AZD7762 alone on days 1 and 8 of a 14-day cycle (cycle 0), followed by AZD7762 plus gemcitabine 1,000 mg/m2 on days 1 and 8 of 22-day cycles, in ascending AZD7762 dose cohorts.  Results: Twenty patients received AZD7762 at doses of 6 mg (n = 3), 9 mg (n = 3), 21 mg (n = 6) and 30 mg (n = 8).  Dose-limiting toxicities occurred in 2/6 evaluable patients in the 30-mg cohort: one, CTCAE grade 3 elevated troponin T (cycle 0: AZD7762 monotherapy); one, neutropenia, thrombocytopenia, and elevated aspartate aminotransferase and alanine aminotransferase (cycle 1: combination therapy).  The 30 mg dose was therefore regarded as non-tolerable.  The most common adverse events (AEs) in cycle 0 (AZD7762 monotherapy) were bradycardia (50 %), hypertension (25 %) and fatigue (15 %).  Overall, the most common AEs were bradycardia (55 %), neutropenia (45 %) and hypertension, fatigue and rash (30 % each).  Grade ≥3 AEs were reported in 11 patients, the most common being neutropenia (45 %) and leukopenia (25 %).  AZD7762 exposure increased approx. linearly.  Gemcitabine did not appear to affect AZD7762 PK.  There were no objective responses; five patients (all lung cancer) had stable disease.  Conclusions: The max. tolerated dose of AZD7762 in combination with gemcitabine, 1,000 mg/m2 was detd. as 21 mg in Japanese patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWxvmjbQe4HbVg90H21EOLACvtfcHk0lj_m4wdvpT5Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOrtbnJ&md5=249621625eab6c9d7e0a85d4f4f47977</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1007%2Fs00280-013-2234-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-013-2234-6%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DT.%26aulast%3DEsaki%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DF.%26aulast%3DArita%26aufirst%3DS.%26aulast%3DNosaki%26aufirst%3DK.%26aulast%3DMakiyama%26aufirst%3DA.%26aulast%3DKometani%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DC.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DTakeoka%26aufirst%3DH.%26aulast%3DAgbo%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DX.%26atitle%3DPhase%2520I%252C%2520dose-escalation%2520study%2520of%2520AZD7762%2520alone%2520and%2520in%2520combination%2520with%2520gemcitabine%2520in%2520Japanese%2520patients%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D72%26spage%3D619%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worland, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P. M.</span><span> </span><span class="NLM_article-title">UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1093%2Fjnci%2F88.14.956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=8667426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK28XkvV2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1996&pages=956-965&author=Q.+Wangauthor=S.+Fanauthor=A.+Eastmanauthor=P.+J.+Worlandauthor=E.+A.+Sausvilleauthor=P.+M.+O%E2%80%99Connor&title=UCN-01%3A+a+potent+abrogator+of+G2+checkpoint+function+in+cancer+cells+with+disrupted+p53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01: A potent abrogator of G2 checkpoint function in cancer cells with disrupted p53</span></div><div class="casAuthors">Wang, Qizhi; Fan, Saijun; Eastman, Alan; Worland, Peter J.; Sausville, Edward A.; O'Connor, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">956-965</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">National Cancer Institute</span>)
        </div><div class="casAbstract">Arrest of the cell cycle in G2 phase following DNA damage helps protect cell viability by allowing time for DNA repair before entry into mitosis (M phase).  Abrogation of G2 arrest sensitizes cells to the effects of DNA-damaging agents.  UCN-01 (7-hydroxystaurosporine), a protein kinase C inhibitor that may block G2 checkpoint regulation, has been reported to enhance the cytotoxicity of mitomycin C, a known DNA-damaging agent.  We studied the effect of UCN-01 on G2 checkpoint control in human lymphoma CA46 cells, whose sensitivity to various DNA-damaging agents and G2 response to DNA damage have been characterized.  We also assessed the ability of UCN-01 to enhance the cytotoxicity of γ irradn. in CA46 cells and human colon carcinoma HT-29 cells, both of which are mutant for p53 function.  The influence of p53 function on UCN-01-mediated abrogation of the G2 checkpoint and enhancement of DNA-damaging agent cytotoxicity was studied, in transfected human breast carcinoma MCF-7 cells that either expressed or did not express the human papillomavirus type-16 E6 protein.  MCF-7 cells have normal p53 function, and the E6 protein binds p53 protein and promotes its destruction.  The effect of UCN-01 on cell cycle arrest induced by γ irradn. was studied in CA46 cells and in transfected MCF-7 cells by use of flow cytometry.  A histone H1 phosphorylation assay was employed to measure cyclin B1/Cdc2 kinase activity in exts. derived from irradiated and nonirradiated CA46 cells that had been either treated or not treated with UCN-01; the phosphorylation status of Cdc2 kinase protein in the same exts. was detd. by use of western blotting.  The effect of UCN-01 on the cytotoxicity of γ irradn. in CA46 and HT-29 cells was detd. by use of MTT (thiazolyl blue) and clonogenic (colony-forming) assays, resp.; a clonogenic assay was also used to measure the effect of UCN-01 on the cytotoxicity of cisplatin in transfected and nontransfected MCF-7 cells.  G2 arrest induced in CA46 cells by γ irradn. was inhibited by treatment with UCN-01 in a dose-dependent manner; arrest in G2 was completely abrogated by exposure to 300 nM UCN-01.  Biochem. markers indicative of the G2/M transition, including the activation of cyclin B1/Cdc2 kinase and the suppression of Cdc2 threonine-14 and tyrosine-15 phosphorylation, were detected in irradiated cells treated with UCN-01.  UCN-01 enhanced the cytotoxicity of γ irradn. in CA46 and HT-29 cells.  MCF-7 cells with functional p53 protein were more resistant to G2 checkpoint abrogation by UCN-01 than MCF-7 cells with disrupted p53 function.  UCN-01 markedly enhanced the cell-killing activity of cisplatin in MCF-7 cells defective for p53 function.  UCN-01 is a potent abrogator of G2 checkpoint control in cancer cells with disrupted p53 function.  UCN-01 might be capable of enhancing the effectiveness of DNA-damaging agents in the treatment of tumors with cells lacking normal p53 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqxwzeE4ynrVg90H21EOLACvtfcHk0lhaIbwG1cTdsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvV2qt7g%253D&md5=9bfd08779e874cfb0f8b5429d2420e77</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F88.14.956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F88.14.956%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DEastman%26aufirst%3DA.%26aulast%3DWorland%26aufirst%3DP.%2BJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DUCN-01%253A%2520a%2520potent%2520abrogator%2520of%2520G2%2520checkpoint%2520function%2520in%2520cancer%2520cells%2520with%2520disrupted%2520p53%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1996%26volume%3D88%26spage%3D956%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Gojo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norsworthy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1217-1227&author=I.+Gojoauthor=A.+Perlauthor=S.+Lugerauthor=M.+R.+Baerauthor=K.+J.+Norsworthyauthor=K.+S.+Bauerauthor=M.+Tidwellauthor=S.+Fleckingerauthor=M.+Carrollauthor=E.+A.+Sausville&title=Phase+I+study+of+UCN-01+and+perifosine+in+patients+with+relapsed+and+refractory+acute+leukemias+and+high-risk+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGojo%26aufirst%3DI.%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DLuger%26aufirst%3DS.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DBauer%26aufirst%3DK.%2BS.%26aulast%3DTidwell%26aufirst%3DM.%26aulast%3DFleckinger%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DPhase%2520I%2520study%2520of%2520UCN-01%2520and%2520perifosine%2520in%2520patients%2520with%2520relapsed%2520and%2520refractory%2520acute%2520leukemias%2520and%2520high-risk%2520myelodysplastic%2520syndrome%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwala, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandara, D. R.</span><span> </span><span class="NLM_article-title">A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=741-748&author=T.+Liauthor=S.+D.+Christensenauthor=P.+H.+Frankelauthor=K.+A.+Margolinauthor=S.+S.+Agarwalaauthor=T.+Luuauthor=P.+C.+Mackauthor=P.+N.+Laraauthor=D.+R.+Gandara&title=A+phase+II+study+of+cell+cycle+inhibitor+UCN-01+in+patients+with+metastatic+melanoma%3A+a+California+Cancer+Consortium+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DS.%2BD.%26aulast%3DFrankel%26aufirst%3DP.%2BH.%26aulast%3DMargolin%26aufirst%3DK.%2BA.%26aulast%3DAgarwala%26aufirst%3DS.%2BS.%26aulast%3DLuu%26aufirst%3DT.%26aulast%3DMack%26aufirst%3DP.%2BC.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DGandara%26aufirst%3DD.%2BR.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520cell%2520cycle%2520inhibitor%2520UCN-01%2520in%2520patients%2520with%2520metastatic%2520melanoma%253A%2520a%2520California%2520Cancer%2520Consortium%2520trial%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D741%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taricani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penaflor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-10-0928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21321066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=591-602&author=T.+J.+Guziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=M.+Labroliauthor=F.+Shanahanauthor=N.+Davisauthor=L.+Taricaniauthor=D.+Wiswellauthor=W.+Seghezziauthor=E.+Penaflorauthor=B.+Bhagwatauthor=W.+Wangauthor=D.+Guauthor=Y.+Hsiehauthor=S.+Leeauthor=M.+Liuauthor=D.+Parry&title=Targeting+the+replication+checkpoint+using+SCH+900776%2C+a+potent+and+functionally+selective+CHK1+inhibitor+identified+via+high+content+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening</span></div><div class="casAuthors">Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Labroli, Marc; Shanahan, Frances; Davis, Nicole; Taricani, Lorena; Wiswell, Derek; Seghezzi, Wolfgang; Penaflor, Ervin; Bhagwat, Bhagyashree; Wang, Wei; Gu, Danling; Hsieh, Yunsheng; Lee, Suining; Liu, Ming; Parry, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (CHK1) is an essential serine/threonine kinase that responds to DNA damage and stalled DNA replication.  CHK1 is essential for maintenance of replication fork viability during exposure to DNA antimetabolites.  In human tumor cell lines, ablation of CHK1 function during antimetabolite exposure led to accumulation of double-strand DNA breaks and cell death.  Here, we extend these observations and confirm ablation of CHK2 does not contribute to these phenotypes and may diminish them.  Furthermore, concomitant suppression of cyclin-dependent kinase (CDK) activity is sufficient to completely antagonize the desired CHK1 ablation phenotypes.  These mechanism-based observations prompted the development of a high-content, cell-based screen for γ-H2AX induction, a surrogate marker for double-strand DNA breaks.  This mechanism-based functional approach was used to optimize small mol. inhibitors of CHK1.  Specifically, the assay was used to mechanistically define the optimal in-cell profile with compds. exhibiting varying degrees of CHK1, CHK2, and CDK selectivity.  Using this approach, SCH 900776 was identified as a highly potent and functionally optimal CHK1 inhibitor with minimal intrinsic antagonistic properties.  SCH 900776 exposure phenocopies short interfering RNA-mediated CHK1 ablation and interacts synergistically with DNA antimetabolite agents in vitro and in vivo to selectively induce dsDNA breaks and cell death in tumor cell backgrounds.  Mol Cancer Ther; 10(4); 591-602.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_DnP2RPokHLVg90H21EOLACvtfcHk0lhaIbwG1cTdsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D&md5=884137ebd69d0959b583a6338a89b87a</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0928%26sid%3Dliteratum%253Aachs%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DPenaflor%26aufirst%3DE.%26aulast%3DBhagwat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520using%2520SCH%2520900776%252C%2520a%2520potent%2520and%2520functionally%2520selective%2520CHK1%2520inhibitor%2520identified%2520via%2520high%2520content%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisanz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peralta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azorsa, D. O.</span><span> </span><span class="NLM_article-title">RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.ygyno.2010.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20722101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=220-227&author=S.+Aroraauthor=K.+M.+Bisanzauthor=L.+A.+Peraltaauthor=G.+D.+Basuauthor=A.+Choudharyauthor=R.+Tibesauthor=D.+O.+Azorsa&title=RNAi+screening+of+the+kinome+identifies+modulators+of+cisplatin+response+in+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells</span></div><div class="casAuthors">Arora, Shilpi; Bisanz, Kristen M.; Peralta, Lourdes A.; Basu, Gargi D.; Choudhary, Ashish; Tibes, Raoul; Azorsa, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objective: Ovarian cancer retains a poor prognosis among the female gynaecol. malignancies.  It constitutes about 3% of all malignancies in women and accounts for 5% of all female cancer related deaths.  A std. treatment is cytoreductive surgery followed by adjuvant chemotherapy, and re-treatment with platinum based chemotherapy at the time of relapse.  In order to improve cisplatin response in ovarian cancer cells, we utilized a high-throughput RNAi screening to identify kinase modulators.  Methods: A high-throughput RNAi screen was performed using a siRNA library targeting 572 kinases to identify potentiators of cisplatin response in the ovarian cancer cell line SKOV3.  Results: RNAi screening identified at least 55 siRNAs that potentiated the growth inhibitory effects of cisplatin in SKOV3 cells.  Inhibition of ATR and CHK1 resulted in the greatest modulation of cisplatin response.  Drug dose response of cisplatin in the presence of siRNA validated the effects of these target genes.  To show that the siRNA data could be successfully translated into potential therapeutic strategies, CHK1 was further targeted with small mol. inhibitor PD 407824 in combination with cisplatin.  Results showed that treatment of SKOV3 and OVCAR3 cells with CHK1 inhibitor PD 407824 led to sensitization of ovarian cancer cells to cisplatin.  Conclusions: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients.  We also demonstrate the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIt3Fi8as5FrVg90H21EOLACvtfcHk0lgTuO48aQNa8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFWltrc%253D&md5=f965ffe1e3f99395f437048b0a2d4bdb</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2010.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2010.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBisanz%26aufirst%3DK.%2BM.%26aulast%3DPeralta%26aufirst%3DL.%2BA.%26aulast%3DBasu%26aufirst%3DG.%2BD.%26aulast%3DChoudhary%26aufirst%3DA.%26aulast%3DTibes%26aufirst%3DR.%26aulast%3DAzorsa%26aufirst%3DD.%2BO.%26atitle%3DRNAi%2520screening%2520of%2520the%2520kinome%2520identifies%2520modulators%2520of%2520cisplatin%2520response%2520in%2520ovarian%2520cancer%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2010%26volume%3D118%26spage%3D220%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Karp, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatten, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freshwater, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraway, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladstone, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showel, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loechner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span> </span><span class="NLM_article-title">Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6723</span><span class="NLM_x">–</span> <span class="NLM_lpage">6731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-12-2442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23092873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6723-6731&author=J.+E.+Karpauthor=B.+M.+Thomasauthor=J.+M.+Greerauthor=C.+Sorgeauthor=S.+D.+Goreauthor=K.+W.+Pratzauthor=B.+D.+Smithauthor=K.+S.+Flattenauthor=K.+Petersonauthor=P.+Schneiderauthor=K.+Mackeyauthor=T.+Freshwaterauthor=M.+J.+Levisauthor=M.+A.+McDevittauthor=H.+E.+Carrawayauthor=D.+E.+Gladstoneauthor=M.+M.+Showelauthor=S.+Loechnerauthor=D.+A.+Parryauthor=J.+A.+Horowitzauthor=R.+Isaacsauthor=S.+H.+Kaufmann&title=Phase+I+and+pharmacologic+trial+of+cytosine+arabinoside+with+the+selective+checkpoint+1+inhibitor+Sch+900776+in+refractory+acute+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias</span></div><div class="casAuthors">Karp, Judith E.; Thomas, Brian M.; Greer, Jacqueline M.; Sorge, Christopher; Gore, Steven D.; Pratz, Keith W.; Smith, B. Douglas; Flatten, Karen S.; Peterson, Kevin; Schneider, Paula; Mackey, Karen; Freshwater, Tomoko; Levis, Mark J.; McDevitt, Michael A.; Carraway, Hetty E.; Gladstone, Douglas E.; Showel, Margaret M.; Loechner, Sabine; Parry, David A.; Horowitz, Jo Ann; Isaacs, Randi; Kaufmann, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6723-6731</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Incorporation of cytarabine into DNA activates checkpoint kinase 1 (Chk1), which stabilizes stalled replication forks, induces S-phase slowing, and diminishes cytarabine cytotoxicity.  The selective Chk1 inhibitor SCH 900776 abrogates cytarabine-induced S-phase arrest and enhances cytarabine cytotoxicity in acute leukemia cell lines and leukemic blasts in vitro.  To extend these findings to the clin. setting, we have conducted a phase I study of cytarabine and SCH 900776.  Exptl. Design: Twenty-four adults with relapsed and refractory acute leukemias received timed sequential, continuous infusion cytarabine 2 g/m2 over 72 h (667 mg/m2/24 h) beginning on day 1 and again on day 10.  SCH 900776 was administered as a 15- to 30-min infusion on days 2, 3, 11, and 12.  The starting dose of SCH 900776 was 10 mg/m2/dose.  Results: Dose-limiting toxicities consisting of cor. QT interval prolongation and grade 3 palmar-plantar erythrodysesthesia occurred at 140 mg flat dosing (dose level 5, equiv. to 80 mg/m2).  Complete remissions occurred in 8 of 24 (33%) patients, with 7 of 8 at 40 mg/m2 or higher.  SCH 900776 did not accumulate at any dose level.  Marrow blasts obtained pretreatment and during therapy showed increased phosphorylation of H2Ax after SCH 900776 beginning at 40 mg/m2, consistent with unrepaired DNA damage.  Conclusions: These data support a randomized phase II trial of cytarabine +/- SCH 900776 at a recommended flat dose of 100 mg (equiv. to 56 mg/m2) for adults with poor-risk leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1eiYItPvAYrVg90H21EOLACvtfcHk0lgTuO48aQNa8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSiu77N&md5=27c4b385c0ecaf78a7194cd3b2371b62</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2442%26sid%3Dliteratum%253Aachs%26aulast%3DKarp%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DB.%2BM.%26aulast%3DGreer%26aufirst%3DJ.%2BM.%26aulast%3DSorge%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DS.%2BD.%26aulast%3DPratz%26aufirst%3DK.%2BW.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DFlatten%26aufirst%3DK.%2BS.%26aulast%3DPeterson%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMackey%26aufirst%3DK.%26aulast%3DFreshwater%26aufirst%3DT.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DM.%2BA.%26aulast%3DCarraway%26aufirst%3DH.%2BE.%26aulast%3DGladstone%26aufirst%3DD.%2BE.%26aulast%3DShowel%26aufirst%3DM.%2BM.%26aulast%3DLoechner%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DD.%2BA.%26aulast%3DHorowitz%26aufirst%3DJ.%2BA.%26aulast%3DIsaacs%26aufirst%3DR.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520I%2520and%2520pharmacologic%2520trial%2520of%2520cytosine%2520arabinoside%2520with%2520the%2520selective%2520checkpoint%25201%2520inhibitor%2520Sch%2520900776%2520in%2520refractory%2520acute%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D6723%26epage%3D6731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Weiss, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donehower, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKane, S.</span><span> </span><span class="NLM_article-title">Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500mg/m(2) every 21 days in patients with cancer</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=136-144&author=G.+J.+Weissauthor=R.+C.+Donehowerauthor=T.+Iyengarauthor=R.+K.+Ramanathanauthor=K.+Lewandowskiauthor=E.+Westinauthor=K.+Hurtauthor=S.+M.+Hynesauthor=S.+P.+Anthonyauthor=S.+McKane&title=Phase+I+dose-escalation+study+to+examine+the+safety+and+tolerability+of+LY2603618%2C+a+checkpoint+1+kinase+inhibitor%2C+administered+1+day+after+pemetrexed+500mg%2Fm%282%29+every+21+days+in+patients+with+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DDonehower%26aufirst%3DR.%2BC.%26aulast%3DIyengar%26aufirst%3DT.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DLewandowski%26aufirst%3DK.%26aulast%3DWestin%26aufirst%3DE.%26aulast%3DHurt%26aufirst%3DK.%26aulast%3DHynes%26aufirst%3DS.%2BM.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DMcKane%26aufirst%3DS.%26atitle%3DPhase%2520I%2520dose-escalation%2520study%2520to%2520examine%2520the%2520safety%2520and%2520tolerability%2520of%2520LY2603618%252C%2520a%2520checkpoint%25201%2520kinase%2520inhibitor%252C%2520administered%25201%2520day%2520after%2520pemetrexed%2520500mg%252Fm%25282%2529%2520every%252021%2520days%2520in%2520patients%2520with%2520cancer%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Maugeri-Sacca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maria, R.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=525-533&author=M.+Maugeri-Saccaauthor=M.+Bartucciauthor=R.+De+Maria&title=Checkpoint+kinase+1+inhibitors+for+potentiating+systemic+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaugeri-Sacca%26aufirst%3DM.%26aulast%3DBartucci%26aufirst%3DM.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26atitle%3DCheckpoint%2520kinase%25201%2520inhibitors%2520for%2520potentiating%2520systemic%2520anticancer%2520therapy%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2013%26volume%3D39%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Jobson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lountos, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llamas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondapaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardellina, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1<i>H</i>-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1124%2Fjpet.109.154997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19741151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=816-826&author=A.+G.+Jobsonauthor=G.+T.+Lountosauthor=P.+L.+Lorenziauthor=J.+Llamasauthor=J.+Connellyauthor=D.+Cernaauthor=J.+E.+Tropeaauthor=A.+Ondaauthor=G.+Zoppoliauthor=S.+Kondapakaauthor=G.+Zhangauthor=N.+J.+Caplenauthor=J.+H.+Cardellinaauthor=S.+S.+Yooauthor=A.+Monksauthor=C.+Selfauthor=D.+S.+Waughauthor=R.+H.+Shoemakerauthor=Y.+Pommier&title=Cellular+inhibition+of+checkpoint+kinase+2+%28Chk2%29+and+potentiation+of+camptothecins+and+radiation+by+the+novel+Chk2+inhibitor+PV1019+%5B7-nitro-1H-indole-2-carboxylic+acid+%7B4-%5B1-%28guanidinohydrazone%29-ethyl%5D-phenyl%7D-amide%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]</span></div><div class="casAuthors">Jobson, Andrew G.; Lountos, George T.; Lorenzi, Philip L.; Llamas, Jenny; Connelly, John; Cerna, David; Tropea, Joseph E.; Onda, Akikazu; Zoppoli, Gabriele; Kondapaka, Sudhir; Zhang, Guangtao; Caplen, Natasha J.; Cardellina, John H., II; Yoo, Stephen S.; Monks, Anne; Self, Christopher; Waugh, David S.; Shoemaker, Robert H.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Chk2 is a checkpoint kinase involved in the ataxia telangiectasia mutated pathway, which is activated by genomic instability and DNA damage, leading to either cell death (apoptosis) or cell cycle arrest.  Chk2 provides an unexplored therapeutic target against cancer cells.  We recently reported 4,4'-diacetyldiphenylurea-bis(guanylhydrazone) (NSC 109555) as a novel chemotype Chk2 inhibitor.  We have now synthesized a deriv. of NSC 109555, PV1019 (NSC 744039) [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide], which is a selective submicromolar inhibitor of Chk2 in vitro.  The cocrystal structure of PV1019 bound in the ATP binding pocket of Chk2 confirmed enzymic/biochem. observations that PV1019 acts as a competitive inhibitor of Chk2 with respect to ATP.  PV1019 was found to inhibit Chk2 in cells.  It inhibits Chk2 autophosphorylation (which represents the cellular kinase activation of Chk2), Cdc25C phosphorylation, and HDMX degrdn. in response to DNA damage.  PV1019 also protects normal mouse thymocytes against ionizing radiation-induced apoptosis, and it shows synergistic antiproliferative activity with topotecan, camptothecin, and radiation in human tumor cell lines.  We also show that PV1019 and Chk2 small interfering RNAs can exert antiproliferative activity themselves in the cancer cells with high Chk2 expression in the NCl-60 screen.  These data indicate that PV1019 is a potent and selective inhibitor of Chk2 with chemotherapeutic and radiosensitization potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoekmxYz7hWN7Vg90H21EOLACvtfcHk0ljWHCGWfz2aYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLzF&md5=904829f9a750c67489e2e90cddd94205</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154997%26sid%3Dliteratum%253Aachs%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DLountos%26aufirst%3DG.%2BT.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLlamas%26aufirst%3DJ.%26aulast%3DConnelly%26aufirst%3DJ.%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DOnda%26aufirst%3DA.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DKondapaka%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DCaplen%26aufirst%3DN.%2BJ.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DSelf%26aufirst%3DC.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCellular%2520inhibition%2520of%2520checkpoint%2520kinase%25202%2520%2528Chk2%2529%2520and%2520potentiation%2520of%2520camptothecins%2520and%2520radiation%2520by%2520the%2520novel%2520Chk2%2520inhibitor%2520PV1019%2520%255B7-nitro-1H-indole-2-carboxylic%2520acid%2520%257B4-%255B1-%2528guanidinohydrazone%2529-ethyl%255D-phenyl%257D-amide%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D816%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101150b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=580-590&author=J.+J.+Caldwellauthor=E.+J.+Welshauthor=C.+Matijssenauthor=V.+E.+Andersonauthor=L.+Antoniauthor=K.+Boxallauthor=F.+Urbanauthor=A.+Hayesauthor=F.+I.+Raynaudauthor=L.+J.+Rigoreauauthor=T.+Raynhamauthor=G.+W.+Aherneauthor=L.+H.+Pearlauthor=A.+W.+Oliverauthor=M.+D.+Garrettauthor=I.+Collins&title=Structure-based+design+of+potent+and+selective+2-%28quinazolin-2-yl%29phenol+inhibitors+of+checkpoint+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm101150b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101150b%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DWelsh%26aufirst%3DE.%2BJ.%26aulast%3DMatijssen%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DV.%2BE.%26aulast%3DAntoni%26aufirst%3DL.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DOliver%26aufirst%3DA.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520selective%25202-%2528quinazolin-2-yl%2529phenol%2520inhibitors%2520of%2520checkpoint%2520kinase%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D580%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Fernandez-Medarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, E.</span><span> </span><span class="NLM_article-title">Ras in cancer and developmental diseases</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1177%2F1947601911411084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=21779504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=344-358&author=A.+Fernandez-Medardeauthor=E.+Santos&title=Ras+in+cancer+and+developmental+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ras in cancer and developmental diseases</span></div><div class="casAuthors">Fernandez-Medarde, Alberto; Santos, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-358</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations identified in human cancer about 3 decades ago.  Studies during the last quarter century have characterized the Ras proteins as essential components of signaling networks controlling cellular proliferation, differentiation, or survival.  The oncogenic mutations of the H-ras, N-ras, or K-ras genes frequently found in human tumors are known to throw off balance the normal outcome of those signaling pathways, thus leading to tumor development.  Oncogenic mutations in a no. of other upstream or downstream components of Ras signaling pathways (including membrane RTKs or cytosolic kinases) have been detected more recently in assocn. with a variety of cancers.  Interestingly, the oncogenic Ras mutations and the mutations in other components of Ras/MAPK signaling pathways appear to be mutually exclusive events in most tumors, indicating that deregulation of Ras-dependent signaling is the essential requirement for tumorigenesis.  In contrast to sporadic tumors, sep. studies have identified germline mutations in Ras and various other components of Ras signaling pathways that occur in specific assocn. with a no. of different familial, developmental syndromes frequently sharing common phenotypic cardiofaciocutaneous features.  Finally, even without being a causative force, defective Ras signaling has been cited as a contributing factor to many other human illnesses, including diabetes and immunol. and inflammatory disorders.  We aim this review at summarizing and updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development of various tumoral and nontumoral pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8FC347lm6bVg90H21EOLACvtfcHk0lgrn_QhXSyxVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D&md5=048ad92dd5959250e4a2b8e0319ff225</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1177%2F1947601911411084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911411084%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Medarde%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DE.%26atitle%3DRas%2520in%2520cancer%2520and%2520developmental%2520diseases%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D344%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Pells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divjak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span> </span><span class="NLM_article-title">Developmentally-regulated expression of murine K-ras isoforms</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=1781-1786&author=S.+Pellsauthor=M.+Divjakauthor=P.+Romanowskiauthor=H.+Impeyauthor=N.+J.+Hawkinsauthor=A.+R.+Clarkeauthor=M.+L.+Hooperauthor=D.+J.+Williamson&title=Developmentally-regulated+expression+of+murine+K-ras+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPells%26aufirst%3DS.%26aulast%3DDivjak%26aufirst%3DM.%26aulast%3DRomanowski%26aufirst%3DP.%26aulast%3DImpey%26aufirst%3DH.%26aulast%3DHawkins%26aufirst%3DN.%2BJ.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DHooper%26aufirst%3DM.%2BL.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26atitle%3DDevelopmentally-regulated%2520expression%2520of%2520murine%2520K-ras%2520isoforms%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D1781%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Bar-Sagi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span> </span><span class="NLM_article-title">Ras and Rho GTPases: a family reunion</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=227-238&author=D.+Bar-Sagiauthor=A.+Hall&title=Ras+and+Rho+GTPases%3A+a+family+reunion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DA.%26atitle%3DRas%2520and%2520Rho%2520GTPases%253A%2520a%2520family%2520reunion%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D227%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Hoa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjaard, R. A.</span><span> </span><span class="NLM_article-title">Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7154</span><span class="NLM_x">–</span> <span class="NLM_lpage">7156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=7154-7156&author=M.+Hoaauthor=S.+L.+Davisauthor=S.+J.+Amesauthor=R.+A.+Spanjaard&title=Amplification+of+wild-type+K-ras+promotes+growth+of+head+and+neck+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoa%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DS.%2BL.%26aulast%3DAmes%26aufirst%3DS.%2BJ.%26aulast%3DSpanjaard%26aufirst%3DR.%2BA.%26atitle%3DAmplification%2520of%2520wild-type%2520K-ras%2520promotes%2520growth%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D7154%26epage%3D7156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Coleman, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throneburg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisham, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. J.</span><span> </span><span class="NLM_article-title">Overexpression of c-K-ras, c-N-ras and transforming growth factor beta co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=1005-1012&author=W.+B.+Colemanauthor=D.+B.+Throneburgauthor=J.+W.+Grishamauthor=G.+J.+Smith&title=Overexpression+of+c-K-ras%2C+c-N-ras+and+transforming+growth+factor+beta+co-segregate+with+tumorigenicity+in+morphologically+transformed+C3H+10T1%2F2+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DW.%2BB.%26aulast%3DThroneburg%26aufirst%3DD.%2BB.%26aulast%3DGrisham%26aufirst%3DJ.%2BW.%26aulast%3DSmith%26aufirst%3DG.%2BJ.%26atitle%3DOverexpression%2520of%2520c-K-ras%252C%2520c-N-ras%2520and%2520transforming%2520growth%2520factor%2520beta%2520co-segregate%2520with%2520tumorigenicity%2520in%2520morphologically%2520transformed%2520C3H%252010T1%252F2%2520cell%2520lines%26jtitle%3DCarcinogenesis%26date%3D1994%26volume%3D15%26spage%3D1005%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Buday, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downward, J.</span><span> </span><span class="NLM_article-title">Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=611-620&author=L.+Budayauthor=J.+Downward&title=Epidermal+growth+factor+regulates+p21ras+through+the+formation+of+a+complex+of+receptor%2C+Grb2+adapter+protein%2C+and+Sos+nucleotide+exchange+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuday%26aufirst%3DL.%26aulast%3DDownward%26aufirst%3DJ.%26atitle%3DEpidermal%2520growth%2520factor%2520regulates%2520p21ras%2520through%2520the%2520formation%2520of%2520a%2520complex%2520of%2520receptor%252C%2520Grb2%2520adapter%2520protein%252C%2520and%2520Sos%2520nucleotide%2520exchange%2520factor%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D611%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosshans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labourier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinert, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, F. J.</span><span> </span><span class="NLM_article-title">RAS is regulated by the let-7 microRNA family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2005.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15766527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1yhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=635-647&author=S.+M.+Johnsonauthor=H.+Grosshansauthor=J.+Shingaraauthor=M.+Byromauthor=R.+Jarvisauthor=A.+Chengauthor=E.+Labourierauthor=K.+L.+Reinertauthor=D.+Brownauthor=F.+J.+Slack&title=RAS+is+regulated+by+the+let-7+microRNA+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">RAS is regulated by the let-7 microRNA family</span></div><div class="casAuthors">Johnson, Steven M.; Grosshans, Helge; Shingara, Jaclyn; Byrom, Mike; Jarvis, Rich; Cheng, Angie; Labourier, Emmanuel; Reinert, Kristy L.; Brown, David; Slack, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">635-647</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including humans, where they are implicated in cancer.  The let-7 miRNA times seam cell terminal differentiation in C. elegans.  Here the authors show that the let-7 family neg. regulates let-60/RAS.  Loss of let-60/RAS suppresses let-7, and the let-60/RAS 3'UTR contains multiple let-7 complementary sites (LCSs), restricting reporter gene expression in a let-7-dependent manner.  Mir-84, a let-7 family member, is largely absent in vulval precursor cell P6.p at the time that let-60/RAS specifies the 1° vulval fate in that cell, and mir-84 overexpression suppresses the multivulva phenotype of activating let-60/RAS mutations.  The 3'UTRs of the human RAS genes contain multiple LCSs, allowing let-7 to regulate RAS expression.  Let-7 expression is lower in lung tumors than in normal lung tissue, while RAS protein is significantly higher in lung tumors, providing a possible mechanism for let-7 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEwsudQP-3rVg90H21EOLACvtfcHk0lgrn_QhXSyxVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1yhsbs%253D&md5=d651c7df1048b5f664e3da3fa0357066</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DGrosshans%26aufirst%3DH.%26aulast%3DShingara%26aufirst%3DJ.%26aulast%3DByrom%26aufirst%3DM.%26aulast%3DJarvis%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DLabourier%26aufirst%3DE.%26aulast%3DReinert%26aufirst%3DK.%2BL.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DSlack%26aufirst%3DF.%2BJ.%26atitle%3DRAS%2520is%2520regulated%2520by%2520the%2520let-7%2520microRNA%2520family%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D635%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Bernhard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanbridge, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakanauskas, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerniglia, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, W. G.</span><span> </span><span class="NLM_article-title">Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6597-6600&author=E.+J.+Bernhardauthor=E.+J.+Stanbridgeauthor=S.+Guptaauthor=A.+K.+Guptaauthor=D.+Sotoauthor=V.+J.+Bakanauskasauthor=G.+J.+Cernigliaauthor=R.+J.+Muschelauthor=W.+G.+McKenna&title=Direct+evidence+for+the+contribution+of+activated+N-ras+and+K-ras+oncogenes+to+increased+intrinsic+radiation+resistance+in+human+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernhard%26aufirst%3DE.%2BJ.%26aulast%3DStanbridge%26aufirst%3DE.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DSoto%26aufirst%3DD.%26aulast%3DBakanauskas%26aufirst%3DV.%2BJ.%26aulast%3DCerniglia%26aufirst%3DG.%2BJ.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DMcKenna%26aufirst%3DW.%2BG.%26atitle%3DDirect%2520evidence%2520for%2520the%2520contribution%2520of%2520activated%2520N-ras%2520and%2520K-ras%2520oncogenes%2520to%2520increased%2520intrinsic%2520radiation%2520resistance%2520in%2520human%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6597%26epage%3D6600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=537-540&author=L.+A.+Diazauthor=R.+T.+Williamsauthor=J.+Wuauthor=I.+Kindeauthor=J.+R.+Hechtauthor=J.+Berlinauthor=B.+Allenauthor=I.+Bozicauthor=J.+G.+Reiterauthor=M.+A.+Nowakauthor=K.+W.+Kinzlerauthor=K.+S.+Olinerauthor=B.+Vogelstein&title=The+molecular+evolution+of+acquired+resistance+to+targeted+EGFR+blockade+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DKinde%26aufirst%3DI.%26aulast%3DHecht%26aufirst%3DJ.%2BR.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DBozic%26aufirst%3DI.%26aulast%3DReiter%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DM.%2BA.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DOliner%26aufirst%3DK.%2BS.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DThe%2520molecular%2520evolution%2520of%2520acquired%2520resistance%2520to%2520targeted%2520EGFR%2520blockade%2520in%2520colorectal%2520cancers%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Hancock, J. F.</span><span> </span><span class="NLM_article-title">Ras proteins: different signals from different locations</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrm1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=12728271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=373-384&author=J.+F.+Hancock&title=Ras+proteins%3A+different+signals+from+different+locations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Ras proteins: different signals from different locations</span></div><div class="casAuthors">Hancock, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-385</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ras signaling has classically been thought to occur exclusively at the inner surface of a relatively uniform plasma membrane.  Recent studies have shown that Ras proteins interact dynamically with specific microdomains of the plasma membrane as well as with other internal cell membranes.  These different membrane microenvironments modulate Ras signal output and highlight the complex interplay between Ras location and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIio6gLe-jnbVg90H21EOLACvtfcHk0lhbBcY-LrCZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7g%253D&md5=f72470c5749f4db56f7db5397df86742</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fnrm1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1105%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DJ.%2BF.%26atitle%3DRas%2520proteins%253A%2520different%2520signals%2520from%2520different%2520locations%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D373%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Farnesyltransferase inhibitors</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1053%2Fj.seminoncol.2003.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14981578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFelsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=28-39&author=S.+M.+Sebtiauthor=A.+A.+Adjei&title=Farnesyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Farnesyltransferase inhibitors</span></div><div class="casAuthors">Sebti, Said M.; Adjei, Alex A.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1, Suppl. 1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  The farnesyltransferase inhibitors (FTIs) were designed to inhibit the post-translational processing of Ras proteins, which are mutated in 30% of all human cancers.  Recent studies suggest, however, that the target of FTIs may be a protein other than Ras, and that these agents may be more appropriately used to treat tumors with activated wild-type ras signaling.  Preliminary results from several phase II and phase III studies have been reported.  The FTIs fail to show significant single-agent activity in non-small cell lung cancer, small cell lung cancer, pancreatic cancer, refractory colorectal cancer, and bladder cancer.  Activity has been shown in hematol. malignancies (acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome), breast cancer, and glioma.  Several combination studies of FTIs and std. cytotoxic agents are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-ex_kxKCurVg90H21EOLACvtfcHk0lhbBcY-LrCZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFelsbw%253D&md5=8c5f181e40f7d504e13eb0a9f05922fe</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2003.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2003.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DFarnesyltransferase%2520inhibitors%26jtitle%3DSemin.%2520Oncol.%26date%3D2004%26volume%3D31%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Targeting protein prenylation for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnrc3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22020205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=775-791&author=N.+Berndtauthor=A.+D.+Hamiltonauthor=S.+M.+Sebti&title=Targeting+protein+prenylation+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein prenylation for cancer therapy</span></div><div class="casAuthors">Berndt, Norbert; Hamilton, Andrew D.; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid post-translational modifications that are required for the transforming activity of many oncogenic proteins, including some RAS family members.  This observation prompted the development of inhibitors of farnesyltransferase (FT) and geranylgeranyltransferase 1 (GGT1) as potential anticancer drugs.  In this Review, we discuss the mechanisms by which FT and GGT1 inhibitors (FTIs and GGTIs, resp.) affect signal transduction pathways, cell cycle progression, proliferation and cell survival.  In contrast to their preclin. efficacy, only a small subset of patients responds to FTIs.  Identifying tumors that depend on farnesylation for survival remains a challenge, and strategies to overcome this are discussed.  One GGTI has recently entered the clinic, and the safety and efficacy of GGTIs await results from clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmj2vv2fG4gLVg90H21EOLACvtfcHk0lhY5xboDJ2KWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF&md5=c98505df79a037234fb260801c9b97aa</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnrc3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3151%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DTargeting%2520protein%2520prenylation%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D775%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Winter-Vann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dela Cruz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergo, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toone, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, P. J.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4336</span><span class="NLM_x">–</span> <span class="NLM_lpage">4341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.0408107102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=15784746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4336-4341&author=A.+M.+Winter-Vannauthor=R.+A.+Baronauthor=W.+Wongauthor=J.+dela+Cruzauthor=J.+D.+Yorkauthor=D.+M.+Goodenauthor=M.+O.+Bergoauthor=S.+G.+Youngauthor=E.+J.+Tooneauthor=P.+J.+Casey&title=A+small-molecule+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase+with+antitumor+activity+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span></div><div class="casAuthors">Winter-Vann, Ann M.; Baron, Rudi A.; Wong, Waihay; dela Cruz, June; York, John D.; Gooden, David M.; Bergo, Martin O.; Young, Stephen G.; Toone, Eric J.; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4336-4341</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Many key regulatory proteins, including members of the Ras family of GTPases, are modified at their C terminus by a process termed prenylation.  This processing is initiated by the addn. of an isoprenoid lipid, and the proteins are further modified by a proteolytic event and methylation of the C-terminal prenylcysteine.  Although the biol. consequences of prenylation have been characterized extensively, the contributions of prenylcysteine methylation to the functions of the modified proteins are not well understood.  This reaction is catalyzed by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt).  Recent genetic disruption studies have provided strong evidence that blocking Icmt activity has profound consequences on oncogenic transformation.  Here, we report the identification of a selective small-mol. inhibitor of Icmt, 2-[5-(3-methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil).  Cysmethynil treatment results in inhibition of cell growth in an Icmt-dependent fashion, demonstrating mechanism-based activity of the compd.  Treatment of cancer cells with cysmethynil results in mislocalization of Ras and impaired epidermal growth factor signaling.  In a human colon cancer cell line, cysmethynil treatment blocks anchorage-independent growth, and this effect is reversed by overexpression of Icmt.  These findings provide a compelling rationale for development of Icmt inhibitors as another approach to anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-1GtT0roj7Vg90H21EOLACvtfcHk0lhY5xboDJ2KWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D&md5=8cbe478e0911934e2868d5b5eb376a58</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408107102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408107102%26sid%3Dliteratum%253Aachs%26aulast%3DWinter-Vann%26aufirst%3DA.%2BM.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DW.%26aulast%3Ddela%2BCruz%26aufirst%3DJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DToone%26aufirst%3DE.%2BJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520with%2520antitumor%2520activity%2520in%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D4336%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Ostrem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+inhibitors+allosterically+control+GTP+affinity+and+effector+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lhY5xboDJ2KWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520inhibitors%2520allosterically%2520control%2520GTP%2520affinity%2520and%2520effector%2520interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Shima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijiri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, T.</span><span> </span><span class="NLM_article-title">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">8182</span><span class="NLM_x">–</span> <span class="NLM_lpage">8187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1073%2Fpnas.1217730110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23630290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8182-8187&author=F.+Shimaauthor=Y.+Yoshikawaauthor=M.+Yeauthor=M.+Arakiauthor=S.+Matsumotoauthor=J.+Liaoauthor=L.+Huauthor=T.+Sugimotoauthor=Y.+Ijiriauthor=A.+Takedaauthor=Y.+Nishiyamaauthor=C.+Satoauthor=S.+Muraokaauthor=A.+Tamuraauthor=T.+Osodaauthor=K.+Tsudaauthor=T.+Miyakawaauthor=H.+Fukunishiauthor=J.+Shimadaauthor=T.+Kumasakaauthor=M.+Yamamotoauthor=T.+Kataoka&title=In+silico+discovery+of+small-molecule+Ras+inhibitors+that+display+antitumor+activity+by+blocking+the+Ras-effector+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span></div><div class="casAuthors">Shima, Fumi; Yoshikawa, Yoko; Ye, Min; Araki, Mitsugu; Matsumoto, Shigeyuki; Liao, Jingling; Hu, Lizhi; Sugimoto, Takeshi; Ijiri, Yuichi; Takeda, Azusa; Nishiyama, Yuko; Sato, Chie; Muraoka, Shin; Tamura, Atsuo; Osoda, Tsutomu; Tsuda, Ken-ichiro; Miyakawa, Tomoya; Fukunishi, Hiroaki; Shimada, Jiro; Kumasaka, Takashi; Yamamoto, Masaki; Kataoka, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8187, S8182/1-S8182/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently obsd. in human cancers, making them promising anticancer drug targets.  Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-defined surface pockets suitable for drug binding.  Only recently, such pockets have been found in the crystal structures of a unique conformation of Ras·GTP.  Here we report the successful development of small-mol. Ras inhibitors by an in silico screen targeting a pocket found in the crystal structure of M-Ras·GTP carrying an H-Ras-type substitution P40D.  The selected compd. Kobe0065 and its analog Kobe2602 exhibit inhibitory activity toward H-Ras·GTP-c-Raf-1 binding both in vivo and in vitro.  They effectively inhibit both anchorage-dependent and -independent growth and induce apoptosis of H-rasG12V-transformed NIH 3T3 cells, which is accompanied by down-regulation of downstream mols. such as MEK/ERK, Akt, and RalA as well as an upstream mol., Son of sevenless.  Moreover, they exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-rasG12V gene by oral administration.  The NMR structure of a complex of the compd. with H-Ras·GTPT355, exclusively adopting the unique conformation, confirms its insertion into one of the surface pockets and provides a mol. basis for binding inhibition toward multiple RasGTP-interacting mols.  This study proves the effectiveness of our strategy for structure-based drug design to target Ras·GTP, and the resulting Kobe0065-family compds. may serve as a scaffold for the development of Ras inhibitors with higher potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk-yi5md5AbVg90H21EOLACvtfcHk0lhGQDYv4SGetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K&md5=aa6569874162595cf17825f2528b4cd3</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217730110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217730110%26sid%3Dliteratum%253Aachs%26aulast%3DShima%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DIjiri%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DMuraoka%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DOsoda%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DK.%26aulast%3DMiyakawa%26aufirst%3DT.%26aulast%3DFukunishi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DT.%26atitle%3DIn%2520silico%2520discovery%2520of%2520small-molecule%2520Ras%2520inhibitors%2520that%2520display%2520antitumor%2520activity%2520by%2520blocking%2520the%2520Ras-effector%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D8182%26epage%3D8187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Rusconi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caiola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span> </span><span class="NLM_article-title">RAS/RAF/MEK inhibitors in oncology</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.2174%2F092986712799320510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=22257058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Kktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1164-1176&author=P.+Rusconiauthor=E.+Caiolaauthor=M.+Broggini&title=RAS%2FRAF%2FMEK+inhibitors+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">RAS/RAF/MEK inhibitors in oncology</span></div><div class="casAuthors">Rusconi, P.; Caiola, E.; Broggini, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1164-1176</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The RAS/RAF/MEK signaling pathway plays a central role in mediating both proliferation and survival of cancer cells.  These proteins are a group of serine/threonine kinases activated in response to a variety of extracellular stimuli and mediate signal transduction from the cell surface towards both nuclear and cytosolic targets.  In combination with several other signaling pathways, they can differentially alter phosphorylation status of the transcription factors.  A controlled regulation of these cascades is involved in cell proliferation and differentiation, whereas an unregulated activation of these kinases can result in oncogenesis.  Dysregulation of the RAS/RAF/MEK pathway was detected in > 30% of human tumors, however mutations in the MEK1 and MEK2 genes are seldom, so that hyperactivation of MEK1/2 usually results from gain-of-function mutations in RAS and/or B-RAF.  In addn., alteration of the pathways is often assocd. with drug resistance in the clinic, such as the case of K-RAS mutant expressing tumors.  Since RAS protein is a difficult target, alternative ways altering post-translational modifications using farnesyl transferase inhibitors were adopted.  Drug discovery programs have therefore largely focused on B-RAF and MEK.  In this review we will discuss the most promising strategies developed to target these kinases and the most recent inhibitors facing the preclin. and clin. setting, also considering their structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPn09xagNe5rVg90H21EOLACvtfcHk0lhGQDYv4SGetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Kktro%253D&md5=8f035e72d81b5703de0e5782102726e9</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F092986712799320510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320510%26sid%3Dliteratum%253Aachs%26aulast%3DRusconi%26aufirst%3DP.%26aulast%3DCaiola%26aufirst%3DE.%26aulast%3DBroggini%26aufirst%3DM.%26atitle%3DRAS%252FRAF%252FMEK%2520inhibitors%2520in%2520oncology%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1164%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Kim, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wistuba, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenschein, G. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erasmus, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alden, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kies, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitrakopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. K.</span><span> </span><span class="NLM_article-title">The BATTLE trial: personalizing therapy for lung cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=44-53&author=E.+S.+Kimauthor=R.+S.+Herbstauthor=I.+I.+Wistubaauthor=J.+J.+Leeauthor=G.+R.+Blumenscheinauthor=A.+Tsaoauthor=D.+J.+Stewartauthor=M.+E.+Hicksauthor=J.+Erasmusauthor=S.+Guptaauthor=C.+M.+Aldenauthor=S.+Liuauthor=X.+Tangauthor=F.+R.+Khuriauthor=H.+T.+Tranauthor=B.+E.+Johnsonauthor=J.+V.+Heymachauthor=L.+Maoauthor=F.+Fossellaauthor=M.+S.+Kiesauthor=V.+Papadimitrakopoulouauthor=S.+E.+Davisauthor=S.+M.+Lippmanauthor=W.+K.+Hong&title=The+BATTLE+trial%3A+personalizing+therapy+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlumenschein%26aufirst%3DG.%2BR.%26aulast%3DTsao%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DD.%2BJ.%26aulast%3DHicks%26aufirst%3DM.%2BE.%26aulast%3DErasmus%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DAlden%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DTran%26aufirst%3DH.%2BT.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DFossella%26aufirst%3DF.%26aulast%3DKies%26aufirst%3DM.%2BS.%26aulast%3DPapadimitrakopoulou%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DS.%2BE.%26aulast%3DLippman%26aufirst%3DS.%2BM.%26aulast%3DHong%26aufirst%3DW.%2BK.%26atitle%3DThe%2520BATTLE%2520trial%253A%2520personalizing%2520therapy%2520for%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D44%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Heidorn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milagre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhomen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.cell.2009.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20141835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVWitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=209-221&author=S.+J.+Heidornauthor=C.+Milagreauthor=S.+Whittakerauthor=A.+Nourryauthor=I.+Niculescu-Duvasauthor=N.+Dhomenauthor=J.+Hussainauthor=J.+S.+Reis-Filhoauthor=C.+J.+Springerauthor=C.+Pritchardauthor=R.+Marais&title=Kinase-dead+BRAF+and+oncogenic+RAS+cooperate+to+drive+tumor+progression+through+CRAF"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF</span></div><div class="casAuthors">Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Nourry, Arnaud; Niculescu-Duvas, Ion; Dhomen, Nathalie; Hussain, Jahan; Reis-Filho, Jorge S.; Springer, Caroline J.; Pritchard, Catrin; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-221</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We describe a mechanism of tumorigenesis mediated by kinase-dead BRAF in the presence of oncogenic RAS.  We show that drugs that selectively inhibit BRAF drive RAS-dependent BRAF binding to CRAF, CRAF activation, and MEK-ERK signaling.  This does not occur when oncogenic BRAF is inhibited, demonstrating that BRAF inhibition per se does not drive pathway activation; it only occurs when BRAF is inhibited in the presence of oncogenic RAS.  Kinase-dead BRAF mimics the effects of the BRAF-selective drugs and kinase-dead Braf and oncogenic Ras cooperate to induce melanoma in mice.  Our data reveal another paradigm of BRAF-mediated signaling that promotes tumor progression.  They highlight the importance of understanding pathway signaling in clin. practice and of genotyping tumors prior to administering BRAF-selective drugs, to identify patients who are likely to respond and also to identify patients who may experience adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMSb6ckHpR07Vg90H21EOLACvtfcHk0ljIdFfP9yEaJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVWitL0%253D&md5=80af840cb978f5956b3d998b185115f4</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DHeidorn%26aufirst%3DS.%2BJ.%26aulast%3DMilagre%26aufirst%3DC.%26aulast%3DWhittaker%26aufirst%3DS.%26aulast%3DNourry%26aufirst%3DA.%26aulast%3DNiculescu-Duvas%26aufirst%3DI.%26aulast%3DDhomen%26aufirst%3DN.%26aulast%3DHussain%26aufirst%3DJ.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26aulast%3DPritchard%26aufirst%3DC.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DKinase-dead%2520BRAF%2520and%2520oncogenic%2520RAS%2520cooperate%2520to%2520drive%2520tumor%2520progression%2520through%2520CRAF%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D209%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Callahan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimek, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merghoub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span> </span><span class="NLM_article-title">Progression of RAS-mutant leukemia during RAF inhibitor treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">2316</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1056%2FNEJMoa1208958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23134356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=2316-2321&author=M.+K.+Callahanauthor=R.+Rampalauthor=J.+J.+Hardingauthor=V.+M.+Klimekauthor=Y.+R.+Chungauthor=T.+Merghoubauthor=J.+D.+Wolchokauthor=D.+B.+Solitauthor=N.+Rosenauthor=O.+Abdel-Wahabauthor=R.+L.+Levineauthor=P.+B.+Chapman&title=Progression+of+RAS-mutant+leukemia+during+RAF+inhibitor+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Progression of RAS-mutant leukemia during RAF inhibitor treatment</span></div><div class="casAuthors">Callahan, Margaret K.; Rampal, Raajit; Harding, James J.; Klimek, Virginia M.; Chung, Young Rock; Merghoub, Taha; Wolchok, Jedd D.; Solit, David B.; Rosen, Neal; Abdel-Wahab, Omar; Levine, Ross L.; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2316-2321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Vemurafenib, a selective RAF inhibitor, extends survival among patients with BRAF V600E-mutant melanoma.  Vemurafenib inhibits ERK signaling in BRAF V600E-mutant cells but activates ERK signaling in BRAF wild-type cells.  This paradoxical activation of ERK signaling is the mechanistic basis for the development of RAS-mutant squamous-cell skin cancers in patients treated with RAF inhibitors.  We report the accelerated growth of a previously unsuspected RAS-mutant leukemia in a patient with melanoma who was receiving vemurafenib.  Exposure to vemurafenib induced hyperactivation of ERK signaling and proliferation of the leukemic cell population, an effect that was reversed on drug withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLDR-0oiU3L7Vg90H21EOLACvtfcHk0ljIdFfP9yEaJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKmt77K&md5=82e34747b22f505104ce8ebb8d197144</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1208958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1208958%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DM.%2BK.%26aulast%3DRampal%26aufirst%3DR.%26aulast%3DHarding%26aufirst%3DJ.%2BJ.%26aulast%3DKlimek%26aufirst%3DV.%2BM.%26aulast%3DChung%26aufirst%3DY.%2BR.%26aulast%3DMerghoub%26aufirst%3DT.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DProgression%2520of%2520RAS-mutant%2520leukemia%2520during%2520RAF%2520inhibitor%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D2316%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamphier, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span> </span><span class="NLM_article-title">Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=829-839&author=N.+Tanakaauthor=M.+Ishiharaauthor=M.+Kitagawaauthor=H.+Haradaauthor=T.+Kimuraauthor=T.+Matsuyamaauthor=M.+S.+Lamphierauthor=S.+Aizawaauthor=T.+W.+Makauthor=T.+Taniguchi&title=Cellular+commitment+to+oncogene-induced+transformation+or+apoptosis+is+dependent+on+the+transcription+factor+IRF-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DIshihara%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DMatsuyama%26aufirst%3DT.%26aulast%3DLamphier%26aufirst%3DM.%2BS.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DCellular%2520commitment%2520to%2520oncogene-induced%2520transformation%2520or%2520apoptosis%2520is%2520dependent%2520on%2520the%2520transcription%2520factor%2520IRF-1%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D829%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Serrano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurrach, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2FS0092-8674%2800%2981902-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=9054499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=593-602&author=M.+Serranoauthor=A.+W.+Linauthor=M.+E.+McCurrachauthor=D.+Beachauthor=S.+W.+Lowe&title=Oncogenic+ras+provokes+premature+cell+senescence+associated+with+accumulation+of+p53+and+p16INK4a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</span></div><div class="casAuthors">Serrano, Manuel; Lin, Athena W.; Mccurrach, Mila E.; Beach, David; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-602</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Oncogenic ras can transform most immortal rodent cells to a tumorigenic state.  However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.  Here the authors show that expression of oncogenic ras in primary human or rodent cells results in a permanent G1 arrest.  The arrest induced by ras is accompanied by accumulation of p53 and p16, and is phenotypically indistinguishable from cellular senescence.  Inactivation of either p53 or p16 prevents ras-induced arrest in rodent cells, and E1A achieves a similar effect in human cells.  These observations suggest that the onset of cellular senescence does not simply reflect the accumulation of cell divisions, but can be prematurely activated in response to an oncogenic stimulus.  Negation of ras-induced senescence may be relevant during multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTv0YzGcJpLVg90H21EOLACvtfcHk0lgaPcIjtix9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSit7k%253D&md5=6856c4d670f34b65635da4ee11abc498</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981902-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981902-9%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%2BW.%26aulast%3DMcCurrach%26aufirst%3DM.%2BE.%26aulast%3DBeach%26aufirst%3DD.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DOncogenic%2520ras%2520provokes%2520premature%2520cell%2520senescence%2520associated%2520with%2520accumulation%2520of%2520p53%2520and%2520p16INK4a%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D593%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Cox, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Der, C. J.</span><span> </span><span class="NLM_article-title">The dark side of Ras: regulation of apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8999</span><span class="NLM_x">–</span> <span class="NLM_lpage">9006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1038%2Fsj.onc.1207111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=14663478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=8999-9006&author=A.+D.+Coxauthor=C.+J.+Der&title=The+dark+side+of+Ras%3A+regulation+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The dark side of Ras: regulation of apoptosis</span></div><div class="casAuthors">Cox, Adrienne D.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">56</span>),
    <span class="NLM_cas:pages">8999-9006</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutational activation of Ras promotes oncogenesis by disrupting a multitude of normal cellular processes.  Perhaps, best characterized and understood are the mechanisms by which oncogenic Ras promotes deregulated cell cycle progression and uncontrolled cellular proliferation.  However, it is now clear that oncogenic Ras can also deregulate processes that control apoptosis.  In light of the diversity of downstream effector targets known to facilitate Ras function, it is perhaps not surprising that Ras regulation of cell survival is complex, involving the balance and interplay of multiple signaling networks.  While our understanding of these events is still far from complete, and is complicated by cell type and signaling context differences, several important mechanisms have begun to emerge.  We review the role and mechanism of specific effectors in regulating the antiapoptotic (Raf, phosphatidylinositol 3-kinase and Tiam1) and apoptotic (Nore1 and RASSF1) actions of oncogenic Ras, and discuss the possibility that the effector actions of p120RasGAP make a significant contribution to Ras regulation of apoptotic events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFAJRj7yjhbVg90H21EOLACvtfcHk0lgaPcIjtix9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOmsro%253D&md5=9b1b257ddc3638c187ea260c4817ca98</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207111%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520dark%2520side%2520of%2520Ras%253A%2520regulation%2520of%2520apoptosis%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D8999%26epage%3D9006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Vicent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayles, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet-Cordero, E. A.</span><span> </span><span class="NLM_article-title">Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3940</span><span class="NLM_x">–</span> <span class="NLM_lpage">3952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=3940-3952&author=S.+Vicentauthor=R.+Chenauthor=L.+C.+Saylesauthor=C.+Linauthor=R.+G.+Walkerauthor=A.+K.+Gillespieauthor=A.+Subramanianauthor=G.+Hinkleauthor=X.+Yangauthor=S.+Saifauthor=D.+E.+Rootauthor=V.+Huffauthor=W.+C.+Hahnauthor=E.+A.+Sweet-Cordero&title=Wilms+tumor+1+%28WT1%29+regulates+KRAS-driven+oncogenesis+and+senescence+in+mouse+and+human+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVicent%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSayles%26aufirst%3DL.%2BC.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DR.%2BG.%26aulast%3DGillespie%26aufirst%3DA.%2BK.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DHinkle%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSaif%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHuff%26aufirst%3DV.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSweet-Cordero%26aufirst%3DE.%2BA.%26atitle%3DWilms%2520tumor%25201%2520%2528WT1%2529%2520regulates%2520KRAS-driven%2520oncogenesis%2520and%2520senescence%2520in%2520mouse%2520and%2520human%2520models%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D3940%26epage%3D3952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koopman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=489-500&author=A.+Singhauthor=P.+Greningerauthor=D.+Rhodesauthor=L.+Koopmanauthor=S.+Violetteauthor=N.+Bardeesyauthor=J.+Settleman&title=A+gene+expression+signature+associated+with+%E2%80%9CK-Ras+addiction%E2%80%9D+reveals+regulators+of+EMT+and+tumor+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DRhodes%26aufirst%3DD.%26aulast%3DKoopman%26aufirst%3DL.%26aulast%3DViolette%26aufirst%3DS.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DA%2520gene%2520expression%2520signature%2520associated%2520with%2520%25E2%2580%259CK-Ras%2520addiction%25E2%2580%259D%2520reveals%2520regulators%2520of%2520EMT%2520and%2520tumor%2520cell%2520survival%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26spage%3D489%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampkin, T.</span><span> </span><span class="NLM_article-title">Targeting Polo-like kinase in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1078-0432.CCR-09-1380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20068088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=384-389&author=Y.+Degenhardtauthor=T.+Lampkin&title=Targeting+Polo-like+kinase+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting polo-like kinase in cancer therapy</span></div><div class="casAuthors">Degenhardt, Yan; Lampkin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plk) function in mitosis and maintaining DNA integrity.  There are four family members, of which Plk1 represents a target for anticancer therapy.  Plk1 is only expressed in dividing cells with peak expression during G2/M.  Plk1 functions in multiple steps of mitosis, and is overexpressed in many tumor types.  Mitotic arrest and inhibition of proliferation, apoptosis, and tumor growth inhibition have been obsd. in preclin. studies using small interfering RNAs (siRNA) or small mols. that inhibit Plk1.  Preclin. studies also show that Plk1 inhibitors may be active against tumors with RAS mutations and that tumor cells with mutations in TP53 are more sensitive to inhibition of Plk1.  Several Plk inhibitors are in phase I or II clin. studies.  As expected, hematol. toxicity is the primary dose-limiting toxicity.  Some patients have achieved clin. response, although in some studies only at doses above the max. tolerated dose defined in the study.  Further evaluation is necessary to discern the clin. utility of Plk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-WiWxvJiS7Vg90H21EOLACvtfcHk0lhpU6sOJ_Wmnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D&md5=94d00dd707dc1ca59ed9d58b0099ba89</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1380%26sid%3Dliteratum%253Aachs%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DLampkin%26aufirst%3DT.%26atitle%3DTargeting%2520Polo-like%2520kinase%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D384%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tap, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gounder, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ustoyev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2024</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1200%2FJCO.2012.46.5476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=23569312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2024-2028&author=M.+A.+Dicksonauthor=W.+D.+Tapauthor=M.+L.+Keohanauthor=S.+P.+D%E2%80%99Angeloauthor=M.+M.+Gounderauthor=C.+R.+Antonescuauthor=J.+Landaauthor=L.+X.+Qinauthor=D.+D.+Rathboneauthor=M.+M.+Condyauthor=Y.+Ustoyevauthor=A.+M.+Cragoauthor=S.+Singerauthor=G.+K.+Schwartz&title=Phase+II+trial+of+the+CDK4+inhibitor+PD0332991+in+patients+with+advanced+CDK4-amplified+well-differentiated+or+dedifferentiated+liposarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span></div><div class="casAuthors">Dickson, Mark A.; Tap, William D.; Keohan, Mary Louise; D'Angelo, Sandra P.; Gounder, Mrinal M.; Antonescu, Cristina R.; Landa, Jonathan; Qin, Li-Xuan; Rathbone, Dustin D.; Condy, Mercedes M.; Ustoyev, Yelena; Crago, Aimee M.; Singer, Samuel; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2024-2028</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose CDK4 is amplified in > 90% of well-differentiated (WDLS) and dedifferentiated liposarcomas (DDLS).  The selective cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitor PD0332991 inhibits growth and induces senescence in cell lines and xenografts.  In a phase I trial of PD0332991, several patients with WDLS or DDLS experienced prolonged stable disease.  We performed an open-label phase II study to det. the safety and efficacy of PD0332991 in patients with advanced WDLS/DDLS.  Patients and Methods Patients age ≥ 18 years experiencing disease progression while receiving systemic therapy before enrollment received PD0332991 200 mg orally once per day for 14 consecutive days in 21-day cycles.  All were required to have CDK4 amplification by fluorescence in situ hybridization and retinoblastoma protein (RB) expression by immunohistochem. (≥ 1 +).  The primary end point was progression-free survival (PFS) at 12 wk, with 12-wk PFS of ≥ 40% considered promising and ≤ 20% not promising.  If ≥ nine of 28 patients were progression free at 12 wk, PD0332991 would be considered active.  Results We screened 48 patients (44 of 48 had CDK4 amplification; 41 of 44 were RB pos.).  Of those, 30 were enrolled, and 29 were evaluable for the primary end point.  Grade 3 to 4 events included anemia (17%), thrombocytopenia (30%), neutropenia (50%), and febrile neutropenia (3%).  At 12 wk, PFS was 66% (90% CI, 51 % to 100%), significantly exceeding the primary end point.  The median PFS was 18 wk.  There was one partial response.  Conclusion Treatment with the CDK4 inhibitor PD0332991 was assocd. with a favorable progression-free rate in patients with CDK4-amplified and RB-expressing WDLS/DDLS who had progressive disease despite systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNBEhZMJmyrVg90H21EOLACvtfcHk0lhpU6sOJ_Wmnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL&md5=d0c2be513ba6cda5014428939c7ec975</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.5476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.5476%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DKeohan%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DS.%2BP.%26aulast%3DGounder%26aufirst%3DM.%2BM.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLanda%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.%2BX.%26aulast%3DRathbone%26aufirst%3DD.%2BD.%26aulast%3DCondy%26aufirst%3DM.%2BM.%26aulast%3DUstoyev%26aufirst%3DY.%26aulast%3DCrago%26aufirst%3DA.%2BM.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DPhase%2520II%2520trial%2520of%2520the%2520CDK4%2520inhibitor%2520PD0332991%2520in%2520patients%2520with%2520advanced%2520CDK4-amplified%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2024%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">Use of isogenic human cancer cells for high-throughput screening and drug discovery</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=940-945&author=C.+J.+Torranceauthor=V.+Agrawalauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=Use+of+isogenic+human+cancer+cells+for+high-throughput+screening+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DAgrawal%26aufirst%3DV.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DUse%2520of%2520isogenic%2520human%2520cancer%2520cells%2520for%2520high-throughput%2520screening%2520and%2520drug%2520discovery%26jtitle%3DNat.%2520Biotechnol.%26date%3D2001%26volume%3D19%26spage%3D940%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winslow, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magendantz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolliday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span> </span><span class="NLM_article-title">Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">8773</span><span class="NLM_x">–</span> <span class="NLM_lpage">8778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8773-8778&author=A.+T.+Shawauthor=M.+M.+Winslowauthor=M.+Magendantzauthor=C.+Ouyangauthor=J.+Dowdleauthor=A.+Subramanianauthor=T.+A.+Lewisauthor=R.+L.+Maglathinauthor=N.+Tollidayauthor=T.+Jacks&title=Selective+killing+of+K-ras+mutant+cancer+cells+by+small+molecule+inducers+of+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DWinslow%26aufirst%3DM.%2BM.%26aulast%3DMagendantz%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DC.%26aulast%3DDowdle%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DT.%2BA.%26aulast%3DMaglathin%26aufirst%3DR.%2BL.%26aulast%3DTolliday%26aufirst%3DN.%26aulast%3DJacks%26aufirst%3DT.%26atitle%3DSelective%2520killing%2520of%2520K-ras%2520mutant%2520cancer%2520cells%2520by%2520small%2520molecule%2520inducers%2520of%2520oxidative%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D8773%26epage%3D8778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Yagoda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Rechenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaganjor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolpaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smukste, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessnick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=864-868&author=N.+Yagodaauthor=M.+von+Rechenbergauthor=E.+Zaganjorauthor=A.+J.+Bauerauthor=W.+S.+Yangauthor=D.+J.+Fridmanauthor=A.+J.+Wolpawauthor=I.+Smuksteauthor=J.+M.+Peltierauthor=J.+J.+Bonifaceauthor=R.+Smithauthor=S.+L.+Lessnickauthor=S.+Sahasrabudheauthor=B.+R.+Stockwell&title=RAS-RAF-MEK-dependent+oxidative+cell+death+involving+voltage-dependent+anion+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYagoda%26aufirst%3DN.%26aulast%3Dvon%2BRechenberg%26aufirst%3DM.%26aulast%3DZaganjor%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DFridman%26aufirst%3DD.%2BJ.%26aulast%3DWolpaw%26aufirst%3DA.%2BJ.%26aulast%3DSmukste%26aufirst%3DI.%26aulast%3DPeltier%26aufirst%3DJ.%2BM.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DSahasrabudhe%26aufirst%3DS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRAS-RAF-MEK-dependent%2520oxidative%2520cell%2520death%2520involving%2520voltage-dependent%2520anion%2520channels%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D864%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">649</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1016%2Fj.ejphar.2010.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20854805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=649&publication_year=2010&pages=51-58&author=W.+Guoauthor=X.+Weiauthor=S.+Wuauthor=L.+Wangauthor=H.+Pengauthor=J.+Wangauthor=B.+Fang&title=Antagonistic+effect+of+flavonoids+on+NSC-741909-mediated+antitumor+activity+via+scavenging+of+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species</span></div><div class="casAuthors">Guo, Wei; Wei, Xiaoli; Wu, Shuhong; Wang, Li; Peng, Henry; Wang, Ji; Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">649</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NSC-741909 (1-[(4-chlorophenyl)methyl]-1H-Indole-3-methanol) is a novel anticancer agent that is highly active against several NCI-60 cancer cell lines.  This agent induces sustained activation of mitogen-activated protein kinases (MAPK), including JNK and p38 MAP kinases.  However, the mechanisms of its selective antitumor activity in some cancer cell lines remain unknown.  We tested the combined effects of NSC-741909 and several kinase inhibitors that target the Raf/MEK/ERK1/2 or PI3K/AKT pathways in two sensitive lung cancer cells.  We found that PD98059 (2'-amino-3'-methoxyflavone), a flavone deriv. and a selective MEK inhibitor, can dramatically block the cell killing effect of NSC-741909.  To det. whether this inhibitory effect is assocd. with MEK inhibition or other mechanisms, we evaluated the effects of other MEK inhibitors with different chem. structures and flavone derivs. that do not have an effect on MEK.  We found that several flavonoids can markedly block NSC-741909-induced apoptosis and JNK activation in a time-dependent manner, regardless of whether they inhibit MEK or not.  In contrast, NSC-741909-induced JNK activation and apoptosis were not blocked by other MEK-specific inhibitors U0126 and CI1040.  Our results also showed that NSC-741909 induced a dramatic increase of reactive oxygen species in sensitive cells and that flavonoids effectively blocked the NSC-741909-induced reactive oxygen species prodn. which are assocd. with flavonoids antagonistic effects on NSC-741909-induced JNK activation and apoptosis.  Those results demonstrated that flavonoids-mediated antagonist effect is through scavenging of reactive oxygen species.  Our results may have implication on the design of clin. evaluation of antitumor activity of NSC-741909 or its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHaPky_XrXo7Vg90H21EOLACvtfcHk0lgu-RzpWs5sZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktbjM&md5=b4025b9029b51ee322cb58f6e67c8abc</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntagonistic%2520effect%2520of%2520flavonoids%2520on%2520NSC-741909-mediated%2520antitumor%2520activity%2520via%2520scavenging%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D649%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Oxidative stress in NSC-741909-induced apoptosis of cancer cells</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1186%2F1479-5876-8-37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=20398386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A280%3ADC%252BC3czjslakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=37&author=X.+Weiauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=P.+Huangauthor=J.+Liuauthor=B.+Fang&title=Oxidative+stress+in+NSC-741909-induced+apoptosis+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in NSC-741909-induced apoptosis of cancer cells</span></div><div class="casAuthors">Wei Xiaoli; Guo Wei; Wu Shuhong; Wang Li; Huang Peng; Liu Jinsong; Fang Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  NSC-741909 is a novel anticancer agent that can effectively suppress the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers.  We recently showed that NSC-741909-induced antitumor activity is associated with sustained Jun N-terminal kinase (JNK) activation, resulting from suppression of JNK dephosphorylation associated with decreased protein levels of MAPK phosphatase-1.  However, the mechanisms of NSC-741909-induced antitumor activity remain unclear.  Because JNK is frequently activated by oxidative stress in cells, we hypothesized that reactive oxygen species (ROS) may be involved in the suppression of JNK dephosphorylation and the cytotoxicity of NSC-741909.  METHODS:  The generation of ROS was measured by using the cell-permeable nonfluorescent compound H2DCF-DA and flow cytometry analysis.  Cell viability was determined by sulforhodamine B assay.  Western blot analysis, immunofluorescent staining and flow cytometry assays were used to determine apoptosis and molecular changes induced by NSC-741909.  RESULTS:  Treatment with NSC-741909 induced robust ROS generation and marked MAPK phosphatase-1 and -7 clustering in NSC-741909-sensitive, but not resistant cell lines, in a dose- and time-dependent manner.  The generation of ROS was detectable as early as 30 min and ROS levels were as high as 6- to 8-fold above basal levels after treatment.  Moreover, the NSC-741909-induced ROS generation could be blocked by pretreatment with antioxidants, such as nordihydroguaiaretic acid, aesculetin, baicalein, and caffeic acid, which in turn, inhibited the NSC-741909-induced JNK activation and apoptosis.  CONCLUSION:  Our results demonstrate that the increased ROS production was associated with NSC-741909-induced antitumor activity and that ROS generation and subsequent JNK activation is one of the primary mechanisms of NSC-741909-mediated antitumor cell activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5uKg0iJiIOP_I8Jvzw4xCfW6udTcc2eYxiAcTd9XeELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czjslakug%253D%253D&md5=2764d03fa3d1c25a6e5b47beb9ce4ad3</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-8-37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-8-37%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DOxidative%2520stress%2520in%2520NSC-741909-induced%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2010%26volume%3D8%26spage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Interruption of RNA processing machinery by a small compound 1-[(4-chlorophenyl)methyl]-1<i>H</i>-indole-3-carboxaldehyde (oncrasin-1)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm500415t&amp;key=10.1158%2F1535-7163.MCT-08-0839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm500415t&amp;key=19208825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm500415t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=441-448&author=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=R.+Wangauthor=L.+Weiauthor=J.+Liuauthor=B.+Fang&title=Interruption+of+RNA+processing+machinery+by+a+small+compound+1-%5B%284-chlorophenyl%29methyl%5D-1H-indole-3-carboxaldehyde+%28oncrasin-1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)</span></div><div class="casAuthors">Guo, Wei; Wu, Shuhong; Wang, Li; Wang, Rui-Yu; Wei, Xiaoli; Liu, Jinsong; Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein kinase Cι (PKCι) is activated by oncogenic Ras proteins and is required for K-Ras-induced transformation and colonic carcinogenesis in vivo.  However, the role of PKCι in signal transduction and oncogenesis is not clear.  We recently identified a small mol., designated 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1), that can selectively kill K-Ras mutant cancer cells and induce abnormal nuclear aggregation of PKCι in sensitive cells but not in resistant cells.  To det. the causes and biol. consequences of PKCι aggregates in the nucleus, we analyzed the effect of oncrasin-1 on proteins involved in DNA repair and RNA processing.  Our results showed that oncrasin-1 treatment led to co-aggregation of PKCι and splicing factors into mega-spliceosomes but had no obvious effects on the DNA repair mol. Rad51.  Moreover, oncrasin-1 treatment suppressed the phosphorylation of the largest subunit of RNA polymerase II and the expression of intron-less reporter genes in sensitive cells but not in resistant cells, suggesting that suppression of RNA transcription is a major effect of oncrasin-1 treatment.  Studies with cultured cells or with recombinant proteins showed that oncrasin-1 can disrupt the interaction of PKCι and cyclin-dependent protein kinase 9/cyclin T1 complex, which is known to phosphorylate the largest subunit of RNA polymerase II and is required for RNA transcription.  Together, our results suggest that oncrasin-1 suppresses the function of RNA processing machinery and that PKCι might be involved in the biol. function of RNA processing complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTkzIuYMfNPLVg90H21EOLACvtfcHk0lgu-RzpWs5sZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFamsbg%253D&md5=282a8af2e04fe0ffd70bc416d6002201</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0839%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DInterruption%2520of%2520RNA%2520processing%2520machinery%2520by%2520a%2520small%2520compound%25201-%255B%25284-chlorophenyl%2529methyl%255D-1H-indole-3-carboxaldehyde%2520%2528oncrasin-1%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D441%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e28487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e28487&author=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=X.+Weiauthor=X.+Liuauthor=J.+Wangauthor=Z.+Luauthor=M.+Hollingsheadauthor=B.+Fang&title=Antitumor+activity+of+a+novel+oncrasin+analogue+is+mediated+by+JNK+activation+and+STAT3+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520novel%2520oncrasin%2520analogue%2520is%2520mediated%2520by%2520JNK%2520activation%2520and%2520STAT3%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De28487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymach, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swisher, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1456-1464&author=X.+Liuauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=J.+Wangauthor=B.+Daiauthor=E.+S.+Kimauthor=J.+V.+Heymachauthor=M.+Wangauthor=L.+Girardauthor=J.+Minnaauthor=J.+A.+Rothauthor=S.+G.+Swisherauthor=B.+Fang&title=Antitumor+activity+of+a+novel+STAT3+inhibitor+and+redox+modulator+in+non-small+cell+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DSwisher%26aufirst%3DS.%2BG.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520novel%2520STAT3%2520inhibitor%2520and%2520redox%2520modulator%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1456%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Jaspers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersbergen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sol, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drost, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wientjens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doroshow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottenberg, S.</span><span> </span><span class="NLM_article-title">Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=68-81&author=J.+E.+Jaspersauthor=A.+Kersbergenauthor=U.+Boonauthor=W.+Solauthor=D.+L.+vanauthor=S.+A.+Zanderauthor=R.+Drostauthor=E.+Wientjensauthor=J.+Jiauthor=A.+Alyauthor=J.+H.+Doroshowauthor=A.+Cranstonauthor=N.+M.+Martinauthor=A.+Lauauthor=M.+J.+O%E2%80%99Connorauthor=S.+Ganesanauthor=P.+Borstauthor=J.+Jonkersauthor=S.+Rottenberg&title=Loss+of+53BP1+causes+PARP+inhibitor+resistance+in+Brca1-mutated+mouse+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaspers%26aufirst%3DJ.%2BE.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DSol%26aufirst%3DW.%26aulast%3Dvan%26aufirst%3DD.%2BL.%26aulast%3DZander%26aufirst%3DS.%2BA.%26aulast%3DDrost%26aufirst%3DR.%26aulast%3DWientjens%26aufirst%3DE.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DAly%26aufirst%3DA.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DGanesan%26aufirst%3DS.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DRottenberg%26aufirst%3DS.%26atitle%3DLoss%2520of%252053BP1%2520causes%2520PARP%2520inhibitor%2520resistance%2520in%2520Brca1-mutated%2520mouse%2520mammary%2520tumors%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">16948</span><span class="NLM_x">–</span> <span class="NLM_lpage">16955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16948-16955&author=X.+Weiauthor=W.+Guoauthor=S.+Wuauthor=L.+Wangauthor=Y.+Luauthor=B.+Xuauthor=J.+Liuauthor=B.+Fang&title=Inhibiting+JNK+dephosphorylation+and+induction+of+apoptosis+by+novel+anticancer+agent+NSC-741909+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DInhibiting%2520JNK%2520dephosphorylation%2520and%2520induction%2520of%2520apoptosis%2520by%2520novel%2520anticancer%2520agent%2520NSC-741909%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16948%26epage%3D16955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span> </span><span class="NLM_article-title">Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2668</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101417n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2668-2679&author=S.+Wuauthor=L.+Wangauthor=W.+Guoauthor=X.+Liuauthor=J.+Liuauthor=X.+Weiauthor=B.+Fang&title=Analogues+and+derivatives+of+oncrasin-1%2C+a+novel+inhibitor+of+the+C-terminal+domain+of+RNA+polymerase+II+and+their+antitumor+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm101417n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101417n%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DB.%26atitle%3DAnalogues%2520and%2520derivatives%2520of%2520oncrasin-1%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520C-terminal%2520domain%2520of%2520RNA%2520polymerase%2520II%2520and%2520their%2520antitumor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2668%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500415t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm500415t%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500415t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679955178d02d1f3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
